{
  "questions": [
    {
      "body": "Proteomic analyses need prior knowledge of the organism complete genome. Is the complete genome of the bacteria of the genus Arthrobacter available?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28904741",
        "http://www.ncbi.nlm.nih.gov/pubmed/28450506",
        "http://www.ncbi.nlm.nih.gov/pubmed/21677849",
        "http://www.ncbi.nlm.nih.gov/pubmed/28315371",
        "http://www.ncbi.nlm.nih.gov/pubmed/23039946",
        "http://www.ncbi.nlm.nih.gov/pubmed/28642378",
        "http://www.ncbi.nlm.nih.gov/pubmed/28138355"
      ],
      "ideal_answer": [
        "Yes, the complete genome sequence of Arthrobacter (two strains) is deposited in GenBank."
      ],
      "exact_answer": "yes",
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001173",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016678"
      ],
      "type": "yesno",
      "id": "51593dc8d24251bc05000099",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 80,
          "text": "Complete genome sequence of Arthrobacter phenanthrenivorans type strain (Sphe3).",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21677849",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 111,
          "text": "Complete genome sequence and metabolic potential of the quinaldine-degrading bacterium Arthrobacter sp. Rue61a.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23039946",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 278,
          "offsetInEndSection": 387,
          "text": "Here, we described the high quality draft genome sequence, annotations and the features ofArthrobactersp. B6.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28138355",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 118,
          "text": "Complete genome sequence of Arthrobacter sp. ZXY-2 associated with effective atrazine degradation and salt adaptation.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28315371",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 206,
          "text": "We announce here the draft genome sequence ofArthrobactersp. strain EpSL27, isolated from the stem and leaves of the medicinal plantEchinacea purpureaand able to inhibit human-pathogenic bacterial strains. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28642378",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "We report here the 4.6-Mb genome sequence of a nylon oligomer-degrading bacterium,Arthrobactersp. strain KI72.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28450506",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 287,
          "text": "Arthrobacter alpinusR3.8 is a psychrotolerant bacterial strain isolated from a soil sample obtained at Rothera Point, Adelaide Island, close to the Antarctic Peninsula. Strain R3.8 was sequenced in order to help discover potential cold active enzymes with biotechnological applications. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28904741",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is pregnancy an additional risk during during H1N1 infection?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22901103",
        "http://www.ncbi.nlm.nih.gov/pubmed/22551713",
        "http://www.ncbi.nlm.nih.gov/pubmed/22782418",
        "http://www.ncbi.nlm.nih.gov/pubmed/22482974",
        "http://www.ncbi.nlm.nih.gov/pubmed/22851818",
        "http://www.ncbi.nlm.nih.gov/pubmed/20148081",
        "http://www.ncbi.nlm.nih.gov/pubmed/24051575",
        "http://www.ncbi.nlm.nih.gov/pubmed/22515877",
        "http://www.ncbi.nlm.nih.gov/pubmed/22859826",
        "http://www.ncbi.nlm.nih.gov/pubmed/22331165",
        "http://www.ncbi.nlm.nih.gov/pubmed/22564554",
        "http://www.ncbi.nlm.nih.gov/pubmed/21596080",
        "http://www.ncbi.nlm.nih.gov/pubmed/21756329",
        "http://www.ncbi.nlm.nih.gov/pubmed/20531946",
        "http://www.ncbi.nlm.nih.gov/pubmed/20100064",
        "http://www.ncbi.nlm.nih.gov/pubmed/21913391",
        "http://www.ncbi.nlm.nih.gov/pubmed/22411229",
        "http://www.ncbi.nlm.nih.gov/pubmed/19643469",
        "http://www.ncbi.nlm.nih.gov/pubmed/21252793",
        "http://www.ncbi.nlm.nih.gov/pubmed/22030045",
        "http://www.ncbi.nlm.nih.gov/pubmed/23116790",
        "http://www.ncbi.nlm.nih.gov/pubmed/22272853",
        "http://www.ncbi.nlm.nih.gov/pubmed/22120858"
      ],
      "ideal_answer": [
        "Pregnant women are at increased risk for complications from pandemic influenza H1N1 virus infection. Pregnant women, because of their altered immunity and physiological adaptations, are at higher risk of developing pulmonary complications, especially in the second and third trimesters. Pregnancy, particularly during the third trimester, increases the risk of complications and early antiviral treatment is associated with improved outcomes."
      ],
      "exact_answer": "yes",
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018566",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D053118",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012306",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D011247"
      ],
      "type": "yesno",
      "id": "531a3fe3b166e2b806000038",
      "snippets": [
        {
          "offsetInBeginSection": 495,
          "offsetInEndSection": 566,
          "text": "H1N1 influenza in pregnancy can be associated with severe complications",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20148081",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1461,
          "offsetInEndSection": 1560,
          "text": "This case series confirms a high number of complications in pregnant women due to pandemic H1N1/09.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20100064",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1841,
          "offsetInEndSection": 1936,
          "text": "Pregnant women might be at increased risk for complications from pandemic H1N1 virus infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19643469",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1491,
          "offsetInEndSection": 1592,
          "text": "Pregnant women are at increased risk for complications from pandemic influenza H1N1 virus infection. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22030045",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1458,
          "offsetInEndSection": 1756,
          "text": "Vaccination of pregnant women against influenza A (H1N1) by Russian subunit formulation (MonoGrippol plus) showed reactogenicity comparable to control group by the level of influence on general metabolic and immunologic homeostasis and on the course of pregnancy, which is an evidence of its safety",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21913391",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 145,
          "offsetInEndSection": 284,
          "text": "Pregnancy was identified as a major risk factor for increased mortality and morbidity due to H1N1 influenza in the pandemic of 2009 to 2010",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21756329",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 940,
          "offsetInEndSection": 1285,
          "text": "While it is not possible to ascertain retrospectively if myocarditis was caused by either infection with H1N1 virus or as a result of pregnancy (in the absence of endomyocardial biopsies), the significant association with myocardial involvement in both women demonstrates the increased risk of exposure to H1N1 influenza virus in pregnant women.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21756329",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1664,
          "offsetInEndSection": 1940,
          "text": "Although limited in size, the fully prospective nature of the safety follow-up of these women vaccinated during pregnancy is unique and offers an important degree of reassurance for the use of the AS03 adjuvanted H1N1 (2009) vaccine in this high risk group for H1N1 infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21596080",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 117,
          "offsetInEndSection": 320,
          "text": "During the H1N1 2009 pandemic, pregnant women constituted one of the priority groups for vaccination in many countries, creating a need for close monitoring of the safety of the vaccine in pregnant women",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21596080",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 154,
          "text": "Emerging data suggest that pregnancy conveys high risk for severe complications from the 2009 pandemic influenza A virus (2009 H1N1) infection",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21252793",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 199,
          "text": "Pregnant women have been identified as a group at risk, both for respiratory complications than for the admissions to the Intensive Care Unit (ICU) during the 2009 H1N1 influenza pandemic",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20531946",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1567,
          "offsetInEndSection": 1681,
          "text": "This report mitigates substantially the presumed severity of pandemic H1N1/09 influenza infection during pregnancy",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20531946",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1105,
          "offsetInEndSection": 1230,
          "text": "The results of our study do not indicate a risk for the pregnant woman and the developing embryo/fetus after H1N1 vaccination",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22564554",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1529,
          "offsetInEndSection": 1704,
          "text": "This large cohort study found no evidence of an increased risk of fetal death associated with exposure to an adjuvanted pandemic A/H1N1 2009 influenza vaccine during pregnancy",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22551713",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1006,
          "offsetInEndSection": 1158,
          "text": "Our results suggest that second- or third-trimester H1N1 vaccination was associated with improved fetal and neonatal outcomes during the recent pandemic",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22515877",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 146,
          "offsetInEndSection": 278,
          "text": "Pregnant women might thus be at increased risk of complications from pandemic H1N1 virus infection, and illness may progress rapidly",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22482974",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1258,
          "offsetInEndSection": 1332,
          "text": "Pregnant women with H1N1 infection seem to benefit from antiviral therapy.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22482974",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 755,
          "offsetInEndSection": 863,
          "text": "arly identification and treatment were the most important factors in different countries and areas examined.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22411229",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 864,
          "offsetInEndSection": 1013,
          "text": "The vaccine and antiviral drugs that have been the most efficient means to control the novel virus appear to be safe but require more extensive study",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22411229",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 822,
          "offsetInEndSection": 987,
          "text": "However, there were significant differences between the two groups in relation to mean age, treatment with oseltamivir, schooling, and presence of other risk factors",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22331165",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 128,
          "offsetInEndSection": 286,
          "text": "To investigate whether exposure to an adjuvanted influenza A(H1N1)pdm09 vaccine during pregnancy was associated with increased risk of adverse fetal outcomes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22782418",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2168,
          "offsetInEndSection": 2386,
          "text": "In this Danish cohort, exposure to an adjuvanted influenza A(H1N1)pdm09 vaccine during pregnancy was not associated with a significantly increased risk of major birth defects, preterm birth, or fetal growth restriction",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22782418",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 641,
          "offsetInEndSection": 755,
          "text": "Most people affected by the virus, including pregnant women, suffer a mild viral illness, and make a full recovery",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22851818",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1032,
          "offsetInEndSection": 1216,
          "text": "Pregnant women, because of their altered immunity and physiological adaptations, are at higher risk of developing pulmonary complications, especially in the second and third trimesters",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22851818",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1491,
          "offsetInEndSection": 1678,
          "text": "The pregnancy outcomes were also poor for women who were affected by the virus with a fivefold increase in the perinatal mortality rate and threefold increase in the preterm delivery rate",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22851818",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 13,
          "offsetInEndSection": 249,
          "text": "regnant women were at increased risk for serious outcomes of 2009 pandemic influenza A virus subtype H1N1 (influenza A[H1N1]pdm09) infection, but little is known about the overall impact of the pandemic on neonatal and maternal outcomes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22859826",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1572,
          "offsetInEndSection": 1700,
          "text": "In this large, geographically diverse population, A(H1N1)pdm09 infection increased the risk for hospitalization during pregnancy",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22859826",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1358,
          "offsetInEndSection": 1582,
          "text": "Vaccination during pregnancy with Pandemrix(\u00ae) appeared to have no ill effects on the pregnancy. On the contrary, the rate of preterm birth and low birthweight was lower than expected, which agrees with some previous results",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22901103",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 475,
          "offsetInEndSection": 745,
          "text": "During the influenza A(H1N1)pmd09 pandemic, although many cases occurred in younger adults, the risk factors identified for severe infections and complications were similar to those for seasonal influenza, including chronic respiratory, renal, liver, and heart diseases.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23116790",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1110,
          "offsetInEndSection": 1228,
          "text": "In terms of pregnancy, the studies have shown contradictory results due to variations in methodology and medical care.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23116790",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1229,
          "offsetInEndSection": 1413,
          "text": "However, it seems that pregnancy, particularly during the third trimester, increases the risk of complications, and that early antiviral treatment is associated with improved outcomes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23116790",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 903,
          "offsetInEndSection": 1024,
          "text": "Pregnant women with mild clinical illness secondary to 2009 H1N1 were not at a greater risk of adverse pregnancy outcomes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24051575",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1026,
          "offsetInEndSection": 1098,
          "text": "However, severely infected women were more likely to deliver SGA infants",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24051575",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1852,
          "offsetInEndSection": 1984,
          "text": "Gestational age is associated with the risk of developing critical infection. The risk increases with increasing weeks of gestation.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22120858",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 67,
          "offsetInEndSection": 205,
          "text": " Following the start of winter in Liaoning province in China, the number of pregnant women infected with influenza increased significantly",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22120858",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 236,
          "text": "regnancy, with or without additional complications, constitutes a high-risk condition for complications of influenza infection and warrants early intervention with neuraminidase inhibitors such as oseltamivir, if influenza is suspected",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22272853",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which antibiotics target peptidoglycan biosynthesis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/9210483",
        "http://www.ncbi.nlm.nih.gov/pubmed/10801476",
        "http://www.ncbi.nlm.nih.gov/pubmed/12440876",
        "http://www.ncbi.nlm.nih.gov/pubmed/21091161",
        "http://www.ncbi.nlm.nih.gov/pubmed/22280885",
        "http://www.ncbi.nlm.nih.gov/pubmed/8891144",
        "http://www.ncbi.nlm.nih.gov/pubmed/21867549",
        "http://www.ncbi.nlm.nih.gov/pubmed/11751110",
        "http://www.ncbi.nlm.nih.gov/pubmed/2334153",
        "http://www.ncbi.nlm.nih.gov/pubmed/7590155",
        "http://www.ncbi.nlm.nih.gov/pubmed/25224006",
        "http://www.ncbi.nlm.nih.gov/pubmed/20515462",
        "http://www.ncbi.nlm.nih.gov/pubmed/7793878",
        "http://www.ncbi.nlm.nih.gov/pubmed/18558445",
        "http://www.ncbi.nlm.nih.gov/pubmed/12197711",
        "http://www.ncbi.nlm.nih.gov/pubmed/22815801",
        "http://www.ncbi.nlm.nih.gov/pubmed/16832063"
      ],
      "ideal_answer": [
        "Under some conditions, both ramoplanin and vancomycin probes produce helicoid staining patterns along the cylindrical walls of B. subtilis cells. This work has implications for the design of ramoplanin derivatives and may influence how other proposed substrate binding antibiotics are studied. This was confirmed by in vitro studies involving a wall-membrane particulate fraction from Gaffkya homari in which peptidoglycan synthesis from UDP-MurNAc-tetrapeptide was inhibited by ramoplanin but not by vancomycin. New results support a two-state model for septal and peripheral PG synthesis at mid-cell, involvement of essential cell division proteins in PG remodeling, and mid-cell localization of proteins that organize PG biosynthesis and that form the protein translocation apparatus.",
        "Antibiotics which inhibit bacterial peptidoglycan biosynthesis are the most widely used in current clinical practice. Cells treated with ampicillin, D-cycloserine, or fosfomycin had only one chloroplast after cell division, suggesting that the cells divided without chloroplast division. The antibiotics bacitracin and vancomycin showed no obvious effect. Colchicine inhibits Closterium cell elongation after division.  Surprisingly, also cinnamycin of Streptomyces cinnamoneus cinnamoneus), previously known to bind specifically to phosphatidylethanolamin of biological membranes, provoked strong cell wall biosynthetic stress. Other substances include fluorescent derivatives of two PG-binding antibiotics, vancomycin and ramoplanin. The muraymycins constitute a new antibiotic family whose core structure contains a glycosylated uronic acid derivative joined by an aminopropane group to a hexahydro-2-imino-4-pyrimidylglycyl residue (epicapreomycidine) containing dipeptide that is further extended by a urea-valine moiety. The muraymycins inhibited peptidoglycan biosynthesis. Ramoplanin is a cyclicdepsipeptide antibiotic that inhibits peptidoglycan biosynthesis. The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. Ramoplanin, a new lipoglycopeptide antibiotic, inhibits cell wall peptidoglycan biosynthesis in gram-positive bacteria."
      ],
      "exact_answer": [
        [
          "colchicine"
        ],
        [
          "fosfomycin"
        ],
        [
          "bacitracin"
        ],
        [
          "vancomycin"
        ],
        [
          "D-cycloserine",
          "seromycin"
        ],
        [
          "ampicillin"
        ],
        [
          "cinnamycin"
        ],
        [
          "ramoplanin"
        ],
        [
          "muraymycin"
        ],
        [
          "mersacidin"
        ]
      ],
      "type": "list",
      "id": "571529efcb4ef8864c000001",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 128,
          "text": "Treatment with antibiotics that interfere with peptidoglycan biosynthesis inhibits chloroplast division in the desmid Closterium",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22815801",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 247,
          "offsetInEndSection": 360,
          "text": "To detect cells just after division, we used colchicine, which inhibits Closterium cell elongation after division",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22815801",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 618,
          "offsetInEndSection": 685,
          "text": "The antibiotics bacitracin and vancomycin showed no obvious effect.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22815801",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 448,
          "offsetInEndSection": 616,
          "text": "cells treated with ampicillin, D-cycloserine, or fosfomycin had only one chloroplast after cell division, suggesting that the cells divided without chloroplast division",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22815801",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 67,
          "offsetInEndSection": 245,
          "text": "We investigated the effects of antibiotics that interfere with peptidoglycan biosynthesis on chloroplast division in the desmid Closterium peracerosum-strigosum-littorale complex",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22815801",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 105,
          "text": "Recent advances in pneumococcal peptidoglycan biosynthesis suggest new vaccine and antimicrobial targets.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22280885",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 418,
          "offsetInEndSection": 657,
          "text": "Of late, the peptidoglycan (PG) layer, the most important component of the bacterial cell wall has been the subject of drug targeting because, first, it is essential for the survivability of eubacteria and secondly, it is absent in humans.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21091161",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 129,
          "text": "Antibiotics which inhibit bacterial peptidoglycan biosynthesis are the most widely used in current clinical practice.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21867549",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1587,
          "offsetInEndSection": 1710,
          "text": "A dose-response experiment with an E. coli strain susceptible to ampicillin demonstrated a weak effect before the MIC dose.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21867549",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1245,
          "offsetInEndSection": 1408,
          "text": " In an initial approach, the procedure accurately discriminates susceptible, intermediate and resistant strains of Escherichia coli to amoxicillin/clavulanic acid.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21867549",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1047,
          "offsetInEndSection": 1255,
          "text": "Surprisingly, also cinnamycin of Streptomyces cinnamoneus cinnamoneus), previously known to bind specifically to phosphatidylethanolamin of biological membranes, provoked strong cell wall biosynthetic stress.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18558445",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 571,
          "offsetInEndSection": 727,
          "text": "Here, we compare the staining patterns observed in Bacillus subtilis using fluorescent derivatives of two PG-binding antibiotics, vancomycin and ramoplanin.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16832063",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 879,
          "offsetInEndSection": 1061,
          "text": "Ramoplanin probes may be better imaging agents than vancomycin probes because they yield clear staining patterns at concentrations well below their minimum inhibitory concentrations.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16832063",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 75,
          "text": "Structures of the muraymycins, novel peptidoglycan biosynthesis inhibitors.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12197711",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 315,
          "offsetInEndSection": 605,
          "text": "The muraymycins constitute a new antibiotic family whose core structure contains a glycosylated uronic acid derivative joined by an aminopropane group to a hexahydro-2-imino-4-pyrimidylglycyl residue (epicapreomycidine) containing dipeptide that is further extended by a urea-valine moiety.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12197711",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 742,
          "offsetInEndSection": 796,
          "text": "The muraymycins inhibited peptidoglycan biosynthesis. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12197711",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 97,
          "text": "Rethinking ramoplanin: the role of substrate binding in inhibition of peptidoglycan biosynthesis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12440876",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 87,
          "text": "Ramoplanin is a cyclicdepsipeptide antibiotic that inhibits peptidoglycan biosynthesis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12440876",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 87,
          "text": "Vancomycin binds to bacterial cell-wall intermediates to achieve its antibiotic effect.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10801476",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 98,
          "text": "The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9210483",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "The lantibiotic mersacidin has been previously reported to interfere with bacterial peptidoglycan biosynthesis",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9210483",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 225,
          "offsetInEndSection": 454,
          "text": "Here, we focus on the target reaction and describe a mersacidin-induced accumulation of UDP-N-acetylmuramoyl-pentapeptide, indicating that inhibition of peptidoglycan synthesis occurs after the formation of cytoplasmic precursors",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9210483",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1099,
          "offsetInEndSection": 1430,
          "text": "The analogy to the glycopeptides may hint at an interaction of mersacidin with the peptidoglycan precursor rather than with the enzyme. Unlike vancomycin however, mersacidin inhibits peptidoglycan formation from UDP-N-acetylmuramoyl-tripeptide and is active against Enterococcus faecium expressing the vanA resistance gene cluster.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9210483",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 134,
          "text": "Inhibition of peptidoglycan biosynthesis in vancomycin-susceptible and -resistant bacteria by a semisynthetic glycopeptide antibiotic.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8891144",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 449,
          "text": "LY191145 is a p-chlorobenzyl derivative of LY264826 (A82846B) with activity against both vancomycin-susceptible and -resistant enterococci. Incorporation of L-[14C]lysine into peptidoglycan of intact vancomycin-susceptible and -resistant Enterococcus faecium was inhibited by LY191145 (50% inhibitory concentrations of 1 and 5 microgram/ml, respectively). Inhibition was accompanied by accumulation of UDP-muramyl-peptide precursors in the cytoplasm",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8891144",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1102,
          "offsetInEndSection": 1397,
          "text": "The fact that inhibition of peptidoglycan biosynthesis by LY191145 was not readily antagonized by an excess of free acyl-D-alanyl-D-alanine or acyl-D-alanyl-D-lactate ligands indicates that the manner in which this compound inhibits transglycosylation may not be identical to that of vancomycin.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8891144",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 851,
          "offsetInEndSection": 980,
          "text": "Comparison with tunicamycin-treated cells indicated that peptidoglycan rather than teichoic acid metabolism is primarily affected",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7793878",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 982,
          "offsetInEndSection": 1076,
          "text": "Mersacidin caused the excretion of a putative cell wall precursor into the culture supernatant",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7793878",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 109,
          "text": "Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism?",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7793878",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 267,
          "text": "Mersacidin is an antibiotic peptide produced by Bacillus sp. strain HIL Y-85,54728 that belongs to the group of lantibiotics. Its activity in vivo against methicillin-resistant Staphylococcus aureus strains compares with that of the glycopeptide antibiotic vancomycin",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7793878",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 413,
          "offsetInEndSection": 521,
          "text": "Incubation of Staphylococcus simulans 22 with mersacidin resulted in the cessation of growth and slow lysis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7793878",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1213,
          "offsetInEndSection": 1437,
          "text": "n contrast to vancomycin, the activity of mersacidin was not antagonized by the tripeptide diacetyl-L-Lys-D-Ala-D-Ala, indicating that on the molecular level its mode of action differs from those of glycopeptide antibiotics.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7793878",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 55,
          "text": "Inhibition of peptidoglycan biosynthesis by ramoplanin.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2334153",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 119,
          "text": "Ramoplanin, a new lipoglycopeptide antibiotic, inhibits cell wall peptidoglycan biosynthesis in gram-positive bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2334153",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 196,
          "text": "Bacitracin and other antibiotics that inhibit late stages in peptidoglycan biosynthesis induce vancomycin resistance in a high-level, inducibly vancomycin-resistant strain of Enterococcus faecium.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7590155",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1632,
          "offsetInEndSection": 1814,
          "text": "This effect does not involve a change in the permeability of the cell wall by this drug and is consistent with the identification of D-alanine racemase as a target of D-cycloserine. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11751110",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1217,
          "offsetInEndSection": 1459,
          "text": "CONCLUSIONS: Several pathways and genes downregulated by fosfomycin have been identified, in contrast to previously described cell wall active antibiotics, and was explained by starvation response induced by phosphoenolpyruvate accumulation. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20515462",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 994,
          "offsetInEndSection": 1092,
          "text": "The target pathway - peptidoglycan biosynthesis - was upregulated following fosfomycin treatment. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20515462",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 120,
          "text": "Ramoplanin, a new lipoglycopeptide antibiotic, inhibits cell wall peptidoglycan biosynthesis in gram-positive bacteria. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2334153",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 213,
          "text": "Fosfomycin inhibited the first enzymatic step of peptidoglycan synthesis, which was followed by decreased levels of peptidoglycan precursors but enhanced levels of substrates such as UDP-GlcNAc and alanine-alanine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25224006",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 119,
          "text": "In contrast, vancomycin and ampicillin inhibited the last stage of peptidoglycan construction on the outer cell surface.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25224006",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 975,
          "offsetInEndSection": 1197,
          "text": "The target pathway - peptidoglycan biosynthesis - was upregulated following fosfomycin treatment. Modulation of transport processes, cofactor biosynthesis, energy metabolism and nucleic acid biosynthesis was also observed.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20515462",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 120,
          "text": "Ramoplanin, a new lipoglycopeptide antibiotic, inhibits cell wall peptidoglycan biosynthesis in gram-positive bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2334153",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Are stress granules involved in the pathogenesis of Amyotrophic Lateral Sclerosis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23474818",
        "http://www.ncbi.nlm.nih.gov/pubmed/24297750",
        "http://www.ncbi.nlm.nih.gov/pubmed/24013423",
        "http://www.ncbi.nlm.nih.gov/pubmed/23257289",
        "http://www.ncbi.nlm.nih.gov/pubmed/24312274",
        "http://www.ncbi.nlm.nih.gov/pubmed/23629963",
        "http://www.ncbi.nlm.nih.gov/pubmed/21173160",
        "http://www.ncbi.nlm.nih.gov/pubmed/20699327",
        "http://www.ncbi.nlm.nih.gov/pubmed/25429138",
        "http://www.ncbi.nlm.nih.gov/pubmed/20674093",
        "http://www.ncbi.nlm.nih.gov/pubmed/26557057",
        "http://www.ncbi.nlm.nih.gov/pubmed/20606625",
        "http://www.ncbi.nlm.nih.gov/pubmed/24920614",
        "http://www.ncbi.nlm.nih.gov/pubmed/24090136",
        "http://www.ncbi.nlm.nih.gov/pubmed/22405725",
        "http://www.ncbi.nlm.nih.gov/pubmed/25888396",
        "http://www.ncbi.nlm.nih.gov/pubmed/24336168",
        "http://www.ncbi.nlm.nih.gov/pubmed/25216585",
        "http://www.ncbi.nlm.nih.gov/pubmed/23152885",
        "http://www.ncbi.nlm.nih.gov/pubmed/19765185"
      ],
      "ideal_answer": [
        "Stress granules are cytoplasmic inclusions that repress translation of a subset of RNAs in times of cellular stress, and several proteins implicated in neurodegeneration (i.e. Ataxin-2 and SMN) interact with stress granules. Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. ALS-linked mutations in profilin 1 alter stress granule dynamics, providing further evidence for the potential role of stress granules in ALS pathogenesis. ALS mutations in FUS NLS can impair FUS nuclear localization, induce cytoplasmic inclusions and stress granules, and potentially perturb RNA metabolism.",
        "Yes, stress granules (SGs) have been linked to several pathologies including inflammatory diseases, cancer, viral infection, and neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)."
      ],
      "exact_answer": "yes",
      "concepts": [
        "http://amigo.geneontology.org/amigo/term/GO:0034063",
        "http://www.disease-ontology.org/api/metadata/DOID:332",
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000690",
        "http://amigo.geneontology.org/amigo/term/GO:0097165",
        "http://amigo.geneontology.org/amigo/term/GO:0035617"
      ],
      "type": "yesno",
      "id": "56c81fd15795f9a73e00000c",
      "snippets": [
        {
          "offsetInBeginSection": 333,
          "offsetInEndSection": 544,
          "text": "SGs have been linked to several pathologies including inflammatory diseases, cancer, viral infection, and neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26557057",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 534,
          "offsetInEndSection": 624,
          "text": "Like several other ALS-associated proteins, CREST is recruited to induced stress granules.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25888396",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1234,
          "offsetInEndSection": 1453,
          "text": "Our data indicate that CREST and certain other ALS-linked proteins share several features implicated in ALS pathogenesis, namely the ability to aggregate, be recruited to stress granules and alter paraspeckle integrity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25888396",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 120,
          "offsetInEndSection": 250,
          "text": "A unifying feature of many proteins associated with ALS, including TDP-43 and ataxin-2, is that they localize to stress granules. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24336168",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 114,
          "offsetInEndSection": 292,
          "text": "Two RNA-binding proteins, TDP-43 and FUS, aggregate in the degenerating motor neurons of ALS patients, and mutations in the genes encoding these proteins cause some forms of ALS.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23629963",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 586,
          "offsetInEndSection": 796,
          "text": "Recent work connecting TDP-43 and FUS to stress granules has suggested how this cellular pathway, which involves protein aggregation as part of its normal function, might be coopted during disease pathogenesis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23629963",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 507,
          "text": "Amyotrophic lateral sclerosis (ALS)-linked fused in sarcoma/translocated in liposarcoma (FUS/TLS or FUS) is concentrated within cytoplasmic stress granules under conditions of induced stress. Since only the mutants, but not the endogenous wild-type FUS, are associated with stress granules under most of the stress conditions reported to date, the relationship between FUS and stress granules represents a mutant-specific phenotype and thus may be of significance in mutant-induced pathogenesis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24090136",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 586,
          "text": "Fused in sarcoma (FUS) belongs to the group of RNA-binding proteins implicated as underlying factors in amyotrophic lateral sclerosis (ALS) and certain other neurodegenerative diseases. Multiple FUS gene mutations have been linked to hereditary forms, and aggregation of FUS protein is believed to play an important role in pathogenesis of these diseases. In cultured cells, FUS variants with disease-associated amino acid substitutions or short deletions affecting nuclear localization signal (NLS) and causing cytoplasmic mislocalization can be sequestered into stress granules (SGs).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24013423",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 97,
          "text": "Profilin 1 associates with stress granules and ALS-linked mutations alter stress granule dynamics",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24920614",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1201,
          "offsetInEndSection": 1529,
          "text": "Here we report that profilin 1 and related protein profilin 2 are novel stress granule-associated proteins in mouse primary cortical neurons and in human cell lines and that ALS-linked mutations in profilin 1 alter stress granule dynamics, providing further evidence for the potential role of stress granules in ALS pathogenesis",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24920614",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 655,
          "offsetInEndSection": 897,
          "text": "Furthermore, in response to oxidative stress or heat shock conditions in cultures and in vivo, the ALS-linked FUS mutants, but not wild-type FUS, assembled into perinuclear stress granules in proportion to their cytoplasmic expression levels.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20699327",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 94,
          "text": "Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20699327",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 969,
          "offsetInEndSection": 1150,
          "text": "Our results suggest that the ALS mutations in FUS NLS can impair FUS nuclear localization, induce cytoplasmic inclusions and stress granules, and potentially perturb RNA metabolism.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20674093",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 173,
          "text": "RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23257289",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 180,
          "text": "TDP-43 is an RNA-binding protein linked to amyotrophic lateral sclerosis (ALS) that is known to regulate the splicing, transport, and storage of specific mRNAs into stress granules",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25429138",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 246,
          "text": "In amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration, TAR DNA binding protein 43 (TDP-43) accumulates in the cytoplasm of affected neurons and glia, where it associates with stress granules (SGs) and forms large inclusions",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24312274",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 190,
          "text": "Amyotrophic lateral sclerosis (ALS)-linked fused in sarcoma/translocated in liposarcoma (FUS/TLS or FUS) is concentrated within cytoplasmic stress granules under conditions of induced stress",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24090136",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 93,
          "text": "Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20699327",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 650,
          "offsetInEndSection": 793,
          "text": "Mutations in Fus cause amyotrophic lateral sclerosis (ALS) and the mutant protein forms inclusions that appear to correspond to stress granules",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24297750",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 327,
          "offsetInEndSection": 474,
          "text": "Recent work also suggests that TDP-43 associates with cytoplasmic stress granules, which are transient structures that form in response to stress. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21173160",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 376,
          "offsetInEndSection": 605,
          "text": "We found that in response to oxidative stress and to environmental insults of different types TDP-43 is capable to assemble into stress granules (SGs), ribonucleoprotein complexes where protein synthesis is temporarily arrested. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19765185",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 906,
          "offsetInEndSection": 1233,
          "text": "Moreover, proteins known to be stress granule markers co-deposit with inclusions in fALS and FTLD-FUS patients, implicating stress granule formation in the pathogenesis of these diseases. We propose that two pathological hits, namely nuclear import defects and cellular stress, are involved in the pathogenesis of FUS-opathies.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20606625",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 191,
          "text": "Amyotrophic lateral sclerosis (ALS)-linked fused in sarcoma/translocated in liposarcoma (FUS/TLS or FUS) is concentrated within cytoplasmic stress granules under conditions of induced stress.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24090136",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 89,
          "text": "Amyotrophic lateral sclerosis-linked FUS/TLS alters stress granule assembly and dynamics.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24090136",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1237,
          "offsetInEndSection": 1236,
          "text": "Moreover, proteins known to be stress granule markers co-deposit with inclusions in fALS and FTLD-FUS patients, implicating stress granule formation in the pathogenesis of these diseases. We propose that two pathological hits, namely nuclear import defects and cellular stress, are involved in the pathogenesis of FUS-opathies.  .",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20606625",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 109,
          "text": "Autophagy regulates amyotrophic lateral sclerosis-linked fused in sarcoma-positive stress granules in neurons",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25216585",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 322,
          "offsetInEndSection": 437,
          "text": "However, the role of autophagy in regulation of FUS-positive stress granules (SGs) and aggregates remains unclear. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25216585",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 642,
          "offsetInEndSection": 874,
          "text": "Although co-localized primarily in the nucleus in normal condition, FUS/TLS and PRMT1 were partially recruited to the cytoplasmic granules under oxidative stress, which were merged with stress granules (SGs) markers in SH-SY5Y cell.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23152885",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 145,
          "text": "The effect of PRMT1-mediated arginine methylation on the subcellular localization, stress granules, and detergent-insoluble aggregates of FUS/TLS",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23152885",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1097,
          "offsetInEndSection": 1320,
          "text": "Stress granules are cytoplasmic inclusions that repress translation of a subset of RNAs in times of cellular stress, and several proteins implicated in neurodegeneration (i.e. Ataxin-2 and SMN) interact with stress granules",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22405725",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1038,
          "offsetInEndSection": 1305,
          "text": "These findings support a two-hit hypothesis, whereby cytoplasmic mislocalization of FUS protein, followed by cellular stress, contributes to the formation of cytoplasmic aggregates that may sequester FUS, disrupt RNA processing and initiate motor neuron degeneration.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23474818",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 543,
          "offsetInEndSection": 779,
          "text": "Here, we exploited a Drosophila model of ALS and neuronal cell lines to elucidate the role of the RNA-binding ability of FUS in regulating FUS-mediated toxicity, cytoplasmic mislocalization and incorporation into stress granules (SGs). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23257289",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 48,
          "text": "Stress granules as crucibles of ALS pathogenesis",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23629963",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "Which viruses are best known to cause myocarditis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18039618",
        "http://www.ncbi.nlm.nih.gov/pubmed/18277927",
        "http://www.ncbi.nlm.nih.gov/pubmed/2641165",
        "http://www.ncbi.nlm.nih.gov/pubmed/14993139",
        "http://www.ncbi.nlm.nih.gov/pubmed/3889351",
        "http://www.ncbi.nlm.nih.gov/pubmed/8199011"
      ],
      "ideal_answer": [
        "The most frequent viruses causing myocarditis are Enterovirus, Adenovirus and Coxsackie B viruses."
      ],
      "exact_answer": [
        [
          "Enterovirus"
        ],
        [
          "Adenovirus"
        ],
        [
          "Coxsackie B virus"
        ]
      ],
      "type": "list",
      "id": "517a8c918ed59a060a000043",
      "snippets": [
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 183,
          "text": "Enteroviruses (EV) are an important cause of neonatal disease including hepatitis, meningoencephalitis, and myocarditis that can lead to death or severe long-term sequelae",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18277927",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 147,
          "text": "Enteroviruses have been considered to be the most common cause of acute myocarditis and possible consequence of dilated cardiomyopathy.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18039618",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1008,
          "offsetInEndSection": 1116,
          "text": "n our study the adenovirus genome was found to be the most frequent virus genome in explanted heart tissues.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18039618",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 99,
          "text": "Coxsackie B viruses (types 1 to 5) are the most frequent reported cause of acute viral myocarditis.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3889351",
          "endSection": "sections.0"
        }
      ]
    },
    {
      "body": "What is the function of 6SRNA in bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/58611",
        "http://www.ncbi.nlm.nih.gov/pubmed/17332013",
        "http://www.ncbi.nlm.nih.gov/pubmed/15262935",
        "http://www.ncbi.nlm.nih.gov/pubmed/23667906",
        "http://www.ncbi.nlm.nih.gov/pubmed/22214309",
        "http://www.ncbi.nlm.nih.gov/pubmed/2579060"
      ],
      "ideal_answer": [
        "6S RNA, first described as a ncRNA in E. coli, mimics an open promoter structure, which has a large bulge with two hairpin/stalk structures that regulate transcription through interactions with RNA polymerase. Escherichia coli 6S RNA represents a non-coding RNA (ncRNA), which, based on the conserved secondary structure and previous functional studies, had been suggested to interfere with transcription. The carboxy terminus containing the Arg-Gly-Gly (RGG) repeat domains in these proteins are necessary for cis-repression of transcription activation and HAT activity by the N-terminal glutamine-rich domain.",
        "Escherichia coli 6S RNA represents a non-coding RNA (ncRNA), which, based on the conserved secondary structure and previous functional studies, had been suggested to interfere with transcription. 6S RNA-deficient cells are at a disadvantage for survival in stationary phase, a time when 6S RNA regulates transcription. 6S RNA regulation of both sigma(70) and sigma(S) activities contributes to increased cell persistence during nutrient deprivation. 6S RNA acts as a template for the transcription of defined RNA molecules in the absence of DNA. 6S RNA, first described as a ncRNA in E. coli, mimics an open promoter structure, which has a large bulge with two hairpin/stalk structures that regulate transcription through interactions with RNA polymerase.",
        "6S RNA function enhances long-term cell survival. "
      ],
      "type": "summary",
      "id": "57169662cb4ef8864c000008",
      "snippets": [
        {
          "offsetInBeginSection": 464,
          "offsetInEndSection": 643,
          "text": "Qbeta replicase lacking subunit alpha (R-alpha) is capable of replicating templates other than (+) strand, such as (--), \"6S\" RNA, poly(C) etc., in the absence of the host factor.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/58611",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 75,
          "text": "Escherichia coli 6S RNA gene is part of a dual-function transcription unit.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2579060",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 152,
          "offsetInEndSection": 697,
          "text": "The DNA sequence results confirm the accuracy of the previously established RNA sequence and, with genomic hybridization data, reveal that there is only one copy of the 6S DNA in the chromosome. Consistent with its relaxed mode of expression, the promoter region of the 6S RNA gene was found to lack the hypothetical GC-rich discriminator domain common to other stable RNA genes under stringent control. The sequence results also revealed the occurrence of a 540-base-pair open reading frame immediately downstream from the 6S RNA coding region.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2579060",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 49,
          "text": "6S RNA function enhances long-term cell survival.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15262935",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 143,
          "offsetInEndSection": 265,
          "text": "6S RNA-deficient cells are at a disadvantage for survival in stationary phase, a time when 6S RNA regulates transcription.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15262935",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 495,
          "offsetInEndSection": 685,
          "text": "6S RNA inhibition of sigma(70)-dependent transcription was not ubiquitous, in spite of the fact that the vast majority of sigma(70)-RNA polymerase is bound by 6S RNA during stationary phase.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15262935",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 686,
          "offsetInEndSection": 856,
          "text": "The sigma(70)-dependent promoters inhibited by 6S RNA contain an extended -10 promoter element, suggesting that this feature may define a class of 6S RNA-regulated genes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15262935",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 875,
          "offsetInEndSection": 980,
          "text": " a secondary effect of 6S RNA in the activation of sigma(S)-dependent transcription at several promoters.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15262935",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 998,
          "offsetInEndSection": 1128,
          "text": "6S RNA regulation of both sigma(70) and sigma(S) activities contributes to increased cell persistence during nutrient deprivation.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15262935",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 196,
          "text": "Escherichia coli 6S RNA represents a non-coding RNA (ncRNA), which, based on the conserved secondary structure and previous functional studies, had been suggested to interfere with transcription. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17332013",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 590,
          "offsetInEndSection": 702,
          "text": "Preferred binding of 6S RNA to Esigma(70) was confirmed, however weaker binding to Esigma(38) was also observed.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17332013",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1152,
          "offsetInEndSection": 1355,
          "text": "Moreover, we show for the first time that 6S RNA acts as a template for the transcription of defined RNA molecules in the absence of DNA. In conclusion, this study reveals new aspects of 6S RNA function.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17332013",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 293,
          "offsetInEndSection": 501,
          "text": "6S RNA, first described as a ncRNA in E. coli, mimics an open promoter structure, which has a large bulge with two hairpin/stalk structures that regulate transcription through interactions with RNA polymerase",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22214309",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 398,
          "offsetInEndSection": 746,
          "text": "The release reaction depends on a characteristic property of 6S RNAs, namely to act as template for the de novo synthesis of small RNAs, termed pRNAs.Here, we used limited hydrolysis with structure-specific RNases and in-line probing of isolated 6S RNA and 6SRNA \u223c pRNA complexes to investigate the molecular details leading to the release reaction",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23667906",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 398,
          "offsetInEndSection": 748,
          "text": "The release reaction depends on a characteristic property of 6S RNAs, namely to act as template for the de novo synthesis of small RNAs, termed pRNAs.Here, we used limited hydrolysis with structure-specific RNases and in-line probing of isolated 6S RNA and 6SRNA \u223c pRNA complexes to investigate the molecular details leading to the release reaction. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23667906",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 399,
          "offsetInEndSection": 748,
          "text": "The release reaction depends on a characteristic property of 6S RNAs, namely to act as template for the de novo synthesis of small RNAs, termed pRNAs.Here, we used limited hydrolysis with structure-specific RNases and in-line probing of isolated 6S RNA and 6SRNA \u223c pRNA complexes to investigate the molecular details leading to the release reaction.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23667906",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is the suggested therapy for Mycobacterium avium infection?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19929882",
        "http://www.ncbi.nlm.nih.gov/pubmed/1832527",
        "http://www.ncbi.nlm.nih.gov/pubmed/9875582",
        "http://www.ncbi.nlm.nih.gov/pubmed/11073759",
        "http://www.ncbi.nlm.nih.gov/pubmed/1387133",
        "http://www.ncbi.nlm.nih.gov/pubmed/10714126",
        "http://www.ncbi.nlm.nih.gov/pubmed/16584300",
        "http://www.ncbi.nlm.nih.gov/pubmed/8733409"
      ],
      "ideal_answer": [
        "The activity of TLC G-65 (a liposomal gentamicin preparation), alone and in combination with rifapentine, clarithromycin, clofazimine and ethambutol, was evaluated in the beige mouse (C57BL/6J--bgj/bgj) model of disseminated Mycobacterium avium infection. TLC G-65 in combination with rifapentine appears to be an attractive regimen for the treatment of infections caused by bacteria in the M. avium complex. Rifampin 10 mg/kg daily, ciprofloxacin 500 mg twice daily, clofazimine 100 mg every day, and ethambutol 15 mg/kg orally daily for 24 weeks, with or without amikacin 10 mg/kg intravenously or intramuscularly 5 days weekly for the first 4 weeks. In vivo phage treatment may also be used in some cases.",
        "Rifampin 10 mg/kg daily, ciprofloxacin 500 mg twice daily, clofazimine 100 mg every day, and ethambutol 15 mg/kg orally daily for 24 weeks, with or without amikacin 10 mg/kg intravenously or intramuscularly 5 days weekly for the first 4 weeks",
        "The activity of TLC G-65 (a liposomal gentamicin preparation), alone and in combination with rifapentine, clarithromycin, clofazimine and ethambutol, was evaluated in the beige mouse (C57BL/6J--bgj/bgj) model of disseminated Mycobacterium avium infection"
      ],
      "type": "summary",
      "id": "5710ade4cf1c32585100002c",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 254,
          "text": "The activity of TLC G-65 (a liposomal gentamicin preparation), alone and in combination with rifapentine, clarithromycin, clofazimine and ethambutol, was evaluated in the beige mouse (C57BL/6J--bgj/bgj) model of disseminated Mycobacterium avium infection",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1387133",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 728,
          "offsetInEndSection": 880,
          "text": "TLC G-65 in combination with rifapentine appears to be an attractive regimen for the treatment of infections caused by bacteria in the M. avium complex.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1387133",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 379,
          "offsetInEndSection": 621,
          "text": "Rifampin 10 mg/kg daily, ciprofloxacin 500 mg twice daily, clofazimine 100 mg every day, and ethambutol 15 mg/kg orally daily for 24 weeks, with or without amikacin 10 mg/kg intravenously or intramuscularly 5 days weekly for the first 4 weeks",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9875582",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 266,
          "offsetInEndSection": 493,
          "text": "TM4 is a lytic mycobacteriophage that kills both extracellular M. avium and M. tuberculosis. When delivered by M. smegmatis transiently infected with TM4, it kills both M. avium and M. tuberculosis within RAW 264.7 macrophages.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16584300",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 753,
          "offsetInEndSection": 898,
          "text": "The patient was commenced on a 3-drug regimen with rifabutin, ethambutol and clarithromycin and has remained asymptomatic now for over 9 months. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10714126",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 184,
          "text": "A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11073759",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 123,
          "text": "Activity of clarithromycin against Mycobacterium avium infection in patients with the acquired immune deficiency syndrome. ",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1832527",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "Evolution was favorable with multiple-drug therapy including rifampicin, ethambutol, and clarithromycin, along with a slight reduction in immunosuppression.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19929882",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 159,
          "text": "The turning point in antimicrobial therapy of Mycobacterium avium infections came with the development of two new macrolides, clarithromycin and azithromycin.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8733409",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 63,
          "text": "Clarithromycin against Mycobacterium avium complex infections.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8733409",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "What is the indication for prophylactic use of antibiotics in COPD?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20477251",
        "http://www.ncbi.nlm.nih.gov/pubmed/22108462",
        "http://www.ncbi.nlm.nih.gov/pubmed/11498704"
      ],
      "ideal_answer": [
        "In a subset of patients with severe disease and prone to developing infections prophylactic use of antibiotics may reduce number of exacerbations and improve social and health care costs."
      ],
      "exact_answer": [
        "Reduction of number of exacerbations"
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D029424",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000900",
        "http://www.disease-ontology.org/api/metadata/DOID:3083",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D019072"
      ],
      "type": "factoid",
      "id": "515df063298dcd4e51000029",
      "snippets": [
        {
          "offsetInBeginSection": 193,
          "offsetInEndSection": 657,
          "text": "Yet recent well-designed studies have demonstrated that prophylactic antibiotic use is of significant benefit to patients prone to developing infections. Study patients suffered from recurrent urinary tract infections, COPD or were mechanically ventilated in intensive care units. In the first 2 populations, use of antibiotics was associated with an increase in carriage of antibiotic-resistant bacteria, but in intensive care patients the opposite was documented",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22108462",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1293,
          "offsetInEndSection": 1459,
          "text": "Guidelines do not recommend the use of prophylactic antibiotics in COPD but there is preliminary evidence to suggest that they may reduce the number of exacerbations.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20477251",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 585,
          "offsetInEndSection": 784,
          "text": "A short prophylactic treatment course with azithromycin is a good alternative in the management of patients with severe, advanced COPD, and could lead to an improvement in social and healthcare costs",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11498704",
          "endSection": "sections.0"
        }
      ]
    },
    {
      "body": "Does helicobacter pylori infection increase risk for ischemic stroke?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12063957",
        "http://www.ncbi.nlm.nih.gov/pubmed/18988408",
        "http://www.ncbi.nlm.nih.gov/pubmed/21060340",
        "http://www.ncbi.nlm.nih.gov/pubmed/15694938",
        "http://www.ncbi.nlm.nih.gov/pubmed/18249521",
        "http://www.ncbi.nlm.nih.gov/pubmed/22713083",
        "http://www.ncbi.nlm.nih.gov/pubmed/12725602",
        "http://www.ncbi.nlm.nih.gov/pubmed/19355997",
        "http://www.ncbi.nlm.nih.gov/pubmed/18665936",
        "http://www.ncbi.nlm.nih.gov/pubmed/12388919",
        "http://www.ncbi.nlm.nih.gov/pubmed/11588309",
        "http://www.ncbi.nlm.nih.gov/pubmed/22688569",
        "http://www.ncbi.nlm.nih.gov/pubmed/11157171",
        "http://www.ncbi.nlm.nih.gov/pubmed/17669100",
        "http://www.ncbi.nlm.nih.gov/pubmed/11155465",
        "http://www.ncbi.nlm.nih.gov/pubmed/16230797",
        "http://www.ncbi.nlm.nih.gov/pubmed/21775946",
        "http://www.ncbi.nlm.nih.gov/pubmed/11253332",
        "http://www.ncbi.nlm.nih.gov/pubmed/18346651",
        "http://www.ncbi.nlm.nih.gov/pubmed/14500942",
        "http://www.ncbi.nlm.nih.gov/pubmed/16386288",
        "http://www.ncbi.nlm.nih.gov/pubmed/16004850",
        "http://www.ncbi.nlm.nih.gov/pubmed/9805426",
        "http://www.ncbi.nlm.nih.gov/pubmed/24890556",
        "http://www.ncbi.nlm.nih.gov/pubmed/21669114",
        "http://www.ncbi.nlm.nih.gov/pubmed/18706211",
        "http://www.ncbi.nlm.nih.gov/pubmed/16466297",
        "http://www.ncbi.nlm.nih.gov/pubmed/15166387",
        "http://www.ncbi.nlm.nih.gov/pubmed/12147540",
        "http://www.ncbi.nlm.nih.gov/pubmed/9436737",
        "http://www.ncbi.nlm.nih.gov/pubmed/11412864"
      ],
      "ideal_answer": [
        "Findings regarding association between helicobacter pylori infection and ischemic stroke risk are conflicting. There is evidence to suggest that helicobacter pylori infection is associated with increased risk for ischemic stroke and should be considered stroke risk factors. However, some studies reported no association between helicobacter pylori infection and stroke."
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016480",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016481"
      ],
      "type": "summary",
      "id": "551c2cd26b348bb82c00000d",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 393,
          "text": "Helicobacter pylori (H. pylori) infection is reported to be associated with many extragastrointestinal manifestations, such as hematological diseases [idiopathic thrombocytopenic purpura (ITP) and unexplained iron deficiency anemia (IDA)], cardiovascular diseases (ischemic heart diseases), neurological disorders (stroke, Parkinson's disease, Alzheimer's disease), obesity and skin disorders.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22713083",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 105,
          "text": "Helicobacter pylori infection contributes to high risk of ischemic stroke: evidence from a meta-analysis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22688569",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1701,
          "offsetInEndSection": 1859,
          "text": "This meta-analysis indicated that chronic H. pylori infection was significantly associated with an increased risk of IS, especially for non-cardioembolic IS. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22688569",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 205,
          "text": "In the last years, a considerable number of studies have been performed on the relationship between infection from Helicobacter Pylori and atherosclerotic diseases, like stroke and ischemic heart disease. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21775946",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 112,
          "offsetInEndSection": 249,
          "text": "However, there are conflicting results on the relevance of chronic infection by Helicobacter pylori as a risk factor for ischemic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21669114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2123,
          "offsetInEndSection": 2266,
          "text": "CONCLUSIONS: This case-control study does not reveal any strong association between chronic Helicobacter pylori infection and ischemic stroke. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21669114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 738,
          "offsetInEndSection": 1106,
          "text": "Case-control and prospective studies indicate that chronic infections, such as periodontitis, chronic bronchitis and infection with Helicobacter pylori, Chlamydia pneumoniae or Cytomegalovirus, might increase stroke risk, although considerable variation exists in the results of these studies, and methodological issues regarding serological results remain unresolved.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21060340",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1040,
          "offsetInEndSection": 1208,
          "text": "Chronic infections, presently discussed as stroke risk factors mainly include periodontitis and infections with Helicobacter pylori (Hp) and Chlamydia pneumoniae (Cp). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19355997",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 805,
          "offsetInEndSection": 901,
          "text": "CONCLUSION: H. Pylori gastritis is not independently associated with increased risk for stroke. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18988408",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1309,
          "offsetInEndSection": 1495,
          "text": "CONCLUSIONS: Our results support the hypothesis that CagA-seropositive strains infection is significantly associated with susceptibility to ischemic strokes and coronary heart diseases. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18706211",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 115,
          "text": "BACKGROUND: Previous studies suggested an association between CagA-positive H. pylori strains and ischemic stroke. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18665936",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1070,
          "offsetInEndSection": 1199,
          "text": "CONCLUSIONS: Our findings suggest that CagA-positive strains of H. pylori are significantly associated to atherosclerotic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18665936",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1304,
          "offsetInEndSection": 1452,
          "text": "We concluded that H pylori infection is common in DM and seems to be linked to the presence of atherosclerosis and ischemic cerebrovascular stroke. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18346651",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 651,
          "offsetInEndSection": 897,
          "text": "Interesting results show that H. pylori infection affects atherosclerosis and is weakly associated with ischemic heart disease and stroke. Moreover, CagA-positive H. pylori strains may play a role in the natural history of atherosclerotic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18249521",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 137,
          "offsetInEndSection": 284,
          "text": "Interestingly, the majority of the extradigestive-related literature is focused on two vascular manifestations: stroke and ischemic heart disease. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17669100",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 289,
          "offsetInEndSection": 490,
          "text": "Chronic infectious diseases that may increase the risk of stroke include periodontitis, chronic bronchitis and infections with microbial antigens, such as Helicobacter pylori and Chlamydia pneumoniae. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16466297",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1315,
          "offsetInEndSection": 1446,
          "text": "CONCLUSIONS: These results suggest that H. pylori infection is a risk factor for ischemic stroke and that CD14 polymorphism is not.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16386288",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1453,
          "offsetInEndSection": 1653,
          "text": " CONCLUSIONS: Our case-control study provides evidence of an association between the immune response to H. pylori , a marker of prior infection with this organism and noncardioembolic ischemic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16230797",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 320,
          "text": "Case-control studies and a few prospective studies have indicated that chronic infections may add to the risk of stroke and that acute infections may act as trigger factors for stroke. Such chronic infections include periodontal disease, infection with Chlamydia pneumoniae or Helicobacter pylori, and chronic bronchitis",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16004850",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1267,
          "offsetInEndSection": 1602,
          "text": "Chronic H. pylori infection still showed an overall association with ischemic stroke (odds ratio for all subtypes combined: 2.57; 95% CI: 1.09-6.08) after adjusting for major cardiovascular risk factors. These results suggest that chronic H. pylori infection may be a triggering factor that increases the risk of acute ischemic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15694938",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 119,
          "text": "BACKGROUND AND PURPOSE: Studies on Helicobacter pylori infection and risk of ischemic stroke yielded variable results. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15166387",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1208,
          "offsetInEndSection": 1357,
          "text": "CONCLUSIONS: Our results support the hypothesis of an association between infection with CagA-positive H. pylori strains and acute cerebral ischemia.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15166387",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1064,
          "offsetInEndSection": 1315,
          "text": " Chronic infections (eg, infection with Chlamydia pneumoniae or Helicobacter pylori) were found to increase the risk of stroke; however, study results are at variance, residual confounding is not excluded, and causality is not established at present. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14500942",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1182,
          "offsetInEndSection": 1395,
          "text": "CONCLUSIONS: Infection with Helicobacter pylori is associated with an increased risk of stroke and increased fibrinogen levels but these findings can be attributed to a confounding effect of socio-economic status.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12725602",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1532,
          "offsetInEndSection": 1698,
          "text": " CONCLUSIONS: Hp infection represents risk factor of ischemic stoke via an interaction of Hp cytotoxins or cytokines with atherosclerotic plaques in carotic arteries.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12388919",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1415,
          "offsetInEndSection": 1608,
          "text": "CONCLUSIONS: The association between H pylori and acute cerebrovascular disease seems to be due to a higher prevalence of more virulent H pylori strains in patients with atherosclerotic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12147540",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1748,
          "offsetInEndSection": 1891,
          "text": "CONCLUSIONS: H. pylori infection appears to be significantly more frequent in middle-aged patients with acute ischemic stroke than in controls.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12063957",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 995,
          "offsetInEndSection": 1353,
          "text": "Chronic H pylori infection was associated with a higher risk of stroke caused by small-artery occlusion (adjusted odds ratio, 3.31; 95% CI, 1.15 to 9.56) and a lower risk of cardioembolic stroke (adjusted odds ratio, 0.21; 95% CI, 0.06 to 0.71). Overall, elevated H pylori as well as elevated C pneumoniae antibodies were not associated with ischemic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11588309",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 61,
          "offsetInEndSection": 188,
          "text": "Presently, it is insufficiently established whether Helicobacter pylori infection represents a risk factor for ischemic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11412864",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1003,
          "offsetInEndSection": 1101,
          "text": " H. pylori seropositivity may be an independent risk factor for stroke of atherothrombotic origin.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11412864",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1199,
          "offsetInEndSection": 1452,
          "text": "Appropriately randomized studies employing an antibiotic treatment for patients affected by ischemic vascular disease will answer the question of whether H. pylori has a causal role in the pathogenesis of acute myocardial infarction and ischemic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11253332",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 424,
          "offsetInEndSection": 579,
          "text": "Results on the association between this bacterium and acute myocardial infarction or stroke are controversial, due to the degree of studies heterogeneity. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11155465",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 736,
          "offsetInEndSection": 1010,
          "text": "Interventional randomized studies employing an antibiotic treatment for patients affected by ischemic vascular diseases will rapidly answer the question of wheather Helicobacter pylori has a causal role in the pathogenesis of acute myocardial infarction and ischemic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11155465",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1415,
          "offsetInEndSection": 1584,
          "text": " CONCLUSION: Chronic H pylori infection is an independent risk factor for ischaemic cerebrovascular disease and may act, at least in part, by increasing atherosclerosis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9436737",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 59,
          "offsetInEndSection": 187,
          "text": "Presently, it is insufficiently established whether Helicobacter pylori infection represents a risk factor for ischemic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11412864",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2048,
          "offsetInEndSection": 2177,
          "text": "This case-control study does not reveal any strong association between chronic Helicobacter pylori infection and ischemic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21669114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 99,
          "offsetInEndSection": 237,
          "text": "However, there are conflicting results on the relevance of chronic infection by Helicobacter pylori as a risk factor for ischemic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21669114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1065,
          "offsetInEndSection": 1314,
          "text": "Chronic infections (eg, infection with Chlamydia pneumoniae or Helicobacter pylori) were found to increase the risk of stroke; however, study results are at variance, residual confounding is not excluded, and causality is not established at present.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14500942",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 118,
          "text": "BACKGROUND AND PURPOSE: Studies on Helicobacter pylori infection and risk of ischemic stroke yielded variable results.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15166387",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 129,
          "text": "This case-control study does not reveal any strong association between chronic Helicobacter pylori infection and ischemic stroke.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21669114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 60,
          "offsetInEndSection": 186,
          "text": "Presently, it is insufficiently established whether Helicobacter pylori infection represents a risk factor for ischemic stroke",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11412864",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 288,
          "offsetInEndSection": 487,
          "text": "Chronic infectious diseases that may increase the risk of stroke include periodontitis, chronic bronchitis and infections with microbial antigens, such as Helicobacter pylori and Chlamydia pneumoniae",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16466297",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 93,
          "text": "Studies on Helicobacter pylori infection and risk of ischemic stroke yielded variable results",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15166387",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 61,
          "offsetInEndSection": 187,
          "text": "Presently, it is insufficiently established whether Helicobacter pylori infection represents a risk factor for ischemic stroke",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11412864",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 101,
          "offsetInEndSection": 237,
          "text": "However, there are conflicting results on the relevance of chronic infection by Helicobacter pylori as a risk factor for ischemic stroke",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21669114",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is the biological role of expansins in fungi?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/15195944",
        "http://www.ncbi.nlm.nih.gov/pubmed/18400936",
        "http://www.ncbi.nlm.nih.gov/pubmed/20478643",
        "http://www.ncbi.nlm.nih.gov/pubmed/18406638",
        "http://www.ncbi.nlm.nih.gov/pubmed/15605243",
        "http://www.ncbi.nlm.nih.gov/pubmed/19479322"
      ],
      "ideal_answer": [
        "Expansins are extracellular proteins that increase plant cell-wall extensibility. These wall-loosening proteins are involved in cell wall extension and polysaccharide degradation. In fungi expansins and expansin-like proteins have been found to localize in the conidial cell wall and are probably involved in cell wall remodeling during germination."
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005658"
      ],
      "type": "summary",
      "id": "513eec89bee46bd34c00000d",
      "snippets": [
        {
          "offsetInBeginSection": 88,
          "offsetInEndSection": 174,
          "text": "interactions with alpha-expansin in cell wall extension and polysaccharide degradation",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20478643",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1430,
          "offsetInEndSection": 1524,
          "text": "cell wall swelling may not be a significant event during the action of expansin and hydrolases",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20478643",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 442,
          "offsetInEndSection": 585,
          "text": "To evaluate a putative implication of three newly identified expansin/family 45 endoglucanase-like (EEL) proteins in lignocellulose degradation",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19479322",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1082,
          "offsetInEndSection": 1232,
          "text": "Our results show that EglD is a conidial cell wall localized expansin-like protein, which could be involved in cell wall remodeling during germination",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18406638",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 229,
          "text": "Swollenin, a protein first characterized in the saprophytic fungus Trichoderma reesei, contains an N-terminal carbohydrate-binding module family 1 domain (CBD) with cellulose-binding function and a C-terminal expansin-like domain",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18400936",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 86,
          "text": "alpha-Expansins are extracellular proteins that increase plant cell-wall extensibility",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15605243",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1448,
          "offsetInEndSection": 1561,
          "text": "these wall-loosening proteins are directly involved in the accommodation of the fungus by infected cortical cells",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15605243",
          "endSection": "sections.0"
        }
      ]
    },
    {
      "body": "What distinguishes lantibiotics from antibiotics?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12361237",
        "http://www.ncbi.nlm.nih.gov/pubmed/19009315",
        "http://www.ncbi.nlm.nih.gov/pubmed/21905643",
        "http://www.ncbi.nlm.nih.gov/pubmed/8264800",
        "http://www.ncbi.nlm.nih.gov/pubmed/24069959",
        "http://www.ncbi.nlm.nih.gov/pubmed/21470152",
        "http://www.ncbi.nlm.nih.gov/pubmed/15044440",
        "http://www.ncbi.nlm.nih.gov/pubmed/23168402",
        "http://www.ncbi.nlm.nih.gov/pubmed/11945173",
        "http://www.ncbi.nlm.nih.gov/pubmed/25787977",
        "http://www.ncbi.nlm.nih.gov/pubmed/19393544",
        "http://www.ncbi.nlm.nih.gov/pubmed/1482192",
        "http://www.ncbi.nlm.nih.gov/pubmed/24621781",
        "http://www.ncbi.nlm.nih.gov/pubmed/24210177",
        "http://www.ncbi.nlm.nih.gov/pubmed/23475977"
      ],
      "ideal_answer": [
        "Lantibiotic compounds are ribosomally synthesized antimicrobial peptides against which bacteria are not able to produce resistance, hence making them a good alternative to antibiotics. It is interesting that low levels of resistance have been reported for lantibiotics compared with commercial antibiotics. Given that there are very few examples of naturally occurring lantibiotic resistance, attempts have been made to deliberately induce resistance phenotypes in order to investigate this phenomenon. Other general forms of resistance include the formation of spores or biofilms, which are a common mechanistic response to many classes of antimicrobials.",
        "One potentially interesting class of antimicrobials are the modified bacteriocins termed lantibiotics, which are bacterially produced, posttranslationally modified, lanthionine/methyllanthionine-containing peptides. Low levels of resistance have been reported for lantibiotics compared with commercial antibiotics. Nisin is the oldest and the most widely used lantibiotic, in food preservation, without having developed any significant resistance against it.",
        "One potentially interesting class of antimicrobials are the modified bacteriocins termed lantibiotics, which are bacterially produced, posttranslationally modified, lanthionine/methyllanthionine-containing peptides."
      ],
      "exact_answer": [
        "Lantibiotics are post-translationally modified natural peptides containing lanthionine"
      ],
      "concepts": [
        "http://www.biosemantics.org/jochem#4275453",
        "http://www.biosemantics.org/jochem#4260744"
      ],
      "type": "factoid",
      "id": "5719f5c67de986d80d00000d",
      "snippets": [
        {
          "offsetInBeginSection": 124,
          "offsetInEndSection": 339,
          "text": "One potentially interesting class of antimicrobials are the modified bacteriocins termed lantibiotics, which are bacterially produced, posttranslationally modified, lanthionine/methyllanthionine-containing peptides.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25787977",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 363,
          "offsetInEndSection": 460,
          "text": "low levels of resistance have been reported for lantibiotics compared with commercial antibiotics",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25787977",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 658,
          "offsetInEndSection": 877,
          "text": "Mechanisms that hinder the action of lantibiotics are often innate systems that react to the presence of any cationic peptides/proteins or ones which result from cell well damage, rather than being lantibiotic specific.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25787977",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 82,
          "text": "Lantibiotics are biologically active peptides produced by Gram-positive bacteria. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23168402",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 129,
          "offsetInEndSection": 269,
          "text": "Lantibiotics are post-translationally modified, ribosomally synthesised antimicrobial peptides with a broad spectrum antimicrobial activity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24069959",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 103,
          "offsetInEndSection": 287,
          "text": "Lantibiotic compounds are ribosomally synthesized antimicrobial peptides against which bacteria are not able to produce resistance, hence making them a good alternative to antibiotics.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24621781",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 282,
          "offsetInEndSection": 422,
          "text": "Lantibiotics are ribosomally synthesized peptide antibiotics that are posttranslationally modified to introduce (methyl)lanthionine bridges.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23475977",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 157,
          "text": "Lantibiotics are defined as peptide antibiotics containing the unusual amino acids mesolanthionine, 3-methyllanthionine, dehydroalanine, and dehydrobutyrine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8264800",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 138,
          "text": "Lantibiotics are antibiotic peptides distinguished by the presence of the rare thioether amino acids lanthionine and/or methyllanthionine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11945173",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 171,
          "text": "Lantibiotics are ribosomally synthesized, post-translationally modified, peptide antibiotics containing unusual amino acids such as dehydrated amino acids and lanthionine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21470152",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 205,
          "text": "Lantibiotics are peptide antibiotics, realizing their unique secondary structure by posttranslational modifications, the most important one being the formation of the characteristic amino acid lanthionine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21905643",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 61,
          "text": "Lantibiotics are lanthionine-containing peptide antibiotics. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15044440",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "Lantibiotics, a group of lanthionine-containing peptides, display their antibiotic activity by combining different killing mechanisms within one molecule. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009315",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 601,
          "offsetInEndSection": 697,
          "text": "Lantibiotics are ribosomally synthesized as prepeptides, which are posttranslationally modified.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8264800",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is there an association between borna virus and brain tumor?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10483922",
        "http://www.ncbi.nlm.nih.gov/pubmed/10227422",
        "http://www.ncbi.nlm.nih.gov/pubmed/1731117",
        "http://www.ncbi.nlm.nih.gov/pubmed/17020949",
        "http://www.ncbi.nlm.nih.gov/pubmed/17306587",
        "http://www.ncbi.nlm.nih.gov/pubmed/11507219",
        "http://www.ncbi.nlm.nih.gov/pubmed/11070091",
        "http://www.ncbi.nlm.nih.gov/pubmed/21937656",
        "http://www.ncbi.nlm.nih.gov/pubmed/8917593",
        "http://www.ncbi.nlm.nih.gov/pubmed/15596826",
        "http://www.ncbi.nlm.nih.gov/pubmed/8184547",
        "http://www.ncbi.nlm.nih.gov/pubmed/10518583",
        "http://www.ncbi.nlm.nih.gov/pubmed/11907227",
        "http://www.ncbi.nlm.nih.gov/pubmed/22848506"
      ],
      "ideal_answer": [
        "There is no data to suggest an association between borna virus and brain tumor. Borna disease virus establishes a persistent infection in the central nervous system of vertebrate animal species as well as in tissue cultures causing cellular damage. Infected neural cells, include astrocytes, neurons, oligodendroglioma cell line. Borna disease virus replicates and can cause damage of brain cells."
      ],
      "exact_answer": "no",
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001890",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001891",
        "http://www.disease-ontology.org/api/metadata/DOID:1319",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001932",
        "http://www.disease-ontology.org/api/metadata/DOID:5154"
      ],
      "type": "yesno",
      "id": "530f685c329f5fcf1e000002",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 191,
          "text": "Borna disease virus (BDV), a nonsegmented, negative-strand RNA virus, infects a wide variety of mammalian species and readily establishes a long-lasting, persistent infection in brain cells. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21937656",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 242,
          "text": "To investigate the biological characteristics of field isolates of Borna disease virus (BDV), as well as to understand BDV infections outside endemic countries, we isolated the virus from brain samples of a heifer with Borna disease in Japan.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17306587",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 150,
          "text": "Neonatal Borna disease virus (BDV) infection of the rat brain is associated with microglial activation and damage to the certain neuronal populations.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17020949",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1204,
          "offsetInEndSection": 1677,
          "text": "In addition, compared to uninfected mixed cultures, activation of microglia in BDV-infected mixed cultures was associated with a significantly greater lipopolysaccharide-induced release of tumor necrosis factor alpha, interleukin 1beta, and interleukin 10. Taken together, the present data are the first in vitro evidence that persistent BDV infection of neurons and astrocytes rather than direct exposure to the virus or dying neurons is critical for activating microglia.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17020949",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 613,
          "offsetInEndSection": 708,
          "text": "Usually, Borna disease virus is not cleared from the brain but rather persists in neural cells.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15596826",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 92,
          "text": "Varied persistent life cycles of Borna disease virus in a human oligodendroglioma cell line.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11907227",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 151,
          "text": "Borna disease virus (BDV) establishes a persistent infection in the central nervous system of vertebrate animal species as well as in tissue cultures. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11907227",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1553,
          "offsetInEndSection": 1719,
          "text": "Thus, our findings show that BDV may have established a persistent infection at low levels of viral expression in OL cells with the possibility of a latent infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11907227",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1726,
          "offsetInEndSection": 1899,
          "text": "These results suggested that BDV infection may cause direct damage in the developing brain by inhibiting the function of amphoterin due to binding by the p24 phosphoprotein.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507219",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 280,
          "offsetInEndSection": 462,
          "text": "We describe a model for investigating disorders of central nervous system development based on neonatal rat infection with Borna disease virus, a neurotropic noncytolytic RNA virus. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10518583",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 222,
          "text": "Borna disease virus (BDV) replicates in brain cells. The neonatally infected rat with BDV exhibits developmental-neuromorphological abnormalities, neuronal cytolysis, and multiple behavioral and physiological alterations. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10483922",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 161,
          "text": "Borna disease virus (BDV) causes central nervous system (CNS) disease in several vertebrate species, which is frequently accompanied by behavioral abnormalities.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10227422",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "text": "Intrinsic responses to Borna disease virus infection of the central nervous system.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8917593",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 160,
          "text": "Immune cells invading the central nervous system (CNS) in response to Borna disease virus (BDV) antigens are central to the pathogenesis of Borna disease (BD). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8917593",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 281,
          "offsetInEndSection": 439,
          "text": "We report here the partial purification and characterization of cell-free BDV from the tissue culture supernatant of infected human neuroblastoma SKNSH cells.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8184547",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 166,
          "text": "We have used the reverse transcriptase-polymerase chain reaction technique to gain insight into the pathogenesis of encephalitis caused by Borna disease virus (BDV). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1731117",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 850,
          "offsetInEndSection": 1064,
          "text": "In contrast, in the BDV-infected primary mixed cultures, we observed proliferation of microglia cells that acquired the round morphology and expressed major histocompatibility complex molecules of classes I and II.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17020949",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which virus is Cidofovir (Vistide) indicated for?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19725597",
        "http://www.ncbi.nlm.nih.gov/pubmed/9814660",
        "http://www.ncbi.nlm.nih.gov/pubmed/11772283",
        "http://www.ncbi.nlm.nih.gov/pubmed/11154213"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A10493715",
          "o": "RXNORM"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A10493715",
          "o": "Cidofovir Injectable Solution"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/prefMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C1251348",
          "o": "http://linkedlifedata.com/resource/umls/label/A10493715"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#prefLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C1251348",
          "o": "http://linkedlifedata.com/resource/umls/label/A10493715"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A10493715",
          "o": "377136"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#broader",
          "s": "http://linkedlifedata.com/resource/umls/id/C1236858",
          "o": "http://linkedlifedata.com/resource/umls/id/C1251348"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#prefLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C1236858",
          "o": "http://linkedlifedata.com/resource/umls/label/A10660704"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A10660704",
          "o": "Cidofovir Injectable Solution [Vistide]"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A10660704",
          "o": "362931"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A1751684",
          "o": "J0740"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A1751684",
          "o": "INJECTION, CIDOFOVIR, 375 MG"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#prefLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0520139",
          "o": "http://linkedlifedata.com/resource/umls/label/A1751684"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A10418206",
          "o": "RXNORM"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#prefLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0984907",
          "o": "http://linkedlifedata.com/resource/umls/label/A10418206"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A10418206",
          "o": "Cidofovir 75 MG/ML"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A1751684",
          "o": "HCPCS"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A10725904",
          "o": "571699"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#prefLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C1605899",
          "o": "http://linkedlifedata.com/resource/umls/label/A10725904"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A10725904",
          "o": "Cidofovir 75 MG/ML [Vistide]"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A10660704",
          "o": "RXNORM"
        }
      ],
      "ideal_answer": [
        "Cidofovir is commonly used in the treatment of cytomegalovirus (CMV) infection and disease."
      ],
      "exact_answer": [
        "cytomegalovirus"
      ],
      "concepts": [
        "http://www.biosemantics.org/jochem#4236374",
        "http://www.biosemantics.org/jochem#4261248"
      ],
      "type": "factoid",
      "id": "52bf1cad03868f1b0600000a",
      "snippets": [
        {
          "offsetInBeginSection": 326,
          "offsetInEndSection": 457,
          "text": "Currently, there are four antivirals available that are active against CMV: ganciclovir, valganciclovir, foscarnet, and cidofovir. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19725597",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 598,
          "offsetInEndSection": 731,
          "text": "At present, the antiviral drugs ganciclovir, foscarnet and cidofovir are commonly used in the treatment of CMV infection and disease.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11772283",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1245,
          "offsetInEndSection": 1360,
          "text": "Cidofovir can be considered as second-line therapy in patients with CMV disease failing previous antiviral therapy.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11154213",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1042,
          "offsetInEndSection": 1128,
          "text": "dditional drugs like lobucavir and cidofovir have been used for specific indications. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9814660",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which proteins act as factors that promote transcription-coupled repair in bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18707026",
        "http://www.ncbi.nlm.nih.gov/pubmed/20702425",
        "http://www.ncbi.nlm.nih.gov/pubmed/22427630",
        "http://www.ncbi.nlm.nih.gov/pubmed/15687384",
        "http://www.ncbi.nlm.nih.gov/pubmed/20110508",
        "http://www.ncbi.nlm.nih.gov/pubmed/24554077",
        "http://www.ncbi.nlm.nih.gov/pubmed/21559463",
        "http://www.ncbi.nlm.nih.gov/pubmed/17572090",
        "http://www.ncbi.nlm.nih.gov/pubmed/8807287",
        "http://www.ncbi.nlm.nih.gov/pubmed/9535092",
        "http://www.ncbi.nlm.nih.gov/pubmed/21145481",
        "http://www.ncbi.nlm.nih.gov/pubmed/24118570",
        "http://www.ncbi.nlm.nih.gov/pubmed/20696893",
        "http://www.ncbi.nlm.nih.gov/pubmed/22749141",
        "http://www.ncbi.nlm.nih.gov/pubmed/20638914",
        "http://www.ncbi.nlm.nih.gov/pubmed/12086674",
        "http://www.ncbi.nlm.nih.gov/pubmed/16469698",
        "http://www.ncbi.nlm.nih.gov/pubmed/7869378",
        "http://www.ncbi.nlm.nih.gov/pubmed/20178806",
        "http://www.ncbi.nlm.nih.gov/pubmed/20436399",
        "http://www.ncbi.nlm.nih.gov/pubmed/22960746"
      ],
      "ideal_answer": [
        "Transcription coupled nucleotide excision repair (TC-NER or TCR) is a cellular process by which UV-induced damage and other road-blocks encountered in the transcribed strand are restored. Bacterial transcription-coupled repair is initiated when RNA polymerase stalled at a DNA lesion is removed by Mfd (Mutation frequency decline), an ATP-dependent DNA translocase. Mfd is the major transcription repair coupling factor in bacteria. Also, the transcription elongation factor NusA, in addition to its role in recruiting translesion synthesis (TLS) DNA polymerases to gaps encountered during transcription,  promotes an alternative class of TCR involved in the identification and removal of a class of lesion, such as the N(2)-f-dG lesion."
      ],
      "exact_answer": [
        [
          "Mfd"
        ],
        [
          "NusA"
        ]
      ],
      "concepts": [
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0090262",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0006283"
      ],
      "type": "list",
      "id": "55451e53bf90a13052000003",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 534,
          "text": "Transcription-coupled repair (TCR) is a cellular process by which some forms of DNA damage are repaired more rapidly from transcribed strands of active genes than from nontranscribed strands or the overall genome. In humans, the TCR coupling factor, CSB, plays a critical role in restoring transcription following both UV-induced and oxidative DNA damage. It also contributes indirectly to the global repair of some forms of oxidative DNA damage. The Escherichia coli homolog, Mfd, is similarly required for TCR of UV-induced lesions.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22427630",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 298,
          "text": "Transcription coupled nucleotide excision repair (TC-NER) is involved in correcting UV-induced damage and other road-blocks encountered in the transcribed strand. Mutation frequency decline (Mfd) is a transcription repair coupling factor, involved in repair of template strand during transcription.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21559463",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 474,
          "offsetInEndSection": 622,
          "text": "the transcription-repair coupling factor, Mfd, promotes direct restart of the fork following the collision by facilitating displacement of the RNAP.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20436399",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 302,
          "text": "We report observations suggesting that the transcription elongation factor NusA promotes a previously unrecognized class of transcription-coupled repair (TCR) in addition to its previously proposed role in recruiting translesion synthesis (TLS) DNA polymerases to gaps encountered during transcription.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20696893",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1382,
          "offsetInEndSection": 1524,
          "text": "NusA participates in an alternative class of TCR involved in the identification and removal of a class of lesion, such as the N(2)-f-dG lesion",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20696893",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 222,
          "offsetInEndSection": 370,
          "text": "Bacterial transcription-coupled repair is initiated when RNA polymerase stalled at a DNA lesion is removed by Mfd, an ATP-dependent DNA translocase.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22960746",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 200,
          "text": "Transcription-coupled repair, the targeted repair of the transcribed strands of active genes, is defective in bacteria, yeast, and human cells carrying mutations in mfd, RAD26 and ERCC6, respectively.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8807287",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 531,
          "offsetInEndSection": 984,
          "text": "The effect of the bacterial transcription-repair coupling factor, Mfd, at such lesions is not known: it has been suggested that Mfd may promote mutagenesis by increasing the efficiency with which RNA polymerase bypasses non-bulky lesions, but it has also been reported that 8-oxoguanine, a major product of oxidative DNA damage that is efficiently bypassed by RNA polymerase, is subject to Mfd-dependent transcription-coupled repair in Escherichia coli.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18707026",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 164,
          "text": "The transcription-repair coupling factor (TRCF, the product of the mfd gene) is a widely conserved bacterial protein that mediates transcription-coupled DNA repair.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20702425",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 388,
          "offsetInEndSection": 679,
          "text": "Recent structural studies of the bacterial transcription-repair coupling factor, Mfd, have revealed a modular architecture in which an ATP-dependent DNA-based motor is coupled to protein-protein interaction domains that can attach the motor to RNA polymerase and the DNA repair protein UvrA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17572090",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 140,
          "text": "The bacterial Mfd protein is a transcription-repair coupling factor that performs two key functions during transcription-coupled DNA repair.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15687384",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 726,
          "offsetInEndSection": 883,
          "text": "Mfd remains bound to the DNA in a long-lived complex that could act as a marker for sites of DNA damage, directing assembly of subsequent DNA repair factors.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22960746",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 203,
          "text": "Transcription and DNA repair are coupled in E. coli by the Mfd protein, which dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12086674",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 141,
          "offsetInEndSection": 328,
          "text": "The first is to remove RNA polymerase (RNAP) complexes that have been stalled by a DNA lesion from the site of damage, and the second is to mediate the recruitment of DNA repair proteins.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15687384",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 280,
          "text": "Coupling of transcription and DNA repair in bacteria is mediated by transcription-repair coupling factor (TRCF, the product of the mfd gene), which removes transcription elongation complexes stalled at DNA lesions and recruits the nucleotide excision repair machinery to the site.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16469698",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 726,
          "offsetInEndSection": 882,
          "text": "Mfd remains bound to the DNA in a long-lived complex that could act as a marker for sites of DNA damage, directing assembly of subsequent DNA repair factors",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22960746",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 558,
          "offsetInEndSection": 747,
          "text": "Mfd may act through a translocase activity that rewinds upstream DNA, leading either to translocation or to release of RNA polymerase when the enzyme active site cannot continue elongation.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12086674",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 388,
          "offsetInEndSection": 678,
          "text": "Recent structural studies of the bacterial transcription-repair coupling factor, Mfd, have revealed a modular architecture in which an ATP-dependent DNA-based motor is coupled to protein-protein interaction domains that can attach the motor to RNA polymerase and the DNA repair protein UvrA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17572090",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 121,
          "text": "E. coli Transcription repair coupling factor (Mfd protein) rescues arrested complexes by promoting forward translocation.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12086674",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 456,
          "offsetInEndSection": 621,
          "text": "We also find that the transcription-repair coupling factor, Mfd, promotes direct restart of the fork following the collision by facilitating displacement of the RNAP",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20436399",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 452,
          "offsetInEndSection": 612,
          "text": "We also found that the transcription-repair coupling factor Mfd promotes direct restart of the fork after the collision by facilitating displacement of the RNAP",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20110508",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 488,
          "offsetInEndSection": 761,
          "text": "We show that Mfd-dependent TCR in bacteria involves the formation of a damage search complex that can detect lesions downstream of a stalled RNAP, and that the strand specificity of the accelerated repair pathway is independent of the requirement for a lesion to stall RNAP",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24554077",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 47,
          "offsetInEndSection": 202,
          "text": "coli by the Mfd protein, which dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12086674",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Are people with blood group O protected against severe Malaria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22771625",
        "http://www.ncbi.nlm.nih.gov/pubmed/17959777",
        "http://www.ncbi.nlm.nih.gov/pubmed/23071435",
        "http://www.ncbi.nlm.nih.gov/pubmed/22818742",
        "http://www.ncbi.nlm.nih.gov/pubmed/15814030"
      ],
      "ideal_answer": [
        "It appears that individuals who are of blood-group O are relatively resistant to the severe disease caused by P. falciparum infection."
      ],
      "exact_answer": "yes",
      "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:14067",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001769",
        "http://www.disease-ontology.org/api/metadata/DOID:4176",
        "http://www.disease-ontology.org/api/metadata/DOID:12365",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008288",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001789"
      ],
      "type": "yesno",
      "id": "551ae6c564b14b4618000001",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 135,
          "text": "Differential carbonylation of cytoskeletal proteins in blood group O erythrocytes: potential role in protection against severe malaria.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22771625",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1267,
          "offsetInEndSection": 1460,
          "text": ". Our findings indicate a possible correlation between the protection against severe malaria in blood group O individuals and a specific pattern of 4-HNE-carbonylation of cytoskeleton proteins.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22771625",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 133,
          "offsetInEndSection": 314,
          "text": "There is a predominance of blood group O in malaria-endemic regions, and several lines of evidence suggest that ABO blood groups may influence the outcome of P. falciparum infection",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071435",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1304,
          "offsetInEndSection": 1541,
          "text": "These data provide the first evidence that ABO blood group antigens influence macrophage clearance of P. falciparum-infected erythrocytes and suggest an additional mechanism by which blood group O may confer resistance to severe malaria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071435",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 86,
          "text": "Blood group phenotypes A and B are risk factors for cerebral malaria in Odisha, India.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22818742",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 519,
          "offsetInEndSection": 652,
          "text": "type O is significantly associated with protection against CM, patients with type A and B group had increased risk for developing CM.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22818742",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 111,
          "text": "Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17959777",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 448,
          "text": "Malaria has been a major selective force on the human population, and several erythrocyte polymorphisms have evolved that confer resistance to severe malaria. Plasmodium falciparum rosetting, a parasite virulence phenotype associated with severe malaria, is reduced in blood group O erythrocytes compared with groups A, B, and AB, but the contribution of the ABO blood group system to protection against severe malaria has received little attention",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17959777",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 450,
          "offsetInEndSection": 579,
          "text": "We hypothesized that blood group O may confer resistance to severe falciparum malaria through the mechanism of reduced rosetting.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17959777",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1008,
          "offsetInEndSection": 1142,
          "text": "It appears that individuals who are of blood-group O are relatively resistant to the severe disease caused by P. falciparum infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15814030",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is Mycobacterium avium less susceptible to antibiotics than Mycobacterium tuberculosis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19956964",
        "http://www.ncbi.nlm.nih.gov/pubmed/21258569",
        "http://www.ncbi.nlm.nih.gov/pubmed/15328105",
        "http://www.ncbi.nlm.nih.gov/pubmed/16410940",
        "http://www.ncbi.nlm.nih.gov/pubmed/12355367",
        "http://www.ncbi.nlm.nih.gov/pubmed/17548640",
        "http://www.ncbi.nlm.nih.gov/pubmed/19302308",
        "http://www.ncbi.nlm.nih.gov/pubmed/15347635",
        "http://www.ncbi.nlm.nih.gov/pubmed/10988097",
        "http://www.ncbi.nlm.nih.gov/pubmed/17897062",
        "http://www.ncbi.nlm.nih.gov/pubmed/1441463",
        "http://www.ncbi.nlm.nih.gov/pubmed/19119013"
      ],
      "ideal_answer": [
        "Mycobacterium avium causes disseminated infection in patients with acquired immune deficiency syndrome. M tuberculosis disease is preventable and curable and yet communicable, physicians should maintain a high degree of suspicion for tuberculosis in HIV-infected adults. In comparison, the goal of treating M avium complex in patients with advanced HIV disease is to reduce constitutional symptoms and improve survival. Patients who were suspected to have disseminated mycobacterial infection, presenting fever and (preferably) a CD4 T cell count<100.0 cell/mL were investigated. Twelve (15%) of the 80 blood cultures were positive for mycobacteria, with Mycobacterium avium being identified in 7 (8.8%) samples and M. tuberculosis in 5 (6.2%).  The antimycobacterial activities of RS-112997, RS-124922 and RS-118641, three capuramycin analogues that inhibit phospho-N-acetylmuramyl-pentapeptide translocase, were tested against clinical isolates of Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare. The MIC50/90 (mg/L) results for RS-118641 were: M. tuberculosis, 1/2; multidrug-resistant (MDR) M. tuberculosis, 0.5/2; M. avium, 4/8; and M. intracellulare, 0.06/0.5"
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5710a650cf1c32585100002b",
      "snippets": [
        {
          "offsetInBeginSection": 1447,
          "offsetInEndSection": 1550,
          "text": "The prevalence of MAC lung infection in two inner city hospitals was four times higher than that of TB.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21258569",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1792,
          "offsetInEndSection": 1908,
          "text": "Most patients with combined infection were clinically consistent with MTB and responded to anti MTB treatment alone.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21258569",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1719,
          "offsetInEndSection": 1868,
          "text": "The triplex PCR developed by us could be used to detect and differentiate M. tuberculosis, M. avium and other mycobacteria in a single reaction tube.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19302308",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 402,
          "offsetInEndSection": 567,
          "text": "Twelve (15%) of the 80 blood cultures were positive for mycobacteria, with Mycobacterium avium being identified in 7 (8.8%) samples and M. tuberculosis in 5 (6.2%). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16410940",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 296,
          "text": "The antimycobacterial activities of RS-112997, RS-124922 and RS-118641, three capuramycin analogues that inhibit phospho-N-acetylmuramyl-pentapeptide translocase, were tested against clinical isolates of Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15347635",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 461,
          "offsetInEndSection": 627,
          "text": "The MIC50/90 (mg/L) results for RS-118641 were: M. tuberculosis, 1/2; multidrug-resistant (MDR) M. tuberculosis, 0.5/2; M. avium, 4/8; and M. intracellulare, 0.06/0.5",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15347635",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1456,
          "offsetInEndSection": 1692,
          "text": "These results suggest that capuramycin analogues exhibit strong antimycobacterial potential and should be considered for further evaluation in the treatment of M. tuberculosis and M. avium-M. intracellulare complex infections in humans.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15347635",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 103,
          "text": "Mycobacterium avium causes disseminated infection in patients with acquired immune deficiency syndrome.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12355367",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 421,
          "offsetInEndSection": 694,
          "text": "Overall incidences of Mycobacterium tuberculosis (TB) and Mycobacterium avium complex (MAC) were 0.8 and 1.4 cases/100 person-years of follow-up (PYF), decreasing from 1.8 (TB) and 3.5 cases/100 PYF (MAC) before September 1995 to 0.3 and 0.2 cases/100 PYF after March 1997.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10988097",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 427,
          "offsetInEndSection": 750,
          "text": "Because M tuberculosis disease is preventable and curable and yet communicable, physicians should maintain a high degree of suspicion for tuberculosis in HIV-infected adults. In comparison, the goal of treating M avium complex in patients with advanced HIV disease is to reduce constitutional symptoms and improve survival.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1441463",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1210,
          "offsetInEndSection": 1385,
          "text": "MAC pulmonary disease should be considered in the differential diagnosis of SPNs, even when encountered in geographic regions with a high prevalence of pulmonary tuberculosis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19956964",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 186,
          "offsetInEndSection": 400,
          "text": "From April 2001 to February 2002, 80 blood samples from patients who were suspected to have disseminated mycobacterial infection, presenting fever and (preferably) a CD4 T cell count<100.0 cell/mL were investigated",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16410940",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 146,
          "text": "IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17548640",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 228,
          "text": "Clinical utility of rifabutin 1 (RBT), a potent antibiotic used in multidrug regimens for tuberculosis (TB) as well as for infections caused by Mycobacterium avium complex (MAC), has been hampered due to dose-limiting toxicity. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19119013",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 214,
          "offsetInEndSection": 364,
          "text": "Effective therapeutic regimens exist that are limited by the emergence of drug resistance and the inability of antibiotics to kill dormant organisms. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12355367",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 226,
          "text": "Clinical utility of rifabutin 1 (RBT), a potent antibiotic used in multidrug regimens for tuberculosis (TB) as well as for infections caused by Mycobacterium avium complex (MAC), has been hampered due to dose-limiting toxicity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19119013",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 40,
          "offsetInEndSection": 179,
          "text": "a potent antibiotic used in multidrug regimens for tuberculosis (TB) as well as for infections caused by Mycobacterium avium complex (MAC),",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19119013",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 228,
          "text": "Clinical utility of rifabutin 1 (RBT), a potent antibiotic used in multidrug regimens for tuberculosis (TB) as well as for infections caused by Mycobacterium avium complex (MAC), has been hampered due to dose-limiting toxicity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19119013",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1048,
          "offsetInEndSection": 1214,
          "text": "tuberculosis appear to have different genetic mechanisms for resisting the effects of these antibiotics, with pks12 playing a relatively more significant role in MAC.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15328105",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which bacteria caused plague?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/8052312",
        "http://www.ncbi.nlm.nih.gov/pubmed/16410352"
      ],
      "ideal_answer": [
        "Yersinia pestis is the causative bacteria of the plague."
      ],
      "exact_answer": [
        "Yersinia pestis"
      ],
      "type": "factoid",
      "id": "571cdd227de986d80d00000f",
      "snippets": [
        {
          "offsetInBeginSection": 187,
          "offsetInEndSection": 344,
          "text": " the causative bacteria Yersinia pestis as an agent of biological warfare have highlighted the need for a safe, efficacious, and rapidly producible vaccine. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16410352",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 175,
          "offsetInEndSection": 256,
          "text": "Yersinia, the causative bacteria of the bubonic plague and other enteric diseases",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8052312",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is paramyxovirus involved in human subacute thyroiditis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22819125",
        "http://www.ncbi.nlm.nih.gov/pubmed/1691523",
        "http://www.ncbi.nlm.nih.gov/pubmed/20960165",
        "http://www.ncbi.nlm.nih.gov/pubmed/806773",
        "http://www.ncbi.nlm.nih.gov/pubmed/16279854",
        "http://www.ncbi.nlm.nih.gov/pubmed/22459018",
        "http://www.ncbi.nlm.nih.gov/pubmed/2998895",
        "http://www.ncbi.nlm.nih.gov/pubmed/20886354",
        "http://www.ncbi.nlm.nih.gov/pubmed/1180050",
        "http://www.ncbi.nlm.nih.gov/pubmed/9637274",
        "http://www.ncbi.nlm.nih.gov/pubmed/9797"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2004/02/skos/core#altLabel",
          "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:7165",
          "o": "Granulomatous thyroiditis"
        }
      ],
      "ideal_answer": [
        "There is no evidence that paramyxovirus are involved in etiology of subacute thyroiditis."
      ],
      "exact_answer": "no",
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013968",
        "http://www.disease-ontology.org/api/metadata/DOID:7165",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018109",
        "http://www.disease-ontology.org/api/metadata/DOID:7187",
        "http://www.disease-ontology.org/api/metadata/DOID:7166"
      ],
      "type": "yesno",
      "id": "513efe01bee46bd34c00000e",
      "snippets": [
        {
          "offsetInBeginSection": 95,
          "offsetInEndSection": 310,
          "text": "Most cases of subacute thyroiditis are caused by a variety of viruses, for example, Coxsackie, cytomegalovirus, Epstein-Barr virus, and adenovirus. Influenza immunization or infection may cause subacute thyroiditis.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22819125",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 396,
          "offsetInEndSection": 483,
          "text": "Coxsackie virus has been reported to be one of the viruses associated with the disease.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20886354",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 154,
          "text": "The etiology of subacute granulomatous thyroiditis (SAT) is obscure, although it is postulated to be associated with viral infections and genetic factors.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9637274",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1511,
          "offsetInEndSection": 1587,
          "text": "The results suggest that SAT is not usually associated with acute infections",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9637274",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1589,
          "offsetInEndSection": 1699,
          "text": "No evidence was obtained to support the proposed role of enteroviruses as an important etiologic agent of SAT.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9637274",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 802,
          "offsetInEndSection": 1400,
          "text": "The viral antibodies evaluated were those of Influenza A and B, Coxsackie A9, B1, B2, B3, B4, B5 and B6, Echo 3, 7, 11 and 12, Parainfluenza 1, 2, 3 and 4, and Adeno 8 virus. The following results were obtained: In class I HLA typing, the frequency of HLA-Bw35 in SAT was 67.4%, which was significantly (p less than 0.0001) higher than that in the control (14.1%). On the other hand, the frequency of Cw1 in SAT (14.6%) was significantly (p less than 0.01) lower than that of the control (32.1%), and that of Cw3 (65.2%) was significantly (p less than 0.01) higher than that of the control (46.5%).",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2998895",
          "endSection": "sections.0"
        }
      ]
    },
    {
      "body": "Why does cranberry juice help combat urinary tract infections?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21688109",
        "http://www.ncbi.nlm.nih.gov/pubmed/19921981",
        "http://www.ncbi.nlm.nih.gov/pubmed/24304610",
        "http://www.ncbi.nlm.nih.gov/pubmed/21480803",
        "http://www.ncbi.nlm.nih.gov/pubmed/19636526",
        "http://www.ncbi.nlm.nih.gov/pubmed/19257836",
        "http://www.ncbi.nlm.nih.gov/pubmed/20495471",
        "http://www.ncbi.nlm.nih.gov/pubmed/23440506",
        "http://www.ncbi.nlm.nih.gov/pubmed/9110682",
        "http://www.ncbi.nlm.nih.gov/pubmed/19284180",
        "http://www.ncbi.nlm.nih.gov/pubmed/22499815"
      ],
      "ideal_answer": [
        "Cranberry products affect the surface properties, such as fimbriae and lipopolysaccharides, and adhesion of fimbriated and nonfimbriated E. coli."
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D029799",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014552",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014551"
      ],
      "type": "summary",
      "id": "5314ad66dae131f847000004",
      "snippets": [
        {
          "offsetInBeginSection": 1339,
          "offsetInEndSection": 1486,
          "text": " Cranberry products affect the surface properties, such as fimbriae and lipopolysaccharides, and adhesion of fimbriated and nonfimbriated E. coli. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19257836",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 301,
          "offsetInEndSection": 435,
          "text": " Cranberry juice has been shown to be effective in preventing adhesion of bacteria such as Escherichia coli to the bladder epithelium.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22499815",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 755,
          "offsetInEndSection": 1014,
          "text": "Inhibition of adherence to an extent of about 70% with multi-drug resistant E. coli strains was observed on uroepithelial cell. The anti-adherence bioactivity of the proanthocyanidin was detected at concentrations of 10-50 \u00b5g/ml with significant bacteriuria. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21688109",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 828,
          "offsetInEndSection": 1156,
          "text": "Still with regard to antibiotic treatment in women, a recently published study investigated also the potential cranberry juice interaction with beta-lactam antibiotics supporting the hypothesis that cranberry juice in usual quantities as prophylaxis for UTI is not likely to alter the pharmacokinetics of these oral antibiotics.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20495471",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 582,
          "offsetInEndSection": 781,
          "text": "In vitro studies have shown that binding of the P fimbriae of Escherichia coli to the uroepithelial tissue can be inhibited in the presence of proanthocyanidins, the active ingredient of cranberries.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19636526",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 918,
          "offsetInEndSection": 1172,
          "text": "NDM at concentrations between 0.2/mL and 1mg/mL significantly (P<.05) decreased secretion of extracellular FTF, as well as down-regulated ftf expression in a dose-dependent manner. NDM also markedly reduced the luciferase activity under the ftf promoter.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19284180",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 9,
          "offsetInEndSection": 189,
          "text": "Cranberry juice has long been recognized in folk medicine as a therapeutic agent, mainly in urinary tract infections. Its proposed mechanism of action is antiadhesion of bacteria. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19284180",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1427,
          "offsetInEndSection": 1617,
          "text": "The AFM adhesion force measurements were consistent with the results of a hemagglutination assay, confirming that oral consumption of CJC could act against adhesion of uropathogenic E. coli.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21480803",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 798,
          "offsetInEndSection": 945,
          "text": "These data suggest that daily consumption of concentrated cranberry juice can significantly prevent the recurrence of symptomatic UTIs in children.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19921981",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "To which family does the Zika virus belong?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25310102"
      ],
      "triples": [
        {
          "p": "http://purl.uniprot.org/core/reviewed",
          "s": "http://purl.uniprot.org/taxonomy/64320",
          "o": "false"
        },
        {
          "p": "http://purl.uniprot.org/core/scientificName",
          "s": "http://purl.uniprot.org/taxonomy/64320",
          "o": "Zika virus"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A0820708",
          "o": "64320"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0820708",
          "o": "Zika virus"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A14224049",
          "o": "Zika virus (organism)"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0318793",
          "o": "http://linkedlifedata.com/resource/umls/label/A0820708"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#prefLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0318793",
          "o": "http://linkedlifedata.com/resource/umls/label/A14224049"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A0820708",
          "o": "NCBI Taxonomy"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A14224049",
          "o": "Metathesaurus Names"
        }
      ],
      "ideal_answer": [
        "The Zika virus belongs to the family Flaviviridae."
      ],
      "exact_answer": [
        "Flaviviridae"
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005190",
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014780",
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014777",
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009679"
      ],
      "type": "factoid",
      "id": "56b76d916e3f8eaf4c000001",
      "snippets": [
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 69,
          "text": "Zika virus (ZIKV; genus Flavivirus, family Flaviviridae) ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25310102",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "List types of avoided words in bacterial genomes",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12762852",
        "http://www.ncbi.nlm.nih.gov/pubmed/9171096"
      ],
      "ideal_answer": [
        "Short palindromic sequences (4, 5 and 6 bp palindromes) are avoided at a statistically significant level in the genomes of several bacteria, including the completely sequenced Haemophilus influenzae and Synechocystis sp. genomes and in the complete genome of the archaeon Methanococcus jannaschii. Palindromes corresponding to sites for restriction enzymes from other species are also avoided, albeit less significantly, suggesting that in the course of evolution bacterial DNA has been exposed to a wide spectrum of restriction enzymes, probably as the result of lateral transfer mediated by mobile genetic elements, such as plasmids and prophages. Palindromic words appear to accumulate in DNA once it becomes isolated from restriction-modification systems, as demonstrated by the case of organellar genomes."
      ],
      "exact_answer": [
        [
          "Short palindromic sequences (4, 5 and 6 bp palindromes)"
        ],
        [
          "Palindromes corresponding to sites for restriction enzymes from other species"
        ]
      ],
      "type": "list",
      "id": "56a37e33496b62f23f000003",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "Avoidance of palindromic words in bacterial and archaeal genomes: a close connection with restriction enzymes.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9171096",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 297,
          "text": "Short palindromic sequences (4, 5 and 6 bp palindromes) are avoided at a statistically significant level in the genomes of several bacteria, including the completely sequenced Haemophilus influenzae and Synechocystis sp. genomes and in the complete genome of the archaeon Methanococcus jannaschii.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9171096",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 804,
          "offsetInEndSection": 1154,
          "text": "Palindromes corresponding to sites for restriction enzymes from other species are also avoided, albeit less significantly, suggesting that in the course of evolution bacterial DNA has been exposed to a wide spectrum of restriction enzymes, probably as the result of lateral transfer mediated by mobile genetic elements, such as plasmids and prophages",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9171096",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1156,
          "offsetInEndSection": 1315,
          "text": "Palindromic words appear to accumulate in DNA once it becomes isolated from restriction-modification systems, as demonstrated by the case of organellar genomes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9171096",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1496,
          "offsetInEndSection": 1642,
          "text": "In certain cases, a comparison of avoided palindromic words in taxonomically related bacteria shows a pattern of relatedness of their R-M systems.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12762852",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 180,
          "text": "Recognition sites for type II restriction and modification enzymes in genomes of several bacteria are recognized as semi-palindromic motifs and are avoided at a significant degree.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12762852",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1200,
          "offsetInEndSection": 1506,
          "text": "On the basis of the set of most avoided words, and in accordance to the IUPAC coding standards, suggestions are made regarding potential recognition sequences. In certain cases, a comparison of avoided palindromic words in taxonomically related bacteria shows a pattern of relatedness of their R-M systems.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12762852",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Are retroviruses used for gene therapy?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23921576",
        "http://www.ncbi.nlm.nih.gov/pubmed/23843498",
        "http://www.ncbi.nlm.nih.gov/pubmed/23884859",
        "http://www.ncbi.nlm.nih.gov/pubmed/23860311",
        "http://www.ncbi.nlm.nih.gov/pubmed/19435468",
        "http://www.ncbi.nlm.nih.gov/pubmed/21943326",
        "http://www.ncbi.nlm.nih.gov/pubmed/24120896",
        "http://www.ncbi.nlm.nih.gov/pubmed/23845947",
        "http://www.ncbi.nlm.nih.gov/pubmed/23845948",
        "http://www.ncbi.nlm.nih.gov/pubmed/23845071",
        "http://www.ncbi.nlm.nih.gov/pubmed/12686720",
        "http://www.ncbi.nlm.nih.gov/pubmed/16251873",
        "http://www.ncbi.nlm.nih.gov/pubmed/15912200"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0598504",
          "o": "http://linkedlifedata.com/resource/umls/label/A1306652"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A1306651",
          "o": "gene transplantation for gene therapy"
        },
        {
          "p": "http://data.linkedct.org/resource/linkedct/intervention_name",
          "s": "http://data.linkedct.org/resource/intervention/39568",
          "o": "Gene Therapy"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://data.linkedct.org/resource/intervention/39568",
          "o": "Intervention #39568 (Genetic:Gene Therapy)"
        },
        {
          "p": "http://data.linkedct.org/resource/linkedct/intervention_name",
          "s": "http://data.linkedct.org/resource/intervention/17724",
          "o": "gene therapy"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://data.linkedct.org/resource/intervention/17724",
          "o": "Intervention #17724 (Procedure:gene therapy)"
        }
      ],
      "ideal_answer": [
        "Gene therapy is one of the most promising and active fields in therapeutic research. Gene therapy is a treatment option that introduces genetic material in vivo or ex vivo into the cells of an affected organism in order to: exchange a defective gene; manipulate a disease-related gene; or introduce an additional gene copy for overexpression of the encoded protein to generate a curative biological effect. Somatic gene therapy is gene transfer by a specific vector to a somatic cell; in contrast to germline gene therapy, the modification of the cell is restricted to the recipient and cannot be passed to her/his progeny. High efficiency of gene transfer, high specificity for the target cells, long-lasting expression of the transgene and safety without adverse reactions are the desired characteristics of an ideal vector for gene transfer.\nRetroviral (gretroviral and lentiviral) vectors have now been used in more than 350 gene-therapy studies. Retroviral vectors are particularly suited for gene-correction of cells due to long-term and stable expression of the transferred transgene(s), and also because little effort is required for their cloning and production. Several monogenic inherited diseases, mostly immunodeficiencies, can now be successfully treated."
      ],
      "exact_answer": "yes",
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005796",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012191",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012190",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016458",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015316",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0010467",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012192"
      ],
      "type": "yesno",
      "id": "52ce531f03868f1b06000031",
      "snippets": [
        {
          "offsetInBeginSection": 401,
          "offsetInEndSection": 600,
          "text": "Several immunodeficiencies have been treated successfully by stem cell-targeted, retroviral-mediated gene transfer with reconstitution of the immune system following infusion of the transduced cells.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23843498",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 538,
          "offsetInEndSection": 809,
          "text": "In this work we have developed and tested a self-inactivating (SIN) gammaretroviral vector (SINfes.gp91s) containing a codon-optimized transgene (gp91(phox)) under the transcriptional control of a myeloid promoter for the gene therapy of the X-linked form of CGD (X-CGD).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23845071",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 352,
          "offsetInEndSection": 529,
          "text": " We used a lentiviral vector encoding functional WASP to genetically correct HSPCs from three WAS patients and reinfused the cells after a reduced-intensity conditioning regimen",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23845947",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 236,
          "offsetInEndSection": 459,
          "text": "We used a lentiviral vector to transfer a functional ARSA gene into hematopoietic stem cells (HSCs) from three presymptomatic patients who showed genetic, biochemical, and neurophysiological evidence of late infantile MLD. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23845948",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 204,
          "offsetInEndSection": 307,
          "text": "We assessed lentiviral vectors (LVs) targeted to the EC surface marker CD105 for in vivo gene delivery.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23884859",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 400,
          "offsetInEndSection": 506,
          "text": "gef and apoptin genes were cloned into a doxycycline-regulated retrovirus-mediated gene expression system.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23921576",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which micro-RNAs have been associated in the pathogenesis of Rheumatoid Arthritis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20840794",
        "http://www.ncbi.nlm.nih.gov/pubmed/18383392",
        "http://www.ncbi.nlm.nih.gov/pubmed/21611196",
        "http://www.ncbi.nlm.nih.gov/pubmed/23649045",
        "http://www.ncbi.nlm.nih.gov/pubmed/21600203",
        "http://www.ncbi.nlm.nih.gov/pubmed/18759964",
        "http://www.ncbi.nlm.nih.gov/pubmed/22161761",
        "http://www.ncbi.nlm.nih.gov/pubmed/22903258",
        "http://www.ncbi.nlm.nih.gov/pubmed/21339228",
        "http://www.ncbi.nlm.nih.gov/pubmed/22823586",
        "http://www.ncbi.nlm.nih.gov/pubmed/21339227",
        "http://www.ncbi.nlm.nih.gov/pubmed/19404929",
        "http://www.ncbi.nlm.nih.gov/pubmed/20459811",
        "http://www.ncbi.nlm.nih.gov/pubmed/24283221",
        "http://www.ncbi.nlm.nih.gov/pubmed/21279994",
        "http://www.ncbi.nlm.nih.gov/pubmed/19931339",
        "http://www.ncbi.nlm.nih.gov/pubmed/24120842",
        "http://www.ncbi.nlm.nih.gov/pubmed/23318734",
        "http://www.ncbi.nlm.nih.gov/pubmed/21416408",
        "http://www.ncbi.nlm.nih.gov/pubmed/18438844",
        "http://www.ncbi.nlm.nih.gov/pubmed/22100329",
        "http://www.ncbi.nlm.nih.gov/pubmed/23280137",
        "http://www.ncbi.nlm.nih.gov/pubmed/23385088",
        "http://www.ncbi.nlm.nih.gov/pubmed/20223711",
        "http://www.ncbi.nlm.nih.gov/pubmed/20870441",
        "http://www.ncbi.nlm.nih.gov/pubmed/20864373",
        "http://www.ncbi.nlm.nih.gov/pubmed/21354921",
        "http://www.ncbi.nlm.nih.gov/pubmed/22494429",
        "http://www.ncbi.nlm.nih.gov/pubmed/23138379",
        "http://www.ncbi.nlm.nih.gov/pubmed/22562984"
      ],
      "ideal_answer": [
        "Different expression patterns of mir-146a, miRNA-155, miRNA-124a, mir-203, mir-223, mir-346, mir-132, mir-363, mir-498, mir-15a, and mir-16 were documented in several tissue sample types of RA patients."
      ],
      "exact_answer": [
        [
          "miR-155"
        ],
        [
          "miR-146a"
        ],
        [
          "miR-124a"
        ],
        [
          "miR-222"
        ],
        [
          "miR-223"
        ],
        [
          "miR-203"
        ],
        [
          "miR-346"
        ],
        [
          "miR-132"
        ],
        [
          "miR-363"
        ],
        [
          "miR-498"
        ],
        [
          "miR-15a"
        ],
        [
          "miR-16"
        ],
        [
          "miR-18a"
        ]
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001172",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D035683",
        "http://www.disease-ontology.org/api/metadata/DOID:7148",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0009405"
      ],
      "type": "list",
      "id": "533c3533c45e133714000004",
      "snippets": [
        {
          "offsetInBeginSection": 1447,
          "offsetInEndSection": 1548,
          "text": "This study provides the first description of increased expression of miRNA miR-155 and miR-146a in RA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18383392",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 100,
          "offsetInEndSection": 275,
          "text": "In this study we investigated the expression, regulation, and function of miR-155 and miR-146a in rheumatoid arthritis (RA) synovial fibroblasts (RASFs) and RA synovial tissue",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18383392",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 199,
          "offsetInEndSection": 355,
          "text": "The objective of this study was to identify the expression pattern of microRNA-146 (miR-146) in synovial tissue from patients with rheumatoid arthritis (RA)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18438844",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1478,
          "offsetInEndSection": 1619,
          "text": "This study shows that miR-146 is expressed in RA synovial tissue and that its expression is induced by stimulation with TNFalpha and IL-1beta",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18438844",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 104,
          "text": "pregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18759964",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 426,
          "offsetInEndSection": 707,
          "text": "Total RNA was isolated from peripheral blood mononuclear cells obtained from patients with rheumatoid arthritis, and healthy and disease control individuals, and the expression of miR-146a, miR-155, miR-132, miR-16, and microRNA let-7a was analyzed using quantitative real-time PCR",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18759964",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 718,
          "offsetInEndSection": 977,
          "text": "Rheumatoid arthritis peripheral blood mononuclear cells exhibited between 1.8-fold and 2.6-fold increases in miR-146a, miR-155, miR-132, and miR-16 expression, whereas let-7a expression was not significantly different compared with healthy control individuals",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18759964",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2106,
          "offsetInEndSection": 2371,
          "text": "Our data also suggest a possible mechanism contributing to rheumatoid arthritis pathogenesis, whereby miR-146a expression is increased but unable to properly function, leading to prolonged tumor necrosis factor-alpha production in patients with rheumatoid arthritis",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18759964",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1299,
          "offsetInEndSection": 1540,
          "text": "Repression of TRAF6 and/or IRAK-1 in THP-1 cells resulted in up to an 86% reduction in tumor necrosis factor-alpha production, implicating that normal miR-146a function is critical for the regulation of tumor necrosis factor-alpha production",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18759964",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 170,
          "text": "icroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19404929",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1051,
          "offsetInEndSection": 1156,
          "text": "We found that miR-124a levels significantly decreased in RA synoviocytes as compared with OA synoviocytes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19404929",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1485,
          "offsetInEndSection": 1597,
          "text": "Induction of miR-124a in RA synoviocytes significantly suppressed the production of the CDK-2 and MCP-1 proteins",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19404929",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1774,
          "offsetInEndSection": 1903,
          "text": "he results of this study suggest that miR-124a is a key miRNA in the posttranscriptional regulatory mechanisms of RA synoviocytes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19404929",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 87,
          "text": "iR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19931339",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 286,
          "offsetInEndSection": 627,
          "text": "Although a multifactorial pathogenesis has been hypothesized, the precise mechanisms leading to the disease are still poorly understood at the molecular level. miRNA expression profile analysis highlighted that miR-223 is the only miRNA that is strikingly deregulated in peripheral T-lymphocytes from RA patients compared with healthy donors",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19931339",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1055,
          "offsetInEndSection": 1275,
          "text": "In summary, our data provide a first characterization of the miRNA expression profiles of peripheral T-lymphocytes of RA patients, identifying miR-223 as overexpressed in CD4(+) naive T-lymphocytes from these individuals",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19931339",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 118,
          "text": "Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20459811",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 594,
          "offsetInEndSection": 692,
          "text": "The role of miR-146a overexpression in regulating T cell apoptosis was evaluated by flow cytometry",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20459811",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1483,
          "offsetInEndSection": 1763,
          "text": "We have detected increased miR-146a in CD4+ T cells of RA patients and its close correlation with TNF-alpha levels. Our findings that miR-146a overexpression suppresses T cell apoptosis indicate a role of miR-146a in RA pathogenesis and provide potential novel therapeutic targets",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20459811",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 92,
          "text": "icroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20840794",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 936,
          "offsetInEndSection": 1059,
          "text": "Six miRNAs, let-7a, miR-26, miR-146a/b, miR-150, and miR-155 were significantly up regulated in the IL-17 producing T cells",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20840794",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1487,
          "offsetInEndSection": 1601,
          "text": "These results indicated that miR-146a was associated with IL-17 expression in the PBMC and synovium in RA patients",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20840794",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2,
          "offsetInEndSection": 163,
          "text": "polymorphism in the 3'-UTR of interleukin-1 receptor-associated kinase (IRAK1), a target gene of miR-146a, is associated with rheumatoid arthritis susceptibility",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20870441",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 263,
          "offsetInEndSection": 374,
          "text": "MicroRNA-146a was found to be increased in synovial fibroblasts, synovial tissue and PBMC from patients with RA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20870441",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1011,
          "offsetInEndSection": 1134,
          "text": "This is the first study that addresses association of a variant in a target of miR-146a, IRAK1 gene, with RA susceptibility",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20870441",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 117,
          "text": "ltered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21279994",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 115,
          "offsetInEndSection": 335,
          "text": "Previously, we described increased expression of miR-155 and miR-146a in rheumatoid arthritis (RA) and showed a repressive effect of miR-155 on matrix metalloproteinase (MMP) expression in RA synovial fibroblasts (RASFs)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21279994",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1575,
          "offsetInEndSection": 1670,
          "text": "The current results demonstrate methylation-dependent regulation of miR-203 expression in RASFs",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21279994",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1671,
          "offsetInEndSection": 1879,
          "text": " Importantly, they also show that elevated levels of miR-203 lead to increased secretion of MMP-1 and IL-6 via the NF-\u03baB pathway and thereby contribute to the activated phenotype of synovial fibroblasts in RA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21279994",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 120,
          "text": "iR-124a as a key regulator of proliferation and MCP-1 secretion in synoviocytes from patients with rheumatoid arthritis",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21339227",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 364,
          "offsetInEndSection": 498,
          "text": "Transfection of miR-124a into RA synoviocytes significantly suppressed their proliferation and arrested the cell cycle at the G1 phase",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21339227",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 766,
          "offsetInEndSection": 911,
          "text": "It is proposed that miR-124a is a key miRNA in the post-transcriptional regulatory mechanisms of RA synoviocytes, and has a therapeutic potential",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21339227",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 156,
          "text": "Expression of miR-146a and miR-16 in peripheral blood mononuclear cells of patients with rheumatoid arthritis and their correlation to the disease activity",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21354921",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 960,
          "offsetInEndSection": 1128,
          "text": "The elevated expression levels of miR-146a and miR-16 are correlated to RA disease activity, suggesting their value in assessment of the clinical disease activity of RA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21354921",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 125,
          "text": "iR-346 controls release of TNF-\u03b1 protein and stability of its mRNA in rheumatoid arthritis via tristetraprolin stabilization",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21611196",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 426,
          "offsetInEndSection": 650,
          "text": "Using a microarray, we found two miRNAs, miR-125b and miR-939 predicted to target the 3'-UTR of TNF-\u03b1 mRNA, to be up-regulated in RA FLS in response to LPS, but their repression did not restore mature TNF-\u03b1 expression in FLS",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21611196",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 652,
          "offsetInEndSection": 781,
          "text": "We showed previously that miR-346, which is upregulated in LPS-activated FLS, inhibited Btk expression that stabilized TNF-\u03b1 mRNA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21611196",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 354,
          "offsetInEndSection": 555,
          "text": "Different expression patterns of mir-146a, miRNA-155, miRNA-124a, mir-203, mir-223, mir-346, mir-132, mir-363, mir-498, mir-15a, and mir-16 were documented in several tissue sample types of RA patients",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22100329",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 107,
          "text": "own-regulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22161761",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 848,
          "offsetInEndSection": 1055,
          "text": "Basal expression levels of miR-34a* were found to be reduced in synovial fibroblasts from RA patients compared to osteoarthritis patients, whereas levels of miR-34a, miR-34b/b*, and miR-34c/c* did not differ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22161761",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1623,
          "offsetInEndSection": 1724,
          "text": "Our data provide evidence of a methylation-specific down-regulation of proapoptotic miR-34a* in RASFs",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22161761",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 170,
          "text": "dentification of microRNA-221/222 and microRNA-323-3p association with rheumatoid arthritis via predictions using the human tumour necrosis factor transgenic mouse model",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22562984",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 720,
          "offsetInEndSection": 867,
          "text": "miR-seq demonstrated that TghuTNF-SF exhibit a distinct pathogenic profile with 22 significantly upregulated and 30 significantly downregulated miR",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22562984",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 869,
          "offsetInEndSection": 1063,
          "text": "Validation assays confirmed the dysregulation of miR-223, miR-146a and miR-155 previously associated with human rheumatoid arthritis (RA) pathology, as well as that of miR-221/222 and miR-323-3p",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22562984",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1594,
          "offsetInEndSection": 1678,
          "text": "the authors identified miR-221/222 and miR-323-3p as novel dysregulated miR in RA SF",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22562984",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1495,
          "offsetInEndSection": 1633,
          "text": "Further association studies may contribute to determining the role of miR-146a single-nucleotide polymorphisms in immune-mediated diseases",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22823586",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 144,
          "text": "iR-146a polymorphism is associated with asthma but not with systemic lupus erythematosus and juvenile rheumatoid arthritis in Mexican patients.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22823586",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 99,
          "text": "verexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22903258",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 80,
          "offsetInEndSection": 159,
          "text": "MicroRNA-223 (miR-223) is reported to play critical roles in osteoclastogenesis",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22903258",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1474,
          "offsetInEndSection": 1589,
          "text": "MiR-223 is intensely expressed in RA synovium, and overexpression of miR-223 suppresses osteoclastogenesis in vitro",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22903258",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1591,
          "offsetInEndSection": 1700,
          "text": "This study demonstrates the possibility of gene therapy with miR-223 to treat bone destruction in RA patients",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22903258",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 931,
          "offsetInEndSection": 1085,
          "text": "MiR-223 was more highly expressed in RA synovium than in osteoarthritis (OA) synovium due to the increased number of miR-223-positive cells in RA synovium",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22903258",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 124,
          "text": "ssociation of pre-miRNA-146a rs2910164 and pre\u2011miRNA-499 rs3746444 polymorphisms and susceptibility to rheumatoid arthritis",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23138379",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1263,
          "offsetInEndSection": 1439,
          "text": "Our findings demonstrated that the hsa-mir-499 rs3746444, but not mir-146a rs2910164, polymorphism is associated with an increased RA risk in a sample of the Iranian population",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23138379",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 139,
          "text": "umor necrosis factor \u03b1-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-\u03baB signaling",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23280137",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 11,
          "offsetInEndSection": 161,
          "text": "To elucidate whether the microRNA (miRNA) cluster miR-17-92 contributes to the activated phenotype of rheumatoid arthritis synovial fibroblasts (RASFs",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23280137",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 803,
          "offsetInEndSection": 895,
          "text": "We found that TNF\u03b1 induces the expression of miR-17-92 in RASFs in an NF-\u03baB-dependent manner",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23280137",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1151,
          "offsetInEndSection": 1270,
          "text": "Using reporter gene assays, we identified the NF-\u03baB pathway inhibitor TNF\u03b1-induced protein 3 as a new target of miR-18a",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23280137",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1431,
          "offsetInEndSection": 1708,
          "text": "Our data suggest that the miR-17-92-derived miR-18a contributes to cartilage destruction and chronic inflammation in the joint through a positive feedback loop in NF-\u03baB signaling, with concomitant up-regulation of matrix-degrading enzymes and mediators of inflammation in RASFs",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23280137",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 529,
          "offsetInEndSection": 774,
          "text": "As inflammation and joint damage are the main hallmarks of RA, we focused on the three miRNAs, miR-146a, miR-155 and miR-223, whose functions have been studied in both the processes and the pathogenic role investigated in the experimental models",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23318734",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 785,
          "offsetInEndSection": 979,
          "text": "Focusing on the role of miR-146a, miR-155 and miR-223 in RA pathogenesis emphasizes the intertwined relationships between bone homeostasis and immunity, and the prominent role of monocytes in RA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23318734",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 517,
          "offsetInEndSection": 619,
          "text": "In a final perspective section we discuss the potential impact of therapeutic miR-155 modulation in RA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649045",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 15,
          "offsetInEndSection": 151,
          "text": "correlation between whole blood and PBMC expression levels of miR-155 and miR-146a in healthy controls and rheumatoid arthritis patients",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24120842",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 654,
          "offsetInEndSection": 821,
          "text": "We demonstrated a highly significant linear correlation between miR-146a and miR-155 expression in PBMC and whole blood, from both healthy individuals and RA patients.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24120842",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 9,
          "offsetInEndSection": 183,
          "text": "expression of specific microRNAs (miRNA) in peripheral blood-derived mononuclear cells (PBMC), particularly miR-146a and miR-155, is associated with rheumatoid arthritis (RA)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24120842",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 106,
          "text": "icroRNA-323-3p with clinical potential in rheumatoid arthritis, Alzheimer's disease and ectopic pregnancy",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24283221",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 332,
          "offsetInEndSection": 491,
          "text": "It has been shown that miR-323-3p associates with the pathogenesis of several diseases, such as rheumatoid arthritis, Alzheimer's disease and ectopic pregnancy",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24283221",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which are the smallest known subviral pathogens of plants?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10494833",
        "http://www.ncbi.nlm.nih.gov/pubmed/10592219",
        "http://www.ncbi.nlm.nih.gov/pubmed/25503469",
        "http://www.ncbi.nlm.nih.gov/pubmed/16519798",
        "http://www.ncbi.nlm.nih.gov/pubmed/25731957",
        "http://www.ncbi.nlm.nih.gov/pubmed/15231279",
        "http://www.ncbi.nlm.nih.gov/pubmed/22345560",
        "http://www.ncbi.nlm.nih.gov/pubmed/1717335",
        "http://www.ncbi.nlm.nih.gov/pubmed/16679345",
        "http://www.ncbi.nlm.nih.gov/pubmed/2672273",
        "http://www.ncbi.nlm.nih.gov/pubmed/15040183"
      ],
      "ideal_answer": [
        "Contrary to earlier beliefs, viruses are not the smallest causative agents of infectious diseases. Single-stranded RNAs as small as 246 nucleotides exist in certain higher plants and cause more than a dozen crop diseases. These RNAs have been termed viroids. Viroids are plant subviral pathogens whose genomes are constituted by a single-stranded and covalently closed small RNA molecule that does not encode for any protein.",
        "Since the discovery of non-coding, small, highly structured, satellite RNAs (satRNAs) and viroids as subviral pathogens of plants , have been of great interest to molecular biologists as possible living fossils of pre-cellular evolution in an RNA world."
      ],
      "exact_answer": [
        "Viroids"
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D010944"
      ],
      "type": "factoid",
      "id": "56e0447a51531f7e3300000b",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 253,
          "text": "Since the discovery of non-coding, small, highly structured, satellite RNAs (satRNAs) and viroids as subviral pathogens of plants , have been of great interest to molecular biologists as possible living fossils of pre-cellular evolution in an RNA world.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25731957",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1186,
          "offsetInEndSection": 1382,
          "text": "PFOR2 analysis of the small RNA libraries from grapevine and apple plants led to the discovery of Grapevine latent viroid (GLVd) and Apple hammerhead viroid-like RNA (AHVd-like RNA), respectively.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25503469",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1020,
          "offsetInEndSection": 1190,
          "text": "We show that viroids from the two known families are readily identified and their full-length sequences assembled by PFOR from small RNAs sequenced from infected plants. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22345560",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 167,
          "text": "Viroids are plant subviral pathogens whose genomes are constituted by a single-stranded and covalently closed small RNA molecule that does not encode for any protein. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16679345",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 105,
          "text": "Viroids are small, circular, single-stranded RNA molecules that cause several infectious plant diseases. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15231279",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 57,
          "text": "Viroids: petite RNA pathogens with distinguished talents.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15231279",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 68,
          "text": "Subviral pathogens of plants: viroids and viroidlike satellite RNAs.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1717335",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 258,
          "text": "Contrary to earlier beliefs, viruses are not the smallest causative agents of infectious diseases. Single-stranded RNAs as small as 246 nucleotides exist in certain higher plants and cause more than a dozen crop diseases. These RNAs have been termed viroids.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1717335",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 41,
          "text": "Subviral pathogens of plants: the viroids",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2672273",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 175,
          "text": "Viroids, satellite RNAs, satellites viruses and the human hepatitis delta virus form the 'brotherhood' of the smallest known infectious RNA agents, known as the subviral RNAs.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16519798",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 42,
          "text": "Subviral pathogens of plants: the viroids.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2672273",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 109,
          "text": "Viroids, subviral pathogens of plants, are composed of a single-stranded circular RNA of 246-399 nucleotides.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10494833",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 306,
          "text": "During 1970 and 1971, I discovered that a devastating disease of potato plants is not caused by a virus, as had been assumed, but by a new type of subviral pathogen, the viroid. Viroids are so small--one fiftieth of the size of the smallest viruses--that many scientists initially doubted their existence. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15040183",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 93,
          "text": "The database of the smallest known auto-replicable RNA species: viroids and viroid-like RNAs.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10592219",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 186,
          "text": "Viroids, satellite RNAs, satellites viruses and the human hepatitis delta virus form the &apos;brotherhood&apos; of the smallest known infectious RNA agents, known as the subviral RNAs.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16519798",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 323,
          "text": " Replicating circular RNAs are independent plant pathogens known as viroids, or act to modulate the pathogenesis of plant and animal viruses as their satellite RNAs. The rate of discovery of these subviral pathogens was low over the past 40 years because the classical approaches are technical demanding and time-consuming.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25503469",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which are the major phycobiliproteins present in cyanobacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/15242812",
        "http://www.ncbi.nlm.nih.gov/pubmed/18062815",
        "http://www.ncbi.nlm.nih.gov/pubmed/16569506",
        "http://www.ncbi.nlm.nih.gov/pubmed/2431391",
        "http://www.ncbi.nlm.nih.gov/pubmed/1409666",
        "http://www.ncbi.nlm.nih.gov/pubmed/24063013",
        "http://www.ncbi.nlm.nih.gov/pubmed/20306699",
        "http://www.ncbi.nlm.nih.gov/pubmed/12416885",
        "http://www.ncbi.nlm.nih.gov/pubmed/17234404",
        "http://www.ncbi.nlm.nih.gov/pubmed/10744320",
        "http://www.ncbi.nlm.nih.gov/pubmed/6802826",
        "http://www.ncbi.nlm.nih.gov/pubmed/16592117",
        "http://www.ncbi.nlm.nih.gov/pubmed/3127591",
        "http://www.ncbi.nlm.nih.gov/pubmed/18954974",
        "http://www.ncbi.nlm.nih.gov/pubmed/1903389",
        "http://www.ncbi.nlm.nih.gov/pubmed/9548282",
        "http://www.ncbi.nlm.nih.gov/pubmed/11690696",
        "http://www.ncbi.nlm.nih.gov/pubmed/19224391",
        "http://www.ncbi.nlm.nih.gov/pubmed/8187585",
        "http://www.ncbi.nlm.nih.gov/pubmed/16190625",
        "http://www.ncbi.nlm.nih.gov/pubmed/12767340",
        "http://www.ncbi.nlm.nih.gov/pubmed/8344905",
        "http://www.ncbi.nlm.nih.gov/pubmed/23664178",
        "http://www.ncbi.nlm.nih.gov/pubmed/3931221",
        "http://www.ncbi.nlm.nih.gov/pubmed/2502578",
        "http://www.ncbi.nlm.nih.gov/pubmed/24435274",
        "http://www.ncbi.nlm.nih.gov/pubmed/16593484",
        "http://www.ncbi.nlm.nih.gov/pubmed/3086870",
        "http://www.ncbi.nlm.nih.gov/pubmed/7678762",
        "http://www.ncbi.nlm.nih.gov/pubmed/11504069",
        "http://www.ncbi.nlm.nih.gov/pubmed/8419325"
      ],
      "ideal_answer": [
        "Phycobiliproteins are derived from the photosynthetic apparatus of cyanobacteria and eukaryotic algae, and form their large extrinsic antenna complexes called phycobilisomes. Phycobilisomes have a core composed from allophycocyanin (APC) and rods, which are of variable phycobiliprotein composition. C-Phycocyanin (C-Pc) is one of the major light harvesting biliprotein pigments constitutively produced by many cyanobacteria, such as Spirulina platenesis (a blue-green alga). B-Phycoerythrin (B-PE) is an other major light-harvesting pigment found in red algae and cyanobacteria. R-phycoerythrin (R-PE) is the major light-harvesting pigment protein of most red algal phycobilisomes."
      ],
      "exact_answer": [
        [
          "allophycocyanin (APC)"
        ],
        [
          "C-Phycocyanin (C-Pc)"
        ],
        [
          "B-Phycoerythrin (B-PE)"
        ],
        [
          "R-phycoerythrin (R-PE)"
        ]
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000458",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D052979"
      ],
      "type": "list",
      "id": "55439140ed966d112c00000a",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 162,
          "text": "An extensive range of pigments including phycobiliproteins are present in algae. C-phycocyanin (C-PC), a phycobiliprotein, is one of the key pigments of Spirulina",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24063013",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 71,
          "text": "Spirulina platensis produces nutraceutical product C-phycocyanin (C-PC)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23664178",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 114,
          "text": "C-Phycocyanin (C-Pc) is one of the major biliprotein pigments of unicellular cyanbacterium of Spirulina platenesis",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306699",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 258,
          "text": "Marine Synechococcus owe their specific vivid color (ranging from blue-green to orange) to their large extrinsic antenna complexes called phycobilisomes, comprising a central allophycocyanin core and rods of variable phycobiliprotein composition.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18062815",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 259,
          "offsetInEndSection": 408,
          "text": "Three major pigment types can be defined depending on the major phycobiliprotein found in the rods (phycocyanin, phycoerythrin I or phycoerythrin II)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18062815",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 85,
          "text": "Phycocyanin--a major phycobiliprotein constitutively produced by many cyanobacteria--",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17234404",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 86,
          "text": "R-phycoerythrin was isolated and purified from a red alga, Polysiphonia urceolata Grev",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16569506",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 81,
          "offsetInEndSection": 180,
          "text": "C-phycocyanin (C-PC), one of the major phycobiliproteins of Spirulina platensis (a blue-green alga)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16190625",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 176,
          "text": "C-Phycocyanin (C-PC), the major light harvesting biliprotein from Spirulina platensis is of greater importance because of its various biological and pharmacological properties.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15242812",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 73,
          "text": "B-Phycoerythrin (B-PE) is a major light-harvesting pigment of microalgae.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12767340",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 305,
          "text": "Phycoerythrin is a major light-harvesting pigment of red algae and cyanobacteria that is widely used as a fluorescent probe and analytical reagent. In this paper, B-phycoerythrin and R-phycocyanin in native state, from the red alga Porphyridium cruentum were obtained by an inexpensive and simple process.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11690696",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 102,
          "text": "Phycobiliproteins are derived from the photosynthetic apparatus of cyanobacteria and eukaryotic algae.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11504069",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 573,
          "offsetInEndSection": 667,
          "text": "the three major phycobiliprotein types, namely allophycocyanin, phycocyanin, and phycoerythrin",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11504069",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 116,
          "text": "Phycoerythrin is a major light-harvesting pigment of red algae and cyanobacteria widely used as a fluorescent probe.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10744320",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 250,
          "offsetInEndSection": 271,
          "text": "allophycocyanin (APC)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8187585",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 95,
          "text": "R-phycoerythrin is the major light-harvesting pigment protein of most red algal phycobilisomes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8344905",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 926,
          "offsetInEndSection": 1172,
          "text": "The purified protein had three absorption peaks at 498, 535, and 565 nm and displayed a fluorescence maximum at 580 nm, which was consistent with the typical spectrum of R-phycoerythrin. The purified R-PE was also identified with electrophoresis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16569506",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 199,
          "text": "Phycobilisomes, the major light-harvesting complexes of cyanobacteria are multimolecular structures made up of chromophoric proteins called phycobiliproteins and non chromophoric linker polypeptides.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2431391",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 198,
          "offsetInEndSection": 397,
          "text": "We report here the isolation and nucleotide sequence of the genes, cpeA and cpeB, which in Calothrix PCC 7601 encode the alpha and beta subunits of phycoerythrin, one of the major phycobiliproteins.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2431391",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 295,
          "text": "The major light-harvesting complex in eukaryotic red algae and prokaryotic cyanobacteria is the phycobilisome, a water-soluble complex located on the outer surface of the photosynthetic membranes and composed of both pigmented phycobiliproteins (85%) and non-pigmented linker (15%) polypeptides.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3127591",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 120,
          "text": "Phycocyanin is a major protein produced by cyanobacteria, but very few phycocyanin-producing strains have been reported.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18954974",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 194,
          "offsetInEndSection": 340,
          "text": "In the present work, phycocyanin (PC) and phycoerythrin (PE) from a Nostoc species are proposed as protein markers for electrophoretic techniques.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9548282",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 211,
          "text": "Rod structure of a phycoerythrin II-containing phycobilisome. I. Organization and sequence of the gene cluster encoding the major phycobiliprotein rod components in the genome of marine Synechococcus sp. WH8020.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8419325",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1244,
          "offsetInEndSection": 1410,
          "text": "We now present data showing that the allophycocyanin genes and a second set of phycocyanin genes are transcribed into major mRNAs of 1400 and 1600 bases, respectively",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3086870",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 660,
          "offsetInEndSection": 847,
          "text": "The amino acid sequences deduced from both rpeA and rpeB present strong homologies with those previously reported for phycoerythrin subunits of cyanobacteria, rhodophyta, and cryptomonads",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1409666",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1412,
          "offsetInEndSection": 1605,
          "text": "These transcripts are present in RNA isolated from cultures grown in red and green light, although lower levels of the 1600-base phycocyanin transcript are present in cells grown in green light",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3086870",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 119,
          "text": "Phycocyanin is a major protein produced by cyanobacteria, but very few phycocyanin-producing strains have been reported",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18954974",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 294,
          "text": "The major light-harvesting complex in eukaryotic red algae and prokaryotic cyanobacteria is the phycobilisome, a water-soluble complex located on the outer surface of the photosynthetic membranes and composed of both pigmented phycobiliproteins (85%) and non-pigmented linker (15%) polypeptides",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3127591",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 175,
          "text": "Phycocyanin--a major phycobiliprotein constitutively produced by many cyanobacteria--holds several promising applications in diagnostics, biomedical research, and therapeutics",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17234404",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 198,
          "text": "Phycobilisomes, the major light-harvesting complexes of cyanobacteria are multimolecular structures made up of chromophoric proteins called phycobiliproteins and non chromophoric linker polypeptides",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2431391",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is the presumed key event in Fanconi anemia pathogenesis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22675617",
        "http://www.ncbi.nlm.nih.gov/pubmed/15601828",
        "http://www.ncbi.nlm.nih.gov/pubmed/19609304",
        "http://www.ncbi.nlm.nih.gov/pubmed/20937699",
        "http://www.ncbi.nlm.nih.gov/pubmed/15502827",
        "http://www.ncbi.nlm.nih.gov/pubmed/22258451",
        "http://www.ncbi.nlm.nih.gov/pubmed/15383454"
      ],
      "ideal_answer": [
        "Monoubiquitination of the Fanconi anaemia protein FANCD2 is a key event leading to repair of interstrand cross-links. Failure of FANCD2 monoubiquitination by the nuclear FA protein complex has a severe impact on the DNA repair functions of cells."
      ],
      "exact_answer": [
        "FANCD2 monoubiquitination"
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D051856",
        "http://www.disease-ontology.org/api/metadata/DOID:13636",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005199",
        "http://www.disease-ontology.org/api/metadata/DOID:1062"
      ],
      "type": "factoid",
      "id": "54edf72c94afd61504000013",
      "snippets": [
        {
          "offsetInBeginSection": 92,
          "offsetInEndSection": 278,
          "text": "A key event in FA pathway activation is the monoubiquitylation of the FA complementation group I (FANCI)-FANCD2 (ID) complex by FA complementation group L (FANCL), an E3 ubiquitin ligase",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20937699",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 116,
          "text": "Monoubiquitination of the Fanconi anaemia protein FANCD2 is a key event leading to repair of interstrand cross-links",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19609304",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 438,
          "offsetInEndSection": 746,
          "text": "Here we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15502827",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 369,
          "text": "Fanconi anemia (FA) is characterized by congenital abnormalities, bone marrow failure, chromosome fragility, and cancer susceptibility. Eight FA-associated genes have been identified so far, the products of which function in the FA/BRCA pathway. A key event in the pathway is the monoubiquitination of the FANCD2 protein, which depends on a multiprotein FA core complex",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15383454",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 434,
          "offsetInEndSection": 744,
          "text": " Here we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15502827",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 97,
          "offsetInEndSection": 377,
          "text": "This event also causes phosphorylation of the Fanconi anemia (FA) protein FANCI, triggering its monoubiquitination of the key DNA repair factor FANCD2 by the FA core E3 ligase complex, thereby promoting this central pathway of DNA repair which permits replication to be restarted.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22258451",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 438,
          "offsetInEndSection": 747,
          "text": "Here we show that the protein defective in individuals with Fanconi anemia belonging to complementation group B is an essential component of the nuclear protein 'core complex' responsible for monoubiquitination of FANCD2, a key event in the DNA-damage response pathway associated with Fanconi anemia and BRCA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15502827",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 246,
          "offsetInEndSection": 370,
          "text": "A key event in the pathway is the monoubiquitination of the FANCD2 protein, which depends on a multiprotein FA core complex.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15383454",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 399,
          "offsetInEndSection": 562,
          "text": "The key event of the FA pathway is dependent on an eight-protein core complex (CC), required for the monoubiquitination of each member of the FANCD2-FANCI complex.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22675617",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 207,
          "offsetInEndSection": 387,
          "text": "FA proteins (FancA/C/E/F/G/L) form a multiprotein complex, which is responsible for DNA damage-induced FancD2 monoubiquitination, a key event for cellular resistance to DNA damage.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15601828",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 92,
          "offsetInEndSection": 279,
          "text": "A key event in FA pathway activation is the monoubiquitylation of the FA complementation group I (FANCI)-FANCD2 (ID) complex by FA complementation group L (FANCL), an E3 ubiquitin ligase.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20937699",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 246,
          "offsetInEndSection": 369,
          "text": "A key event in the pathway is the monoubiquitination of the FANCD2 protein, which depends on a multiprotein FA core complex",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15383454",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 97,
          "offsetInEndSection": 376,
          "text": "This event also causes phosphorylation of the Fanconi anemia (FA) protein FANCI, triggering its monoubiquitination of the key DNA repair factor FANCD2 by the FA core E3 ligase complex, thereby promoting this central pathway of DNA repair which permits replication to be restarted",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22258451",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which types of bacterial microflora are associated with the progression of peri-implantitis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20976394",
        "http://www.ncbi.nlm.nih.gov/pubmed/9526919",
        "http://www.ncbi.nlm.nih.gov/pubmed/14598129",
        "http://www.ncbi.nlm.nih.gov/pubmed/23937262"
      ],
      "ideal_answer": [
        "Bacteria such as A. actinomycetemcomitans, P. gingivalis, T. forsythensis, T. denticola, P. intermedia and F. nucleatum are associated with the progression of peri-implantitis."
      ],
      "exact_answer": [
        [
          "A. actinomycetemcomitans"
        ],
        [
          "P. gingivalis"
        ],
        [
          "T. denticola"
        ],
        [
          "T. forsythia"
        ],
        [
          "P. intermedia"
        ],
        [
          "F. nucleatum"
        ]
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D057873"
      ],
      "type": "list",
      "id": "553babc0f321868558000007",
      "snippets": [
        {
          "offsetInBeginSection": 522,
          "offsetInEndSection": 758,
          "text": " Later, the specific plaque hypothesis established the role of some microorganisms such as A. actinomycetemcomitans, P. gingivalis, T. forsythensis, T. denticola, P. intermedia and F. nucleatum in different forms of periodontal diseases",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20976394",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1082,
          "offsetInEndSection": 1259,
          "text": "The microbiological analysis revealed that the total bacterial load increased during the period following ligature removal and established an anaerobic Gram-negative microflora.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23937262",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 502,
          "offsetInEndSection": 681,
          "text": "Most periodontal pathogens are common saprophytes of the oral cavity, expressing their virulence only in a susceptible host or when some changes come about in the oral environment",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14598129",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 726,
          "offsetInEndSection": 1013,
          "text": "Overall, the types and relative proportions of putative periodontal pathogens in plaque associated with ligature-induced peri-implantitis and ligature-induced periodontitis were similar. Only levels of anaerobic Actinomyces and spirochetes were significantly different between both sites",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9526919",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Are viruses involved in the etiology of human subacute thyroiditis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18422033",
        "http://www.ncbi.nlm.nih.gov/pubmed/19138419",
        "http://www.ncbi.nlm.nih.gov/pubmed/20960165",
        "http://www.ncbi.nlm.nih.gov/pubmed/11109652",
        "http://www.ncbi.nlm.nih.gov/pubmed/23227861",
        "http://www.ncbi.nlm.nih.gov/pubmed/22819125",
        "http://www.ncbi.nlm.nih.gov/pubmed/19627727",
        "http://www.ncbi.nlm.nih.gov/pubmed/20671410",
        "http://www.ncbi.nlm.nih.gov/pubmed/22527824",
        "http://www.ncbi.nlm.nih.gov/pubmed/1856259",
        "http://www.ncbi.nlm.nih.gov/pubmed/1691523",
        "http://www.ncbi.nlm.nih.gov/pubmed/18421188",
        "http://www.ncbi.nlm.nih.gov/pubmed/12608662",
        "http://www.ncbi.nlm.nih.gov/pubmed/22459018",
        "http://www.ncbi.nlm.nih.gov/pubmed/20886354",
        "http://www.ncbi.nlm.nih.gov/pubmed/9790279",
        "http://www.ncbi.nlm.nih.gov/pubmed/10971829",
        "http://www.ncbi.nlm.nih.gov/pubmed/4936649",
        "http://www.ncbi.nlm.nih.gov/pubmed/10525005",
        "http://www.ncbi.nlm.nih.gov/pubmed/22136271",
        "http://www.ncbi.nlm.nih.gov/pubmed/15332726",
        "http://www.ncbi.nlm.nih.gov/pubmed/16279854",
        "http://www.ncbi.nlm.nih.gov/pubmed/9915102"
      ],
      "ideal_answer": [
        "Subacute thyroiditis (SAT) is an inflammatory disorder of the thyroid caused probably by viruses\nThe principal classes of viruses involed  in SAT include Epstein Barr and Retroviridae"
      ],
      "exact_answer": "yes",
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014780",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D050033",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013190",
        "http://www.disease-ontology.org/api/metadata/DOID:7187",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0003831",
        "http://www.disease-ontology.org/api/metadata/DOID:7166",
        "http://www.disease-ontology.org/api/metadata/DOID:7165",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007453",
        "http://www.uniprot.org/uniprot/PERT_CANFA",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013958",
        "http://www.uniprot.org/uniprot/PERT_RAT",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013962",
        "http://www.uniprot.org/uniprot/PERT_HUMAN",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013966",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013968",
        "http://www.uniprot.org/uniprot/PERT_PIG",
        "http://www.uniprot.org/uniprot/PERT_MOUSE",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013957"
      ],
      "type": "yesno",
      "id": "513711055274a5fb0700000e",
      "snippets": [
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 180,
          "text": "he etiology of subacute (de Quervain's) thyroiditis (SAT) is uncertain, although it probably represents a nonspecific inflammatory response by the thyroid to a variety of viruses.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1856259",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 93,
          "text": "Subacute thyroiditis is an inflammatory disorder of the thyroid caused probably by viruses. I",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11109652",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 713,
          "offsetInEndSection": 853,
          "text": "We believe that the etiologic agent was the Epstein-Barr virus because heterophile and Epstein-Barr virus-specific antibodies were positive.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11109652",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 711,
          "offsetInEndSection": 1051,
          "text": "ltogether, these results indicate that the mechanism of inhibition of Spumavirinae infection by interferon differs from that described for the other Retroviridae, and particularly for types B, C and D viruses. Our data is of therapeutic interest since Spumavirinae have been linked to pathological processes such as de Quervain thyroiditis.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1691523",
          "endSection": "sections.0"
        }
      ]
    },
    {
      "body": "What is the reason for the narcolepsy cases developed after H1N1 influenza vaccination?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21866560",
        "http://www.ncbi.nlm.nih.gov/pubmed/23486871",
        "http://www.ncbi.nlm.nih.gov/pubmed/24048081",
        "http://www.ncbi.nlm.nih.gov/pubmed/23884811",
        "http://www.ncbi.nlm.nih.gov/pubmed/21963829",
        "http://www.ncbi.nlm.nih.gov/pubmed/21676420",
        "http://www.ncbi.nlm.nih.gov/pubmed/22530521",
        "http://www.ncbi.nlm.nih.gov/pubmed/22213222"
      ],
      "ideal_answer": [
        "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility."
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014611",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D053118",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014612",
        "http://www.disease-ontology.org/api/metadata/DOID:8986",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009290"
      ],
      "type": "summary",
      "id": "530cf54dab4de4de0c000009",
      "snippets": [
        {
          "offsetInBeginSection": 747,
          "offsetInEndSection": 957,
          "text": "The proposed mechanism for postvaccination narcolepsy is one in which an environmental trigger causes or enhances an antibody-mediated autoimmune response in patients with a preexisting genetic susceptibility. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24048081",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 224,
          "text": "The loss of hypothalamic hypocretin/orexin (hcrt) producing neurons causes narcolepsy with cataplexy. An autoimmune basis for the disease has long been suspected and recent results have greatly strengthened this hypothesis. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21963829",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 663,
          "offsetInEndSection": 776,
          "text": "pointing towards processes such as molecular mimicry or bystander activation as crucial for disease development. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21963829",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 581,
          "offsetInEndSection": 840,
          "text": "Although no formal link can be established, the unusual characteristics of the reported cases and the striking temporal relationship suggests that narcolepsy may be the result of an autoimmune reaction triggered by H1N1\u00a0vaccination in susceptible individuals.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21676420",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1141,
          "offsetInEndSection": 1251,
          "text": "Pandemrix vaccination is a precipitating factor for narcolepsy, especially in combination with HLA-DQB1*0602. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23486871",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 363,
          "offsetInEndSection": 524,
          "text": "Recently identified autoantibodies to Tribbles homologue 2 in some patients, as well as cases associated with H1N1 vaccination, support an autoimmune mechanism. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22213222",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1367,
          "offsetInEndSection": 1701,
          "text": "n China, narcolepsy onset is highly correlated with seasonal and annual patterns of upper airway infections, including H1N1 influenza. In 2010, the peak seasonal onset of narcolepsy was phase delayed by 6 months relative to winter H1N1 infections, and the correlation was independent of H1N1 vaccination in the majority of the sample.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21866560",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2016,
          "offsetInEndSection": 2141,
          "text": "H1N1 vaccination was strongly associated with an increased risk of narcolepsy-cataplexy in both children and adults in France",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23884811",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which enzymes are involved in global genome nucleotide excision repair (GG-NER) in bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20004108",
        "http://www.ncbi.nlm.nih.gov/pubmed/19617358",
        "http://www.ncbi.nlm.nih.gov/pubmed/19933360",
        "http://www.ncbi.nlm.nih.gov/pubmed/24290807",
        "http://www.ncbi.nlm.nih.gov/pubmed/23963890",
        "http://www.ncbi.nlm.nih.gov/pubmed/23245695",
        "http://www.ncbi.nlm.nih.gov/pubmed/21145481",
        "http://www.ncbi.nlm.nih.gov/pubmed/19762288",
        "http://www.ncbi.nlm.nih.gov/pubmed/22559785",
        "http://www.ncbi.nlm.nih.gov/pubmed/25463394"
      ],
      "ideal_answer": [
        "Nucleotide excision repair (NER) is universally used to recognize and remove many types of DNA damage. In eubacteria, the NER system typically consists of UvrA, UvrB, UvrC, the UvrD helicase, DNA polymerase I, and ligase.  Damage recognition during bacterial NER depends upon UvrA, which binds to the damage and loads UvrB onto the DNA. Subsequently, UvrA, UvrB and UvrC form the excinuclease protein UvrABC endonuclease, a multi-enzymatic complex which carries out repair of damaged DNA in sequential manner. In some cases, Cho may be the effective nuclease for NER, rather than UvrC. UvrC nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD, a superfamily 1A helicase. In gram-positive organisms, PcrA helicase can also displace UvrC and the excised oligonucleotide from a post-incision NER complex."
      ],
      "exact_answer": [
        [
          "UvrA"
        ],
        [
          "UvrB"
        ],
        [
          "UvrC nuclease"
        ],
        [
          "UvrD 1A helicase"
        ],
        [
          "DNA polymerase I"
        ],
        [
          "Ligase"
        ],
        [
          "Cho nuclease (instead of UvrC)"
        ],
        [
          "PcrA helicase (instead of Uvrd, in gram-positive bacteria)"
        ]
      ],
      "concepts": [
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000720",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000109",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0006289",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0070911",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004260"
      ],
      "type": "list",
      "id": "5547a7e9f35db75526000006",
      "snippets": [
        {
          "offsetInBeginSection": 169,
          "offsetInEndSection": 455,
          "text": "we evaluated the in vivo role of NER in the repair of DNA adducts generated by psoralens (mono- or bi-functional) and UV-A light (PUVA) in E. coli. Cultures of wild-type E. coli K12 and mutants for uvrA, uvrB, uvrC or uvrAC genes were treated with PUVA and cell survival was determined.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20004108",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 221,
          "text": "Nucleotide excision repair (NER) is universally used to recognize and remove many types of DNA damage. In eubacteria, the NER system typically consists of UvrA, UvrB, UvrC, the UvrD helicase, DNA polymerase I, and ligase.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19933360",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 207,
          "text": "During nucleotide excision repair (NER) in bacteria the UvrC nuclease and the short oligonucleotide that contains the DNA lesion are removed from the post-incision complex by UvrD, a superfamily 1A helicase.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762288",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 349,
          "offsetInEndSection": 416,
          "text": "UvrD interacts with UvrB, a component of the post-incision complex.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762288",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1162,
          "offsetInEndSection": 1400,
          "text": "PcrA helicase from Bacillus stearothermophilus can also displace UvrC and the excised oligonucleotide from a post-incision NER complex, which supports the idea that PcrA performs a UvrD-like function during NER in gram-positive organisms.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762288",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 957,
          "offsetInEndSection": 1032,
          "text": "Cho rather than UvrC seems to be an effective nuclease for the NER of DPCs.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19617358",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 312,
          "offsetInEndSection": 478,
          "text": "Nucleotide excision repair consists of excinuclease protein UvrABC endonuclease, multi-enzymatic complex which carries out repair of damaged DNA in sequential manner.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23963890",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 223,
          "offsetInEndSection": 502,
          "text": "Escherichia coli K12 mutant strains deficient in nucleotide excision repair (NER) were submitted to increasing concentrations of cisplatin, and the results revealed that uvrA and uvrB mutants are sensitive to this agent, while uvrC and cho mutants remain as the wild type strain.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23245695",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 401,
          "offsetInEndSection": 1194,
          "text": "we used a genetic approach to investigate the roles of nucleotide excision repair (NER) pathway components in H. pylori mutation and recombination. RESULTS: Inactivation of any of the four uvr genes strongly increased the susceptibility of H. pylori to DNA damage by ultraviolet light. Inactivation of uvrA and uvrB significantly decreased mutation frequencies whereas only the uvrA deficient mutant exhibited a significant decrease of the recombination frequency after natural transformation. A uvrC mutant did not show significant changes in mutation or recombination rates; however, inactivation of uvrC promoted the incorporation of significantly longer fragments of donor DNA (2.2-fold increase) into the recipient chromosome. A deletion of uvrD induced a hyper-recombinational phenotype.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22559785",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 586,
          "text": "Transcription-coupled DNA repair (TCR) is a subpathway of nucleotide excision repair (NER) that is triggered when RNA polymerase is stalled by DNA damage. Lesions targeted by TCR are repaired more quickly than lesions repaired by the transcription-independent \"global\" NER pathway, but the mechanism underlying this rate enhancement is not understood. Damage recognition during bacterial NER depends upon UvrA, which binds to the damage and loads UvrB onto the DNA. Bacterial TCR additionally requires the Mfd protein, a DNA translocase that removes the stalled transcription complexes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21145481",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "How is yellow fever virus transmitted?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20513550",
        "http://www.ncbi.nlm.nih.gov/pubmed/23697028",
        "http://www.ncbi.nlm.nih.gov/pubmed/21143108",
        "http://www.ncbi.nlm.nih.gov/pubmed/23411863",
        "http://www.ncbi.nlm.nih.gov/pubmed/21413253",
        "http://www.ncbi.nlm.nih.gov/pubmed/24056028",
        "http://www.ncbi.nlm.nih.gov/pubmed/23967358",
        "http://www.ncbi.nlm.nih.gov/pubmed/21199140",
        "http://www.ncbi.nlm.nih.gov/pubmed/23523817",
        "http://www.ncbi.nlm.nih.gov/pubmed/22999801",
        "http://www.ncbi.nlm.nih.gov/pubmed/21723310",
        "http://www.ncbi.nlm.nih.gov/pubmed/20874041",
        "http://www.ncbi.nlm.nih.gov/pubmed/16913829",
        "http://www.ncbi.nlm.nih.gov/pubmed/22966141",
        "http://www.ncbi.nlm.nih.gov/pubmed/22594140",
        "http://www.ncbi.nlm.nih.gov/pubmed/24027319",
        "http://www.ncbi.nlm.nih.gov/pubmed/18645665",
        "http://www.ncbi.nlm.nih.gov/pubmed/22264275",
        "http://www.ncbi.nlm.nih.gov/pubmed/23980723",
        "http://www.ncbi.nlm.nih.gov/pubmed/22377581",
        "http://www.ncbi.nlm.nih.gov/pubmed/22897918",
        "http://www.ncbi.nlm.nih.gov/pubmed/15705322",
        "http://www.ncbi.nlm.nih.gov/pubmed/23740065",
        "http://www.ncbi.nlm.nih.gov/pubmed/16707042",
        "http://www.ncbi.nlm.nih.gov/pubmed/23133693"
      ],
      "ideal_answer": [
        "Yellow fever virus is transmitted by mosquitoes and is restricted to Africa, Central and South America and the Caribbean. \nYellow fever virus is a flavivirus, and there is only one antigenic type. It was taken to the Americas by the early slave traders, and nowadays reported in Africa, America, Asia and Europe. Yellow fever virus is transmitted by two different cycles: \n-from human to human by the mosquito Aedes aegypti; which is well-adapted to breeding around human habitations; the infection can be maintained in this way as \u2018urban\u2019 yellow fever.\n-from infected monkeys to humans by mosquitoes such as Haemagogus. This is \u2018jungle\u2019 yellow fever and is seen in Africa and South America.\n\nYellow fever is not transmitted directly from human to human by day-to-day contact, but transmission from ill patients to healthcare workers has been reported, notably after needlestick injury."
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015004",
        "http://www.disease-ontology.org/api/metadata/DOID:9682",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015005"
      ],
      "type": "summary",
      "id": "533aaab6d6d3ac6a34000062",
      "snippets": [
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 472,
          "text": "Yellow Fever (YF) is an acute viral communicable disease transmitted by an arbovirus of the flavivirus genus. It is primarily a zoonotic disease, especially the monkeys. Worldwide, an estimated 200\u2009000 cases of yellow fever occurred each year, and the case-fatality rate is ~15%. Forty-five endemic countries in Africa and Latin America, with a population of close to 1 billion, are at risk. Up to 50% of severely affected persons from YF die without treatment",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24056028",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 20,
          "offsetInEndSection": 565,
          "text": "yellow fever virus (YFV) are transmitted between arthropod vectors and vertebrate hosts. While barriers limiting arbovirus population diversity have been observed in mosquitoes, whether barriers exist in vertebrate hosts is unclear. To investigate whether arboviruses encounter bottlenecks during dissemination in the vertebrate host, we infected immunocompetent mice and immune-deficient mice lacking alpha/beta interferon (IFN-\u03b1/\u03b2) receptors (IFNAR\u207b/\u207b mice) with a pool of genetically marked viruses to evaluate dissemination and host barriers",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24027319",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 190,
          "text": "Re-emergence of vector-borne diseases such as dengue and yellow fever, which are both transmitted by the Aedes aegypti mosquito, has been correlated with insecticide resistance. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23980723",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 393,
          "text": "Arthropod-borne viruses are important emerging pathogens world-wide. Viruses transmitted by mosquitoes, such as dengue, yellow fever, and Japanese encephalitis viruses, infect hundreds of millions of people and animals each year. Global surveillance of these viruses in mosquito vectors using molecular based assays is critical for prevention and control of the associated diseases",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23967358",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 204,
          "offsetInEndSection": 489,
          "text": "fever and dengue fever are mosquito-borne infectious diseases transmitted by Aedes aegyptii, the presence of yellow fever in Sudan and dengue fever in Saudi Arabia are threats to Egypt with the reemerging of Ae. aegyptii in Southern Egypt, larvae control is feasible than flying adults",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23697028",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 39,
          "offsetInEndSection": 282,
          "text": "dengue virus (DENV) and yellow fever virus (YFV), that originated in sylvatic cycles maintained in non-human primates and forest-dwelling mosquitoes have emerged repeatedly into sustained human-to-human transmission by Aedes aegypti mosquitoes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23523817",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 284,
          "offsetInEndSection": 439,
          "text": "Sylvatic cycles of both viruses remain active, and where the two viruses overlap in West Africa they utilize similar suites of monkeys and Aedes mosquitoes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23523817",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 572,
          "offsetInEndSection": 1098,
          "text": "First, the sylvatic cycle of YFV originated in Africa and was introduced into the New World, probably as a result of the slave trade, but is absent in Asia; in contrast, sylvatic DENV likely originated in Asia and has spread to Africa but not to the New World. Second, while sylvatic YFV can emerge into extensive urban outbreaks in humans, these invariably die out, whereas four different types of DENV have established human transmission cycles that are ecologically and evolutionarily distinct from their sylvatic ancestors",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23523817",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1100,
          "offsetInEndSection": 1358,
          "text": "Finally, transmission of YFV among humans has been documented only in Africa and the Americas, whereas DENV is transmitted among humans across most of the range of competent Aedes vectors, which in the last decade has included every continent save Antarctica",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23523817",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 114,
          "offsetInEndSection": 237,
          "text": "Mosquito-transmitted diseases such as malaria, dengue, yellow fever and filariasis are the main contributors to this burden",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23411863",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 67,
          "offsetInEndSection": 272,
          "text": "yellow fever (YFV) viruses is increasing in many parts of the world. The viruses are primarily transmitted by Aedes aegypti, a highly domesticated mosquito species that is notoriously difficult to control.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23133693",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 72,
          "offsetInEndSection": 202,
          "text": "The first of these to be discovered was yellow fever virus in 1901, and three to four new species are still being found every year",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22966141",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 540,
          "text": "The causative agent of yellow fever is an arbovirus of the Flaviviridae family transmitted by infected Aedes mosquitoes, particularly in Africa. In the Central African Republic since 2006, cases have been notified in the provinces of Ombella-Mpoko, Ouham-Pende, Basse-Kotto, Haute-Kotto and in Bangui the capital. As the presence of a vector of yellow fever virus (YFV) represents a risk for spread of the disease, we undertook entomological investigations at these sites to identify potential vectors of YFV and their abundance",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22897918",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 21,
          "offsetInEndSection": 203,
          "text": " family Flaviviridae, includes a number of important arthropod-transmitted human pathogens such as dengue viruses, West Nile virus, Japanese encephalitis virus and yellow fever virus",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22377581",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 502,
          "offsetInEndSection": 948,
          "text": "Reports of the detection of these viruses with no recognized pathogenic role in humans are increasing in mosquitoes collected around the world, particularly in those sampled in entomological surveys targeting pathogenic flaviviruses. The presence of six potential flaviviruses, detected from independent European arbovirus surveys undertaken in the Czech Republic, Italy, Portugal, Spain and the UK between 2007 and 2010, is reported in this work",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22377581",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 416,
          "text": "Yellow Fever virus (YFV) is an important arboviral pathogen in much of sub-Saharan Africa and the tropical Americas. It is the prototype member of the genus Flavivirus and is transmitted primarily by Aedes (Stegomyia) mosquitoes. The incidence of human infections in endemic areas has risen in recent years. Prompt and dependable identification of YFV is a critical component of response to suspect cases",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22264275",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 358,
          "text": "Health-care professionals can help travelers by providing accurate pre-travel counseling for mosquito-transmitted diseases such as malaria, yellow fever, and dengue fever. Governments and international organizations will benefit from knowledge survey among health professionals in this field to promote the development of travel health profession",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21199140",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 26,
          "offsetInEndSection": 165,
          "text": "United States made 12 million visits to developing countries in Asia, South America, Central America, Oceania, the Middle East, and Africa.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20874041",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 13,
          "offsetInEndSection": 223,
          "text": " Yellow fever is a serious illness public health importance and is transmitted by mosquitoes of the genera Haemagogus and Sabethes in the rural and forest environments, and by Aedes aegypti in the urban setting",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18645665",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 582,
          "offsetInEndSection": 919,
          "text": "Many specialist human viruses also have mammalian or avian origins. Indeed, a substantial proportion of mammalian viruses may be capable of crossing the species barrier into humans, although only around half of these are capable of being transmitted by humans and around half again of transmitting well enough to cause major outbreaks. A",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22966141",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Carbapenemase-producing gram-negative bacteria is a major health concern because their resistance to antibiotics.\nList the most frequent carbapenemases found in Enterobacteriaceae.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20534805",
        "http://www.ncbi.nlm.nih.gov/pubmed/23114438",
        "http://www.ncbi.nlm.nih.gov/pubmed/22553235",
        "http://www.ncbi.nlm.nih.gov/pubmed/20237104",
        "http://www.ncbi.nlm.nih.gov/pubmed/22796889",
        "http://www.ncbi.nlm.nih.gov/pubmed/20960935",
        "http://www.ncbi.nlm.nih.gov/pubmed/20686438",
        "http://www.ncbi.nlm.nih.gov/pubmed/17594211",
        "http://www.ncbi.nlm.nih.gov/pubmed/18070960",
        "http://www.ncbi.nlm.nih.gov/pubmed/17227206",
        "http://www.ncbi.nlm.nih.gov/pubmed/22383444",
        "http://www.ncbi.nlm.nih.gov/pubmed/20649801",
        "http://www.ncbi.nlm.nih.gov/pubmed/20542902",
        "http://www.ncbi.nlm.nih.gov/pubmed/19386850"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://linkedlifedata.com/resource/pubmed/mesh/Enterobacteriaceae",
          "o": "Enterobacteriaceae"
        }
      ],
      "ideal_answer": [
        "The most frequent carbapenemases in Enterobacteriaceae  are OXA-48, KPC, VIM, NDM, IMP, SME, NMC, GES, IMI and MBL."
      ],
      "exact_answer": [
        [
          "OXA-48"
        ],
        [
          "KPC"
        ],
        [
          "VIM"
        ],
        [
          "NDM"
        ],
        [
          "IMP"
        ],
        [
          "SME"
        ],
        [
          "NMC"
        ],
        [
          "GES"
        ],
        [
          "IMI"
        ],
        [
          "MBL"
        ]
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004352",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000903",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004756",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0046677",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004755",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D024881",
        "http://www.uniprot.org/uniprot/BLAN_ENTCL",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015780"
      ],
      "type": "list",
      "id": "515870cdd24251bc0500008f",
      "snippets": [
        {
          "offsetInBeginSection": 513,
          "offsetInEndSection": 653,
          "text": "The most frequent carbapenemases in Enterobacteriaceae were OXA-48, KPC and VIM-1; in P. aeruginosa it was VIM-2 and in A. baumannii OXA-23.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23114438",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 485,
          "offsetInEndSection": 576,
          "text": "bla(IMP), bla(VIM), bla(SPM), bla(SIM) and bla(GIM), and of bla(KPC), bla(NDM) and bla(OXA-",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22796889",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 147,
          "text": "Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22553235",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 121,
          "text": "The Check-MDR CT102 DNA microarray enables detection of the most prevalent carbapenemases (NDM, VIM, KPC, OXA-48 and IMP)",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22383444",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 642,
          "offsetInEndSection": 706,
          "text": "63 KPC producers, 47 MBL producers, and 31 KPC and MBL producers",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20542902",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 347,
          "offsetInEndSection": 475,
          "text": "OXA-48 producers were poorly detected, but all systems reliably detected isolates with KPC and most with metallo-carbapenemases.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20534805",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 347,
          "offsetInEndSection": 699,
          "text": "Producers of IMP-, VIM-, and KPC-type carbapenemases with high levels of resistance to cephalosporins and to carbapenems were detected at 1x10(1) CFU/ml. The OXA-48 producers were not detected on ChromID ESBL medium unless coexpressing ESBLs, whereas carbapenemase-producing isolates with MICs of <4 microg/ml were not detected on CHROMagar KPC medium.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20237104",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 288,
          "offsetInEndSection": 641,
          "text": "The most frequent carbapenemase was KPC-2 or -3 (73 strains), followed by VIM-1 (14), IMP-1 (11), SME-2 (5), and NMC-A (1). All serine carbapenemases were detected in the United States, while MbetaL-producing strains were isolated in Europe. Carbapenemase-producing Enterobacteriaceae showed high rates of resistance to most antimicrobial agents tested.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18070960",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1672,
          "offsetInEndSection": 1848,
          "text": "By using this methodology, isolates producing KPC, GES, Sme, IMI, and NMC-A carbapenemases were successfully distinguished from those producing other classes of beta-lactamases",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19386850",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 887,
          "offsetInEndSection": 975,
          "text": "KPC-2 and KPC-3 were the most frequently occurring carbapenemases (24 isolates, 20.2%) i",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17227206",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 167,
          "offsetInEndSection": 243,
          "text": "K. pneumoniae strains with known KPC (n\u2003=\u200331) or VIM (n\u2003=\u200320) carbapenemases",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20649801",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 140,
          "text": "Carbapenemases including Klebsiella pneumoniae carbapenemases (KPC) are widespread among clinical isolates in the family Enterobacteriaceae.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20960935",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 98,
          "text": "Outbreak of vim-1-carbapenemase-producing Enterobacter cloacae in a pediatric intensive care unit.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20686438",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 340,
          "offsetInEndSection": 498,
          "text": "mergence of pediatric infections caused by carbapenemases-producing Enterobacteriaceae is a critical issue as they are resistant to most \u03b2-lactam antibiotics.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20686438",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1147,
          "offsetInEndSection": 1531,
          "text": "SME-2-producing S. marcescens were isolated in the New York City area, Texas, and Ohio, while NMC-A was found in one E. cloacae strain from New York. In contrast, metallo-beta-lactamases were prevalent in Europe. IMP-1-producing E. cloacae (11 isolates) were detected in Turkey, while VIM-1-producing strains were found in Italy (Enterobacter spp.) and Greece (Klebsiella pneumoniae).",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17227206",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 402,
          "offsetInEndSection": 553,
          "text": "d several simple confirmatory methods that allow the recognition of bacteria producing class A carbapenemases, including KPC, Sme, IMI, NMC-A, and GES,",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19386850",
          "endSection": "sections.0"
        }
      ]
    },
    {
      "body": "Provide examples of how molecular transporters contribute to multi-drug resistance in bacteria.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23746717",
        "http://www.ncbi.nlm.nih.gov/pubmed/24056102",
        "http://www.ncbi.nlm.nih.gov/pubmed/23755047",
        "http://www.ncbi.nlm.nih.gov/pubmed/22053181",
        "http://www.ncbi.nlm.nih.gov/pubmed/24123816",
        "http://www.ncbi.nlm.nih.gov/pubmed/24297686",
        "http://www.ncbi.nlm.nih.gov/pubmed/16290174",
        "http://www.ncbi.nlm.nih.gov/pubmed/23894076",
        "http://www.ncbi.nlm.nih.gov/pubmed/23870163",
        "http://www.ncbi.nlm.nih.gov/pubmed/24014018",
        "http://www.ncbi.nlm.nih.gov/pubmed/23742803"
      ],
      "ideal_answer": [
        "MDR efflux pumps began causing clinical problems relatively recently, in parallel with the extensive use of antibiotics in medicine and as supplements in animal feeds. However, our analyses indicate that these MDR efflux pumps did not arise through recent mutations in genes encoding transporters that changed their substrate specificities.\n\nInstead, such MDR pumps are encoded within the genomes of virtually all microorganisms, so these genes are present and thus need only to be activated to become problematic. Moreover, lateral transfer of genes among bacteria has occurred frequently, particularly for plasmid-encoded systems, suggesting that such genes can be acquired fairly readily even if they are not initially present. Finally, although mutations that enable transporters to act on different types of substrate are rare, experiments and phylogenetic analyses indicate that simple point mutations can readily narrow or broaden a particular transporter's specificity toward a single class of compounds (e.g., sugars, amino acids, or drugs)."
      ],
      "concepts": [
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0008559",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0042493",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0015238",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004364",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D024881",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004351",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004352",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0015893",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0006810",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:2001023",
        "http://www.uniprot.org/uniprot/RDR1_YEAST",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0009816",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0090484",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0006855",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D024901",
        "http://www.biosemantics.org/jochem#4264759",
        "http://www.uniprot.org/uniprot/PDR1_YEAST",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:2001025",
        "http://www.uniprot.org/uniprot/AB29G_ARATH",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:2001024",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001419"
      ],
      "type": "summary",
      "id": "52ed264a98d023950500002f",
      "snippets": [
        {
          "offsetInBeginSection": 123,
          "offsetInEndSection": 298,
          "text": " One of the common mechanisms of multidrug resistance in eukaryotic cells is the active efflux of a broad range of xenobiotics through ATP-binding cassette (ABC) transporters.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24297686",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1529,
          "offsetInEndSection": 2042,
          "text": "Overall, the phylogenetic diversity of As-resistant bacteria in underground water was very limited if compared with lentic and lotic waters. Lastly, our molecular data support the hypothesis that the horizontal gene transfer of ars in As-containing freshwater environments is not limited to closely-related genomes, but also occurs between bacteria that are distant from an evolutionary viewpoint, thereby indicating that such genetic events may be considered a source of microbial resistance to arsenic-toxicity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23870163",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1511,
          "offsetInEndSection": 1729,
          "text": "We postulate that the RND transporter All3143 and the predicted membrane fusion protein All3144, as homologs of E. coli AcrB and AcrA, respectively, are major players for antibiotic resistance in Anabaena sp. PCC 7120.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014018",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1111,
          "offsetInEndSection": 1347,
          "text": "These observations suggest a physiological association between c-di-AMP and the MDR transporters and support the model that MDR transporters mediate c-di-AMP secretion to regulate peptidoglycan synthesis in response to cell wall stress.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24056102",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1553,
          "offsetInEndSection": 1686,
          "text": "Our data suggest that SmbFT truly displays immunity function and confer protection against Smb and structurally similar lantibiotics.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24123816",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1262,
          "offsetInEndSection": 1487,
          "text": "This study indicates that the tetA gene decreases sensitivity to tigecycline in Salmonella spp. at a low level. With additional resistance mechanisms, tetA-carrying strains can reach the breakpoint for tigecycline resistance.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23746717",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1704,
          "offsetInEndSection": 1894,
          "text": "Efflux pump inhibitors may inhibit the major AcrAB-TolC in Salmonella efflux systems which are the major efflux pumps responsible for multidrug resistance in Gram-negative clinical isolates.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23742803",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 36,
          "offsetInEndSection": 257,
          "text": "(RND)-type efflux transporters play the main role in intrinsic resistance to various antimicrobial agents in many gram-negative bacteria. Here, we estimated 12 RND-type efflux transporter genes in Vibrio parahaemolyticus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23894076",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "List the three most prevalent pathogenic species of Borrelia in Europe.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22522688",
        "http://www.ncbi.nlm.nih.gov/pubmed/23837798",
        "http://www.ncbi.nlm.nih.gov/pubmed/25273355",
        "http://www.ncbi.nlm.nih.gov/pubmed/24533160",
        "http://www.ncbi.nlm.nih.gov/pubmed/24446554",
        "http://www.ncbi.nlm.nih.gov/pubmed/25120960",
        "http://www.ncbi.nlm.nih.gov/pubmed/24886071",
        "http://www.ncbi.nlm.nih.gov/pubmed/23838444",
        "http://www.ncbi.nlm.nih.gov/pubmed/22445929",
        "http://www.ncbi.nlm.nih.gov/pubmed/21876490",
        "http://www.ncbi.nlm.nih.gov/pubmed/25333277",
        "http://www.ncbi.nlm.nih.gov/pubmed/25409015",
        "http://www.ncbi.nlm.nih.gov/pubmed/23045802",
        "http://www.ncbi.nlm.nih.gov/pubmed/24623628",
        "http://www.ncbi.nlm.nih.gov/pubmed/22742788"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A7570463",
          "o": "NCI Thesaurus"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/altMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C0015176",
          "o": "http://linkedlifedata.com/resource/umls/label/A0056849"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/prefMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C0015176",
          "o": "http://linkedlifedata.com/resource/umls/label/A0056850"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0056848",
          "o": "Europe"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/altMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C0015176",
          "o": "http://linkedlifedata.com/resource/umls/label/A7570463"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/altMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C0015176",
          "o": "http://linkedlifedata.com/resource/umls/label/A0056848"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0015176",
          "o": "http://linkedlifedata.com/resource/umls/label/A0056849"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/altMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C0015176",
          "o": "http://linkedlifedata.com/resource/umls/label/A0056847"
        }
      ],
      "ideal_answer": [
        "The most prevalent pathogenic species of Borrelia in Europe are: B. afzelii, B. garinii and B. burgdorferi ss."
      ],
      "exact_answer": [
        [
          "B. afzelii"
        ],
        [
          "B. garinii"
        ],
        [
          "B. burgdorferi ss."
        ]
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015748",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005060",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005061",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D013045",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D058865",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001899",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001898",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D025065"
      ],
      "type": "list",
      "id": "54edaee3445c3b5a5f000003",
      "snippets": [
        {
          "offsetInBeginSection": 299,
          "offsetInEndSection": 577,
          "text": " The Borrelia species causing Lyme borreliosis in Europe express different OspA serotypes on their surface, B. burgdorferi (serotype 1), B. afzelii (serotype 2), B. garinii (serotypes, 3, 5 and 6) and B. bavariensis (serotype 4), while only B. burgdorferi is present in the US. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25409015",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 88,
          "text": "Borrelia afzelii is the predominant Borrelia species causing Lyme borreliosis in Europe.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25273355",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1030,
          "offsetInEndSection": 1169,
          "text": "Moreover we detected Borrelia spielmanii, Borrelia miyamotoi, Babesia divergens, and Babesia venatorum for the first time in Danish ticks. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25120960",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 711,
          "offsetInEndSection": 797,
          "text": "We successfully determined the prevalence of expected (Borrelia burgdorferi sensu lato",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25120960",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 362,
          "text": "Borrelia miyamotoi is a newly described emerging pathogen transmitted to people by Ixodes species ticks and found in temperate regions of North America, Europe, and Asia. There is limited understanding of large scale entomological risk patterns of B. miyamotoi and of Borreila burgdorferi sensu stricto (ss), the agent of Lyme disease, in western North America. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25333277",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 189,
          "text": "In France as elsewhere in Europe the most prevalent TBD in humans is Lyme borreliosis, caused by different bacterial species belonging to Borrelia burgdorferi sensu lato complex",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24886071",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 426,
          "offsetInEndSection": 596,
          "text": "B. miyamotoi belonging to the relapsing fever group and transmitted by the same Ixodes species has been involved in human disease in Russia, the USA and the Netherlands. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24886071",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 138,
          "text": "Laboratory diagnosis of Lyme disease is based on the serological detection of antibodies against the etiologic agent Borrelia burgdorferi.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24623628",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 143,
          "offsetInEndSection": 357,
          "text": "B. burgdorferi sl complex, currently comprising at least 19 genospecies, includes the main pathogenic species responsible for human disease in Europe: B. burgdorferi sensu stricto (ss), B. afzelii, and B. garinii. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24533160",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 177,
          "text": "The European red squirrel (Sciurus vulgaris) has long been suspected to be a reservoir host of the agents of Lyme borreliosis, in particular B. burgdorferi sensu stricto (s.s.).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24446554",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1610,
          "offsetInEndSection": 1765,
          "text": "n adults (n = 227), the prevalence of infection with B. burgdorferi s.l. was 27.3%, with 18.9% B. burgdorferi s.s., 11.9% B. afzelii, and 3.5% B. garinii. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24446554",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 816,
          "offsetInEndSection": 882,
          "text": ": The overall estimated prevalence of B. burgdorferi s.l was 9.7% ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23837798",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1090,
          "offsetInEndSection": 1342,
          "text": ". The most prevalent genospecies was B. afzelii which was detected in 53.5% of Borrelia-positive ticks, followed by B. garinii and B. valaisiana with 26.2% and 5.5%, respectively. Also, B. bavariensis and B. burgdorferi s.s. DNA in single I. ricinus ti",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23837798",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1052,
          "offsetInEndSection": 1279,
          "text": " Among all the analysed antigens those of B. burgdorferi s.s. were the most frequent cause of immunological reaction, followed by antigens of B. afzelii and B. garinii. Reaction to antigens of B. spielmanii was rarely detected.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22742788",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 413,
          "offsetInEndSection": 645,
          "text": "Overall, 15.8% ticks were infected with B. burgdorferi s. I. Borrelia afzelii (43.1%) was the predominant genospecies, followed by Borrelia valaisiana (14.7%), Borrelia garinii (13.7%) and Borrelia burgdorferi sensu stricto (6.3%). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23045802",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1156,
          "offsetInEndSection": 1310,
          "text": "In cases where the genospecies could be identified, B. garinii was most frequently found (8x), followed with B. burgdorferi s.s. (4\u00d7) and B. afzelii (3\u00d7).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21876490",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 227,
          "text": "In Europe, Ixodes ricinus is the vector of many pathogens of medical and veterinary relevance, among them Borrelia burgdorferi sensu lato and tick-borne encephalitis virus, which have been the subject of numerous investigations",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22522688",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 966,
          "offsetInEndSection": 1169,
          "text": "The minimum prevalence of Borrelia burgdorferi sensu lato was 2.5%. Borr. afzelii, Borr. burgdorferi sensu stricto, Borr. garinii, Borr. lusitaniae, and Borr. valaisiana were identified by hybridization.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22445929",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is zolpidem an antibiotic?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/8098760",
        "http://www.ncbi.nlm.nih.gov/pubmed/9433391",
        "http://www.ncbi.nlm.nih.gov/pubmed/11154097",
        "http://www.ncbi.nlm.nih.gov/pubmed/1403792",
        "http://www.ncbi.nlm.nih.gov/pubmed/2871178"
      ],
      "ideal_answer": [
        "No, zolpidem is a short-acting imidazopyridine hypnotic drug"
      ],
      "exact_answer": "no",
      "concepts": [
        "http://www.biosemantics.org/jochem#4205693",
        "http://www.biosemantics.org/jochem#4259685",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000900"
      ],
      "type": "yesno",
      "id": "530cf4fe960c95ad0c00000a",
      "snippets": [
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 106,
          "text": "Zolpidem is a short-acting imidazopyridine hypnotic drug that is metabolized mainly by CYP3A4.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9433391",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 461,
          "offsetInEndSection": 719,
          "text": "FGIN-1-27 and alpidem, like the neurosteroid 3 alpha,21-dehydroxy-5 alpha-pregnane-20-one (THDOC), clonazepam and zolpidem (the direct allosteric modulators of gamma-aminobutyric acidA receptors) delay the onset of isoniazid and metrazol-induced convulsions.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8098760",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 231,
          "text": "olpidem is a new, short-acting hypnotic of imidazopyridine structure which binds selectively to a subpopulation of receptors involved in the action of benzodiazepines [omega 1 (BZ1) sites of the gamma-aminobutyric acidA receptors]",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8098760",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2,
          "offsetInEndSection": 231,
          "text": "lpidem is a new, short-acting hypnotic of imidazopyridine structure which binds selectively to a subpopulation of receptors involved in the action of benzodiazepines [omega 1 (BZ1) sites of the gamma-aminobutyric acidA receptors]",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1403792",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1334,
          "offsetInEndSection": 1469,
          "text": "In contrast, after repeated treatment with zolpidem, there was no change in its ability to produce sedative and anticonvulsant effects.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1403792",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 93,
          "text": "Zolpidem, a novel nonbenzodiazepine hypnotic. I. Neuropharmacological and behavioral effects.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2871178",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 204,
          "text": "Zolpidem [N,N,6-trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide hemitartrate] is reported to be a rapid onset, short duration hypnotic that interacts at the benzodiazepine recognition site.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2871178",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 103,
          "text": "The imidazopyridine zolpidem is a short-acting hypnotic chemically distinct from benzodiazepines (BZs).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11154097",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 104,
          "offsetInEndSection": 279,
          "text": "According to its peculiar neuropharmacologic activity (selectivity for the omega 1-BZ receptors), zolpidem is expected to be a pure hypnotic, without the other effects of BZs.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11154097",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10400606",
        "http://www.ncbi.nlm.nih.gov/pubmed/15184558",
        "http://www.ncbi.nlm.nih.gov/pubmed/12067333",
        "http://www.ncbi.nlm.nih.gov/pubmed/9537396"
      ],
      "ideal_answer": [
        "The regulation of Vsr endonuclease levels is growth phase dependent."
      ],
      "exact_answer": "no",
      "concepts": [
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0043765",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0004519"
      ],
      "type": "yesno",
      "id": "553fbe9fe00431e071000001",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 53,
          "text": "Growth phase-dependent regulation of Vsr endonuclease",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10400606",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 162,
          "offsetInEndSection": 213,
          "text": "Vsr endonuclease levels are growth phase dependent.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10400606",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 130,
          "text": "Growth phase-dependent regulation of Vsr endonuclease may contribute to 5-methylcytosine mutational hot spots in Escherichia coli.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10400606",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 213,
          "text": "Using rabbit polyclonal antibodies, we have shown that the Dcm cytosine methylase of Escherichia coli is maintained at a constant level during cell growth, while Vsr endonuclease levels are growth phase dependent.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10400606",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 128,
          "text": "Vsr endonuclease, which initiates very short patch repair, has been hypothesized to regulate mutation in stationary-phase cells.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9537396",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 329,
          "offsetInEndSection": 514,
          "text": "The efficiency of the two pathways changes during the bacterial life cycle; MMR is more efficient during exponential growth and VSP repair is more efficient during the stationary phase.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12067333",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 129,
          "offsetInEndSection": 275,
          "text": "Overexpression of Vsr does dramatically increase the stationary-phase reversion of a Lac- frameshift allele, but the absence of Vsr has no effect.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9537396",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 212,
          "text": "Using rabbit polyclonal antibodies, we have shown that the Dcm cytosine methylase of Escherichia coli is maintained at a constant level during cell growth, while Vsr endonuclease levels are growth phase dependent",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10400606",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 329,
          "offsetInEndSection": 513,
          "text": "The efficiency of the two pathways changes during the bacterial life cycle; MMR is more efficient during exponential growth and VSP repair is more efficient during the stationary phase",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12067333",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 127,
          "text": "Vsr endonuclease, which initiates very short patch repair, has been hypothesized to regulate mutation in stationary-phase cells",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9537396",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "By which mechanism MutT proteins act against DNA lesions in bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23354752",
        "http://www.ncbi.nlm.nih.gov/pubmed/22556419",
        "http://www.ncbi.nlm.nih.gov/pubmed/9328176",
        "http://www.ncbi.nlm.nih.gov/pubmed/23463507",
        "http://www.ncbi.nlm.nih.gov/pubmed/25294823",
        "http://www.ncbi.nlm.nih.gov/pubmed/11856756",
        "http://www.ncbi.nlm.nih.gov/pubmed/20345942",
        "http://www.ncbi.nlm.nih.gov/pubmed/1309939",
        "http://www.ncbi.nlm.nih.gov/pubmed/10608900",
        "http://www.ncbi.nlm.nih.gov/pubmed/9603880",
        "http://www.ncbi.nlm.nih.gov/pubmed/9756871",
        "http://www.ncbi.nlm.nih.gov/pubmed/23481913",
        "http://www.ncbi.nlm.nih.gov/pubmed/12717778",
        "http://www.ncbi.nlm.nih.gov/pubmed/12717453",
        "http://www.ncbi.nlm.nih.gov/pubmed/21178309",
        "http://www.ncbi.nlm.nih.gov/pubmed/15475388",
        "http://www.ncbi.nlm.nih.gov/pubmed/17545288",
        "http://www.ncbi.nlm.nih.gov/pubmed/7739614",
        "http://www.ncbi.nlm.nih.gov/pubmed/22092761",
        "http://www.ncbi.nlm.nih.gov/pubmed/12767940",
        "http://www.ncbi.nlm.nih.gov/pubmed/9140059",
        "http://www.ncbi.nlm.nih.gov/pubmed/21111690",
        "http://www.ncbi.nlm.nih.gov/pubmed/21147134",
        "http://www.ncbi.nlm.nih.gov/pubmed/23043439",
        "http://www.ncbi.nlm.nih.gov/pubmed/10954591",
        "http://www.ncbi.nlm.nih.gov/pubmed/20880409",
        "http://www.ncbi.nlm.nih.gov/pubmed/15850400",
        "http://www.ncbi.nlm.nih.gov/pubmed/23006569",
        "http://www.ncbi.nlm.nih.gov/pubmed/11892789",
        "http://www.ncbi.nlm.nih.gov/pubmed/17616589",
        "http://www.ncbi.nlm.nih.gov/pubmed/23376345",
        "http://www.ncbi.nlm.nih.gov/pubmed/12531387"
      ],
      "ideal_answer": [
        "MutT proteins belong to a class of Nudix hydrolases. The common substrate structure for the proteins of the functionally diverse Nudix superfamily is nucleotide-diphosphate-X, where X is a large variety of leaving groups. The activities of Nudix hydrolases usually result in the release of an inorganic phosphate ion or of a product bearing a terminal phosphate moiety. MutT proteins hydrolyze 8-oxo-G nucleoside triphosphates/diphosphates to the corresponding nucleoside monophosphates and sanitize the nucleotide pool. MutT proteins cleave 8-oxo-dGTP (8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate) at the \u03b1-\u03b2 position; they also cleave 8-oxo-dGTP at the \u03b2-\u03b3 phosphate bond at a rate of 3% of that recorded for hydrolysis at the \u03b1-\u03b2 position. 8-oxo-dGTP induces A to C transversions when misincorporated in DNA opposite to template A. By hydrolyzing 8-oxo-dGTP before their incorporation into DNA, MutT proteins play a critical role in allowing bacteria to avoid A-to-C mutations, which are a hallmark of MutT deficiency. Thus, MutT proteins prevent oxidative DNA lesions, as part of the GO system. Oxidized nucleotides can occur when bacteria are exposed to reactive oxygen species. Also, reactive oxygen species are produced as side products of oxygen utilization, leading to the oxidation of nucleic acids and their precursor nucleotides. Distinct from the Escherichia coli MutT, which hydrolyzes 8-oxo-dGTP and 8-oxo-GTP, the mycobacterial proteins hydrolyze not only 8-oxo-dGTP and 8-oxo-GTP but also dCTP and 5-methyl-dCTP. Moreover, the hydrolysis of 8-oxo-dGTP and 8-oxo-GTP in mycobacteria seems to be catalysed in a two-stage mechanism, since MutT converts these oxidized nucleoside triphosphates to their corresponding nucleoside diphosphates, and not to monophosphates."
      ],
      "concepts": [
        "http://www.uniprot.org/uniprot/MUTT_PROVU"
      ],
      "type": "summary",
      "id": "5549de44f35db7552600000c",
      "snippets": [
        {
          "offsetInBeginSection": 946,
          "offsetInEndSection": 1136,
          "text": "in addition to the well-characterized hydrolysis of 8-oxo-dGTP at the \u03b1-\u03b2 position, MutT cleaves at the \u03b2-\u03b3 phosphate bond at a rate of 3% of that recorded for hydrolysis at the \u03b1-\u03b2 position",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23481913",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1146,
          "offsetInEndSection": 1197,
          "text": "MutT also catalyzes the hydrolysis of 5-methyl-dCTP",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23481913",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 362,
          "text": "The common substrate structure for the functionally diverse Nudix protein superfamily is nucleotide-diphosphate-X, where X is a large variety of leaving groups. The substrate specificity is known for less than 1% of the 29,400 known members. Most activities result in the release of an inorganic phosphate ion or of a product bearing a terminal phosphate moiety.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23481913",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 281,
          "offsetInEndSection": 685,
          "text": "the pathogen is exposed to reactive oxygen species, known to damage dGTP and GTP to 8-oxo-dGTP and 8-oxo-GTP, respectively. Incorporation of the damaged nucleotides in nucleic acids is detrimental to organisms. MutT proteins, belonging to a class of Nudix hydrolases, hydrolyze 8-oxo-G nucleoside triphosphates/diphosphates to the corresponding nucleoside monophosphates and sanitize the nucleotide pool.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23463507",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 810,
          "offsetInEndSection": 1175,
          "text": "Here, we characterized MtuMutT1 and Rv1700 proteins of M. tuberculosis. Unlike other MutT proteins, MtuMutT1 converts 8-oxo-dGTP to 8-oxo-dGDP, and 8-oxo-GTP to 8-oxo-GDP. Rv1700 then converts them to the corresponding nucleoside monophosphates. This observation suggests the presence of a two-stage mechanism of 8-oxo-dGTP/8-oxo-GTP detoxification in mycobacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23463507",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1496,
          "offsetInEndSection": 1544,
          "text": "A to C mutations (a hallmark of MutT deficiency)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23463507",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 339,
          "text": "Reactive oxygen species are produced as side products of oxygen utilization and can lead to the oxidation of nucleic acids and their precursor nucleotides. Among the various oxidized bases, 8-oxo-7,8-dihydroguanine seems to be the most critical during the transfer of genetic information because it can pair with both cytosine and adenine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23376345",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 492,
          "offsetInEndSection": 618,
          "text": "oxidized form of GMP (8-oxo-GMP) formed by the oxidation of GMP or by the cleavage of 8-oxo-GDP and 8-oxo-GTP by MutT protein.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23376345",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 990,
          "offsetInEndSection": 1214,
          "text": "The 8-oxo-GTP produced in this way and by the oxidation of GTP can be used for RNA synthesis. This misincorporation is prevented by MutT protein, which has the potential to cleave 8-oxo-GTP as well as 8-oxo-GDP to 8-oxo-GMP.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23376345",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 242,
          "offsetInEndSection": 429,
          "text": "By hydrolyzing the oxidized guanine nucleotides before their incorporation into nucleic acids, MutT proteins play a critical role in allowing organisms to avoid their deleterious effects.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23354752",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 723,
          "offsetInEndSection": 911,
          "text": "Distinct from the Escherichia coli MutT, which hydrolyzes 8-oxo-dGTP and 8-oxo-GTP, the mycobacterial proteins hydrolyze not only 8-oxo-dGTP and 8-oxo-GTP but also dCTP and 5-methyl-dCTP. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23354752",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1356,
          "offsetInEndSection": 1404,
          "text": "A-to-C mutations (a hallmark of MutT deficiency)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23354752",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 436,
          "text": "Reactive oxygen species induce oxidative damage in DNA precursors, i.e. dNTPs, leading to point mutations upon incorporation. Escherichia coli mutT strains, deficient in the activity hydrolysing 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphate (8-oxo-dGTP), display more than a 100-fold higher spontaneous mutation frequency over the wild-type strain. 8-oxo-dGTP induces A to C transversions when misincorporated opposite template A.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23043439",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 223,
          "text": "Prevention and correction of oxidative DNA lesions in Pseudomonas aeruginosa is ensured by the DNA oxidative repair system (GO). Single inactivation of mutT, mutY and mutM involved in GO led to elevated mutation rates (MRs)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22092761",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 810,
          "offsetInEndSection": 845,
          "text": "the GO system (mutM, mutY and mutT)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20880409",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 188,
          "text": "Human MTH1 and Escherichia coli MutT proteins hydrolyze 7, 8-dihydro-8-oxo-dGTP (8-oxo-dGTP) to monophosphate, thus avoiding the incorporation of 8-oxo-7,8-dihydroguanine into nascent DNA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10608900",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 872,
          "offsetInEndSection": 972,
          "text": "Unlike other MutT proteins, MtuMutT1 converts 8-oxo-dGTP to 8-oxo-dGDP, and 8-oxo-GTP to 8-oxo-GDP.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23463507",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 487,
          "offsetInEndSection": 681,
          "text": "MutT proteins, belonging to a class of Nudix hydrolases, hydrolyze 8-oxo-G nucleoside triphosphates/diphosphates to the corresponding nucleoside monophosphates and sanitize the nucleotide pool.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23463507",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 240,
          "offsetInEndSection": 428,
          "text": "By hydrolyzing the oxidized guanine nucleotides before their incorporation into nucleic acids, MutT proteins play a critical role in allowing organisms to avoid their deleterious effects.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23354752",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 275,
          "text": "MutT-related proteins, including the Escherichia coli MutT and human MutT homologue 1 (MTH1) proteins, degrade 8-oxo- 7,8-dihydrodeoxyguanosine triphosphate (8-oxo-dGTP) to a monophosphate, thereby preventing mutations caused by the misincorporation of 8-oxoguanine into DNA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12717453",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 794,
          "offsetInEndSection": 943,
          "text": "In mutator strains lacking MutT and/or MutM proteins, 8-oxoguanine of DNA increased to a concentration expected from the increased rate of mutation.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7739614",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 521,
          "offsetInEndSection": 703,
          "text": "coli strains with mutations in genes responsible for the repair of DNA containing oxidative lesions (mutY, mutS, mutM, mutT, nth) were less resistant to AgNP than wild type strains.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23006569",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 934,
          "offsetInEndSection": 1036,
          "text": "MutT and MutY proteins, when active, protect bacteria from mutations induced by 8-oxoG lesions in DNA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12717778",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 196,
          "text": "MutT-related proteins degrade 8-oxo-7,8-dihydrodeoxyguanosine triphosphate (8-oxo-dGTP), a mutagenic substrate for DNA synthesis, in the nucleotide pool, thereby preventing DNA replication errors.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12767940",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 528,
          "offsetInEndSection": 708,
          "text": "coli strains with mutations in genes responsible for the repair of DNA containing oxidative lesions (mutY, mutS, mutM, mutT, nth) were less resistant to AgNP than wild type strains",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23006569",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "List bacteria that may be useful in uranium bioremediation.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19717633",
        "http://www.ncbi.nlm.nih.gov/pubmed/15819846",
        "http://www.ncbi.nlm.nih.gov/pubmed/18378664",
        "http://www.ncbi.nlm.nih.gov/pubmed/11976101",
        "http://www.ncbi.nlm.nih.gov/pubmed/23038171",
        "http://www.ncbi.nlm.nih.gov/pubmed/21112694",
        "http://www.ncbi.nlm.nih.gov/pubmed/12368813",
        "http://www.ncbi.nlm.nih.gov/pubmed/23446832",
        "http://www.ncbi.nlm.nih.gov/pubmed/22327592",
        "http://www.ncbi.nlm.nih.gov/pubmed/19651424",
        "http://www.ncbi.nlm.nih.gov/pubmed/19129865",
        "http://www.ncbi.nlm.nih.gov/pubmed/18451051",
        "http://www.ncbi.nlm.nih.gov/pubmed/21337330",
        "http://www.ncbi.nlm.nih.gov/pubmed/21255372",
        "http://www.ncbi.nlm.nih.gov/pubmed/23275510",
        "http://www.ncbi.nlm.nih.gov/pubmed/12788780",
        "http://www.ncbi.nlm.nih.gov/pubmed/16204552",
        "http://www.ncbi.nlm.nih.gov/pubmed/22510989",
        "http://www.ncbi.nlm.nih.gov/pubmed/22432531",
        "http://www.ncbi.nlm.nih.gov/pubmed/18497157",
        "http://www.ncbi.nlm.nih.gov/pubmed/18843300",
        "http://www.ncbi.nlm.nih.gov/pubmed/12626092",
        "http://www.ncbi.nlm.nih.gov/pubmed/19346346",
        "http://www.ncbi.nlm.nih.gov/pubmed/18279349",
        "http://www.ncbi.nlm.nih.gov/pubmed/21261921",
        "http://www.ncbi.nlm.nih.gov/pubmed/20010635",
        "http://www.ncbi.nlm.nih.gov/pubmed/18450691",
        "http://www.ncbi.nlm.nih.gov/pubmed/18059491",
        "http://www.ncbi.nlm.nih.gov/pubmed/23416228",
        "http://www.ncbi.nlm.nih.gov/pubmed/23894087"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A7801424",
          "o": "D001673"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0598015",
          "o": "http://linkedlifedata.com/resource/umls/label/A1303884"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/prefMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C0598015",
          "o": "http://linkedlifedata.com/resource/umls/label/A7801424"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A1303884",
          "o": "bioremediation"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A7801424",
          "o": "Bioremediation"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A7801424",
          "o": "MeSH"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A1303884",
          "o": "1850-1558"
        }
      ],
      "ideal_answer": [
        "The main bacteria studied in uranium bioremediation are Geobacteraceae. Other bacteria are: \nFirmicutes, \nShewanella oneidensis\nPseudomonas aeruginosa\nAnaeromyxobacter dehalogenans  \nstrain Rf4T"
      ],
      "exact_answer": [
        [
          "Betaproteobacteria"
        ],
        [
          "Firmicutes"
        ],
        [
          "Geobacter",
          "Geobacteraceae",
          "Geobacter uraniireducens"
        ],
        [
          "Shewanella oneidensis"
        ],
        [
          "Pseudomonas aeruginosa"
        ],
        [
          "Anaeromyxobacter dehalogenans"
        ],
        [
          "strain Rf4T"
        ]
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014501",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001673",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017974",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001419",
        "http://www.biosemantics.org/jochem#4278179"
      ],
      "type": "list",
      "id": "530a3e18970c65fa6b000005",
      "snippets": [
        {
          "offsetInBeginSection": 406,
          "offsetInEndSection": 588,
          "text": "Members of the Betaproteobacteria (i.e. Dechloromonas, Ralstonia, Rhodoferax, Polaromonas, Delftia, Chromobacterium) and the Firmicutes dominated the biostimulated aquifer community.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23894087",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 202,
          "text": "Shewanella oneidensis is an important model organism for bioremediation studies because of its diverse respiratory capabilities, conferred in part by multicomponent, branched electron transport systems.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12368813",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 687,
          "offsetInEndSection": 719,
          "text": "metal-reducing Geobacter species",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446832",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 779,
          "offsetInEndSection": 1066,
          "text": " Identifications based on bacterial 16S rRNA sequence analysis showed that the dominant cultivable bacteria belonged to the genus Bacillus. Members of the genera Paenibacillus, Lysinibacillus, Klebsiella, Microbacterium and Chryseobacterium were also isolated from the LAAs soil samples.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23416228",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 60,
          "offsetInEndSection": 70,
          "text": " Geobacter",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23038171",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 36,
          "offsetInEndSection": 50,
          "text": "Geobacteraceae",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11976101",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 2262,
          "offsetInEndSection": 2390,
          "text": "Geobacteraceae will be responsible for much of the Fe(III) and U(VI) reduction during uranium bioremediation in these sediments.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11976101",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 533,
          "offsetInEndSection": 845,
          "text": " Our previous studies have demonstrated that the microbial communities involved in uranium bioremediation and energy harvesting are both dominated by microorganisms in the family Geobacteraceae and that the organisms in this family are responsible for uranium bioremediation and electron transfer to electrodes. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12626092",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 179,
          "offsetInEndSection": 301,
          "text": "the organisms in the family Geobacteraceae that have been found to be associated with metal reduction in previous studies ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12788780",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1475,
          "offsetInEndSection": 1560,
          "text": "to stimulate the activity of Geobacter species during in situ uranium bioremediation.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15819846",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1174,
          "offsetInEndSection": 1188,
          "text": "Geobacteraceae",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16204552",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 354,
          "offsetInEndSection": 530,
          "text": " Geobacter species are known to be important members of the microbial community: (1) a uranium-contaminated aquifer located in Rifle, CO, USA undergoing in situ bioremediation;",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18059491",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 960,
          "offsetInEndSection": 1069,
          "text": "Geobacteraceae feoB transcripts in groundwater samples from a site undergoing in situ uranium bioremediation ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18279349",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1495,
          "offsetInEndSection": 1635,
          "text": " Geobacteraceae activity during metal reduction in carbon-amended microcosms, with the highest expression observed in the glucose treatment.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18378664",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 103,
          "text": "Geobacter uraniireducens sp. nov., isolated from subsurface sediment undergoing uranium bioremediation.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18450691",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 229,
          "text": "A Gram-negative, rod-shaped, motile bacterium, strain Rf4T, which conserves energy from dissimilatory Fe(III) reduction concomitant with acetate oxidation, was isolated from subsurface sediment undergoing uranium bioremediation. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18450691",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 837,
          "offsetInEndSection": 1028,
          "text": ". Constant levels of Geobacter ompB transcripts were detected in groundwater during a field experiment in which acetate was added to the subsurface to promote in situ uranium bioremediation. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18451051",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 231,
          "offsetInEndSection": 280,
          "text": "Geobacter species are the predominant organisms, ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18497157",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1198,
          "offsetInEndSection": 1356,
          "text": "Firmicutes were the predominant organisms whereas no Firmicutes sequences were detected in background sediments which did not have the capacity to sorb U(VI),",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18497157",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 263,
          "offsetInEndSection": 350,
          "text": "Geobacter species that predominates during in situ uranium bioremediation at this site.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18843300",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 146,
          "text": "As part of an effort to diagnose the physiological status of Geobacter species during in situ bioremediation of uranium-contaminated groundwater, ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19129865",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 569,
          "offsetInEndSection": 593,
          "text": "Geobacter uraniireducens",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19129865",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 380,
          "offsetInEndSection": 541,
          "text": " Geobacter species are often the dominant members of the groundwater community during active bioremediation and the primary organisms catalysing U(VI) reduction.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21261921",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 291,
          "text": "Anaeromyxobacter dehalogenans strains implicated in hexavalent uranium reduction and immobilization are present in the fractured saprolite subsurface environment at the U.S. Department of Energy Integrated Field-Scale Subsurface Research Challenge (IFC) site near Oak Ridge, TN. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19346346",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 346,
          "offsetInEndSection": 604,
          "text": "Both enrichments were capable of reducing U(VI) rapidly. 16S rRNA gene clone libraries of the two enrichments revealed that Desulfovibrio spp. are dominant in the sulfate-reducing enrichment, and Clostridium spp. are dominant in the iron-reducing enrichment.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19651424",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1296,
          "offsetInEndSection": 1373,
          "text": ". The results demonstrate that Geobacter species can effectively reduce U(VI)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20010635",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 165,
          "text": "Uranium biomineralization by a metal-resistant Pseudomonas aeruginosa strain isolated from uranium mine waste was characterized for its potential in bioremediation. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21112694",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 115,
          "text": "Uranium biomineralization by a metal resistant Pseudomonas aeruginosa strain isolated from contaminated mine waste.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21112694",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 358,
          "offsetInEndSection": 402,
          "text": "Geobacter-mediated bioremediation of uranium",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21337330",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 772,
          "offsetInEndSection": 835,
          "text": "The cytochrome genes detected were primarily from Geobacter sp.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22327592",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 252,
          "text": "Acetate amendment at uranium contaminated sites in Rifle, CO. leads to an initial bloom of Geobacter accompanied by the removal of U(VI) from the groundwater, followed by an increase of sulfate-reducing bacteria (SRBs) which are poor reducers of U(VI).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22510989",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 186,
          "offsetInEndSection": 271,
          "text": "Whole-genome microarray analyses of a subsurface isolate of Geobacter uraniireducens,",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23275510",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 155,
          "offsetInEndSection": 389,
          "text": " At the US Department of Energy's Integrated Field Research Challenge (IFRC) site in Rifle, CO, the stimulation of Geobacter growth and activity via subsurface acetate addition leads to precipitation of U(VI) from groundwater as U(IV)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21255372",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 215,
          "offsetInEndSection": 442,
          "text": "Here, we report a proteomics-based approach for simultaneously documenting the strain membership and microbial physiology of the dominant Geobacter community members during in situ acetate amendment of the U-contaminated Rifle,",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19717633",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which species of bacteria did the mitochondria originate from?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17251118",
        "http://www.ncbi.nlm.nih.gov/pubmed/9823893",
        "http://www.ncbi.nlm.nih.gov/pubmed/21217797",
        "http://www.ncbi.nlm.nih.gov/pubmed/16381962",
        "http://www.ncbi.nlm.nih.gov/pubmed/11508688",
        "http://www.ncbi.nlm.nih.gov/pubmed/21300273",
        "http://www.ncbi.nlm.nih.gov/pubmed/9711305",
        "http://www.ncbi.nlm.nih.gov/pubmed/16157484",
        "http://www.ncbi.nlm.nih.gov/pubmed/12594925",
        "http://www.ncbi.nlm.nih.gov/pubmed/16822756",
        "http://www.ncbi.nlm.nih.gov/pubmed/10376009"
      ],
      "ideal_answer": [
        "Biologists agree that the ancestor of mitochondria was an alpha-proteobacterium. Although the Alphaproteobacteria are thought to be the closest relatives of the mitochondrial progenitor, there is dispute as to what its particular sister group is. Accumulating evolutionary data point to a monophyletic origin of mitochondria from the order Rickettsiales. Phylogenetic analyses indicate that R. prowazekii is more closely related to mitochondria than is any other microbe studied so far."
      ],
      "exact_answer": [
        "Biologists agree that the ancestor of mitochondria was an alpha-proteobacterium."
      ],
      "concepts": [
        "http://amigo.geneontology.org/amigo/term/GO:0005739",
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001419",
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008928"
      ],
      "type": "factoid",
      "id": "56c58f1b5795f9a73e000001",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 412,
          "text": "Recently, \u03b1-proteobacteria have been shown to possess virus-like gene transfer agents that facilitate high frequency gene transfer in natural environments between distantly related lineages. This system could have driven the genomic integration of the mitochondrial progenitor and its proto-eukaryote host and contributed to the evolutionary mosaic of genes seen in modern-day prokaryotic and eukaryotic genomes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21300273",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 80,
          "offsetInEndSection": 245,
          "text": "Although the Alphaproteobacteria are thought to be the closest relatives of the mitochondrial progenitor, there is dispute as to what its particular sister group is.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21217797",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1172,
          "offsetInEndSection": 1440,
          "text": "More detailed phylogenetic analyses with additional Alphaproteobacteria and including genes from the mitochondria of Reclinomonas americana found matches of mitochondrial genes to those of members of the Rickettsiaceae, Anaplasmataceae, and Rhodospirillaceae families.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21217797",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 80,
          "text": "Biologists agree that the ancestor of mitochondria was an alpha-proteobacterium.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17251118",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 80,
          "text": "Mitochondria originated by permanent enslavement of purple non-sulphur bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16822756",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 192,
          "offsetInEndSection": 339,
          "text": "Phylogenetic analyses based on genes located in the mitochondrial genome indicate that these genes originated from within the alpha-proteobacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12594925",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1133,
          "offsetInEndSection": 1393,
          "text": "The strong relationship with alpha-proteobacterial genes observed for some mitochondrial genes, combined with the lack of such a relationship for others, indicates that the modern mitochondrial proteome is the product of both reductive and expansive processes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12594925",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 107,
          "text": "Accumulating evolutionary data point to a monophyletic origin of mitochondria from the order Rickettsiales.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11508688",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 338,
          "offsetInEndSection": 511,
          "text": "Evolutionary analyses of proteins encoded in the genome contain the strongest phylogenetic evidence to date for the view that mitochondria descend from alpha-proteobacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10376009",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 218,
          "offsetInEndSection": 551,
          "text": "The functional profiles of these genes show similarities to those of mitochondrial genes: no genes required for anaerobic glycolysis are found in either R. prowazekii or mitochondrial genomes, but a complete set of genes encoding components of the tricarboxylic acid cycle and the respiratory-chain complex is found in R. prowazekii.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9823893",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1119,
          "offsetInEndSection": 1250,
          "text": "Phylogenetic analyses indicate that R. prowazekii is more closely related to mitochondria than is any other microbe studied so far.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9823893",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 175,
          "offsetInEndSection": 464,
          "text": "The phylogenetic analysis supports the hypothesis that mitochondria are derived from the alpha-proteobacteria and more specifically from within the Rickettsiaceae. We have estimated that the common ancestor of mitochondria and Rickettsiaceae dates back to more than 1500 million years ago.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9711305",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 434,
          "offsetInEndSection": 665,
          "text": "GOBASE also includes a fully reannotated genome sequence of Rickettsia prowazekii, one of the closest bacterial relatives of mitochondria, and will shortly expand to contain more data from bacteria from which organelles originated.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16381962",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 76,
          "text": "The genome sequence of Rickettsia prowazekii and the origin of mitochondria.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9823893",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 128,
          "text": "Although mitochondria derive from alpha-proteobacteria, many proteins acting in this organelle did not originate from bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16157484",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "How does Hst5 (histatin 5) affect infections by Candida glabrata?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/11442851",
        "http://www.ncbi.nlm.nih.gov/pubmed/7802437",
        "http://www.ncbi.nlm.nih.gov/pubmed/10049295",
        "http://www.ncbi.nlm.nih.gov/pubmed/24247141",
        "http://www.ncbi.nlm.nih.gov/pubmed/16495279",
        "http://www.ncbi.nlm.nih.gov/pubmed/9333052",
        "http://www.ncbi.nlm.nih.gov/pubmed/23613860",
        "http://www.ncbi.nlm.nih.gov/pubmed/20140514"
      ],
      "ideal_answer": [
        "Human salivary histatins, including histatin 5 (Hst 5), are small cationic proteins that are the major source of fungicidal activity of saliva",
        "Human salivary histatins, including histatin 5 (Hst 5), are small cationic proteins that are the major source of fungicidal activity of saliva. We found that Hst 54-15-Spd was significantly more effective in killing C. albicans and Candida glabrata than Hst 5 alone in both planktonic and biofilm growth and that Hst 54-15-Spd retained high activity in both serum and saliva. Histatin 5 (Hst 5) is a small cationic human salivary peptide with high fungicidal activity against C. albicans, however many strains of C. glabrata are resistant. We constructed a conjugate peptide using spermidine (Spd) linked to the active fragment of Hst 5 (Hst 54-15), based upon our findings that C. albicans spermidine transporters are required for Hst 5 uptake and fungicidal activity.",
        "Our results, taken together, demonstrated that histatin-5 possessed the fungicidal activity against Candida species other than C. glabrata. ",
        "Human salivary histatins, including histatin 5 (Hst 5), are small cationic proteins that are the major source of fungicidal activity of saliva. Histatin 5, a human salivary protein with broad-spectrum antifungal activity, is remarkably ineffective against Candida glabrata. Histatin 5 (Hst 5) is a small cationic human salivary peptide with high fungicidal activity against C. albicans, however many strains of C. glabrata are resistant. Since Hst 5 requires fungal binding to cell wall components prior to intracellular translocation, reduced Hst 5 binding to C. glabrata may be the reason for its insensitivity. Hst 5 enters C. albicans cell through polyamine transporters Dur3p and Dur31p that are uncharacterized in C. glabrata. The crucial rate limiting step is reduced uptake that can be overcome by expression of C. albicans Dur proteins in C. glabrata."
      ],
      "type": "summary",
      "id": "5710eec5a5ed216440000004",
      "snippets": [
        {
          "offsetInBeginSection": 247,
          "offsetInEndSection": 389,
          "text": "Human salivary histatins, including histatin 5 (Hst 5), are small cationic proteins that are the major source of fungicidal activity of saliva",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24247141",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 94,
          "offsetInEndSection": 257,
          "text": "Histatin 5 (Hst 5) is a small cationic human salivary peptide with high fungicidal activity against C. albicans, however many strains of C. glabrata are resistant.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23613860",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 258,
          "offsetInEndSection": 433,
          "text": "Since Hst 5 requires fungal binding to cell wall components prior to intracellular translocation, reduced Hst 5 binding to C. glabrata may be the reason for its insensitivity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23613860",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 825,
          "offsetInEndSection": 944,
          "text": "Hst 5 enters C. albicans cell through polyamine transporters Dur3p and Dur31p that are uncharacterized in C. glabrata. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23613860",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1152,
          "offsetInEndSection": 1279,
          "text": "the crucial rate limiting step is reduced uptake that can be overcome by expression of C. albicans Dur proteins in C. glabrata.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23613860",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 129,
          "text": "Histatin 5, a human salivary protein with broad-spectrum antifungal activity, is remarkably ineffective against Candida glabrata.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16495279",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 359,
          "offsetInEndSection": 498,
          "text": "Our results, taken together, demonstrated that histatin-5 possessed the fungicidal activity against Candida species other than C. glabrata.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11442851",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 360,
          "text": "The present study shows that a number of basic antifungal peptides, including human salivary histatin 5, a designed histatin analog designated dhvar4, and a peptide from frog skin, PGLa, are active against amphotericin B-resistant Candida albicans, Candida krusei, and Aspergillus fumigatus strains and against a fluconazole-resistant Candida glabrata isolate.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10049295",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 770,
          "offsetInEndSection": 886,
          "text": "In addition, we tested azole-resistant C. albicans and Candida glabrata strains for their susceptibilities to Hsn-5.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9333052",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1385,
          "offsetInEndSection": 1727,
          "text": "Assessment of the candidacidal activity of Hsn-5 with the well-characterized azole-resistant strains of C. albicans and C. glabrata, however, suggested that the mode of action of histatins against Candida is distinct from that of azole-based antifungal agents because Hsn-5 kills both azole-sensitive and azole-resistant strains equally well.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9333052",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 143,
          "text": "Histatin 5 resistance of Candida glabrata can be reversed by insertion of Candida albicans polyamine transporter-encoding genes DUR3 and DUR31.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23613860",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 95,
          "text": "Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16495279",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 94,
          "offsetInEndSection": 258,
          "text": "Histatin 5 (Hst 5) is a small cationic human salivary peptide with high fungicidal activity against C. albicans, however many strains of C. glabrata are resistant. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23613860",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1110,
          "offsetInEndSection": 1259,
          "text": "Biofilms of C. glabrata GDH1407 and 6115/06 were less susceptible to histatin 5, with 50% RMA of 31.2 +/- 4.8 and 62.5 +/- 0.7 microM, respectively. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20140514",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1043,
          "offsetInEndSection": 1279,
          "text": "Thus, neither C. glabrata cell surface or biofilm matrix \u03b2-1,3-glucan levels affected Hst 5 toxicity; rather the crucial rate limiting step is reduced uptake that can be overcome by expression of C. albicans Dur proteins in C. glabrata.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23613860",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1558,
          "offsetInEndSection": 1704,
          "text": "These results indicate that histatin 5 exhibits antifungal activity against biofilms of C. albicans and C. glabrata developed on denture acrylic. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20140514",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 94,
          "text": "Candida albicans and Candida glabrata are predominant fungi associated with oral candidiasis. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23613860",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1704,
          "offsetInEndSection": 1779,
          "text": "C. glabrata is significantly less sensitive to histatin 5 than C. albicans.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20140514",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 228,
          "offsetInEndSection": 338,
          "text": "We investigated whether the distinct resistance of C. glabrata to histatin 5 is related to similar mechanisms.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16495279",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 109,
          "offsetInEndSection": 209,
          "text": "The authors report a case of disseminated candidiasis due to Candida glabrata with liver metastases.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7802437",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 324,
          "offsetInEndSection": 440,
          "text": "We examined antifungal activities of histatin 5 against planktonic or biofilm Candida albicans and Candida glabrata.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20140514",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 144,
          "text": "Histatin 5 resistance of Candida glabrata can be reversed by insertion of Candida albicans polyamine transporter-encoding genes DUR3 and DUR31.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23613860",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 96,
          "text": "Roles of cellular respiration, CgCDR1, and CgCDR2 in Candida glabrata resistance to histatin 5.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16495279",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 130,
          "text": "Histatin 5, a human salivary protein with broad-spectrum antifungal activity, is remarkably ineffective against Candida glabrata.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16495279",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 94,
          "text": "Candida albicans and Candida glabrata are predominant fungi associated with oral candidiasis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23613860",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Are genes symmetrically distributed between leading and lagging DNA strand in bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22735706",
        "http://www.ncbi.nlm.nih.gov/pubmed/20417622",
        "http://www.ncbi.nlm.nih.gov/pubmed/25425232",
        "http://www.ncbi.nlm.nih.gov/pubmed/23538833",
        "http://www.ncbi.nlm.nih.gov/pubmed/12217498",
        "http://www.ncbi.nlm.nih.gov/pubmed/24273314",
        "http://www.ncbi.nlm.nih.gov/pubmed/21350489",
        "http://www.ncbi.nlm.nih.gov/pubmed/15823418",
        "http://www.ncbi.nlm.nih.gov/pubmed/17532183",
        "http://www.ncbi.nlm.nih.gov/pubmed/14743977",
        "http://www.ncbi.nlm.nih.gov/pubmed/15942025",
        "http://www.ncbi.nlm.nih.gov/pubmed/19221094",
        "http://www.ncbi.nlm.nih.gov/pubmed/11677621",
        "http://www.ncbi.nlm.nih.gov/pubmed/20600808"
      ],
      "ideal_answer": [
        "In most bacteria, genes are preferentially encoded on the leading strand than on the lagging strand. This avoids the potentially detrimental head-on collisions that occur between the replication and transcription machineries when genes are encoded on the lagging strand. Head-on collisions are more deleterious than codirectional collisions, and may lead to replication fork arrest and genomic instability. Genes of some functional categories such as ribosome have higher preferences to be on the leading strands, while genes of other functional categories such as transcription factor have higher preferences on the lagging strands. Strand-biased gene distribution correlates with replication-associated purine asymmetry and the presence or absence of polC. Especially essential and highly transcribed genes and genes whose expression is important for fitness are more preferentially situated at the leading strand in bacteria."
      ],
      "exact_answer": "no",
      "concepts": [
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0006273"
      ],
      "type": "yesno",
      "id": "55425615ed966d112c000003",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 373,
          "text": "Genomic DNA is used as the template for both replication and transcription, whose machineries may collide and result in mutagenesis, among other damages. Because head-on collisions are more deleterious than codirectional collisions, genes should be preferentially encoded on the leading strand to avoid head-on collisions, as is observed in most bacterial genomes examined.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24273314",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 189,
          "offsetInEndSection": 442,
          "text": "Most genes in bacteria are encoded on the leading strand of replication. This presumably avoids the potentially detrimental head-on collisions that occur between the replication and transcription machineries when genes are encoded on the lagging strand.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23538833",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 65,
          "text": "The majority of bacterial genes are located on the leading strand",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22735706",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 555,
          "offsetInEndSection": 660,
          "text": "genes of some functional categories such as ribosome have higher preferences to be on the leading strands",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22735706",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 667,
          "offsetInEndSection": 778,
          "text": "genes of some functional categories such as transcription factor have higher preferences on the lagging strands",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22735706",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 195,
          "offsetInEndSection": 292,
          "text": "essential genes are more preferentially situated at the leading strand than at the lagging strand",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20417622",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1060,
          "offsetInEndSection": 1121,
          "text": "remarkable strand-bias of the distribution of essential genes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20417622",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 345,
          "text": "Head-on encounters between the replication and transcription machineries on the lagging DNA strand can lead to replication fork arrest and genomic instability. To avoid head-on encounters, most genes, especially essential and highly transcribed genes, are encoded on the leading strand such that transcription and replication are co-directional.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21350489",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 90,
          "text": "Replication-associated purine asymmetry may contribute to strand-biased gene distribution.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17532183",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 170,
          "offsetInEndSection": 207,
          "text": "strand-biased gene distribution (SGD)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17532183",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 451,
          "offsetInEndSection": 522,
          "text": "SGD correlates not only with polC, but also with purine asymmetry (PAS)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17532183",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 140,
          "text": "In bacteria, most genes are on the leading strand of replication, a phenomenon attributed to collisions between the DNA and RNA polymerases.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15942025",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 489,
          "offsetInEndSection": 628,
          "text": "genes whose expression is important for fitness are selected to the leading strand because this reduces the duration of these interruptions",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15942025",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 135,
          "text": "Among prokaryotic genomes, the distribution of genes on the leading and lagging strands of the replication fork is known to be biased. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17532183",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 613,
          "offsetInEndSection": 878,
          "text": "We show that the evidence they provided is invalid and that the existence of lagging strand encoded genes is explainable by a balance between deleterious mutations that bring genes from the leading to the lagging strand and purifying selection purging such mutants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24273314",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 123,
          "offsetInEndSection": 434,
          "text": "Based on those experimentally determined for 10 bacteria, we find that essential genes are more preferentially situated at the leading strand than at the lagging strand, for all the 10 genomes studied, confirming previous findings based on either smaller datasets or putatively assigned ones by homology search.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20417622",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 148,
          "text": "The majority of bacterial genes are located on the leading strand, and the percentage of such genes has a large variation across different bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22735706",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 189,
          "offsetInEndSection": 261,
          "text": "Most genes in bacteria are encoded on the leading strand of replication.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23538833",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 516,
          "offsetInEndSection": 712,
          "text": "This paradox could be explained by assuming that the stronger mutation pressure and selection after inversion preferentially eliminate genes transferred from the leading to the lagging DNA strand.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11677621",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 235,
          "offsetInEndSection": 515,
          "text": "We have shown that the relative number of translocations which have switched positions of genes from the leading to the lagging DNA strand is lower than the number of translocations which have transferred genes from the lagging strand to the leading strand of prokaryotic genomes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11677621",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 189,
          "offsetInEndSection": 260,
          "text": "Most genes in bacteria are encoded on the leading strand of replication",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23538833",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 147,
          "text": "The majority of bacterial genes are located on the leading strand, and the percentage of such genes has a large variation across different bacteria",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22735706",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 235,
          "offsetInEndSection": 514,
          "text": "We have shown that the relative number of translocations which have switched positions of genes from the leading to the lagging DNA strand is lower than the number of translocations which have transferred genes from the lagging strand to the leading strand of prokaryotic genomes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11677621",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 648,
          "offsetInEndSection": 921,
          "text": "Using Monte Carlo methods, we have simulated, under experimentally determined directional mutation pressure, the divergence rate and the elimination rate of genes depending on their location in respect to the leading/lagging DNA strands in the asymmetric prokaryotic genome",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15823418",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What are the breath test biomarkers of pulmonary tuberculosis",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22366996",
        "http://www.ncbi.nlm.nih.gov/pubmed/20805989",
        "http://www.ncbi.nlm.nih.gov/pubmed/21219679",
        "http://www.ncbi.nlm.nih.gov/pubmed/22771606",
        "http://www.ncbi.nlm.nih.gov/pubmed/16635588",
        "http://www.ncbi.nlm.nih.gov/pubmed/16194024",
        "http://www.ncbi.nlm.nih.gov/pubmed/23737604",
        "http://www.ncbi.nlm.nih.gov/pubmed/19481976",
        "http://www.ncbi.nlm.nih.gov/pubmed/20189456",
        "http://www.ncbi.nlm.nih.gov/pubmed/23499413",
        "http://www.ncbi.nlm.nih.gov/pubmed/22647661"
      ],
      "ideal_answer": [
        "Nitric oxide, urea, volatile organic compounds, hydrogen peroxide and end products of lipid peroxidation are the breath test biomarkers of pulmonary tuberculosis."
      ],
      "exact_answer": [
        [
          "nitric oxide"
        ],
        [
          "urea"
        ],
        [
          "volatile organic compounds"
        ],
        [
          "hydrogen peroxide"
        ],
        [
          "end products of lipid peroxidation"
        ]
      ],
      "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:2957",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001944",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014397"
      ],
      "type": "list",
      "id": "55181d1e6487737b43000008",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 185,
          "text": "BACKGROUND: Nitric oxide (NO), a key macrophage antimycobacterial mediator that ameliorates immunopathology, is measurable in exhaled breath in individuals with pulmonary tuberculosis. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23737604",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1507,
          "offsetInEndSection": 1677,
          "text": "CONCLUSIONS: Among patients with pulmonary tuberculosis, impaired pulmonary NO bioavailability is associated with more-severe disease and delayed mycobacterial clearance.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23737604",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1123,
          "offsetInEndSection": 1331,
          "text": "Four KI windows corresponded with KI values of VOCs previously identified as biomarkers of pulmonary TB and metabolic products of M. tuberculosis, principally derivatives of naphthalene, benzene and alkanes. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22647661",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 93,
          "text": "Measurement of exhaled nitric oxide as a potential screening tool for pulmonary tuberculosis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21219679",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1119,
          "offsetInEndSection": 1370,
          "text": "CONCLUSION: While eNO measurement has limited value in the direct diagnosis of pulmonary TB, it may be worth developing and evaluating as a cost-effective replacement of chest X-ray in screening algorithms of pulmonary TB where X-ray is not available.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21219679",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 99,
          "text": "13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20805989",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1434,
          "offsetInEndSection": 1577,
          "text": "CONCLUSIONS/SIGNIFICANCE: Urea breath testing may provide a useful diagnostic and biomarker assay for tuberculosis and for treatment response. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20805989",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 773,
          "offsetInEndSection": 1009,
          "text": "RESULTS: Breath VOCs contained apparent biomarkers of active pulmonary tuberculosis comprising oxidative stress products (alkanes and alkane derivatives) and volatile metabolites of M. tuberculosis (cyclohexane and benzene derivatives).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20189456",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 190,
          "text": "Pulmonary tuberculosis may alter volatile organic compounds (VOCs) in breath because Mycobacteria and oxidative stress resulting from Mycobacterial infection both generate distinctive VOCs. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16635588",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1705,
          "offsetInEndSection": 2095,
          "text": "We conclude that volatile biomarkers in breath were sensitive and specific for pulmonary tuberculosis: the breath test distinguished between \"sick versus well\" i.e. between normal controls and patients hospitalized for suspicion of pulmonary tuberculosis, and between infected versus non-infected patients i.e. between those whose sputum cultures were positive or negative for Mycobacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16635588",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 532,
          "offsetInEndSection": 782,
          "text": "RESULTS: The concentrations of H202 and TBARs (1022.96+/-186.02 nM and 4.22+/-0. 80 microM, respectively) were significantly higher in patients with tuberculosis as compared with the controls (398.15+/-37.10 nM and 0.48+/-0.17 microM, respectively). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16194024",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1689,
          "offsetInEndSection": 1852,
          "text": "We conclude that volatile biomarkers in breath were sensitive and specific for pulmonary tuberculosis: the breath test distinguished between \"sick versus well\" i.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16635588",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 239,
          "text": "Volatile organic compounds (VOCs) in breath may contain biomarkers of active pulmonary tuberculosis derived from the infectious organism (metabolites of Mycobacterium tuberculosis) and from the infected host (products of oxidative stress).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20189456",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 60,
          "text": "Volatile biomarkers of pulmonary tuberculosis in the breath.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16635588",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 745,
          "offsetInEndSection": 920,
          "text": "Breath VOCs contained apparent biomarkers of active pulmonary tuberculosis comprising oxidative stress products (alkanes and alkane derivatives) and volatile metabolites of M.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20189456",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1730,
          "offsetInEndSection": 1862,
          "text": "CONCLUSIONS: A six-minute point-of-care breath test for volatile biomarkers accurately identified subjects with active pulmonary TB.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22647661",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 251,
          "text": "BACKGROUND: Volatile organic compounds (VOCs) in breath may contain biomarkers of active pulmonary tuberculosis derived from the infectious organism (metabolites of Mycobacterium tuberculosis) and from the infected host (products of oxidative stress).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20189456",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1707,
          "offsetInEndSection": 1868,
          "text": "We conclude that volatile biomarkers in breath were sensitive and specific for pulmonary tuberculosis: the breath test distinguished between \"sick versus well\" i",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16635588",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1705,
          "offsetInEndSection": 1868,
          "text": "We conclude that volatile biomarkers in breath were sensitive and specific for pulmonary tuberculosis: the breath test distinguished between \"sick versus well\" i.e",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16635588",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 205,
          "offsetInEndSection": 335,
          "text": "We evaluated breath VOC biomarkers in subjects with active pulmonary TB, using an internet-linked rapid point-of-care breath test.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22647661",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1392,
          "offsetInEndSection": 1507,
          "text": "Urea breath testing may provide a useful diagnostic and biomarker assay for tuberculosis and for treatment response",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20805989",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1671,
          "offsetInEndSection": 1790,
          "text": "A six-minute point-of-care breath test for volatile biomarkers accurately identified subjects with active pulmonary TB.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22647661",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which is the mechanism used by bacteria to induce tumors in Arabidopsis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23408907",
        "http://www.ncbi.nlm.nih.gov/pubmed/11043469",
        "http://www.ncbi.nlm.nih.gov/pubmed/23593941",
        "http://www.ncbi.nlm.nih.gov/pubmed/11432846",
        "http://www.ncbi.nlm.nih.gov/pubmed/17172353",
        "http://www.ncbi.nlm.nih.gov/pubmed/10323222",
        "http://www.ncbi.nlm.nih.gov/pubmed/9090878",
        "http://www.ncbi.nlm.nih.gov/pubmed/19794116",
        "http://www.ncbi.nlm.nih.gov/pubmed/15998742",
        "http://www.ncbi.nlm.nih.gov/pubmed/9618535",
        "http://www.ncbi.nlm.nih.gov/pubmed/20696005"
      ],
      "ideal_answer": [
        "The bacteria Agrobacterium tumefaciens infects Arabidopsis, as well as other plants, and induces the formation of tumors by integrating the transferred-DNA (T-DNA) region of the Ti-plasmid into the plant nuclear genome."
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017360",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0009617",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001419"
      ],
      "type": "summary",
      "id": "535917f3c95abccd6f000001",
      "snippets": [
        {
          "offsetInBeginSection": 23,
          "offsetInEndSection": 266,
          "text": "Agrobacterium tumefaciens causes crown gall disease in a wide range of plant species. The neoplastic growth at the infection sites is caused by transferring, integrating, and expressing transfer DNA (T-DNA) from A. tumefaciens into plant cells",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23593941",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 5,
          "offsetInEndSection": 124,
          "text": " gall tumors develop after integration of the T-DNA of virulent Agrobacterium tumefaciens strains into the plant genome",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23408907",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2,
          "offsetInEndSection": 212,
          "text": "robacterium tumefaciens is a plant pathogenic bacterium that causes neoplastic growths, called 'crown gall', via the transfer and integration of transferred DNA (T-DNA) from the bacterium into the plant genome.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20696005",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 127,
          "text": "grobacterium tumefaciens causes crown gall disease by transferring and integrating bacterial DNA (T-DNA) into the plant genome",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19794116",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 144,
          "text": "ransformation of plant cells with T-DNA of virulent agrobacteria is one of the most extreme triggers of developmental changes in higher plants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17172353",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 195,
          "text": "grobacterium tumefaciens infects plants and induces the formation of tumors called \"crown galls\" by integrating the transferred-DNA (T-DNA) region of the Ti-plasmid into the plant nuclear genome",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15998742",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 97,
          "text": "-DNA nuclear import is a central event in genetic transformation of plant cells by Agrobacterium",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11432846",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 92,
          "text": "grobacterium tumefaciens Chry5, which is particularly virulent on soybeans, induces tumors ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11043469",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2,
          "offsetInEndSection": 130,
          "text": " have identified T-DNA tagged Arabidopsis mutants that are resistant to transformation by Agrobacterium tumefaciens (rat mutants",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10323222",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 154,
          "text": "grobacterium tumefaciens induces crown gall tumors on plants by transferring a nucleoprotein complex, the T-complex, from the bacterium to the plant cell",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9618535",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 365,
          "offsetInEndSection": 441,
          "text": "The recalcitrance of another ecotype occurs at a late step in T-DNA transfer",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9090878",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which proteins constitute the methyl-directed mismatch repair system (MMR) in bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21940221",
        "http://www.ncbi.nlm.nih.gov/pubmed/14602928",
        "http://www.ncbi.nlm.nih.gov/pubmed/12067333",
        "http://www.ncbi.nlm.nih.gov/pubmed/16414311",
        "http://www.ncbi.nlm.nih.gov/pubmed/9852252",
        "http://www.ncbi.nlm.nih.gov/pubmed/11591694",
        "http://www.ncbi.nlm.nih.gov/pubmed/8244947",
        "http://www.ncbi.nlm.nih.gov/pubmed/1920448",
        "http://www.ncbi.nlm.nih.gov/pubmed/15709980",
        "http://www.ncbi.nlm.nih.gov/pubmed/10652107",
        "http://www.ncbi.nlm.nih.gov/pubmed/18687413",
        "http://www.ncbi.nlm.nih.gov/pubmed/15503140",
        "http://www.ncbi.nlm.nih.gov/pubmed/12860461",
        "http://www.ncbi.nlm.nih.gov/pubmed/19192394",
        "http://www.ncbi.nlm.nih.gov/pubmed/22473602",
        "http://www.ncbi.nlm.nih.gov/pubmed/20018207",
        "http://www.ncbi.nlm.nih.gov/pubmed/24214875",
        "http://www.ncbi.nlm.nih.gov/pubmed/12513688",
        "http://www.ncbi.nlm.nih.gov/pubmed/19474347",
        "http://www.ncbi.nlm.nih.gov/pubmed/24062730",
        "http://www.ncbi.nlm.nih.gov/pubmed/17951114",
        "http://www.ncbi.nlm.nih.gov/pubmed/20971907",
        "http://www.ncbi.nlm.nih.gov/pubmed/20921378",
        "http://www.ncbi.nlm.nih.gov/pubmed/11952911",
        "http://www.ncbi.nlm.nih.gov/pubmed/3280983",
        "http://www.ncbi.nlm.nih.gov/pubmed/23228104",
        "http://www.ncbi.nlm.nih.gov/pubmed/19029144",
        "http://www.ncbi.nlm.nih.gov/pubmed/15113836"
      ],
      "ideal_answer": [
        "The mismatch repair system (MMR) recognizes and corrects mismatched or unpaired bases caused mainly by DNA polymerase, and contributes to the fidelity of DNA replication in living cells. In bacteria, the methyldirected mismatch repair (MMR) is comprised of MutS and MutL proteins, encoded by the mutS/L operon."
      ],
      "exact_answer": [
        [
          "mutS"
        ],
        [
          "mutL"
        ],
        [
          "mutH"
        ]
      ],
      "concepts": [
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0006298"
      ],
      "type": "list",
      "id": "5540eda30083d1bf0e000006",
      "snippets": [
        {
          "offsetInBeginSection": 427,
          "offsetInEndSection": 472,
          "text": "MutY and MutSL (mismatch repair system [MMR])",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20971907",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 4,
          "offsetInEndSection": 60,
          "text": "Escherichia coli DNA Mismatch Repair (MMR) protein MutS ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18687413",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 424,
          "text": "We have characterized the mismatch repair system (MMR) of the highly radiation-resistant type strain of Deinococcus radiodurans, ATCC 13939. We show that the MMR system is functional in this organism, where it participates in ensuring the fidelity of DNA replication and recombination. The system relies on the activity of two key proteins, MutS1 and MutL, which constitute a conserved core involved in mismatch recognition.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15503140",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 402,
          "offsetInEndSection": 479,
          "text": "the mutS/L operon essential for methyldirected mismatch repair (MMR) activity",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24214875",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 80,
          "text": "The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11952911",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 332,
          "text": "The mismatch repair system (MMR) recognizes and corrects mismatched or unpaired bases caused mainly by DNA polymerase, and contributes to the fidelity of DNA replication in living cells. In Escherichia coli, the MutHLS system is known to function in MMR, and homologues of MutS and MutL are widely conserved in almost all organisms.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15113836",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 206,
          "text": "A simple genetic system has been developed to test the effect of over-expression of wild-type or mutated human MutL homologue 1 (hMLH1) proteins on methyl-directed mismatch repair (MMR) in Escherichia coli.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12513688",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 634,
          "offsetInEndSection": 753,
          "text": "Among these six mutated genes was mutS, which encodes a component of the methyl-directed mismatch repair (MMR) system.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22473602",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 369,
          "offsetInEndSection": 529,
          "text": "The majority of naturally occurring, strong mutators contain defects in the methyl-directed mismatch repair (MMR) system, with mutations in mutS predominating.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12860461",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 219,
          "offsetInEndSection": 385,
          "text": "The picture of MutH-independent MMR in other bacteria is less clear, as MMR components other than MutS and MutL have not been identified in the majority of bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21940221",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 250,
          "text": "The methyl-directed mismatch repair (MMR) mechanism has been extensively studied in vitro and in vivo, but one of the difficulties in determining the biological relationships between the MMR-related proteins is the tendency of MutL to self-aggregate.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19192394",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 639,
          "offsetInEndSection": 757,
          "text": "Among these six mutated genes was mutS, which encodes a component of the methyl-directed mismatch repair (MMR) system.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22473602",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 192,
          "text": "MutL is required to assist the mismatch repair protein MutS during initiation of the methyl-directed mismatch repair (MMR) response in various organisms ranging from prokaryotes to eukaryotes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19029144",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 300,
          "offsetInEndSection": 495,
          "text": "Moreover, methyl-directed mismatch repair (MMR) is known to trigger sensitivity to methylating agents via a mechanism that involves recognition by MutS of the O(6)-mG:T replication intermediates.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20921378",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 286,
          "offsetInEndSection": 424,
          "text": "The system relies on the activity of two key proteins, MutS1 and MutL, which constitute a conserved core involved in mismatch recognition.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15503140",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 136,
          "offsetInEndSection": 314,
          "text": "In Escherichia coli, the best studied mismatch repair (MMR) pathway is the methyl-directed long patch repair system which is mediated by three gene products; MutS, MutL and MutH.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9852252",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1118,
          "offsetInEndSection": 1367,
          "text": "Cells devoid of MutS1 or MutL proteins were as resistant to gamma-rays, mitomycin C and UV-irradiation as wild-type bacteria, suggesting that the mismatch repair system is not essential for the reconstitution of a functional genome after DNA damage.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15503140",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 286,
          "offsetInEndSection": 423,
          "text": "The system relies on the activity of two key proteins, MutS1 and MutL, which constitute a conserved core involved in mismatch recognition",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15503140",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which is the vector of Louping ill virus?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21593276",
        "http://www.ncbi.nlm.nih.gov/pubmed/14422369",
        "http://www.ncbi.nlm.nih.gov/pubmed/9802086",
        "http://www.ncbi.nlm.nih.gov/pubmed/21254926",
        "http://www.ncbi.nlm.nih.gov/pubmed/12557579",
        "http://www.ncbi.nlm.nih.gov/pubmed/19631009",
        "http://www.ncbi.nlm.nih.gov/pubmed/19925041",
        "http://www.ncbi.nlm.nih.gov/pubmed/12233771",
        "http://www.ncbi.nlm.nih.gov/pubmed/15252984",
        "http://www.ncbi.nlm.nih.gov/pubmed/18562534",
        "http://www.ncbi.nlm.nih.gov/pubmed/7815482",
        "http://www.ncbi.nlm.nih.gov/pubmed/17346361",
        "http://www.ncbi.nlm.nih.gov/pubmed/12560576",
        "http://www.ncbi.nlm.nih.gov/pubmed/18823640",
        "http://www.ncbi.nlm.nih.gov/pubmed/19685082",
        "http://www.ncbi.nlm.nih.gov/pubmed/18602711",
        "http://www.ncbi.nlm.nih.gov/pubmed/18841330",
        "http://www.ncbi.nlm.nih.gov/pubmed/22452970",
        "http://www.ncbi.nlm.nih.gov/pubmed/11427261",
        "http://www.ncbi.nlm.nih.gov/pubmed/18471057",
        "http://www.ncbi.nlm.nih.gov/pubmed/22913287",
        "http://www.ncbi.nlm.nih.gov/pubmed/13383364",
        "http://www.ncbi.nlm.nih.gov/pubmed/12519399",
        "http://www.ncbi.nlm.nih.gov/pubmed/22939093",
        "http://www.ncbi.nlm.nih.gov/pubmed/1337231",
        "http://www.ncbi.nlm.nih.gov/pubmed/21771532"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/pubmed/keyword/VIRUSES%2Flouping-ill",
          "o": "http://linkedlifedata.com/resource/pubmed/Keyword"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A2035145",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A2035145",
          "o": "D004669"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A2035145",
          "o": "MeSH"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A2035145",
          "o": "Louping ill viruses"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://linkedlifedata.com/resource/pubmed/keyword/VIRUSES%2Flouping-ill",
          "o": "VIRUSES/louping-ill"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A7781838",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A7781838",
          "o": "D004669"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A7781838",
          "o": "MeSH"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A7781838",
          "o": "Louping ill virus"
        },
        {
          "p": "http://purl.uniprot.org/core/commonName",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "Li"
        },
        {
          "p": "http://purl.uniprot.org/core/complete",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "true"
        },
        {
          "p": "http://purl.uniprot.org/core/host",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "http://purl.uniprot.org/taxonomy/34613"
        },
        {
          "p": "http://purl.uniprot.org/core/host",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "http://purl.uniprot.org/taxonomy/34878"
        },
        {
          "p": "http://purl.uniprot.org/core/host",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "http://purl.uniprot.org/taxonomy/9606"
        },
        {
          "p": "http://purl.uniprot.org/core/host",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "http://purl.uniprot.org/taxonomy/9615"
        },
        {
          "p": "http://purl.uniprot.org/core/host",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "http://purl.uniprot.org/taxonomy/9796"
        },
        {
          "p": "http://purl.uniprot.org/core/host",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "http://purl.uniprot.org/taxonomy/9823"
        },
        {
          "p": "http://purl.uniprot.org/core/host",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "http://purl.uniprot.org/taxonomy/9913"
        },
        {
          "p": "http://purl.uniprot.org/core/host",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "http://purl.uniprot.org/taxonomy/9940"
        },
        {
          "p": "http://purl.uniprot.org/core/mnemonic",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "LIV"
        },
        {
          "p": "http://purl.uniprot.org/core/partOfLineage",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "false"
        },
        {
          "p": "http://purl.uniprot.org/core/rank",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "http://purl.uniprot.org/core/Species"
        },
        {
          "p": "http://purl.uniprot.org/core/reviewed",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "true"
        },
        {
          "p": "http://purl.uniprot.org/core/scientificName",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "Louping ill virus"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "http://purl.uniprot.org/core/Taxon"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#subClassOf",
          "s": "http://purl.uniprot.org/taxonomy/11086",
          "o": "http://purl.uniprot.org/taxonomy/29263"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431097",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431097",
          "o": "11086"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431097",
          "o": "NCBI Taxonomy"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431097",
          "o": "Louping ill virus"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0081054",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A0081054",
          "o": "Metathesaurus Names"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0081054",
          "o": "Louping Ill"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0423465",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A0423465",
          "o": "D008146"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A0423465",
          "o": "MeSH"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0423465",
          "o": "Ill, Louping"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A8352613",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A8352613",
          "o": "063.1"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A8352613",
          "o": "ICD-9-CM"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A8352613",
          "o": "Louping ill"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:10250",
          "o": "http://www.w3.org/2004/02/skos/core#Concept"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#altLabel",
          "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:10250",
          "o": "Louping ill"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#altLabel",
          "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:10250",
          "o": "Louping ill (disorder)"
        }
      ],
      "ideal_answer": [
        "Louping ill virus (LIV) belongs to the mammalian tick-borne virus group of the genus Flavivirus  which cause central nervous system disease. LIV infects the red grouse Lagopus lagopus scoticus, causing high mortality. LIV is transmitted by the tick Ixodes ricinus.",
        "Deer are the key hosts of the vector (Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing high mortality. (PMID: 22939093)"
      ],
      "exact_answer": [
        "Ixodes ricinus"
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014780",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001179",
        "http://www.disease-ontology.org/api/metadata/DOID:10250",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004669",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004199",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004675",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008146"
      ],
      "type": "factoid",
      "id": "51716e808ed59a060a00000b",
      "snippets": [
        {
          "offsetInBeginSection": 528,
          "offsetInEndSection": 664,
          "text": "Deer are the key hosts of the vector (Ixodes ricinus) that transmits LIV to red grouse Lagopus lagopus scoticus, causing high mortality.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22939093",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 94,
          "offsetInEndSection": 426,
          "text": "n Europe the primary arthropod vectors of zoonotic diseases are ticks, which transmit Borrelia burgdorferi sensu lato (the agent of Lyme disease), tick-borne encephalitis virus and louping ill virus between humans, livestock and wildlife. Ixodes ricinus ticks and reported tick-borne disease cases are currently increasing in the UK",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19685082",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 152,
          "text": "Many vector-borne pathogens whose primary vectors are generalists, such as Ixodid ticks, can infect a wide range of host species and are often zoonotic.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19631009",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 174,
          "text": "Tick-borne encephalitis virus (TBEV) and Louping ill virus (LIV) are viruses in the Mammalian tick-borne virus group/genus Flavivirus, causing central nervous system disease.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18471057",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 148,
          "text": "The complex pathogen-host-vector system of the tick-borne louping-ill virus causes economic losses to sheep and red grouse in upland United Kingdom.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17346361",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 396,
          "text": "For pathogens transmitted by biting vectors, one of the fundamental assumptions is often that vector bites are the sole or main route of host infection. Here, we demonstrate experimentally a transmission route whereby hosts (red grouse, Lagopus lagopus scoticus) became infected with a member of the tick-borne encephalitis virus complex, louping ill virus, after eating the infected tick vector.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15252984",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 411,
          "offsetInEndSection": 527,
          "text": "We used Susceptible Infected Recovered (SIR) models parameterized for the tick-borne louping ill virus (LIV) system.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22939093",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 202,
          "text": "This study has examined the efficacy following intramuscular administration of a recombinant Semliki Forest virus (rSFV) vaccine, encoding the prME and NS1 proteins of louping ill virus (LIV), in sheep.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11427261",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 280,
          "text": "Since the recognition that louping-ill, known for well over 100 years as an epizootic disease of sheep in Scotland, was caused by a virus transmitted by arthropods, many other arthropod-borne viruses capable of causing encephalitis in domestic animals or man have been discovered.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14422369",
          "endSection": "sections.0"
        }
      ]
    },
    {
      "body": "What is the role of the Ada O6-alkylguanine alkyltransferase in bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10101186",
        "http://www.ncbi.nlm.nih.gov/pubmed/9079656",
        "http://www.ncbi.nlm.nih.gov/pubmed/7695814",
        "http://www.ncbi.nlm.nih.gov/pubmed/9366274",
        "http://www.ncbi.nlm.nih.gov/pubmed/9484244",
        "http://www.ncbi.nlm.nih.gov/pubmed/3526284",
        "http://www.ncbi.nlm.nih.gov/pubmed/1747932",
        "http://www.ncbi.nlm.nih.gov/pubmed/8512805",
        "http://www.ncbi.nlm.nih.gov/pubmed/8152424",
        "http://www.ncbi.nlm.nih.gov/pubmed/3887409",
        "http://www.ncbi.nlm.nih.gov/pubmed/1520330",
        "http://www.ncbi.nlm.nih.gov/pubmed/8195077",
        "http://www.ncbi.nlm.nih.gov/pubmed/8519412",
        "http://www.ncbi.nlm.nih.gov/pubmed/7662116",
        "http://www.ncbi.nlm.nih.gov/pubmed/9717173",
        "http://www.ncbi.nlm.nih.gov/pubmed/7634390",
        "http://www.ncbi.nlm.nih.gov/pubmed/2105461"
      ],
      "ideal_answer": [
        "The Ada O6-methylguanine-DNA methyltransferase is a multifunctional protein, product of the ada gene. Ada functions in DNA repair by direct dealkylation of alkylated DNA lesions, such as the toxic, mutagenic and carcinogenic O6-alkylguanine (O6-AlkG) and O4-alkylthymine (O4-AlkT) which are restored to guanine and thymine. Ada accepts stoichiometrically the alkyl group from O6-alkylguanine in DNA at the Cys-321 residue and from alkyl phosphotriester at the Cys-69 residue. When methylated at Cys-69, Ada becomes a transcriptional activator of the genes in the ada regulon, including its own. The ada gene controls the inducible resistance to alkylation mutagenesis and killing (the adaptive response). Ada alkyltransferase (ATase) is induced by exposure to low doses of methylating agents. During exponential growth, Ada removes lesions responsible for G:C to A:T transitions and G:C to C:G transversions, while in stationary populations it removes lesions causing G:C to A:T and A:T to G:C transitions, and G:C to C:G, A:T to C:G, and A:T to T:A transversions. Thus, Ada protein acts both as a positive regulator of the ada response and as a DNA repair enzyme."
      ],
      "concepts": [
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0003908",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D019853",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0009617",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0032132"
      ],
      "type": "summary",
      "id": "5541ffc3472cfd8617000004",
      "snippets": [
        {
          "offsetInBeginSection": 4,
          "offsetInEndSection": 135,
          "text": "multifunctional 39 kDa Escherichia coli Ada protein (O6-methylguanine-DNA methyltransferase) (EC 2.1.1.63), product of the ada gene",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9484244",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 318,
          "offsetInEndSection": 693,
          "text": "The Ada protein accepts stoichiometrically the alkyl group from O6-alkylguanine in DNA at the Cys-321 residue and from alkyl phosphotriester at the Cys-69 residue. This protein functions in DNA repair by direct dealkylation of mutagenic O6-alkylguanine. The protein methylated at Cys-69 becomes a transcriptional activator of the genes in the ada regulon, including its own. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9484244",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 127,
          "text": "O6-Alkylguanine DNA-alkyltransferase (ATase) repairs toxic, mutagenic and carcinogenic O6-alkylguanine (O6-alkG) lesions in DNA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9366274",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 173,
          "text": "O6-Methylguanine is removed from DNA via the transfer of the methyl group to a cysteine acceptor site present in the DNA repair protein O6-alkylguanine-DNA alkyltransferase.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9079656",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1392,
          "offsetInEndSection": 1609,
          "text": "DNA repair by O6-alkylguanine-DNA alkyltransferases plays a major role in removing lesions responsible for GC-->AT transitions induced by CCNU, influencing their ultimate distribution with respect to sequence context.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8519412",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 788,
          "offsetInEndSection": 812,
          "text": "alkyltransferase (ATase)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7662116",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1249,
          "offsetInEndSection": 1319,
          "text": "the ada ATase induced by exposure to low doses of a methylating agent.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7662116",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 219,
          "text": "The Escherichia coli Ada and Ogt DNA methyltransferases (MTases) are known to transfer simple alkyl groups from O6-alkylguanine and O4-alkylthymine, directly restoring these alkylated DNA lesions to guanine and thymine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8195077",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 625,
          "offsetInEndSection": 806,
          "text": "During exponential growth, the spontaneous rate of G:C to A:T transitions and G:C to C:G transversions was elevated about fourfold in ada ogt double mutant versus wild-type E. coli.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8195077",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 820,
          "offsetInEndSection": 1125,
          "text": "compared with the wild type, stationary populations of the MTase-deficient E. coli (under lactose selection) displayed increased G:C to A:T and A:T to G:C transitions (10- and 3-fold, respectively) and increased G:C to C:G, A:T to C:G, and A:T to T:A transversions (10-, 2.5-, and 1.7-fold, respectively).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8195077",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 320,
          "offsetInEndSection": 402,
          "text": "ATases are able to repair O6-alkylguanine (O6-AlkG) and O4-alkylthymine (O4-AlkT) ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8512805",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 137,
          "text": "The inducible resistance to alkylation mutagenesis and killing in Escherichia coli (the adaptive response) is controlled by the ada gene.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3887409",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 138,
          "offsetInEndSection": 355,
          "text": "The Ada protein acts both as a positive regulator of the response and as a DNA repair enzyme, correcting premutagenic O6-alkylguanine in DNA by suicidal transfer of the alkyl group to one of its own cysteine residues.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3887409",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 245,
          "text": "Forward mutations induced by 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the lacl gene of Escherichia coli were recovered from bacteria proficient (Ogt+ Ada+) and deficient (Ogt- Ada-) in O6-alkylguanine-DNA alkyltransferase activity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8519412",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 249,
          "text": "Spontaneous mutagenesis in O6-alkylguanine-DNA alkyltransferase-proficient and -deficient (ada ogt mutants) Escherichia coli was studied in two ways: in bacteria growing in nonselective liquid medium and in bacteria resting on selective agar plates.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9717173",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 152,
          "offsetInEndSection": 406,
          "text": "We now show by Southern analysis that the mutation involves a gross deletion covering at least the ogt and fnr genes and that no O6-alkylguanine-DNA-alkyltransferase activity is present in cell-free extracts of an ada::Tn10 derivative of these bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8152424",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 275,
          "text": "O6-Alkylguanine DNA-alkyltransferase (ATase) repairs toxic, mutagenic and carcinogenic O6-alkylguanine (O6-alkG) lesions in DNA by a highly conserved reaction involving the stoichiometric transfer of the alkyl group to the active centre cysteine residue of the ATase protein.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9366274",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 336,
          "text": "Although the human O6-alkylguanine-DNA alkyltransferase (AGT) is very sensitive to inactivation by O6-benzylguanine (BG) or 2,4-diamino-6-benzyloxy-5-nitrosopyrimidine (5-nitroso-BP), the equivalent protein formed by the carboxyl terminal domain of the product of the Escherichia coli ada gene (Ada-C) is unaffected by these inhibitors.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7634390",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 197,
          "text": "A mutant of Bacillus subtilis defective in the constitutive activity of O6-alkylguanine-DNA alkyltransferase was isolated from a strain (ada-1) deficient in the adaptive response to DNA alkylation.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2105461",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 165,
          "text": "Mutations in the Ada O6-alkylguanine-DNA alkyltransferase conferring sensitivity to inactivation by O6-benzylguanine and 2,4-diamino-6-benzyloxy-5-nitrosopyrimidine.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7634390",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 279,
          "text": "The protein O 6-alkylguanine-DNA alkyltransferase(alkyltransferase) is involved in the repair of O 6-alkylguanine and O 4-alkylthymine in DNA and plays an important role in most organisms in attenuating the cytotoxic and mutagenic effects of certain classes of alkylating agents.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10101186",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 90,
          "text": "O6-Alkylguanine-DNA alkyltransferase (EC 2.1.1.63) repairs O6-alkylguanine lesions in DNA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7695814",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 248,
          "text": "Spontaneous mutagenesis in O6-alkylguanine-DNA alkyltransferase-proficient and -deficient (ada ogt mutants) Escherichia coli was studied in two ways: in bacteria growing in nonselective liquid medium and in bacteria resting on selective agar plates",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9717173",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 278,
          "text": "The protein O 6-alkylguanine-DNA alkyltransferase(alkyltransferase) is involved in the repair of O 6-alkylguanine and O 4-alkylthymine in DNA and plays an important role in most organisms in attenuating the cytotoxic and mutagenic effects of certain classes of alkylating agents",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10101186",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1327,
          "offsetInEndSection": 1609,
          "text": "In summary, this paper presents for the first time evidence that DNA repair by O6-alkylguanine-DNA alkyltransferases plays a major role in removing lesions responsible for GC-->AT transitions induced by CCNU, influencing their ultimate distribution with respect to sequence context.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8519412",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 244,
          "text": "Forward mutations induced by 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in the lacl gene of Escherichia coli were recovered from bacteria proficient (Ogt+ Ada+) and deficient (Ogt- Ada-) in O6-alkylguanine-DNA alkyltransferase activity",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8519412",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 115,
          "text": "Repair of O6-benzylguanine by the Escherichia coli Ada and Ogt and the human O6-alkylguanine-DNA alkyltransferases.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9079656",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 274,
          "text": "O6-Alkylguanine DNA-alkyltransferase (ATase) repairs toxic, mutagenic and carcinogenic O6-alkylguanine (O6-alkG) lesions in DNA by a highly conserved reaction involving the stoichiometric transfer of the alkyl group to the active centre cysteine residue of the ATase protein",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9366274",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 89,
          "text": "O6-Alkylguanine-DNA alkyltransferase (EC 2.1.1.63) repairs O6-alkylguanine lesions in DNA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7695814",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which is the causative agent of malaria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12930149",
        "http://www.ncbi.nlm.nih.gov/pubmed/15003844",
        "http://www.ncbi.nlm.nih.gov/pubmed/15117937",
        "http://www.ncbi.nlm.nih.gov/pubmed/19184366",
        "http://www.ncbi.nlm.nih.gov/pubmed/20635416",
        "http://www.ncbi.nlm.nih.gov/pubmed/14556002",
        "http://www.ncbi.nlm.nih.gov/pubmed/19779742",
        "http://www.ncbi.nlm.nih.gov/pubmed/19666023",
        "http://www.ncbi.nlm.nih.gov/pubmed/21670272",
        "http://www.ncbi.nlm.nih.gov/pubmed/22819049",
        "http://www.ncbi.nlm.nih.gov/pubmed/11504465",
        "http://www.ncbi.nlm.nih.gov/pubmed/14638789",
        "http://www.ncbi.nlm.nih.gov/pubmed/22341220",
        "http://www.ncbi.nlm.nih.gov/pubmed/21206476",
        "http://www.ncbi.nlm.nih.gov/pubmed/12626578",
        "http://www.ncbi.nlm.nih.gov/pubmed/2067470",
        "http://www.ncbi.nlm.nih.gov/pubmed/23405174",
        "http://www.ncbi.nlm.nih.gov/pubmed/20078859",
        "http://www.ncbi.nlm.nih.gov/pubmed/15701514",
        "http://www.ncbi.nlm.nih.gov/pubmed/21297002",
        "http://www.ncbi.nlm.nih.gov/pubmed/10585859",
        "http://www.ncbi.nlm.nih.gov/pubmed/23246819",
        "http://www.ncbi.nlm.nih.gov/pubmed/22524128",
        "http://www.ncbi.nlm.nih.gov/pubmed/18522993",
        "http://www.ncbi.nlm.nih.gov/pubmed/18925948",
        "http://www.ncbi.nlm.nih.gov/pubmed/15293910",
        "http://www.ncbi.nlm.nih.gov/pubmed/12929205",
        "http://www.ncbi.nlm.nih.gov/pubmed/12139027",
        "http://www.ncbi.nlm.nih.gov/pubmed/20034997",
        "http://www.ncbi.nlm.nih.gov/pubmed/22216006",
        "http://www.ncbi.nlm.nih.gov/pubmed/21866942",
        "http://www.ncbi.nlm.nih.gov/pubmed/16203971",
        "http://www.ncbi.nlm.nih.gov/pubmed/18248630",
        "http://www.ncbi.nlm.nih.gov/pubmed/20702404",
        "http://www.ncbi.nlm.nih.gov/pubmed/1813841",
        "http://www.ncbi.nlm.nih.gov/pubmed/15339111",
        "http://www.ncbi.nlm.nih.gov/pubmed/18989463",
        "http://www.ncbi.nlm.nih.gov/pubmed/22543099",
        "http://www.ncbi.nlm.nih.gov/pubmed/19038338",
        "http://www.ncbi.nlm.nih.gov/pubmed/22222968",
        "http://www.ncbi.nlm.nih.gov/pubmed/23088152",
        "http://www.ncbi.nlm.nih.gov/pubmed/17822713",
        "http://www.ncbi.nlm.nih.gov/pubmed/15033330",
        "http://www.ncbi.nlm.nih.gov/pubmed/22990975",
        "http://www.ncbi.nlm.nih.gov/pubmed/19931645",
        "http://www.ncbi.nlm.nih.gov/pubmed/21698217",
        "http://www.ncbi.nlm.nih.gov/pubmed/23326533",
        "http://www.ncbi.nlm.nih.gov/pubmed/22563351",
        "http://www.ncbi.nlm.nih.gov/pubmed/22628552",
        "http://www.ncbi.nlm.nih.gov/pubmed/22929299",
        "http://www.ncbi.nlm.nih.gov/pubmed/3911876",
        "http://www.ncbi.nlm.nih.gov/pubmed/22095915",
        "http://www.ncbi.nlm.nih.gov/pubmed/20500669",
        "http://www.ncbi.nlm.nih.gov/pubmed/12125103",
        "http://www.ncbi.nlm.nih.gov/pubmed/14627712",
        "http://www.ncbi.nlm.nih.gov/pubmed/14514358",
        "http://www.ncbi.nlm.nih.gov/pubmed/15878595",
        "http://www.ncbi.nlm.nih.gov/pubmed/19706885",
        "http://www.ncbi.nlm.nih.gov/pubmed/19013823",
        "http://www.ncbi.nlm.nih.gov/pubmed/10703207",
        "http://www.ncbi.nlm.nih.gov/pubmed/23382752",
        "http://www.ncbi.nlm.nih.gov/pubmed/10744765",
        "http://www.ncbi.nlm.nih.gov/pubmed/11087748",
        "http://www.ncbi.nlm.nih.gov/pubmed/22507744",
        "http://www.ncbi.nlm.nih.gov/pubmed/15265796",
        "http://www.ncbi.nlm.nih.gov/pubmed/23046708",
        "http://www.ncbi.nlm.nih.gov/pubmed/15463447",
        "http://www.ncbi.nlm.nih.gov/pubmed/18611947",
        "http://www.ncbi.nlm.nih.gov/pubmed/17868038",
        "http://www.ncbi.nlm.nih.gov/pubmed/15147974",
        "http://www.ncbi.nlm.nih.gov/pubmed/22359643",
        "http://www.ncbi.nlm.nih.gov/pubmed/11115107",
        "http://www.ncbi.nlm.nih.gov/pubmed/18672695",
        "http://www.ncbi.nlm.nih.gov/pubmed/16458301",
        "http://www.ncbi.nlm.nih.gov/pubmed/18221799",
        "http://www.ncbi.nlm.nih.gov/pubmed/18295508",
        "http://www.ncbi.nlm.nih.gov/pubmed/11687659",
        "http://www.ncbi.nlm.nih.gov/pubmed/3011062",
        "http://www.ncbi.nlm.nih.gov/pubmed/2067482",
        "http://www.ncbi.nlm.nih.gov/pubmed/14609342",
        "http://www.ncbi.nlm.nih.gov/pubmed/19768685",
        "http://www.ncbi.nlm.nih.gov/pubmed/21570407",
        "http://www.ncbi.nlm.nih.gov/pubmed/9874251",
        "http://www.ncbi.nlm.nih.gov/pubmed/21601941",
        "http://www.ncbi.nlm.nih.gov/pubmed/2191201",
        "http://www.ncbi.nlm.nih.gov/pubmed/23293353",
        "http://www.ncbi.nlm.nih.gov/pubmed/6728514",
        "http://www.ncbi.nlm.nih.gov/pubmed/11796125",
        "http://www.ncbi.nlm.nih.gov/pubmed/4047719",
        "http://www.ncbi.nlm.nih.gov/pubmed/1648659",
        "http://www.ncbi.nlm.nih.gov/pubmed/15073329",
        "http://www.ncbi.nlm.nih.gov/pubmed/11839179",
        "http://www.ncbi.nlm.nih.gov/pubmed/18082626",
        "http://www.ncbi.nlm.nih.gov/pubmed/23484017",
        "http://www.ncbi.nlm.nih.gov/pubmed/21989409",
        "http://www.ncbi.nlm.nih.gov/pubmed/21904052",
        "http://www.ncbi.nlm.nih.gov/pubmed/15950069",
        "http://www.ncbi.nlm.nih.gov/pubmed/20610151",
        "http://www.ncbi.nlm.nih.gov/pubmed/18628947",
        "http://www.ncbi.nlm.nih.gov/pubmed/9514077",
        "http://www.ncbi.nlm.nih.gov/pubmed/19666593",
        "http://www.ncbi.nlm.nih.gov/pubmed/22057268",
        "http://www.ncbi.nlm.nih.gov/pubmed/19801158",
        "http://www.ncbi.nlm.nih.gov/pubmed/11559352",
        "http://www.ncbi.nlm.nih.gov/pubmed/19706490",
        "http://www.ncbi.nlm.nih.gov/pubmed/8300589",
        "http://www.ncbi.nlm.nih.gov/pubmed/18164079",
        "http://www.ncbi.nlm.nih.gov/pubmed/19380379",
        "http://www.ncbi.nlm.nih.gov/pubmed/11085920",
        "http://www.ncbi.nlm.nih.gov/pubmed/15703443",
        "http://www.ncbi.nlm.nih.gov/pubmed/7715553",
        "http://www.ncbi.nlm.nih.gov/pubmed/20353400",
        "http://www.ncbi.nlm.nih.gov/pubmed/8631352",
        "http://www.ncbi.nlm.nih.gov/pubmed/16222020",
        "http://www.ncbi.nlm.nih.gov/pubmed/18563912",
        "http://www.ncbi.nlm.nih.gov/pubmed/21329764",
        "http://www.ncbi.nlm.nih.gov/pubmed/16042788",
        "http://www.ncbi.nlm.nih.gov/pubmed/22592550",
        "http://www.ncbi.nlm.nih.gov/pubmed/21771420",
        "http://www.ncbi.nlm.nih.gov/pubmed/8816746",
        "http://www.ncbi.nlm.nih.gov/pubmed/23483940",
        "http://www.ncbi.nlm.nih.gov/pubmed/23349974",
        "http://www.ncbi.nlm.nih.gov/pubmed/19267910",
        "http://www.ncbi.nlm.nih.gov/pubmed/22019287",
        "http://www.ncbi.nlm.nih.gov/pubmed/17024857",
        "http://www.ncbi.nlm.nih.gov/pubmed/23342028",
        "http://www.ncbi.nlm.nih.gov/pubmed/22028927",
        "http://www.ncbi.nlm.nih.gov/pubmed/9927744",
        "http://www.ncbi.nlm.nih.gov/pubmed/19020475",
        "http://www.ncbi.nlm.nih.gov/pubmed/15246528",
        "http://www.ncbi.nlm.nih.gov/pubmed/6760901",
        "http://www.ncbi.nlm.nih.gov/pubmed/21209090",
        "http://www.ncbi.nlm.nih.gov/pubmed/1474844"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://www4.wiwiss.fu-berlin.de/diseasome/resource/diseases/710",
          "o": "Malaria"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/altMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A17994656"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A17994656",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A17994656",
          "o": "N0000001924"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A17994656",
          "o": "Malaria"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/altMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A7571934"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A7571934",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A7571934",
          "o": "C34797"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A7571934",
          "o": "NCI Thesaurus"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A7571934"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A7571934",
          "o": "Malaria"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:12365",
          "o": "http://www.w3.org/2004/02/skos/core#Concept"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#altLabel",
          "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:12365",
          "o": "induced malaria"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#altLabel",
          "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:12365",
          "o": "Induced malaria (disorder)"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#broader",
          "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:12365",
          "o": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:0050245"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#broader",
          "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:14326",
          "o": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:12365"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#broader",
          "s": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:12919",
          "o": "http://linkedlifedata.com/resource/diseaseontology/id/DOID:12365"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0082523",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A0082523",
          "o": "U002785"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A0082523",
          "o": "Library of Congress Subject Headings"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A0082523"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0082523",
          "o": "Malaria"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431821",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431821",
          "o": "1656"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431821",
          "o": "WHOART"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A0431821"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431821",
          "o": "MALARIA"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A8312247",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A8312247",
          "o": "67"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A8312247",
          "o": "HL7 Version 2.5"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0206255",
          "o": "http://linkedlifedata.com/resource/umls/label/A8312247"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A8312247",
          "o": "malaria"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431817",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A0431817"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431817",
          "o": "MALARIA"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0483250",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A0483250",
          "o": "2214-5569"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A0483250",
          "o": "CRISP Thesaurus"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A0483250"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0483250",
          "o": "malaria"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/prefMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A8339229"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A8339229",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A8339229",
          "o": "Metathesaurus Names"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A8339229",
          "o": "Malaria"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#prefLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A8339229"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/altMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A0082525"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0082525",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A0082525",
          "o": "D008288"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A0082525",
          "o": "MeSH"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A0082525"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0082525",
          "o": "Malaria"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A8317042",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A8317042",
          "o": "67"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A8317042",
          "o": "HL7 Version 3.0"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0206255",
          "o": "http://linkedlifedata.com/resource/umls/label/A8317042"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A8317042",
          "o": "malaria"
        },
        {
          "p": "http://linkedlifedata.com/resource/umls/altMetaMap",
          "s": "http://linkedlifedata.com/resource/umls/id/C0024530",
          "o": "http://linkedlifedata.com/resource/umls/label/A15661537"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A15661537",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A15661537",
          "o": "T315"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A15661537",
          "o": "Malaria"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0082521",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A0082521",
          "o": "A73"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0082521",
          "o": "Malaria"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431820",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431820",
          "o": "R0121672"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431820",
          "o": "Quick Medical Reference"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431820",
          "o": "MALARIA"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0483249",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A0483249",
          "o": "0000004887"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0483249",
          "o": "malaria"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431816",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431816",
          "o": "U000432"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0431816",
          "o": "MALARIA"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/umls/label/A8340437",
          "o": "http://www.w3.org/2008/05/skos-xl#Label"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#notation",
          "s": "http://linkedlifedata.com/resource/umls/label/A8340437",
          "o": "084"
        },
        {
          "p": "http://www.w3.org/2004/02/skos/core#note",
          "s": "http://linkedlifedata.com/resource/umls/label/A8340437",
          "o": "ICD-9-CM"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A8340437",
          "o": "Malaria"
        },
        {
          "p": "http://purl.uniprot.org/core/category",
          "s": "http://purl.uniprot.org/keywords/461",
          "o": "http://purl.uniprot.org/keywords/9995"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://purl.uniprot.org/keywords/461",
          "o": "http://purl.uniprot.org/core/Concept"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#comment",
          "s": "http://purl.uniprot.org/keywords/461",
          "o": "Protein involved in malaria, a human disease caused by Plasmodium, a parasitic protozoan that grows by sexual reproduction in the Anopheles mosquito."
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://purl.uniprot.org/keywords/461",
          "o": "Malaria"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#subClassOf",
          "s": "http://purl.uniprot.org/keywords/461",
          "o": "http://purl.uniprot.org/keywords/9995"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/pubmed/keyword/MALARIA",
          "o": "http://linkedlifedata.com/resource/pubmed/Keyword"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://linkedlifedata.com/resource/pubmed/keyword/MALARIA",
          "o": "MALARIA"
        },
        {
          "p": "http://www.w3.org/1999/02/22-rdf-syntax-ns#type",
          "s": "http://linkedlifedata.com/resource/pubmed/mesh/Malaria",
          "o": "http://linkedlifedata.com/resource/pubmed/Mesh"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://linkedlifedata.com/resource/pubmed/mesh/Malaria",
          "o": "Malaria"
        }
      ],
      "ideal_answer": [
        "Four Plasmodium species commonly infect humans (Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and Plasmodium ovale). Plasmodium falciparum infects about 5-10% of the world human population per year and it is the causative agent of the most severe and lethal form of malaria. P. falciparum  causes fatal cerebral malaria and is responsible for most deaths, particularly in pregnant women and children under the age of five. P. falciparum is transmitted to the human host by Anopheles mosquitoes and is the most tremendous malaria vector in sub-Saharan Africa. Plasmodium vivax is the causative agent of benign malaria in more temperate climates of the world. Plasmodium gallinaceum is the main bird malaria causative agent and  Plasmodium yoelli is the principle rodent malaria agent."
      ],
      "exact_answer": [
        "Plasmodium species",
        "Plasmodium spp."
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008288",
        "http://www.disease-ontology.org/api/metadata/DOID:12978",
        "http://www.disease-ontology.org/api/metadata/DOID:14067",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D010965",
        "http://www.disease-ontology.org/api/metadata/DOID:12365",
        "http://www.disease-ontology.org/api/metadata/DOID:14324",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016778",
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016780"
      ],
      "type": "factoid",
      "id": "517194ef8ed59a060a000011",
      "snippets": [
        {
          "offsetInBeginSection": 13,
          "offsetInEndSection": 107,
          "text": "lasmodium falciparum the main causative agent of malaria is an important public health vector.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23382752",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 109,
          "text": "Plasmodium falciparum the main causative agent of malaria is an important public health vector. <",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23382752",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 171,
          "text": "Overcoming antigenic variation is one of the major challenges in the development of an effective vaccine against Plasmodium falciparum, a causative agent of human malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23293353",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 156,
          "text": "[The vivax malaria causative agent Plasmodium ovale: the present global area, intraspecies polymorphism, importation to the Russian Federation (1992-2011)].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088152",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 113,
          "text": "The global area for Plasmodium ovale is small as compared with that for other species of human malaria pathogens.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088152",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 109,
          "offsetInEndSection": 1148,
          "text": "Parasites that have been described to affect the central nervous system (CNS), either as the dominant or as a collateral feature, include cestodes (Taenia solium (neurocysticerciasis), Echinococcus granulosus (cerebral cystic echinococcosis), E. multilocularis (cerebral alveolar echinococcosis), Spirometra mansoni (neurosparganosis)), nematodes (Toxocara canis and T. cati (neurotoxocariasis), Trichinella spiralis (neurotrichinelliasis), Angiostrongylus cantonensis and A. costaricensis (neuroangiostrongyliasis), Gnathostoma spinigerum (gnathostomiasis)), trematodes (Schistosoma mansoni (cerebral bilharziosis), Paragonimus westermani (neuroparagonimiasis)), or protozoa (Toxoplasma gondii (neurotoxoplasmosis), Acanthamoeba spp. or Balamuthia mandrillaris (granulomatous amoebic encephalitis), Naegleria (primary amoebic meningo-encephalitis), Entamoeba histolytica (brain abscess), Plasmodium falciparum (cerebral malaria), Trypanosoma brucei gambiense/rhodesiense (sleeping sickness) or Trypanosoma cruzi (cerebral Chagas disease))",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23046708",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 173,
          "text": "Plasmodium falciparum is the causative agent of malaria, a deadly infectious disease for which treatments are scarce and drug-resistant parasites are now increasingly found.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22819049",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 107,
          "offsetInEndSection": 320,
          "text": "In contrast, it has been thought that Plasmodium spp., the causative agent of malaria, rely mainly on cytosolic glycolysis but not mitochondrial oxidative phosphorylation for energy production during blood stages.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22628552",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 165,
          "offsetInEndSection": 447,
          "text": "Whereas no biological activity was previously identified for 1, the material derived from the efficient synthesis enabled additional bioactivity tests leading to the identification of a notable activity against insect cells and Plasmodium falciparum, the causative agent of malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563351",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 102,
          "offsetInEndSection": 283,
          "text": "Plasmodium falciparum, the causative agent of malaria, encodes an SSB protein that localizes to the apicoplast and likely functions in the replication and maintenance of its genome.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22543099",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 174,
          "offsetInEndSection": 411,
          "text": "While observing cells by time-lapse imaging is a standard procedure in many systems, this technique was until recently not available for blood stages of Plasmodium falciparum, the causative agent of the most severe form of human malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22341220",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 170,
          "text": "The causative agent of malaria, Plasmodium, possesses three translationally active compartments: the cytosol, the mitochondrion and a relic plastid called the apicoplast.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22222968",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 166,
          "text": "The merozoite surface protein (MSP)-1 of Plasmodium falciparum, the causative agent of malaria tropica, is considered to be a promising vaccine candidate.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22095915",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 115,
          "offsetInEndSection": 255,
          "text": "The genus Plasmodium, the causative agent of malaria, has the smallest mt genome in the form of a tandemly repeated, linear element of 6 kb.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21329764",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 223,
          "text": "The culminating step of the intraerythrocytic development of Plasmodium falciparum, the causative agent of malaria, is the spectacular release of multiple invasive merozoites on rupture of the infected erythrocyte membrane.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21297002",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 158,
          "offsetInEndSection": 322,
          "text": "Plasmodium falciparum, the causative agent of human malaria, lacks a conventional tricarboxylic acid cycle and depends exclusively on glycolysis for ATP production.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21209090",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 169,
          "text": "Plasmodium falciparum, the causative agent of the most deadly form of human malaria, is unable to salvage pyrimidines and must rely on de novo biosynthesis for survival.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20702404",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 126,
          "offsetInEndSection": 325,
          "text": "The Hsp90 protein from the parasite Plasmodium falciparum, the causative agent of malaria, is critical for this organism's survival; the anti-Hsp90 drug geldanamycin is toxic to P. falciparum growth.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20635416",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 204,
          "text": "A novel family of 1H-imidazol-2-yl-pyrimidine-4,6-diamines has been identified with potent activity against the erythrocyte-stage of Plasmodium falciparum (Pf), the most common causative agent of malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20610151",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 186,
          "offsetInEndSection": 326,
          "text": "The Plasmodium parasite, causative agent of malaria, infects RBC that are phagocytosed by DC and macrophages during the course of infection.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20500669",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 158,
          "text": "Plasmodium falciparum is the causative agent of malaria, a disease where new drug targets are required due to increasing resistance to current anti-malarials.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20353400",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 209,
          "text": "Plasmodium falciparum, the causative agent of human malaria, invades host erythrocytes using several proteins on the surface of the invasive merozoite, which have been proposed as potential vaccine candidates.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19931645",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 219,
          "text": "Few studies have investigated the pathophysiologic mechanisms responsible for what seems to be a possible interaction between Plasmodium falciparum, the causative agent of malaria, and HIV-1 in dually infected patients.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19801158",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 309,
          "offsetInEndSection": 456,
          "text": "We show that orthochromatic cells are the earliest stages that may be invaded by Plasmodium falciparum, the causative agent of fatal human malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19706885",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 136,
          "text": "Infection by Plasmodium, the causative agent of malaria, is associated with hemolysis and therefore with release of hemoglobin from RBC.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19706490",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 115,
          "text": "Plasmodium falciparum, the causative agent of malignant malaria, is among the most severe human infectious diseases",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19666593",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 181,
          "text": "Plasmodium falciparum, the most important causative agent of human malaria, undergoes antigenic variation as a means of prolonging infection and ensuring transmission between hosts.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19666023",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 187,
          "text": "L-Malate dehydrogenase (PfMDH) from Plasmodium falciparum, the causative agent for the most severe form of malaria, has shown remarkable similarities to L: -lactate dehydrogenase (PfLDH).",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19184366",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 138,
          "offsetInEndSection": 303,
          "text": "FQ is able to overcome the chloroquine (CQ) resistance problem, an important limit to the control of Plasmodium falciparum, the principal causative agent of malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18563912",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 165,
          "text": "The causative agent of malaria, Plasmodium falciparum posses a single aquaglyceroporin (PfAQP) which represents a potential drug target for treatment of the disease.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18295508",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 172,
          "text": "An essential requisite for transmission of Plasmodium, the causative agent of malaria, is the successful completion of a complex developmental cycle in its mosquito vector.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18248630",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 180,
          "text": "In Plasmodium falciparum, the causative agent of cerebral malaria, silent information regulator 2 (Sir2) has been implicated in pathogenesis through its role in var gene silencing.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18221799",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 125,
          "text": "Plasmodium falciparum, the causative agent of human malaria, is totally dependent on de novo pyrimidine biosynthetic pathway.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18082626",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 172,
          "text": "Plasmodium falciparum, the causative agent of the fatal form of malaria, synthesizes GMP primarily from IMP and, hence, needs active GMPS (GMP synthetase) for its survival.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17868038",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 157,
          "text": "Plasmodium falciparum is the causative agent of the most severe type of malaria, a life-threatening disease affecting the lives of over three billion people.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17822713",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 11,
          "offsetInEndSection": 150,
          "text": "Plasmodium falciparum, the causative agent of the most serious form of malaria, infects about 5-10% of the world human population per year.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17024857",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 294,
          "text": "Plasmodium vivax is an important human pathogen causing malaria in more temperate climates of the world. Similar to Plasmodium falciparum, the causative agent for malaria tropica, drug resistance is beginning to emerge for this parasite species and this hampers adequate treatment of infection.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16458301",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 225,
          "text": "Malaria kills more than one million people a year, and understanding the historical association between its most notorious causative agent, Plasmodium falciparum, and its mosquito vectors is important in fighting the disease.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16222020",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 166,
          "offsetInEndSection": 347,
          "text": "We show here that macrophages are mandatory for NK cell IFN-gamma secretion in response to erythrocytes infected with Plasmodium falciparum (Pf), a causative agent of human malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16203971",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 76,
          "offsetInEndSection": 167,
          "text": "Plasmodium falciparum is the causative agent of the most severe and mortal type of malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15950069",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 238,
          "text": "Plasmodium falciparum is the main causative agent of tropical malaria, the most severe parasitic disease in the world. Growing resistance of Plasmodia towards available drugs is an increasing problem in countries where malaria is endemic.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15878595",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 117,
          "offsetInEndSection": 234,
          "text": "The presence of antisense RNA in Plasmodium falciparum, the causative agent of severe malaria, remains controversial.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15703443",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 207,
          "text": "Plasmodium falciparum, the causative agent of malaria, is sensitive to oxidative stress and therefore the family of antioxidant enzymes, peroxiredoxins (Prxs) represent a target for antimalarial drug design.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15701514",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 174,
          "text": "In the Republic of Yemen, Plasmodium falciparum is the predominant causative agent of malaria and is associated with adverse consequences for pregnant women and their babies.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15339111",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 166,
          "text": "Plasmodium falciparum, the causative agent of the most lethal form of human malaria, uses multiple ligand-receptor interactions to invade host red blood cells (RBCs).",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15265796",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 295,
          "text": "Comparative genomic analysis of the malaria causative agent, Plasmodium falciparum, with other eukaryotes for which the complete genome is available, revealed that the genome from P. falciparum was more similar to the genome of a plant, Arabidopsis thaliana, than to other non-apicomplexan taxa.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15246528",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 144,
          "text": "Plasmodium falciparum, the causative agent of the most lethal form of human malaria, totally depends on de novo pyrimidine biosynthetic pathway.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15147974",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 177,
          "text": "Plasmodium falciparum, the causative agent of malaria, relies extensively on glycolysis coupled with homolactic fermentation during its blood-borne stages for energy production.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15117937",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 201,
          "text": "Plasmodium falciparum is the causative agent of the most severe form of human malaria. The rapid multiplication of the parasite within human erythrocytes requires an active production of new membranes.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15073329",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 157,
          "offsetInEndSection": 401,
          "text": "Seven sPLA(2)s from groups IA, IB, IIA and III, were tested here in different culture conditions for inhibition of the in vitro intraerythrocytic development of Plasmodium falciparum, the causative agent of the most severe form of human malaria",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15033330",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 127,
          "text": "Plasmodium falciparum, the causative agent of the most lethal form of human malaria, relies on de novo pyrimidine biosynthesis.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15003844",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 152,
          "text": "In spite of research efforts to develop vaccines against the causative agent of human malaria, Plasmodium falciparum, effective control remains elusive.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14638789",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 149,
          "text": "Plasmodium, the causative agent of malaria, has to undergo sexual differentiation and development in anopheline mosquitoes for transmission to occur.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14627712",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 117,
          "offsetInEndSection": 254,
          "text": "For Plasmodium falciparum, a causative agent of tropical malaria, TrxR is an essential protein which has been validated as a drug target.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14609342",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 108,
          "text": "Plasmodium, the causative agent of malaria, must first infect hepatocytes to initiate a mammalian infection.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14556002",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 222,
          "text": "Cyclin dependent protein kinases (CDKs) have become attractive drug targets in an effort to identify effective inhibitors of the parasite Plasmodium falciparum, the causative agent of the most severe form of human malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12930149",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 190,
          "offsetInEndSection": 377,
          "text": "It is well established that protection against one such disease, malaria, requires strong CD8(+) T cell responses targeted against the liver stages of the causative agent, Plasmodium spp.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12626578",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 122,
          "text": "A novel method for the in vitro detection of the protozoan Plasmodium, the causative agent of malaria, has been developed.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12139027",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 149,
          "text": "Trypanosomes do not inhabit or grow in anopheles mosquitoes, the vector for the transmission of Plasmodium parasites the causative agent for malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12125103",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 215,
          "text": "The genome sequence of Plasmodium falciparum, the causative agent of the most severe form of malaria in humans, rapidly approaches completion, but our ability to genetically manipulate this organism remains limited.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11796125",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 95,
          "offsetInEndSection": 229,
          "text": "It is caused by a number of species of the genus Plasmodium, and Plasmodium falciparum is the causative agent of the most lethal form.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11839179",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 181,
          "offsetInEndSection": 333,
          "text": "To complete its life cycle in the mosquito, Plasmodium, the causative agent of malaria, has to traverse the epithelia of the midgut and salivary glands.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11687659",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 158,
          "text": "In Plasmodium falciparum, the causative agent of human malaria, the catalytic subunit gene of cAMP-dependent protein kinase (Pfpka-c) exists as a single copy.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11559352",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 189,
          "offsetInEndSection": 494,
          "text": "Sulfadoxine is the most extensively used drug of this group of drugs and is usually combined with pyrimethamine (Fansidar), particularly for the control of Plasmodium falciparum, the causative agent of the most lethal form of malaria. Resistance to the sulfadoxine/pyrimethamine combination is widespread.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11504465",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 222,
          "text": "A putative glutathione peroxidase gene (Swiss-Prot accession number Z 68200) of Plasmodium falciparum, the causative agent of tropical malaria, was expressed in Escherichia coli and purified to electrophoretic homogeneity.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11087748",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 171,
          "text": "Apical membrane antigen 1 (AMA1) is an asexual blood-stage protein expressed in the invasive merozoite form of Plasmodia species, which are the causative agent of malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11115107",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 350,
          "offsetInEndSection": 571,
          "text": "In the case of Plasmodium falciparum, the causative agent of malaria tropica, this approach is especially interesting, because here both key enzymes, ODC and AdoMetDC, are combined in a bifunctional protein, ODC/AdoMetDC.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11085920",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 214,
          "text": "Plasmodium falciparum, the causative agent of the most lethal form of human malaria, is incapable of de novo purine synthesis, and thus, purine acquisition from the host is an indispensable nutritional requirement.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10744765",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 267,
          "text": "A laboratory model of circulation of the malaria causative agent P. gallinaceum has been used to show that the effect of precocene (antijuvenoid) leads to a statistically significant reduction in the proportion of infected females developing eggs after blood suction.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10703207",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 447,
          "offsetInEndSection": 690,
          "text": "A cell-free incubation system prepared from asexual erythrocytic stages of Plasmodium falciparum, the causative agent of malaria in humans, is capable of synthesizing the same spectrum of GPIs as that found in metabolically labelled parasites.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10585859",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 85,
          "text": "The Plasmodium falciparum malaria parasite is the causative agent of malaria tropica.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9927744",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 133,
          "text": "The gene of an NADP+-specific glutamate dehydrogenase was cloned from Plasmodium falciparum, the causative agent of tropical malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9874251",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 229,
          "text": "This study describes the synergistic interaction of two calcium channel blockers, verapamil (VR) and SR33557 or fantofarone (SR), in reversing chloroquine resistance in Plasmodium falciparum, the causative agent of human malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9514077",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 97,
          "text": "Plasmodium falciparum is the major causative agent of malaria, a disease of worldwide importance.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8816746",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 97,
          "offsetInEndSection": 422,
          "text": "Two enzymes were purified to homogeneity from the intraerythrocytic malarial parasite Plasmodium falciparum: glutathione disulfide reductase, an antioxidative enzyme, which appears to play an essential role for parasite growth and differentiation, and glutamate dehydrogenase, an enzyme not occurring in the host erythrocyte.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8631352",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 205,
          "text": "The paper provides evidence that the An. sacharovi females which do not develop mature eggs after blood-sucking on the malaria-infected donor could not be infected by the bird malaria agent P. gallinaceum.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7715553",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 71,
          "text": "Plasmodium falciparum is the causative agent of malaria tropica in man.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8300589",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 99,
          "text": "Plastid origin of an extrachromosomal DNA molecule from Plasmodium, the causative agent of malaria.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1474844",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 140,
          "text": "[New models of the circulation of the causative agent of malaria Plasmodium gallinaceum using malarial mosquitoes in the fauna of the USSR].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1813841",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 165,
          "text": "[Experimental research on the effect of biologically active substances on the susceptibility of mosquitoes to the causative agent of malaria. 3. Algae, fertilizers].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1648659",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 467,
          "text": "On a model pair Aedes aegypti--Plasmodium gallinaceum in has been shown that changes in the conditions of larvae development caused by the addition into the water medium of the live culture of Synochocystis sp. cyanobacteria or green seaweeds Chlorella vulgaris, acetone extracts from the live culture precipitate or Chlorella powder, as well as nitrogen-containing fertilizer--ammonium chloride did not lower the sensitivity of the imago flying to malaria parasites.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1648659",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 155,
          "offsetInEndSection": 479,
          "text": "The mechanism of chloroquine resistance has not been known but recent evidence from Plasmodium falciparum, the causative agent of the most severe form of human malaria, suggested similarities to the multidrug resistance phenotype (MDR) of mammalian tumour cells which is mediated by a protein molecule termed P-glycoprotein.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15463447",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 283,
          "text": "The feasibility was determined of influencing Ae. aegypti sensitivity to bird malaria agent P. gallinaceum by sublethal concentrations of herbicides (ordram and propanide) and fungicides (fundozol and blue vitriol) introduced into the larvae habitation medium or into the imago feed.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2067482",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 186,
          "text": "[An experimental study of the effect of different biologically active substances on the susceptibility of mosquitoes to the causative agent of malaria. 1. Insect development regulators].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2067470",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 182,
          "text": "It has been shown on the model pair Ae. aegypti-P. gallinaceum that dimilin, an inhibitor of insect chitin synthesis has practically no effect on female sensitivity to malaria agent.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2067470",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 137,
          "text": "[The absence of an action of the pyrethroids deltamethrin and cypermethrin on mosquito susceptibility to the causative agent of malaria].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2191201",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 293,
          "text": "Mosquitos Ae. aegypti and An. stephensi contact with sublethal doses of deltametrin and cypermetrin pyretroids at larval stage and in grown state, when diet includes sugar with pyretroids, had no influence on the sensitivity of survived females to malaria agents P. gallinaceum and P. berghei.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2191201",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 114,
          "offsetInEndSection": 368,
          "text": "This prompted us to purify and characterize the topoisomerases I and II present in the erythrocytes of protozoan parasites of the genus Plasmodium, the causative agent of malaria, in order to later use these enzymatic systems in antimalarial drug assays.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3011062",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 165,
          "text": "The problem of drug resistance of Plasmodium falciparum, the causative agent of tropical malaria and its role in the general system of malaria control are discussed.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3911876",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 97,
          "text": "[Effect of mosquito contact with DDT and their susceptibility to the causative agent of malaria].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/4047719",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 119,
          "text": "[Lack of an effect from repeated blood sucking by mosquitoes on their infectivity with the causative agent of malaria].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6728514",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 137,
          "text": "The lack of repeated bloodsucking does not affect essentially the infection of Ae. aegypti mosquitoes with malaria agent, P. gallinaceum.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6728514",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 207,
          "text": "High resolution 31P-NMR has been used for the non-invasive observation of metabolites and metabolic rates in blood of normal mice and of mice infected with Plasmodium berghei, the causative agent of malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6760901",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 107,
          "text": "BACKGROUND: Plasmodium falciparum the main causative agent of malaria is an important public health vector.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23382752",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 226,
          "text": "The effectiveness of methylene blue (MB) combined with pyrimethamine (PYR), chloroquine (CQ) or quinine (Q) was examined in a classical four-day suppressive test against a causative agent of rodent malaria, Plasmodium berghei.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22990975",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 351,
          "offsetInEndSection": 548,
          "text": "Infection by Plasmodium species, the causative agent of malaria, is currently treated with drug-based therapies, but an increase in drug resistance has led to the need for new methods of treatment.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22592550",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 166,
          "text": "BACKGROUND: The merozoite surface protein (MSP)-1 of Plasmodium falciparum, the causative agent of malaria tropica, is considered to be a promising vaccine candidate.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22095915",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 180,
          "text": "The 23-megabase genome of Plasmodium falciparum, the causative agent of severe human malaria, contains \u223c5300 genes, most of unknown function or lacking homologs in other organisms.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22057268",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1193,
          "offsetInEndSection": 1320,
          "text": "Results of the present study indicate that malaria is endemic in Nouakchott and that P. vivax is the principal causative agent.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22019287",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1333,
          "offsetInEndSection": 1413,
          "text": "Plasmodium vivax was the main causative agent followed by Plasmodium falciparum.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21771420",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 193,
          "text": "Toxoplasma gondii is a member of the phylum Apicomplexa that includes several important human pathogens, such as Cryptosporidium and Plasmodium falciparum, the causative agent of human malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21670272",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 99,
          "text": "Plasmodium falciparum, the major causative agent of human malaria, contains three separate genomes.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21570407",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 176,
          "text": "Plasmodium parasites, the causative agent of malaria, are transmitted through the bites of infected Anopheles mosquitoes resulting in over 250 million new infections each year.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21206476",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 116,
          "offsetInEndSection": 351,
          "text": "The genus Plasmodium, causative agent of malaria, of the phylum Apicomplexa, has the smallest mt genome in the form of a circular and/or tandemly repeated linear element of 6 kb, encoding only three protein genes (cox1, cox3, and cob).",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20034997",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 141,
          "offsetInEndSection": 227,
          "text": "Plasmodium falciparum is the causative agent of the most lethal form of human malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19779742",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 146,
          "offsetInEndSection": 337,
          "text": "In Plasmodium falciparum, the causative agent of the most lethal form of malaria, fatty acid biosynthesis occurs in the apicoplast organelle during the liver stage of the parasite life cycle.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19768685",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 116,
          "text": "Plasmodium falciparum, the causative agent of malignant malaria, is among the most severe human infectious diseases.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19666593",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 34,
          "offsetInEndSection": 172,
          "text": "For transmission to occur, Plasmodium, the causative agent of malaria, must complete a complex developmental cycle in its mosquito vector.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19038338",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 267,
          "offsetInEndSection": 418,
          "text": "FQ is able to overcome the CQ resistance problem, an important limit to the control of Plasmodium falciparum, the principal causative agent of malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19020475",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 272,
          "offsetInEndSection": 511,
          "text": "Some lycorine ester derivatives including LT1 were examined for their inhibitory activity against Trypanosoma brucei brucei, the parasite associated with sleeping sickness, and against Plasmodium falciparum, the causative agent of malaria.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19013823",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 255,
          "text": "A three-dimensional structure of histo-aspartic protease (HAP), a pepsin-like enzyme from the causative agent of malaria Plasmodium falciparum, is suggested on the basis of homologous modeling followed by equilibration by the method of molecular dynamics.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18672695",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 220,
          "text": "BACKGROUND: Understanding gene regulation in Plasmodium, the causative agent of malaria, is an important step in deciphering its complex life cycle as well as leading to possible new targets for therapeutic applications.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18611947",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 161,
          "text": "Plasmodium falciparum, the causative agent of malaria, relies on a complex protein-secretion system for protein targeting into numerous subcellular destinations.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18522993",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 253,
          "text": "We have evaluated a technology called transcriptionally active PCR (TAP) for high throughput identification and prioritization of novel target antigens from genomic sequence data using the Plasmodium parasite, the causative agent of malaria, as a model.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18164079",
          "endSection": "sections.0"
        }
      ]
    },
    {
      "body": "What is the mechanism by which HIV-1-encoded Vif protein allows virus replication?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21725586",
        "http://www.ncbi.nlm.nih.gov/pubmed/23689841",
        "http://www.ncbi.nlm.nih.gov/pubmed/24189052",
        "http://www.ncbi.nlm.nih.gov/pubmed/23316055",
        "http://www.ncbi.nlm.nih.gov/pubmed/23707381",
        "http://www.ncbi.nlm.nih.gov/pubmed/22728817",
        "http://www.ncbi.nlm.nih.gov/pubmed/19887642",
        "http://www.ncbi.nlm.nih.gov/pubmed/20147392"
      ],
      "ideal_answer": [
        "The HIV-1 Vif protein counteracts the antiviral activity of the APOBEC3 family by targeting the proteins for degradation through the ubiquitin-proteasome pathway. More specifically, Vif, serving as a substrate receptor, facilitates ubiquitination of APOBEC3 proteins by forming a Cullin5-based E3 ubiquitin ligase complex, which targets APOBEC3 proteins for rapid proteasomal degradation."
      ],
      "type": "summary",
      "id": "54dfce9b1388e8454a00000b",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 96,
          "text": "A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23707381",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 279,
          "text": "The human immunodeficiency virus type 1 (HIV-1) Vif protein counteracts the antiviral activity of the apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3) family of proteins by targeting the proteins for degradation through the ubiquitin-proteasome pathway",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23707381",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 199,
          "text": "The host protein APOBEC3G (A3G) can limit HIV-1 replication. Its protective effect is overcome by the HIV-1 'viral infectivity factor' (Vif), which targets A3G for proteosomal degradation",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23689841",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 439,
          "offsetInEndSection": 589,
          "text": " Vif is thought to primarily overcome APOBEC3G through an interaction that mediates APOBEC3G ubiquitination and results in its proteasomal degradation",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23316055",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 591,
          "offsetInEndSection": 694,
          "text": "However, Vif may also inhibit APOBEC3G mRNA translation, virion encapsidation, and deamination activity",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23316055",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 174,
          "offsetInEndSection": 470,
          "text": "Vif counteracts the packaging of two cellular cytidine deaminases named APOBEC3G (A3G) and A3F by diverse mechanisms including the recruitment of an E3 ubiquitin ligase complex and the proteasomal degradation of A3G/A3F, the inhibition of A3G mRNA translation or by a direct competition mechanism",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22728817",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 472,
          "offsetInEndSection": 757,
          "text": "In addition, Vif appears to be an active partner of the late steps of viral replication by participating in virus assembly and Gag processing, thus regulating the final stage of virion formation notably genomic RNA dimerization and by inhibiting the initiation of reverse transcription",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22728817",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 311,
          "text": "Human apoplipoprotein B mRNA-editing enzyme-catalytic polypeptide-like (APOBEC) 3G (A3G) is an antiviral protein that blocks HIV-1 replication. However, the antiviral activity of A3G is overcome by the HIV-1 protein Vif. This inhibitory function of Vif is related to its ability to degrade A3G in the proteasome",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21725586",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 76,
          "text": "Polyubiquitination of APOBEC3G is essential for its degradation by HIV-1 Vif",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20147392",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 684,
          "offsetInEndSection": 798,
          "text": "These data suggest that polyubiquitination of APOBEC3G, not that of HIV-1 Vif, is crucial for APOBEC3G degradation",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20147392",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 412,
          "text": "During coevolution with the host, HIV-1 developed the ability to hijack the cellular ubiquitin/proteasome degradation pathway to counteract the antiviral activity of APOBEC3G (A3G), a host cytidine deaminase that can block HIV-1 replication. Abrogation of A3G function involves the HIV-1 Vif protein, which binds A3G and serves as an adapter molecule to recruit A3G to a Cullin5-based E3 ubiquitin ligase complex",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19887642",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 397,
          "offsetInEndSection": 632,
          "text": "HIV-1 counteracts APOBEC3 proteins by encoding the viral protein Vif, which contains distinct domains that specifically interact with these APOBEC3 proteins to ensure their proteasomal degradation, allowing virus replication to proceed",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24189052",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which are the methods for in silico prediction of the origin of replication (ori) among bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18582175",
        "http://www.ncbi.nlm.nih.gov/pubmed/12218031",
        "http://www.ncbi.nlm.nih.gov/pubmed/18237442",
        "http://www.ncbi.nlm.nih.gov/pubmed/24822028",
        "http://www.ncbi.nlm.nih.gov/pubmed/23093601",
        "http://www.ncbi.nlm.nih.gov/pubmed/25309521",
        "http://www.ncbi.nlm.nih.gov/pubmed/17188685",
        "http://www.ncbi.nlm.nih.gov/pubmed/14643658",
        "http://www.ncbi.nlm.nih.gov/pubmed/21364800",
        "http://www.ncbi.nlm.nih.gov/pubmed/17584494",
        "http://www.ncbi.nlm.nih.gov/pubmed/21945744",
        "http://www.ncbi.nlm.nih.gov/pubmed/24808892",
        "http://www.ncbi.nlm.nih.gov/pubmed/19332823",
        "http://www.ncbi.nlm.nih.gov/pubmed/12732098"
      ],
      "ideal_answer": [
        "Several in silico methods have been applied for prediction of the origin of replication (ori). DNA base composition asymmetry, such as GC skew, is the basis of numerous in silico methods used to detect the ori in prokaryotes. The Z curve analysis is also used for ori identification. Comparative genomics, by BLAST analyses of the intergenic sequences compared to related species have been applied in ori prediction. The finding of the dnaA gene and its binding sites, DnaA boxes, as well as the finding of the binding sites of other proteins, such as CtrA and IHF, are fundamental characteristics used for in silico prediction of the ori. Also, the localization of boundary genes, such as cell division cycle (cdc6) gene, and consensus origin recognition box (ORB) sequences have been employed for ori detection. The study of the gene order around the origin sequence and the distribution of the genes encoded in the leading versus the lagging strand are also used for in silico detection of the ori."
      ],
      "exact_answer": [
        [
          "GC skew analysis"
        ],
        [
          "Z curve analysis"
        ],
        [
          "comparative genomics"
        ],
        [
          "dnaA gene location"
        ],
        [
          "localization of dnaA binding sites (DnaA boxes)"
        ],
        [
          "localization of CtrA binding sites"
        ],
        [
          "localization of IHF binding sites"
        ],
        [
          "localization of cell division cycle (cdc6) gene"
        ],
        [
          "localization of other boundary genes"
        ],
        [
          "localization of other consensus origin recognition box (ORB) sequences"
        ],
        [
          "the gene order around the ori"
        ],
        [
          "gene distribution in leading versus lagging strand"
        ]
      ],
      "concepts": [
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0000808",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004261",
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018741",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0003688"
      ],
      "type": "list",
      "id": "5542644fed966d112c000004",
      "snippets": [
        {
          "offsetInBeginSection": 522,
          "offsetInEndSection": 715,
          "text": "Based on the Z-curve theory, we have developed a web-based system Ori-Finder to predict oriCs in bacterial genomes with high accuracy and reliability by taking advantage of comparative genomics",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23093601",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 714,
          "offsetInEndSection": 935,
          "text": "we have applied a combination of multiple in silico approaches - Z curve, the cell division cycle (cdc6) gene location and location of consensus origin recognition box (ORB) sequences for location of origin of replication",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21364800",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 481,
          "offsetInEndSection": 888,
          "text": "Using features that have been previously experimentally verified in the alpha-Proteobacterium Caulobacter crescentus, the origin of DNA replication (ori) regions were identified in silico for Wolbachia strains and eleven other related bacteria belonging to Ehrlichia, Anaplasma, and Rickettsia genera. These features include DnaA-, CtrA- and IHF-binding sites as well as the flanking genes in C. crescentus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17584494",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1127,
          "offsetInEndSection": 1357,
          "text": "The sequences of the ori regions described here are only similar among closely related bacteria while fundamental characteristics like presence of DnaA and IHF binding sites as well as the boundary genes are more widely conserved.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17584494",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 340,
          "offsetInEndSection": 724,
          "text": "We propose a correlation measure and show that it is correctly able to predict the origin of replication in most of the bacterial genomes. When applied to Methanocaldococcus jannaschii, Plasmodium falciparum apicoplast and Nicotiana tabacum plastid, this correlation based method is able to correctly predict the origin of replication whereas the generally used GC skew measure fails.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21945744",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 272,
          "offsetInEndSection": 415,
          "text": "DNA base composition asymmetry is the basis of numerous in silico methods used to detect the origin and terminus of replication in prokaryotes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18582175",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 862,
          "offsetInEndSection": 1153,
          "text": "These analyses include finding the dnaA gene and its binding sites; making BLAST analyses of the intergenic sequences compared to related species; studying the gene order around the origin sequence; and studying the distribution of the genes encoded in the leading versus the lagging strand.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18582175",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 450,
          "offsetInEndSection": 491,
          "text": "DnaA binds a single DnaA box as a monomer",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14643658",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 300,
          "offsetInEndSection": 613,
          "text": "In silico comparative analysis of sequenced mollicute genomes indicated the lack of conservation of gene order in the region containing the predicted origin of replication (oriC) and the existence, in most of the mollicute genomes examined, of putative DnaA boxes lying upstream and downstream from the dnaA gene.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12218031",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 692,
          "offsetInEndSection": 1090,
          "text": "In this paper we have applied a combination of multiple in silico approaches - Z curve, the cell division cycle (cdc6) gene location and location of consensus origin recognition box (ORB) sequences for location of origin of replication in Thermococcus onnurineus, Thermococcus gammatolerans and other Themococcales and compared the results to that of the well-documented case of Pyrococcus abyssi.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21364800",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 269,
          "offsetInEndSection": 413,
          "text": "DNA base composition asymmetry is the basis of numerous in silico methods used to detect the origin and terminus of replication in prokaryotes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18582175",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 595,
          "offsetInEndSection": 737,
          "text": "It increases the prediction accuracy of the replication termini compared with previously documented methods based on genomic base composition.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17188685",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 128,
          "offsetInEndSection": 264,
          "text": "Using compositional skews such as the GC skew, replication origin and terminus can be predicted in silico by observing the shift points.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17188685",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 983,
          "offsetInEndSection": 1119,
          "text": "Here, we summarize the recent advances of in silico prediction of oriCs in bacterial and archaeal genomes using the Z-curve based method",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24822028",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 272,
          "offsetInEndSection": 414,
          "text": "DNA base composition asymmetry is the basis of numerous in silico methods used to detect the origin and terminus of replication in prokaryotes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18582175",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 89,
          "text": "Recent Advances in the Identification of Replication Origins Based on the Z-curve Method.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24822028",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 452,
          "offsetInEndSection": 783,
          "text": "We present a web-based tool Ori-Finder 2 to predict oriCs in the archaeal genomes automatically, based on the integrated method comprising the analysis of base composition asymmetry using the Z-curve method, the distribution of origin recognition boxes identified by FIMO tool, and the occurrence of genes frequently close to oriCs",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25309521",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is the main mechanism by which human papillomavirus proteins E6 and E7 contribute to cell transformation?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10809724",
        "http://www.ncbi.nlm.nih.gov/pubmed/17768080",
        "http://www.ncbi.nlm.nih.gov/pubmed/9537653",
        "http://www.ncbi.nlm.nih.gov/pubmed/8207801",
        "http://www.ncbi.nlm.nih.gov/pubmed/21643539",
        "http://www.ncbi.nlm.nih.gov/pubmed/9223480",
        "http://www.ncbi.nlm.nih.gov/pubmed/20088881",
        "http://www.ncbi.nlm.nih.gov/pubmed/16249186",
        "http://www.ncbi.nlm.nih.gov/pubmed/8397367",
        "http://www.ncbi.nlm.nih.gov/pubmed/1331501",
        "http://www.ncbi.nlm.nih.gov/pubmed/10698500",
        "http://www.ncbi.nlm.nih.gov/pubmed/17332339",
        "http://www.ncbi.nlm.nih.gov/pubmed/9817205",
        "http://www.ncbi.nlm.nih.gov/pubmed/21980285"
      ],
      "ideal_answer": [
        "Although they may have other targets, human papillomavirus proteins E6 and E7 interact with and block the function of p53 and pRb, respectively, therefore deregulating cell cycle and leading to cellular transformation."
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2012/MB_cgi?field=uid&exact=Find+Exact+Term&term=D050725",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0019087"
      ],
      "type": "summary",
      "id": "5178444e8ed59a060a000037",
      "snippets": [
        {
          "offsetInBeginSection": 816,
          "offsetInEndSection": 1116,
          "text": "The ability of high-risk HPV E6 and E7 protein to promote the degradation of p53 and pRb, respectively, has been suggested as a mechanism by which HPV oncogenes induce cellular transformation. E6 and E7 abrogate cell cycle checkpoints and induce genomic instability that leads to malignant conversion",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21643539",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 686,
          "offsetInEndSection": 891,
          "text": "The results showed that tumorigenicity and decreased serum requirement were associated with the ability of E6 to bind to p53, although the subsequent degradation of p53 was not required for these functions",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9537653",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 583,
          "offsetInEndSection": 828,
          "text": "The E7 mutants chosen had either an in-frame deletion in the conserved region 2 (CR2) domain, which is required for binding of the retinoblastoma tumor suppressor protein (pRb) and pRb-like proteins, or an in-frame deletion in the E7 CR1 domain.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9223480",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 416,
          "text": "The recognition of a causal relationship between human papillomaviruses and cancer almost 30 years ago led to a rapid expansion of knowledge in the field, resulting in the description of the main mediators of HPV-induced carcinogenesis, the viral proteins E6 and E7. These oncoproteins show a remarkable pleiotropism in binding host-cell proteins, with the tumour suppressor genes p53 and pRb as their major targets.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17768080",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 567,
          "offsetInEndSection": 793,
          "text": "First, we found that human papillomavirus E6 and E7 oncogenes, which block the function of the p53 and Rb tumor suppressors, respectively, and SV40 small t antigen were required to allow mutant K-Ras(12D) growth transformation",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17332339",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 427,
          "offsetInEndSection": 618,
          "text": "In recent years, it has become clear that in addition to E6-induced degradation of p53 tumor suppressor protein, other targets of E6 are required for mammary epithelial cells immortalization.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10809724",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 364,
          "offsetInEndSection": 498,
          "text": "a general requirement for oncoproteins such as human papillomavirus E6 and E7 has suggested that the p53 and Rb pathways are targeted.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9817205",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 142,
          "text": "Transformation by the human papillomavirus (HPV) early gene products, E6 and E7, involves their interaction with cellular proteins p53 and Rb.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8207801",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1610,
          "offsetInEndSection": 1939,
          "text": "The results from this study support the theory that p53 protein binds HPV-16/18 E6 protein in the cell cytoplasm, thus preventing p53 from exerting its tumor-suppressor function in the nucleus. Hence, inactivation of wild-type p53 by p53-E6 complex formation in cervical cancer may be a critical step in malignant transformation.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8397367",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 1191,
          "offsetInEndSection": 1331,
          "text": "the E7-RbAB interaction involves multiple motifs within the N-terminal domain of E7 and at least two conserved interaction surfaces in RbAB.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20088881",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 966,
          "offsetInEndSection": 1053,
          "text": "Based on these studies we present a mechanistic model for how E7 displaces E2F from pRb",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16249186",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 614,
          "offsetInEndSection": 761,
          "text": "The E7 protein of human papillomavirus type 16 contains an element that binds to pRB and appears to be functionally homologous to the E1A sequences",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1331501",
          "endSection": "sections.0"
        },
        {
          "offsetInBeginSection": 185,
          "offsetInEndSection": 327,
          "text": "Several of the biological activities of HPV16 E7 are mediated by inactivation of the members of the pocket protein family, pRb, p107 and p130.",
          "beginSection": "sections.0",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10698500",
          "endSection": "sections.0"
        }
      ]
    },
    {
      "body": "List bacterial species identified in the iceman tissues.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10640948",
        "http://www.ncbi.nlm.nih.gov/pubmed/10861348",
        "http://www.ncbi.nlm.nih.gov/pubmed/24941044"
      ],
      "ideal_answer": [
        "Spirochete Treponema denticola\nClostridium perfringens\nClostridium ghonii\nClostridium sordellii\nEubacterium tenue\nBacteroides sp\nVibrio\nSphingomonas\nAfipia\nCurtobacterium\nMicrobacterium\nAgromyces"
      ],
      "exact_answer": [
        [
          "Spirochete Treponema denticola"
        ],
        [
          "Clostridium perfringens"
        ],
        [
          "Clostridium ghonii"
        ],
        [
          "Clostridium sordellii"
        ],
        [
          "Eubacterium tenue"
        ],
        [
          "Bacteroides sp"
        ],
        [
          "Vibrio"
        ],
        [
          "Sphingomonas"
        ],
        [
          "Afipia"
        ],
        [
          "Curtobacterium"
        ],
        [
          "Microbacterium"
        ],
        [
          "Agromyces"
        ]
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004755",
        "http://www.nlm.nih.gov/cgi/mesh/2016/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001419",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016045"
      ],
      "type": "list",
      "id": "56d1fd67f22319765a000002",
      "snippets": [
        {
          "offsetInBeginSection": 177,
          "offsetInEndSection": 355,
          "text": "Here, we report the molecular detection of the oral spirochete Treponema denticola in ancient human tissue biopsies of the Iceman, a 5,300-year-old Copper Age natural ice mummy. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24941044",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1207,
          "offsetInEndSection": 1500,
          "text": "The colon, on the other hand, contains several members of the fecal flora of humans, such as Clostridium perfringens, C. ghonii, C. sordellii, Eubacterium tenue, and Bacteroides sp. The Iceman's colon, however, was found to contain, rather unexpectedly, also some members of the genus Vibrio. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10861348",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 643,
          "offsetInEndSection": 822,
          "text": " while the untreated skin still bears the remains of large numbers of bacteria belonging to the genera Sphingomonas, Afipia, Curtobacterium, Microbacterium, Agromyces, and others.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10640948",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "How Flaviviridae family of viruses infects vertebrates?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/23312108",
        "http://www.ncbi.nlm.nih.gov/pubmed/23523057",
        "http://www.ncbi.nlm.nih.gov/pubmed/23110744",
        "http://www.ncbi.nlm.nih.gov/pubmed/23738027",
        "http://www.ncbi.nlm.nih.gov/pubmed/24058903",
        "http://www.ncbi.nlm.nih.gov/pubmed/22541792",
        "http://www.ncbi.nlm.nih.gov/pubmed/21413253",
        "http://www.ncbi.nlm.nih.gov/pubmed/24180115",
        "http://www.ncbi.nlm.nih.gov/pubmed/24086788",
        "http://www.ncbi.nlm.nih.gov/pubmed/23030329",
        "http://www.ncbi.nlm.nih.gov/pubmed/20970724",
        "http://www.ncbi.nlm.nih.gov/pubmed/23242342",
        "http://www.ncbi.nlm.nih.gov/pubmed/23594175",
        "http://www.ncbi.nlm.nih.gov/pubmed/23055570",
        "http://www.ncbi.nlm.nih.gov/pubmed/22172565",
        "http://www.ncbi.nlm.nih.gov/pubmed/23194952",
        "http://www.ncbi.nlm.nih.gov/pubmed/23022371",
        "http://www.ncbi.nlm.nih.gov/pubmed/23963259",
        "http://www.ncbi.nlm.nih.gov/pubmed/24284878",
        "http://www.ncbi.nlm.nih.gov/pubmed/23241081",
        "http://www.ncbi.nlm.nih.gov/pubmed/22981999",
        "http://www.ncbi.nlm.nih.gov/pubmed/21216984",
        "http://www.ncbi.nlm.nih.gov/pubmed/21661323",
        "http://www.ncbi.nlm.nih.gov/pubmed/23103288",
        "http://www.ncbi.nlm.nih.gov/pubmed/22925932",
        "http://www.ncbi.nlm.nih.gov/pubmed/23965926",
        "http://www.ncbi.nlm.nih.gov/pubmed/22627302",
        "http://www.ncbi.nlm.nih.gov/pubmed/23017222",
        "http://www.ncbi.nlm.nih.gov/pubmed/23129759",
        "http://www.ncbi.nlm.nih.gov/pubmed/22948134",
        "http://www.ncbi.nlm.nih.gov/pubmed/22226703",
        "http://www.ncbi.nlm.nih.gov/pubmed/21994755",
        "http://www.ncbi.nlm.nih.gov/pubmed/22363822",
        "http://www.ncbi.nlm.nih.gov/pubmed/23099205",
        "http://www.ncbi.nlm.nih.gov/pubmed/22782946",
        "http://www.ncbi.nlm.nih.gov/pubmed/22897050"
      ],
      "ideal_answer": [
        "A wide range of about 500 different viruses is transmitted by arthropods such as ticks, mosquitoes and sandflies. These arboviruses multiply in the arthropod vector, and for each virus there is a natural cycle involving vertebrates (various birds or mammals) and arthropods. The virus enters the arthropod when the latter takes a blood meal from the infected vertebrate, and passes through the gut wall to reach the salivary gland where replication takes place. Once this has occurred, 1\u20132 weeks after ingesting the virus, the arthropod becomes infectious, and can transmit the virus to another vertebrate during a blood meal. Certain arboviruses that infect ticks are also transmitted directly from adult tick to egg (transovarial transmission), so that future generations of ticks are infected without the need for a vertebrate host."
      ],
      "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014714",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014712",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018067",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018178",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014780",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007239",
        "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=GO:0016032"
      ],
      "type": "summary",
      "id": "53340ca4d6d3ac6a34000042",
      "snippets": [
        {
          "offsetInBeginSection": 16,
          "offsetInEndSection": 390,
          "text": "(WNV) is a neurotropic flavivirus that cycles between mosquitoes and birds but that can also infect humans, horses, and other vertebrate animals. In most humans, WNV infection remains subclinical. However, 20%-40% of those infected may develop WNV disease, with symptoms ranging from fever to meningoencephalitis. A large variety of WNV strains have been described worldwide",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24284878",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 32,
          "offsetInEndSection": 958,
          "text": "can be parasitized by Ixodid ticks, which may be infected with tick-borne pathogens, like Borrelia spp., Babesia spp., Anaplasma, Rickettsia/Coxiella, and tick-borne encephalitis virus. The prevalence of ticks on birds varies over years, season, locality and different bird species. The prevalence of ticks on different species depends mainly on the degree of feeding on the ground. In Europe, the Turdus spp., especially the blackbird, Turdus merula, appears to be most important for harboring ticks. Birds can easily cross barriers, like fences, mountains, glaciers, desserts and oceans, which would stop mammals, and they can move much faster than the wingless hosts. Birds can potentially transport tick-borne pathogens by transporting infected ticks, by being infected with tick-borne pathogens and transmit the pathogens to the ticks, and possibly act as hosts for transfer of pathogens between ticks through co-feeding.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24058903",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 423,
          "offsetInEndSection": 811,
          "text": "The dengue viruses (DENVs) are mosquito-borne flaviviruses transmitted by infected Aedes mosquitoes. Illness manifests across a clinical spectrum with severe disease characterized by intravascular volume depletion and hemorrhage. Recent estimates on the burden of DENV infection determined that there are 390 million dengue infections per year, three times the current estimate by the WHO",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23963259",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 16,
          "offsetInEndSection": 127,
          "text": "(WNV), an arbovirus maintained in a bird-mosquito enzootic cycle, can infect other vertebrates including humans",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23738027",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 16,
          "offsetInEndSection": 347,
          "text": "(WNV), a mosquito-borne flavivirus in the Japanese encephalitis antigenic group, has caused sporadic outbreaks in humans, horses and birds throughout many of the warmer regions of Europe for at least 20 years. Occasional cases of West Nile encephalitis have also been associated with infected blood transfusions and organ donations",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23594175",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 432,
          "text": "Dengue is the most important vector-borne disease in many different parts of the world and is expanding into other areas of the globe without hindrance. The morbidity and mortality due to dengue complications are increasing globally at an alarming rate. Although transmission of the dengue virus has been documented in well-characterized areas of Pakistan, its incidence in Khyber Pakhtunkhawa has not been characterized",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23523057",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 136,
          "offsetInEndSection": 789,
          "text": " A rising incidence of acute hepatitis C virus (HCV) in HIV-infected MSM has been observed since 2000 in Europe, Australia, USA and Asia. Transmission appears to occur through the permucosal rather than the more usual parenteral route. Although often multifactorial, permucosal risk factors can be classified as behavioural (sexual practices and mucosally administered drugs) and biological (HIV and sexually transmitted infections). This review will describe the epidemiology of HCV infection in this cohort. Current and future treatment strategies will also be outlined in the context of novel, orally bioavailable, directly acting antiviral therapies",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23242342",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 713,
          "text": "The genus Flavivirus currently consists of approximately 80 single-strand positive-sense RNA viruses. These replicate in a range of hosts including myriad vertebrate, insect, and tick species. As a consequence of this broad host range, the majority of flaviviruses can be propagated in most vertebrate and insect cell cultures. This ability to infect arthropods and vertebrates usually is essential for maintenance of these viruses in nature. But recently, there has been the discovery of a number of flaviviruses that infect mosquitoes but not vertebrates. It remains largely unknown why certain flaviviruses infect vertebrates and mosquitoes while others infect mosquitoes or vertebrates exclusively",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23241081",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 269,
          "text": "Hepatitis C virus (HCV) transmission among people who inject drugs remains a challenging public health problem. We investigated the risk of HCV transmission by analyzing the direct association of HCV with filters, water to dilute drugs, and water containers",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23129759",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 6,
          "offsetInEndSection": 117,
          "text": " is a mosquito-borne disease caused by four closely related dengue virus (genus Flavivirus)serotypes (DENV-1\u20134)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23110744",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 10,
          "offsetInEndSection": 186,
          "text": " West Nile viruses are enveloped RNA viruses that belong to genus Flavivirus (family Flaviviridae) and are considered important mosquito-borne viral pathogenic agents worldwide",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23099205",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 27,
          "offsetInEndSection": 126,
          "text": " (JEV) is a mosquito-borne pathogenic flavivirus responsible for acute viral encephalitis in humans",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23055570",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 242,
          "text": "Hepatitis C virus infection (HCV) is not infrequent among haemodialysis patients. Most published reports suggest that patient-to-patient spread, either directly or indirectly, is the most common mode of transmission in renal units",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23022371",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 16,
          "offsetInEndSection": 161,
          "text": "POWV) is a rare tick-borne agent of encephalitis in North America. Historically, confirmed cases occurred mainly in the northeastern United State",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23017222",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 16,
          "offsetInEndSection": 257,
          "text": "(WNV) is a zoonotic arthropod-borne pathogen with continued geographical expansion in Europe. We present and evaluate data on the temporal, spatial and bird species focus of the WNV surveillance programme in dead wild birds in Great Britain ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22948134",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 20,
          "offsetInEndSection": 567,
          "text": "YFV) is historically one of the most important viruses to affect human populations. Despite the existence of highly effective vaccines for over 70 years, yellow fever remains a significant and re-emerging cause of morbidity and mortality in endemic and high-risk regions of South America and Africa. The virus may be maintained in sylvatic enzootic/epizootic, transitional and urban epidemic transmission cycles with geographic variation in terms of levels of genetic diversity, the nature of transmission cycles and patterns of outbreak activity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22981999",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 7,
          "offsetInEndSection": 310,
          "text": "is a systemic arthropod-borne viral disease of major global public health importance. At least 2.5 billion people who live in areas of the world where dengue occurs are at risk of developing dengue fever (DF) and its severe complications, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22782946",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 6,
          "offsetInEndSection": 153,
          "text": " is a mosquito-transmitted infection that poses significant global health risks for travelers and individuals living in the tropics and subtropics.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22541792",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 16,
          "offsetInEndSection": 142,
          "text": "(WNV) (Flaviviridae: Flavivirus) is transmitted from mosquitoes to birds, but can cause fatal encephalitis in infected humans.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22226703",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 15,
          "offsetInEndSection": 277,
          "text": "West Nile virus (WNV) is a member of the genus Flavivirus within the Japanese encephalitis antigenic complex. The enzootic virus cycle involves transmission between avian hosts and ornithophilic mosquitoes, whereas humans and horses are considered dead-end hosts",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22172565",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 3,
          "offsetInEndSection": 230,
          "text": " four major flavivirus clades are transmitted by mosquitoes, ticks, directly between vertebrates or directly between arthropods, respectively, but the molecular determinants of mode of transmission in flaviviruses are unknown. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21216984",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 42,
          "offsetInEndSection": 307,
          "text": " Tick-borne encephalitis virus (TBEV), one of the most prevalent arboviruses in Europe and in many parts of Asia. Transmission of TBEV to humans usually occurs by bite of an infected tick or rarely by ingestion of unpasteurized milk products of infected livestock. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20970724",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1995,
          "offsetInEndSection": 2419,
          "text": "Most alphaviruses and flaviviruses survive in nature by replicating alternately in a vertebrate host and a hematophagous arthropod (mosquitoes or, for some flaviviruses, ticks). Arthropod vectors acquire the viral infection by biting a viremic host, and after an extrinsic incubation period during which the virus replicates in the vector's tissues, they transmit virus through salivary secretions to another vertebrate host",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21413253",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 55,
          "offsetInEndSection": 751,
          "text": "Western Hemisphere have drawn attention to West Nile virus (WNV) as an international public health problem. Of particular concern has been the ability for the virus to cause outbreaks of disease in highly populated urban centers. Incrimination of Australian mosquito species is an essential component in determining the receptivity of Australia to the introduction and/or establishment of an exotic strain of WNV and can guide potential management strategies. Based on vector competence experiments and ecological studies, we suggest candidate Australian mosquito species that would most likely be involved in urban transmission of WNV, along with consideration of the endemic WNV subtype, Kunjin",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23965926",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is the molecular pathogenesis of Spinal Muscular Atrophy?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18572081",
        "http://www.ncbi.nlm.nih.gov/pubmed/24112438",
        "http://www.ncbi.nlm.nih.gov/pubmed/23740936"
      ],
      "ideal_answer": [
        "Spinal muscular atrophy is an autosomal recessive neurodegenerative disease characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles, and generalised weakness. It is caused by homozygous disruption of the survival motor neuron 1 (SMN1) gene by deletion, conversion, or mutation, resulting in downregulated biogenesis of uridine-rich small nuclear RNAs (U snRNAs), which are major components of the splicing machinery."
      ],
      "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:0050530",
        "http://www.disease-ontology.org/api/metadata/DOID:0060160",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D014897",
        "http://www.disease-ontology.org/api/metadata/DOID:0050529",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009134",
        "http://www.disease-ontology.org/api/metadata/DOID:12377",
        "http://www.disease-ontology.org/api/metadata/DOID:12376",
        "http://www.disease-ontology.org/api/metadata/DOID:318",
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D055533"
      ],
      "type": "summary",
      "id": "52f124a12059c6d71c000006",
      "snippets": [
        {
          "offsetInBeginSection": 1031,
          "offsetInEndSection": 1144,
          "text": "A mouse model of spinal muscular atrophy, in which the number of Gems is decreased, shows fewer subsets U snRNAs.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24112438",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 210,
          "offsetInEndSection": 514,
          "text": "TDP-43 associates with nuclear bodies including Gemini of coiled bodies (GEMs). GEMs contribute to the biogenesis of uridine-rich small nuclear RNA (U snRNA), a component of splicing machinery. The number of GEMs and a subset of U snRNAs decrease in spinal muscular atrophy, a lower motor neuron disease,",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23740936",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 309,
          "text": "Spinal muscular atrophy is an autosomal recessive neurodegenerative disease characterised by degeneration of spinal cord motor neurons, atrophy of skeletal muscles, and generalised weakness. It is caused by homozygous disruption of the survival motor neuron 1 (SMN1) gene by deletion, conversion, or mutation.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18572081",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What are the birth defects associated with Zika-virus infection?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27032458",
        "http://www.ncbi.nlm.nih.gov/pubmed/27293547",
        "http://www.ncbi.nlm.nih.gov/pubmed/27052792",
        "http://www.ncbi.nlm.nih.gov/pubmed/27366760",
        "http://www.ncbi.nlm.nih.gov/pubmed/27279226",
        "http://www.ncbi.nlm.nih.gov/pubmed/27032431",
        "http://www.ncbi.nlm.nih.gov/pubmed/27143174",
        "http://www.ncbi.nlm.nih.gov/pubmed/27617189",
        "http://www.ncbi.nlm.nih.gov/pubmed/27366586",
        "http://www.ncbi.nlm.nih.gov/pubmed/27812690",
        "http://www.ncbi.nlm.nih.gov/pubmed/27345865",
        "http://www.ncbi.nlm.nih.gov/pubmed/27490087",
        "http://www.ncbi.nlm.nih.gov/pubmed/27009036"
      ],
      "ideal_answer": [
        "Although the full spectrum of adverse reproductive outcomes caused by Zika virus infection is not yet determined, a distinctive phenotype-the congenital Zika syndrome-has emerged. Zika virus infection during pregnancy is a cause of microcephaly and other severe birth defects."
      ],
      "type": "summary",
      "id": "58a989571978bbde22000002",
      "snippets": [
        {
          "offsetInBeginSection": 768,
          "offsetInEndSection": 1090,
          "text": "the first time after the discovery of ZIKV, the Brazilian scientists are studying the possibility for the virus to cause severe congenital infection related to microcephaly and serious birth defects due to the time-spatial coincidence of the alarming increase of newborns with microcephaly and the Brazilian ZIKV epidemic.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27143174",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 116,
          "offsetInEndSection": 286,
          "text": " Although a causal relationship between Zika infection during pregnancy and microcephaly is strongly suspected, such a connection has not yet been scientifically proven. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27052792",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 166,
          "offsetInEndSection": 302,
          "text": "a convincing association between Zika virus infection during pregnancy and birth defects, like microcephaly, among some of the newborns.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27032431",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 955,
          "offsetInEndSection": 1039,
          "text": "counseling pregnant women on the risks of fetal microcephaly and other birth defects",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27032458",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 576,
          "offsetInEndSection": 711,
          "text": "evidence suggests that congenital Zika virus infection is associated with microcephaly and other adverse pregnancy and infant outcomes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27009036",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 734,
          "offsetInEndSection": 885,
          "text": "the virus has been linked to congenital malformations, including microcephaly and other severe neurological diseases, such as Guillain-Barr\u00e9 syndrome. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27279226",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 282,
          "offsetInEndSection": 380,
          "text": " severe birth defects, such as microcephaly, have been linked to infection during early pregnancy.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27293547",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 31,
          "offsetInEndSection": 290,
          "text": "n can be prenatally passed from a pregnant woman to her fetus. There is sufficient evidence to conclude that intrauterine Zika virus infection is a cause of microcephaly and serious brain anomalies, but the full spectrum of anomalies has not been delineated. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27812690",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1699,
          "offsetInEndSection": 1878,
          "text": "Although the full spectrum of adverse reproductive outcomes caused by Zika virus infection is not yet determined, a distinctive phenotype-the congenital Zika syndrome-has emerged.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27812690",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 104,
          "text": "The current Zika virus (ZIKV) outbreak is associated with high numbers of human congenital birth defects",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345865",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 282,
          "offsetInEndSection": 427,
          "text": "However, ZIKV infection in early pregnancy has been associated with severe birth defects, including microcephaly and other developmental issues. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27366586",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 158,
          "text": "Zika virus (ZIKV) infection is a new emerging threat around the globe which might be responsible for microcephaly and Guillain-Barre syndrome in the infants. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27366760",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 186,
          "offsetInEndSection": 282,
          "text": "Zika virus infection during pregnancy is a cause of microcephaly and other severe birth defects ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27490087",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What are some of the effects of Zika Virus in infected individuals?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27557413",
        "http://www.ncbi.nlm.nih.gov/pubmed/27088494",
        "http://www.ncbi.nlm.nih.gov/pubmed/27010422",
        "http://www.ncbi.nlm.nih.gov/pubmed/489960",
        "http://www.ncbi.nlm.nih.gov/pubmed/27612155",
        "http://www.ncbi.nlm.nih.gov/pubmed/26889662",
        "http://www.ncbi.nlm.nih.gov/pubmed/27009036",
        "http://www.ncbi.nlm.nih.gov/pubmed/27330653",
        "http://www.ncbi.nlm.nih.gov/pubmed/23878182",
        "http://www.ncbi.nlm.nih.gov/pubmed/27337505",
        "http://www.ncbi.nlm.nih.gov/pubmed/27654889",
        "http://www.ncbi.nlm.nih.gov/pubmed/27087204",
        "http://www.ncbi.nlm.nih.gov/pubmed/27695855",
        "http://www.ncbi.nlm.nih.gov/pubmed/26969497",
        "http://www.ncbi.nlm.nih.gov/pubmed/22389730",
        "http://www.ncbi.nlm.nih.gov/pubmed/25294619",
        "http://www.ncbi.nlm.nih.gov/pubmed/27631604",
        "http://www.ncbi.nlm.nih.gov/pubmed/27149205",
        "http://www.ncbi.nlm.nih.gov/pubmed/27490087",
        "http://www.ncbi.nlm.nih.gov/pubmed/26925496",
        "http://www.ncbi.nlm.nih.gov/pubmed/26897108",
        "http://www.ncbi.nlm.nih.gov/pubmed/24626205",
        "http://www.ncbi.nlm.nih.gov/pubmed/27862959",
        "http://www.ncbi.nlm.nih.gov/pubmed/27464346"
      ],
      "ideal_answer": [
        "While most of the symptoms of zika virus are relatively mild, zika virus in pregnant mothers can cause microcephaly and other congenital defects in the fetus."
      ],
      "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000071243",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000071244",
        "http://www.disease-ontology.org/api/metadata/DOID:0060478"
      ],
      "type": "summary",
      "id": "58a3275960087bc10a00000f",
      "snippets": [
        {
          "offsetInBeginSection": 513,
          "offsetInEndSection": 710,
          "text": "Maternal-fetal transmission of Zika virus has been documented; evidence suggests that congenital Zika virus infection is associated with microcephaly and other adverse pregnancy and infant outcomes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27009036",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 181,
          "text": "Recent studies have reported an increase in the number of fetuses and neonates with microcephaly whose mothers were infected with the Zika virus (ZIKV) during pregnancy.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27695855",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1577,
          "offsetInEndSection": 2008,
          "text": "While the symptoms associated with Zika virus infection are generally mild, consisting of fever, maculopapular rash, arthralgia and conjunctivitis, there have been reports of more severe reactions that are associated with neurological complications. In pregnant women, fetal neurological complications include brain damage and microcephaly, while in adults there have been several cases of virus-associated Guillain-Barre syndrome.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26925496",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 330,
          "text": "ika virus is a flavivirus transmitted primarily by Aedes species mosquitoes, and symptoms of infection can include rash, fever, arthralgia, and conjunctivitis (1).* Zika virus infection during pregnancy is a cause of microcephaly and other severe brain defects (2). Infection has also been associated with Guillain-Barr\u00e9 syndrome",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27149205",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 385,
          "offsetInEndSection": 502,
          "text": "To better understand the etiologic role and mechanism(s) of Zika virus in causing birth defects such as microcephaly,",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27557413",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 294,
          "offsetInEndSection": 623,
          "text": "Most persons infected with Zika virus have a mild illness or are asymptomatic. However, increasing evidence supports a link between Zika virus infection during pregnancy and adverse pregnancy and birth outcomes (1), and a possible association between recent Zika virus infection and Guillain-Barr\u00e9 syndrome has been reported (2).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27010422",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 642,
          "offsetInEndSection": 775,
          "text": "There is now strong biologic evidence of causality between Zika virus and microcephaly and other neurologic abnormalities identified.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27612155",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 670,
          "offsetInEndSection": 812,
          "text": "Several pieces of evidence suggest that maternal Zika virus infection is associated with adverse neonatal outcomes, most notably microcephaly.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26889662",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 125,
          "offsetInEndSection": 259,
          "text": " Zika virus has gained international attention due to concerns for infection in pregnant women potentially causing fetal microcephaly.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27330653",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 394,
          "text": "Zika virus is a flavivirus transmitted primarily by Aedes aegypti and Aedes albopictus mosquitoes, and infection can be asymptomatic or result in an acute febrile illness with rash (1). Zika virus infection during pregnancy is a cause of microcephaly and other severe birth defects (2). Infection has also been associated with Guillain-Barr\u00e9 syndrome (GBS) (3) and severe thrombocytopenia (4,5)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27490087",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 358,
          "offsetInEndSection": 712,
          "text": "Most Zika virus infections are asymptomatic (1,6). Clinical illness, when it occurs, is generally mild and characterized by acute onset of fever, maculopapular rash, arthralgia, or nonpurulent conjunctivitis. However, Zika virus infection during pregnancy can cause adverse outcomes such as fetal loss, and microcephaly and other serious brain anomalies ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27631604",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1742,
          "offsetInEndSection": 2004,
          "text": "In 2015, Zika virus infection was diagnosed in Brazil where it was associated with microcephaly in the infants of some women who were pregnant when they contracted the disease. Cases of the Guillain-Barr\u00e9 syndrome were also found to be associated with Zika virus",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26969497",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2405,
          "offsetInEndSection": 2522,
          "text": "These findings strengthen the putative association between Zika virus and cases of microcephaly in neonates in Brazil",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26897108",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 54,
          "offsetInEndSection": 310,
          "text": " In response to the current cluster of congenital malformations (microcephaly) and other neurological complications (Guillain-Barr\u00e9 Syndrome) that could be linked to Zika virus infection, WHO declares that Zika virus is of global public health importance. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27087204",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 218,
          "offsetInEndSection": 328,
          "text": "Zika virus infection during pregnancy can cause spontaneous abortion and birth defects, including microcephaly",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27337505",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 252,
          "offsetInEndSection": 497,
          "text": "n the case of Zika virus, an accumulating body of recent evidence implicates the virus in the etiology of serious pathologies of the human nervous system, that is, the occurrence of microcephaly in neonates and Guillain-Barr\u00e9 syndrome in adults.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27464346",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 272,
          "offsetInEndSection": 471,
          "text": "We describe the first case of Guillain-Barr\u00e9 syndrome (GBS) occurring immediately after a Zika virus infection, during the current Zika and type 1 and 3 dengue fever co-epidemics in French Polynesia.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24626205",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 112,
          "offsetInEndSection": 226,
          "text": "We report a case of Zika virus infection in an Australian traveler who returned from Indonesia with fever and rash",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23878182",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2,
          "offsetInEndSection": 701,
          "text": "woman who recently traveled to Thailand came to a local emergency department with a fever and papular rash. She was tested for measles, malaria, and dengue. Positive finding for IgM antibody against dengue and a failure to seroconvert for IgG against dengue for multiple blood samples suggested an alternate flavivirus etiology. Amplification of a conserved region of the non-structural protein 5 gene of the genus Flavivirus yielded a polymerase chain reaction product with a matching sequence of 99% identity with Zika virus. A urine sample and a nasopharygeal swab specimen obtained for the measles investigation were also positive for this virus by reverse transcription polymerase chain reactio",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25294619",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 906,
          "offsetInEndSection": 1548,
          "text": " It is estimated that approximately 18% of individuals infected with ZIKV will go on to develop symptoms. When symptoms develop, it is usually within 3-12 days, although this may vary. Most often, symptoms are mild and self-limited. The most common symptoms are fever, arthralgia, maculopapular rash, and conjunctivitis lasting up to seven days. Less frequent symptoms include headache, vertigo, myalgia, vomiting, and diarrhea. At present, there is no vaccine available to prevent ZIKV and no specific antiviral treatment. Supportive care consisting of rest, hydration, analgesics, antihistamines, and antipyretics is recommended as needed. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27862959",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 4,
          "offsetInEndSection": 211,
          "text": "marked increase in infants born with microcephaly in Brazil after a 2015 outbreak of Zika virus (Zika virus) disease suggests an association between maternal Zika virus infection and congenital microcephaly.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27088494",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 153,
          "offsetInEndSection": 357,
          "text": "Zika virus causes a self-limiting, systemic illness; however, the current outbreak of Zika virus in the Americas has been associated with increased rates of fetal malformations and Guillain-Barr\u00e9 syndrome",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27654889",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "List the three most abundant bacterial phyla present in mouse feces.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25537565",
        "http://www.ncbi.nlm.nih.gov/pubmed/20926643",
        "http://www.ncbi.nlm.nih.gov/pubmed/23457582",
        "http://www.ncbi.nlm.nih.gov/pubmed/19159975"
      ],
      "ideal_answer": [
        "Firmicutes\nProteobacteria \nBacteroidetes"
      ],
      "exact_answer": [
        [
          "Firmicutes"
        ],
        [
          "Proteobacteria"
        ],
        [
          "Bacteroidetes"
        ]
      ],
      "type": "list",
      "id": "58bbbe6822d300530900001a",
      "snippets": [
        {
          "offsetInBeginSection": 862,
          "offsetInEndSection": 1047,
          "text": "Amplicons representing the major phyla encountered in the rumen (Firmicutes, 43.7%; Proteobacteria, 28.7%; Bacteroidetes, 25.3%; Spirochea, 1.1%, and Synergistes, 1.1%) were recovered, ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19159975",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 68,
          "offsetInEndSection": 152,
          "text": "alterations in the gut microbiota (increased Firmicutes and decreased Bacteroidetes)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20926643",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 385,
          "offsetInEndSection": 536,
          "text": "The taxonomic analysis of the metagenomic reads indicated that pygmy loris fecal microbiomes were dominated by Bacteroidetes and Proteobacteria phyla. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23457582",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1025,
          "offsetInEndSection": 1193,
          "text": "Specifically, intermittent hypoxia-exposed mice showed a higher abundance of Firmicutes and a smaller abundance of Bacteroidetes and Proteobacteria phyla than controls.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25537565",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Could plasmepsins be used as targets for developing anti-malaria drugs?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/12767832",
        "http://www.ncbi.nlm.nih.gov/pubmed/25827401",
        "http://www.ncbi.nlm.nih.gov/pubmed/21334328",
        "http://www.ncbi.nlm.nih.gov/pubmed/26214367",
        "http://www.ncbi.nlm.nih.gov/pubmed/18442137",
        "http://www.ncbi.nlm.nih.gov/pubmed/17727268",
        "http://www.ncbi.nlm.nih.gov/pubmed/16838300",
        "http://www.ncbi.nlm.nih.gov/pubmed/15181345",
        "http://www.ncbi.nlm.nih.gov/pubmed/19472268",
        "http://www.ncbi.nlm.nih.gov/pubmed/21136953",
        "http://www.ncbi.nlm.nih.gov/pubmed/14636976",
        "http://www.ncbi.nlm.nih.gov/pubmed/8816746",
        "http://www.ncbi.nlm.nih.gov/pubmed/11841219",
        "http://www.ncbi.nlm.nih.gov/pubmed/24975562",
        "http://www.ncbi.nlm.nih.gov/pubmed/23466235",
        "http://www.ncbi.nlm.nih.gov/pubmed/16054370",
        "http://www.ncbi.nlm.nih.gov/pubmed/12435452",
        "http://www.ncbi.nlm.nih.gov/pubmed/16138859",
        "http://www.ncbi.nlm.nih.gov/pubmed/25719272",
        "http://www.ncbi.nlm.nih.gov/pubmed/22242846",
        "http://www.ncbi.nlm.nih.gov/pubmed/21382523",
        "http://www.ncbi.nlm.nih.gov/pubmed/27718413",
        "http://www.ncbi.nlm.nih.gov/pubmed/24468190",
        "http://www.ncbi.nlm.nih.gov/pubmed/26566224",
        "http://www.ncbi.nlm.nih.gov/pubmed/19437467",
        "http://www.ncbi.nlm.nih.gov/pubmed/9561244",
        "http://www.ncbi.nlm.nih.gov/pubmed/21760810",
        "http://www.ncbi.nlm.nih.gov/pubmed/17585371",
        "http://www.ncbi.nlm.nih.gov/pubmed/24983235",
        "http://www.ncbi.nlm.nih.gov/pubmed/20056606",
        "http://www.ncbi.nlm.nih.gov/pubmed/21428877",
        "http://www.ncbi.nlm.nih.gov/pubmed/15011947"
      ],
      "ideal_answer": [
        "Yes, plasmepsins, which are essential Plasmodium proteases, could be highly promising anti-malarial drug targets."
      ],
      "exact_answer": "yes",
      "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000962",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015195",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D016780",
        "http://www.disease-ontology.org/api/metadata/DOID:12365",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008288"
      ],
      "type": "yesno",
      "id": "58a6d89660087bc10a00002b",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 88,
          "text": "Fighting malaria: structure-guided discovery of nonpeptidomimetic plasmepsin inhibitors.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25719272",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 116,
          "offsetInEndSection": 274,
          "text": "Given that the parasite needs the resulting amino acid building blocks for its growth and development, plasmepsins are an important antimalarial drug target. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25719272",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 652,
          "offsetInEndSection": 1056,
          "text": "Due to early crystallographic evidence, plasmepsin II (Plm II) emerged as well explored target to develop novel antimalarials as well as a starting point to develop inhibitors targeting some other subtypes of plasmepsins i.e. Plm I, II, IV and V. With the advancements in drug discovery, several computational and synthetic approaches were employed in order to develop novel inhibitors targeting Plm II. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25827401",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 106,
          "text": "Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26214367",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 295,
          "text": "Plasmepsin V, an essential aspartyl protease of malaria parasites, has a key role in the export of effector proteins to parasite-infected erythrocytes. Consequently, it is an important drug target for the two most virulent malaria parasites of humans, Plasmodium falciparum and Plasmodium vivax.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26214367",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 219,
          "offsetInEndSection": 388,
          "text": "Plasmepsin V (PmV) is an essential Plasmodium protease and a highly promising antimalarial target, which still lacks molecular characterization and drug-like inhibitors.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26566224",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1375,
          "offsetInEndSection": 1503,
          "text": "Our inhibitors act 'on-target', confirmed by cellular interference of PmV function and biochemical interaction with inhibitors. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26566224",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1826,
          "offsetInEndSection": 2191,
          "text": "Our work disclosed novel pursuable drug design strategies for highly efficient PmV inhibition highlighting novel molecular elements necessary for picomolar activity against PmV. All the presented data are discussed in respect to human aspartic proteases and previously reported inhibitors, highlighting differences and proposing new strategies for drug development.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26566224",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 362,
          "offsetInEndSection": 458,
          "text": "High binding likeness on antimalarial target plasmepsin was detected through molecular docking. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24975562",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1097,
          "offsetInEndSection": 1303,
          "text": "This provides the first direct evidence that PMV activity is essential for protein export in Plasmodium spp. and for parasite survival in human erythrocytes and validates PMV as an antimalarial drug target.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24983235",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 169,
          "offsetInEndSection": 310,
          "text": "The export mechanism involves the Plasmodium export element (PEXEL), which is a cleavage site for the parasite protease, Plasmepsin V (PMV). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24983235",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 152,
          "text": "Plasmepsin II (PM II) is an attractive target for anti-malaria drug discovery, which involves in host hemoglobin degradation in the acidic food vacuole.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23466235",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 202,
          "offsetInEndSection": 480,
          "text": "These methods are utilized to search for inhibitors of the aspartyl proteases, plasmepsin II and cathepsin D. Plasmepsin II, a protease found in the malaria parasite, hydrolyzes human hemoglobin, the nutrient source for the parasite and is a new target for anti-malaria therapy.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9561244",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 836,
          "offsetInEndSection": 1040,
          "text": "Given recent advances in understanding the fundamental roles of the various plasmepsins, it is likely that the most effective antimalarial plasmepsin targets will be the non-digestive vacuole plasmepsins.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22242846",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 142,
          "text": "Plasmepsins (PMs) are essential proteases of the plasmodia parasites and are therefore promising targets for developing drugs against malaria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19472268",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 165,
          "offsetInEndSection": 274,
          "text": "Therefore, the plasmepsins of malaria parasites have been recognized as attractive antimalarial drug targets.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21334328",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 85,
          "offsetInEndSection": 201,
          "text": "As inhibition of plasmepsins leads to the parasite's death, these enzymes can be utilized as potential drug targets.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16138859",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 377,
          "offsetInEndSection": 515,
          "text": "falciparum plasmepsins II and IV make structure-based drug design of antimalarial compounds that focus on inhibiting plasmepsins possible.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18442137",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 250,
          "offsetInEndSection": 462,
          "text": "The malarial parasite encodes two homologous aspartic proteases, plasmepsins I and II, which are essential components of its hemoglobin-degradation pathway and are novel targets for antimalarial drug development.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8816746",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1906,
          "offsetInEndSection": 2052,
          "text": "vivax plasmepsins (PvPMs) from different geographical regions are of utmost importance for drugs and vaccine designs for anti-malarial strategies.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21382523",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 155,
          "offsetInEndSection": 345,
          "text": "In P.falciparum, plasmepsins I, II, IV and HAP have been directly implicated in hemoglobin degradation during malaria infection, and are now considered targets for anti-malarial drug design.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12767832",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1531,
          "offsetInEndSection": 1743,
          "text": "These results shed light on the role of V105 and T108 residues in plasmepsin specificities, and they should be useful in structure-based design of novel, selective inhibitors that may serve as antimalarial drugs.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18442137",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 110,
          "offsetInEndSection": 245,
          "text": "The aspartic proteases plasmepsins, whose inhibition leads to parasite death, are classified as targets for the design of potent drugs.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21760810",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 818,
          "offsetInEndSection": 994,
          "text": "A large compound library of about 1 million chemical compounds was docked on 5 different targets of plasmepsins using two different docking software, namely FlexX and AutoDock.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17727268",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 114,
          "offsetInEndSection": 281,
          "text": "Plasmodium aspartic proteases known as plasmepsins play an important role on haemoglobin degradation and are being studied as drug targets for chemotherapy of malaria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14636976",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 615,
          "offsetInEndSection": 815,
          "text": "Our study revealed about 100 parasite-coded gene products that included many known drug targets such as Pf hypoxanthine guanine phosphoribosyl transferase, Pf L-lactate dehydrogenase, and Plasmepsins.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21136953",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 175,
          "offsetInEndSection": 295,
          "text": "The two aspartic proteases, plasmepsins I and II, from Plasmodium falciparum have recently emerged as potential targets.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16054370",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 146,
          "offsetInEndSection": 303,
          "text": "Plasmepsins are highly promising as drug targets, especially when combined with the inhibition of falcipains that are also involved in hemoglobin catabolism.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17585371",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 984,
          "offsetInEndSection": 1133,
          "text": "Among such enzymes, Plasmepsins (aspartic proteases) and, especially, Falcipains (cysteine proteases) are highly promising antimalarial drug targets.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21428877",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 703,
          "offsetInEndSection": 878,
          "text": "The high sequence conservations between the plasmepsins from the isolates support the notion that the enzymes could be reliable targets for new antimalarial chemotherapeutics.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15181345",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 652,
          "offsetInEndSection": 877,
          "text": "Due to early crystallographic evidence, plasmepsin II (Plm II) emerged as well explored target to develop novel antimalarials as well as a starting point to develop inhibitors targeting some other subtypes of plasmepsins i.e.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25827401",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 469,
          "offsetInEndSection": 651,
          "text": "Plasmepsin, an aspartic protease, which is involved in the hemoglobin breakdown into smaller peptides emerged as a crucial target to develop new chemical entities to counter malaria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25827401",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1160,
          "offsetInEndSection": 1233,
          "text": "were employed in order to develop new chemical entities targeting Plm II.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25827401",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 899,
          "offsetInEndSection": 1055,
          "text": "With the advancements in drug discovery, several computational and synthetic approaches were employed in order to develop novel inhibitors targeting Plm II.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25827401",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1906,
          "offsetInEndSection": 2053,
          "text": "vivax plasmepsins (PvPMs) from different geographical regions are of utmost importance for drugs and vaccine designs for anti-malarial strategies..",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21382523",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 296,
          "offsetInEndSection": 422,
          "text": "We developed a potent inhibitor of plasmepsin V, called WEHI-842, which directly mimics the Plasmodium export element (PEXEL).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26214367",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1768,
          "offsetInEndSection": 1905,
          "text": "In order to validate appropriate use of PM4 as potential anti-malarial drug target, studies on genetic and structural variations among P.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21382523",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 482,
          "offsetInEndSection": 642,
          "text": "Over the past decade, much effort has been placed towards developing plasmepsin inhibitors as antimalarial agents, particularly targeting the digestive vacuole.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22242846",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which infection can be prevented with Dapivirine?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25845860",
        "http://www.ncbi.nlm.nih.gov/pubmed/26061040",
        "http://www.ncbi.nlm.nih.gov/pubmed/26900902",
        "http://www.ncbi.nlm.nih.gov/pubmed/24693866",
        "http://www.ncbi.nlm.nih.gov/pubmed/27398859",
        "http://www.ncbi.nlm.nih.gov/pubmed/20854207",
        "http://www.ncbi.nlm.nih.gov/pubmed/25880636",
        "http://www.ncbi.nlm.nih.gov/pubmed/24449442",
        "http://www.ncbi.nlm.nih.gov/pubmed/14693562",
        "http://www.ncbi.nlm.nih.gov/pubmed/24901365",
        "http://www.ncbi.nlm.nih.gov/pubmed/19029331",
        "http://www.ncbi.nlm.nih.gov/pubmed/26732684",
        "http://www.ncbi.nlm.nih.gov/pubmed/24862093",
        "http://www.ncbi.nlm.nih.gov/pubmed/20574411",
        "http://www.ncbi.nlm.nih.gov/pubmed/26837628",
        "http://www.ncbi.nlm.nih.gov/pubmed/22708075",
        "http://www.ncbi.nlm.nih.gov/pubmed/26514157",
        "http://www.ncbi.nlm.nih.gov/pubmed/19623693",
        "http://www.ncbi.nlm.nih.gov/pubmed/25079391",
        "http://www.ncbi.nlm.nih.gov/pubmed/26963505",
        "http://www.ncbi.nlm.nih.gov/pubmed/18086845",
        "http://www.ncbi.nlm.nih.gov/pubmed/19388819",
        "http://www.ncbi.nlm.nih.gov/pubmed/23360246",
        "http://www.ncbi.nlm.nih.gov/pubmed/23965226",
        "http://www.ncbi.nlm.nih.gov/pubmed/23177261",
        "http://www.ncbi.nlm.nih.gov/pubmed/21109069",
        "http://www.ncbi.nlm.nih.gov/pubmed/19958831",
        "http://www.ncbi.nlm.nih.gov/pubmed/25089538"
      ],
      "ideal_answer": [
        "Vaginal ring containing Dapivirine is used for HIV prevention in women."
      ],
      "exact_answer": [
        "HIV"
      ],
      "concepts": [
        "http://www.biosemantics.org/jochem#http://www.biosemantics.org/jochem#:4243195",
        "http://www.biosemantics.org/jochem#4243195",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007239",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D017053"
      ],
      "type": "factoid",
      "id": "5880b812c872c95565000006",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 519,
          "text": "OBJECTIVES: The objectives of this study were to comprehensively assess mRNA expression of 84 drug transporters in human colorectal biopsies and six representative cell lines, and to investigate the alteration of drug transporter gene expression after exposure to three candidate microbicidal antiretroviral (ARV) drugs (tenofovir, darunavir and dapivirine) in the colorectal epithelium. The outcome of the objectives informs development of optimal ARV-based microbicidal formulations for prevention of HIV-1 infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26514157",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 225,
          "text": "We evaluated the adherence and acceptability of a vaginal ring containing dapivirine, maraviroc, or both drugs for 28\u00a0days during a Phase I placebo-controlled trial in 48 HIV-negative sexually abstinent U.S. women aged 18-40.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26837628",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 74,
          "text": "Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26900902",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 423,
          "offsetInEndSection": 1292,
          "text": "Methods We conducted a phase 3, randomized, double-blind, placebo-controlled trial of a monthly vaginal ring containing dapivirine, a non-nucleoside HIV-1 reverse-transcriptase inhibitor, involving women between the ages of 18 and 45 years in Malawi, South Africa, Uganda, and Zimbabwe. Results Among the 2629 women who were enrolled, 168 HIV-1 infections occurred: 71 in the dapivirine group and 97 in the placebo group (incidence, 3.3 and 4.5 per 100 person-years, respectively). The incidence of HIV-1 infection in the dapivirine group was lower by 27% (95% confidence interval [CI], 1 to 46; P=0.05) than that in the placebo group. In an analysis that excluded data from two sites that had reduced rates of retention and adherence, the incidence of HIV-1 infection in the dapivirine group was lower by 37% (95% CI, 12 to 56; P=0.007) than that in the placebo group.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26900902",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1713,
          "offsetInEndSection": 1902,
          "text": "Conclusions A monthly vaginal ring containing dapivirine reduced the risk of HIV-1 infection among African women, with increased efficacy in subgroups with evidence of increased adherence. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26900902",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 442,
          "text": "BACKGROUND: This was the first microbicide trial conducted in Africa to evaluate an antiretroviral-containing vaginal ring as an HIV prevention technology for women.OBJECTIVES: The trial assessed and compared the safety, acceptability and adherence to product use of a 4-weekly administered vaginal ring containing the antiretroviral microbicide, dapivirine, with a matching placebo ring among women from four countries in sub-Saharan Africa.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26963505",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1817,
          "offsetInEndSection": 2046,
          "text": "CONCLUSIONS: The dapivirine vaginal ring has a favourable safety and acceptability profile. If proven safe and effective in large-scale trials, it will be an important component of combination HIV prevention approaches for women.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26963505",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 176,
          "text": "PURPOSE: To develop polymeric films containing dual combinations of anti-HIV drug candidate tenofovir, maraviroc and dapivirine for vaginal application as topical microbicides.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25079391",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 332,
          "offsetInEndSection": 532,
          "text": "Efficacy trials with a dapivirine-containing vaginal ring for HIV prevention are ongoing and plans to develop multi-purpose vaginal rings for prevention of both HIV and pregnancy have been elaborated.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25880636",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 149,
          "text": "Inhibition of human immunodeficiency virus type 1 infection by the candidate microbicide dapivirine, a nonnucleoside reverse transcriptase inhibitor.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19029331",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 900,
          "offsetInEndSection": 1054,
          "text": "The incidence of HIV-1 infection in the dapivirine group was lower by 27% (95% confidence interval [CI], 1 to 46; P=0.046) than that in the placebo group.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26900902",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1054,
          "offsetInEndSection": 1287,
          "text": "In an analysis that excluded data from two sites that had reduced rates of retention and adherence, the incidence of HIV-1 infection in the dapivirine group was lower by 37% (95% CI, 12 to 56; P=0.007) than that in the placebo group.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26900902",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 608,
          "offsetInEndSection": 830,
          "text": "Within this study the in vitro bioactivity of dapivirine as compared to the NNRTI UC781 was further established and a quick dissolve film was developed for vaginal application of dapivirine for prevention of HIV infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22708075",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 146,
          "text": "Dapivirine, a nonnucleoside reverse transcriptase inhibitor, is in development as a microbicide for the protection of women against HIV infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20574411",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 164,
          "text": "Dapivirine is a nonnucleoside reverse transcriptase inhibitor being developed as a topical microbicide for the prevention of human immunodeficiency virus infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18086845",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 705,
          "offsetInEndSection": 960,
          "text": "Dapivirine from both IVRs was successfully distributed throughout the lower genital tract at concentrations>1000x the EC(50) against wild-type HIV-1 (LAI) in MT4 cells suggesting that IVR delivery of microbicides is a viable option meriting further study.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19388819",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 272,
          "text": "The nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 (Dapivirine) effectively prevented human immunodeficiency virus (HIV) infection in cocultures of monocyte-derived dendritic cells and T cells, representing primary targets in sexual transmission.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14693562",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 345,
          "text": "To assess the potential of polymeric nanoparticles (NPs) to affect the genital distribution and local and systemic pharmacokinetics (PK) of the anti-HIV microbicide drug candidate dapivirine after vaginal delivery.Dapivirine-loaded, poly(ethylene oxide)-coated poly(epsilon-caprolactone) (PEO-PCL) NPs were prepared by a nanoprecipitation method",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24449442",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 271,
          "text": "The nonnucleoside reverse transcriptase inhibitors UC-781 and TMC120-R147681 (Dapivirine) effectively prevented human immunodeficiency virus (HIV) infection in cocultures of monocyte-derived dendritic cells and T cells, representing primary targets in sexual transmission",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14693562",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 165,
          "text": "Dapivirine is a nonnucleoside reverse transcriptase inhibitor being developed as a topical microbicide for the prevention of human immunodeficiency virus infection. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18086845",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 972,
          "offsetInEndSection": 1144,
          "text": "CONCLUSIONS: The study demonstrates proof of concept for a dapivirine-releasing diaphragm with daily release quantities potentially capable of preventing HIV transmission. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23177261",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 304,
          "offsetInEndSection": 740,
          "text": "Antiretroviral-containing vaginal microbicide rings, which release medication over a month or longer, may reduce these adherence challenges.ASPIRE (A Study to Prevent Infection with a Ring for Extended Use) is a phase III, randomized, double-blind, placebo-controlled trial testing the safety and effectiveness of a vaginal ring containing the non-nucleoside reverse transcriptase inhibitor dapivirine for prevention of HIV-1 infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26061040",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 642,
          "offsetInEndSection": 774,
          "text": "Dapivirine demonstrated potent dose-dependent inhibitory effects against a broad panel of HIV type 1 isolates from different clades.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19029331",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 657,
          "offsetInEndSection": 829,
          "text": "Two large efficacy trials of a vaginal ring containing the investigational drug dapivirine demonstrated efficacy and safety in preventing HIV infections in women in Africa.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27398859",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 575,
          "offsetInEndSection": 831,
          "text": "In doing so, we discovered that dapivirine and maraviroc, a non-nucleoside reverse transcriptase inhibitor and an entry inhibitor currently in development as microbicides for HIV PrEP, are differentially metabolized in colorectal tissue and vaginal tissue.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23965226",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1267,
          "offsetInEndSection": 1611,
          "text": "Plasma dapivirine concentrations were low (<1 ng/ml) and remained well below those observed at the maximum tolerated dose for oral treatment (mean Cmax of 2286 \u200ang/ml).CONCLUSION: The dapivirine vaginal ring has a safety and pharmacokinetic profile that supports its use as a sustained-release topical microbicide for HIV-1 prevention in women.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24901365",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 445,
          "offsetInEndSection": 741,
          "text": "ASPIRE (A Study to Prevent Infection with a Ring for Extended Use) is a phase III, randomized, double-blind, placebo-controlled trial testing the safety and effectiveness of a vaginal ring containing the non-nucleoside reverse transcriptase inhibitor dapivirine for prevention of HIV-1 infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26061040",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 232,
          "text": "Dual segment polyurethane intravaginal rings (IVRs) were fabricated to enable sustained release of antiretroviral agents dapivirine and tenofovir to prevent the male to female sexual transmission of the human immunodeficiency virus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19958831",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 937,
          "offsetInEndSection": 1095,
          "text": "The study demonstrates proof of concept for a dapivirine-releasing diaphragm with daily release quantities potentially capable of preventing HIV transmission.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23177261",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Can Pentraxin 3 predict outcomes of sepsis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/15977234",
        "http://www.ncbi.nlm.nih.gov/pubmed/25001601",
        "http://www.ncbi.nlm.nih.gov/pubmed/25227610",
        "http://www.ncbi.nlm.nih.gov/pubmed/26982005",
        "http://www.ncbi.nlm.nih.gov/pubmed/27864924",
        "http://www.ncbi.nlm.nih.gov/pubmed/26872435",
        "http://www.ncbi.nlm.nih.gov/pubmed/24958171",
        "http://www.ncbi.nlm.nih.gov/pubmed/23341967",
        "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
        "http://www.ncbi.nlm.nih.gov/pubmed/22278372",
        "http://www.ncbi.nlm.nih.gov/pubmed/26717657",
        "http://www.ncbi.nlm.nih.gov/pubmed/11445697",
        "http://www.ncbi.nlm.nih.gov/pubmed/25530683",
        "http://www.ncbi.nlm.nih.gov/pubmed/25048752",
        "http://www.ncbi.nlm.nih.gov/pubmed/25591437",
        "http://www.ncbi.nlm.nih.gov/pubmed/24039869",
        "http://www.ncbi.nlm.nih.gov/pubmed/21423699"
      ],
      "ideal_answer": [
        "Yes, Pentraxin 3 s an objective biochemical marker in diagnosis of sepsis; it is helpful in assessment of severity and prognosis of sepsis; it also has a certain clinical value in the assessment of sepsis cardiovascular function damage."
      ],
      "exact_answer": "yes",
      "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018805",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000066891",
        "http://www.biosemantics.org/jochem#4264880"
      ],
      "type": "yesno",
      "id": "5890eb22621ea6ff7e000006",
      "snippets": [
        {
          "offsetInBeginSection": 1447,
          "offsetInEndSection": 1708,
          "text": "As compared with low serum PTX3and sTWEAK cases, cirrhotic patients with high serum PTX3/sTWEAK levels a have higher probability of new severe infections, severe sepsis, septic shock, type 1 hepatorenal syndrome, in-hospital, and 3-month follow-up mortalities. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26872435",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1350,
          "offsetInEndSection": 1543,
          "text": "Neonates with high nPTX3 concentrations also have lowered APGAR scores, increased rate of respiratory distress syndrome, clinical sepsis, IVH, necrotizing enterocolitis and prolonged NICU stay.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25048752",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 3688,
          "offsetInEndSection": 4106,
          "text": "In terms of predicting the prognosis of sepsis with heart failure complications, the PTX3 value's area under ROC curve was larger than that of BNP (respectively 0. 844, 0. 472).CONCLUSION: The PTX3 is an objective biochemical marker in diagnosis of sepsis; it is helpful in assessment of severity and prognosis of sepsis; it also has a certain clinical value in the assessment of sepsis cardiovascular function damage.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26717657",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 82,
          "text": "Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25001601",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1636,
          "offsetInEndSection": 1755,
          "text": "Together, these results suggest that elevation of PTX3 is associated with fulminant disease during A. baumannii sepsis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25001601",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 138,
          "text": "Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 231,
          "offsetInEndSection": 332,
          "text": "PTX3, as a mediator of inflammation, may represent an early marker of severity and outcome in sepsis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1413,
          "offsetInEndSection": 1645,
          "text": "CONCLUSIONS: Persisting high levels of circulating PTX3 over the first days from sepsis onset may be associated with mortality. PTX3 correlates with severity of sepsis and with sepsis-associated coagulation/fibrinolysis dysfunction.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 70,
          "text": "Pentraxin 3 in patients with severe sepsis or shock: the ALBIOS trial.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27864924",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 106,
          "text": "Pentraxin 3: an immune modulator of infection and useful marker for disease severity assessment in sepsis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26982005",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 102,
          "text": "Redox state of pentraxin 3 as a novel biomarker for resolution of inflammation and survival in sepsis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24958171",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 270,
          "offsetInEndSection": 504,
          "text": "The prototypic long pentraxin, pentraxin 3, is an acute phase protein that is structurally related but distinct from C-reactive protein which has proven to correlate with the severity of bacterial infection in critically ill patients.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15977234",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11445697",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 150,
          "text": "Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23341967",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1074,
          "offsetInEndSection": 1278,
          "text": "In addition, high levels of PTX3 were associated with unfavorable outcome.CONCLUSIONS: The long pentraxin PTX3 is elevated in critically ill patients and correlates with severity of disease and infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11445697",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 222,
          "offsetInEndSection": 323,
          "text": "PTX3, as a mediator of inflammation, may represent an early marker of severity and outcome in sepsis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 103,
          "text": "Redox state of pentraxin 3 as a novel biomarker for resolution of inflammation and survival in sepsis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24958171",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 139,
          "text": "Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20119647",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 151,
          "text": "Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23341967",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 177,
          "text": "The proteomic profile of circulating pentraxin 3 (PTX3) complex in sepsis demonstrates the interaction with azurocidin 1 and other components of neutrophil extracellular traps.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22278372",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "Which bacteria cause diphtheria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/8784575",
        "http://www.ncbi.nlm.nih.gov/pubmed/24403054",
        "http://www.ncbi.nlm.nih.gov/pubmed/7766139",
        "http://www.ncbi.nlm.nih.gov/pubmed/23981100",
        "http://www.ncbi.nlm.nih.gov/pubmed/14532240",
        "http://www.ncbi.nlm.nih.gov/pubmed/23357389",
        "http://www.ncbi.nlm.nih.gov/pubmed/812306",
        "http://www.ncbi.nlm.nih.gov/pubmed/22205447",
        "http://www.ncbi.nlm.nih.gov/pubmed/21087580",
        "http://www.ncbi.nlm.nih.gov/pubmed/25578079",
        "http://www.ncbi.nlm.nih.gov/pubmed/21549738",
        "http://www.ncbi.nlm.nih.gov/pubmed/1901182",
        "http://www.ncbi.nlm.nih.gov/pubmed/25887321",
        "http://www.ncbi.nlm.nih.gov/pubmed/23163039",
        "http://www.ncbi.nlm.nih.gov/pubmed/21742447",
        "http://www.ncbi.nlm.nih.gov/pubmed/26607400",
        "http://www.ncbi.nlm.nih.gov/pubmed/24295558",
        "http://www.ncbi.nlm.nih.gov/pubmed/22583953",
        "http://www.ncbi.nlm.nih.gov/pubmed/25320226",
        "http://www.ncbi.nlm.nih.gov/pubmed/16107839",
        "http://www.ncbi.nlm.nih.gov/pubmed/22403045",
        "http://www.ncbi.nlm.nih.gov/pubmed/12661461",
        "http://www.ncbi.nlm.nih.gov/pubmed/10220818",
        "http://www.ncbi.nlm.nih.gov/pubmed/12037265",
        "http://www.ncbi.nlm.nih.gov/pubmed/25297035",
        "http://www.ncbi.nlm.nih.gov/pubmed/22568715",
        "http://www.ncbi.nlm.nih.gov/pubmed/10598381",
        "http://www.ncbi.nlm.nih.gov/pubmed/16406634",
        "http://www.ncbi.nlm.nih.gov/pubmed/24293345",
        "http://www.ncbi.nlm.nih.gov/pubmed/22628666",
        "http://www.ncbi.nlm.nih.gov/pubmed/25587356",
        "http://www.ncbi.nlm.nih.gov/pubmed/18583986",
        "http://www.ncbi.nlm.nih.gov/pubmed/24106714",
        "http://www.ncbi.nlm.nih.gov/pubmed/3112181",
        "http://www.ncbi.nlm.nih.gov/pubmed/10932611",
        "http://www.ncbi.nlm.nih.gov/pubmed/24572455",
        "http://www.ncbi.nlm.nih.gov/pubmed/11568853",
        "http://www.ncbi.nlm.nih.gov/pubmed/22382258"
      ],
      "ideal_answer": [
        "Diphtheria is caused by the bacteria:\n1) Corynebacterium ulcerans and \n2) Corynebacterium diphtheriae."
      ],
      "exact_answer": [
        [
          "Corynebacterium ulcerans",
          "C. ulcerans"
        ],
        [
          "Corynebacterium diphtheriae",
          "C. diphtheriae"
        ]
      ],
      "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001419",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003354",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003352",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004167",
        "http://www.disease-ontology.org/api/metadata/DOID:11405",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D004165"
      ],
      "type": "list",
      "id": "58b548d722d3005309000005",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 256,
          "text": "Corynebacterium ulcerans is a zoonotic pathogen that can produce diphtheria toxin and causes an illness categorized as diphtheria in the European Union because its clinical appearance is similar to that of diphtheria caused by Corynebacterium diphtheriae. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26607400",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 444,
          "text": "The zoonotic bacterium Corynebacterium ulcerans may be pathogenic both in humans and animals: toxigenic strains can cause diphtheria or diphtheria-like disease in humans via diphtheria toxin, while strains producing the dermonecrotic exotoxin phospholipase D may lead to caseous lymphadenitis primarily in wild animals. Diphtheria toxin-positive Corynebacterium ulcerans strains have been isolated mainly from cattle, dogs and cats.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25887321",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 523,
          "offsetInEndSection": 619,
          "text": "Corynebacterium diphtheriae, a pathogenic bacterium that causes diphtheria, has been performed. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24106714",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 141,
          "text": "Corynebacterium ulcerans 0102 carries the gene encoding diphtheria toxin on a prophage different from the C. diphtheriae NCTC 13129 prophage.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22583953",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 299,
          "text": "Corynebacterium ulcerans can cause a diphtheria-like illness, especially when the bacterium is lysogenized with a tox gene-carrying bacteriophage that produces diphtheria toxin. Acquisition of toxigenicity upon phage lysogenization is a common feature of C. ulcerans and C. diphtheriae. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22583953",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 235,
          "text": "Corynebacterium ulcerans (toxigenic C. ulcerans) produces the diphtheria toxin, which causes pharyngeal and cutaneous diphtheria-like disease in people, and this bacterium is commonly detected in dogs and cats that are reared at home. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25578079",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 163,
          "offsetInEndSection": 454,
          "text": "This case demonstrates that strains of C. ulcerans that produce diphtheria toxin can cause infections of the skin that completely mimic typical cutaneous diphtheria, thereby potentially providing a source of bacteria capable of causing life-threatening diseases in the patient's environment.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11568853",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 147,
          "text": "Diphtheria is a serious upper respiratory tract disease caused by the diphtheria toxin (DT) secreted from the bacteria Corynebacterium diphtheriae.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22205447",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 104,
          "offsetInEndSection": 213,
          "text": "ulcerans produce diphtheria toxin, which can cause life-threatening cardiopathies and neuropathies in humans.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22403045",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 176,
          "text": "A high-density growth approach was utilized to produce mutated diphtheria toxin from two strains of Corynebacterium diphtheria: C7 (beta)(tox-201,tox-9) and C7 (beta)(tox-107).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7766139",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1049,
          "offsetInEndSection": 1190,
          "text": "For the primary prevention of disease caused by diphtheria toxin-producing corynebacteria, vaccination with diphtheria toxoid is recommended.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22403045",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 206,
          "offsetInEndSection": 455,
          "text": "ulcerans that produce diphtheria toxin can cause infections of the skin that completely mimic typical cutaneous diphtheria, thereby potentially providing a source of bacteria capable of causing life-threatening diseases in the patient's environment.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11568853",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 92,
          "text": "[A case of diphtheria in the Netherlands due to an infection with Corynebacterium ulcerans].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12661461",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 116,
          "text": "Diphtheria is an acute bacterial illness caused by toxigenic strains of Corynebacterium diphtheriae (C. diphtheriae)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22382258",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 74,
          "text": "Diphtheria is caused by diphtheria toxin-producing Corynebacterium species",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22628666",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 116,
          "text": "Diphtheria, an acute infectious condition caused by Corynebacterium diphtheriae, was once a major killer of children",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23357389",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 194,
          "text": "Diphtheria, caused by toxigenic strains of Corynebacterium diphtheriae, is an ancient disease with high incidence and mortality that has always been characterized by epidemic waves of occurrence",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22568715",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 178,
          "text": "Infections caused by Corynebacterium diphtheriae frequently induce situations in which very small doses of antigens injected intradermally can cause strong inflammatory reactions",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21549738",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 123,
          "text": "Corynebacterium diphtheriae is the etiological agent of diphtheria, a potential fatal disease caused by a corynephage toxin",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24293345",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 117,
          "text": "[Diphtheria in Denmark 1956-1989. Occurrence of Corynebacterium diphtheriae and other diphtheria toxigenic bacteria].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1901182",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 231,
          "text": "Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry as a tool for rapid diagnosis of potentially toxigenic Corynebacterium species in the laboratory management of diphtheria-associated bacteria.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21087580",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 164,
          "offsetInEndSection": 456,
          "text": "This case demonstrates that strains of C. ulcerans that produce diphtheria toxin can cause infections of the skin that completely mimic typical cutaneous diphtheria, thereby potentially providing a source of bacteria capable of causing life-threatening diseases in the patient's environment. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11568853",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 185,
          "text": "Detection of differences in the nucleotide and amino acid sequences of diphtheria toxin from Corynebacterium diphtheriae and Corynebacterium ulcerans causing extrapharyngeal infections.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14532240",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 168,
          "text": "Heterogeneity of diphtheria toxin gene, tox, and its regulatory element, dtxR, in Corynebacterium diphtheriae strains causing epidemic diphtheria in Russia and Ukraine.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8784575",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 148,
          "text": "Diphtheria is a serious upper respiratory tract disease caused by the diphtheria toxin (DT) secreted from the bacteria Corynebacterium diphtheriae. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22205447",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 109,
          "text": "Laboratory guidelines for the diagnosis of infections caused by Corynebacterium diphtheriae and C. ulcerans. ",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10598381",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1139,
          "offsetInEndSection": 1374,
          "text": "A possible biological mechanism for a diphtheria effect on hearing ability exists: The toxin produced by the Corynebacterium diphtheriae bacteria can cause damage to cranial nerves and therefore may affect the auditory neural pathway. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12037265",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1094,
          "offsetInEndSection": 1328,
          "text": "A possible biological mechanism for a diphtheria effect on hearing ability exists: The toxin produced by the Corynebacterium diphtheriae bacteria can cause damage to cranial nerves and therefore may affect the auditory neural pathway.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12037265",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 680,
          "offsetInEndSection": 848,
          "text": "In cases of human infection with potentially toxigenic corynebacteria, it is important to determine the species and examine the isolate for diphtheria toxin production.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22403045",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 916,
          "text": "AIM: Study of the apoptogenic effect of Corynebacterium diphtheriae toxigenic strains on mice peritoneal macrophages in vitro.MATERIALS AND METHODS: Evaluation ofapoptosis induced by Corynebacterium diphtheriae, Corynebacterium pseudodiphtheriticum, Staphylococcus aureus, Streptococcus pyogenes strains was performed by characteristic morphological changes in macrophages in smears stained by azure eosin by Romanovsky-Giemsa.RESULTS: Apoptogenic activity of diphtheria infectious agent was established to be determined by diphtheria exotoxin at early (after 1 hour) and surface structures and pathogenicity enzymes at later (3 hours) stages of effect.CONCLUSION: The ability of diphtheria infectious agent to cause macrophage apoptosis is one of the mechanisms of realization of its pathogenic properties determined by the effect of diphtheria exotoxin, as well as its surface structures and pathogenicity enzymes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23163039",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 163,
          "text": "Extrapharyngeal infections caused by Corynebacterium ulcerans have rarely been reported previously, and diphtheria toxin production has usually not been addressed.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11568853",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 93,
          "text": "Corynebacterium ulcerans may cause diphtheria in humans and caseous lymphadenitis in animals.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24572455",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 748,
          "offsetInEndSection": 979,
          "text": "ulcerans for the first time, we show that related sequence types (STs) might be associated with the presence of the diphtheria toxin gene, which encodes diphtheria toxin (DT), the most important diphtheria-causing virulence factor.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25320226",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 164,
          "text": "Human-to-human-transmitted Corynebacterium diphtheriae was historically the main pathogen causing diphtheria and has therefore been studied extensively in the past.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25320226",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 671,
          "offsetInEndSection": 851,
          "text": "Toxigenic Corynebacterium diphtheriae, the organism causing diphtheria, was thought to have become rare or even have disappeared from previously endemic areas such as South Dakota.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10932611",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 103,
          "text": "Infection of the skin caused by Corynebacterium ulcerans and mimicking classical cutaneous diphtheria.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11568853",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "Which virus type causes Molluscum contagiosum?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/16390992",
        "http://www.ncbi.nlm.nih.gov/pubmed/23372568",
        "http://www.ncbi.nlm.nih.gov/pubmed/24155912",
        "http://www.ncbi.nlm.nih.gov/pubmed/18950398",
        "http://www.ncbi.nlm.nih.gov/pubmed/18616033",
        "http://www.ncbi.nlm.nih.gov/pubmed/9275219",
        "http://www.ncbi.nlm.nih.gov/pubmed/25186152",
        "http://www.ncbi.nlm.nih.gov/pubmed/9525670",
        "http://www.ncbi.nlm.nih.gov/pubmed/3814509",
        "http://www.ncbi.nlm.nih.gov/pubmed/26672647",
        "http://www.ncbi.nlm.nih.gov/pubmed/22301546",
        "http://www.ncbi.nlm.nih.gov/pubmed/8938977",
        "http://www.ncbi.nlm.nih.gov/pubmed/21802105",
        "http://www.ncbi.nlm.nih.gov/pubmed/22688765",
        "http://www.ncbi.nlm.nih.gov/pubmed/24491904",
        "http://www.ncbi.nlm.nih.gov/pubmed/881573",
        "http://www.ncbi.nlm.nih.gov/pubmed/23598933",
        "http://www.ncbi.nlm.nih.gov/pubmed/8850036",
        "http://www.ncbi.nlm.nih.gov/pubmed/24155550",
        "http://www.ncbi.nlm.nih.gov/pubmed/15284701",
        "http://www.ncbi.nlm.nih.gov/pubmed/21228810",
        "http://www.ncbi.nlm.nih.gov/pubmed/22262788",
        "http://www.ncbi.nlm.nih.gov/pubmed/10500212",
        "http://www.ncbi.nlm.nih.gov/pubmed/10502526",
        "http://www.ncbi.nlm.nih.gov/pubmed/25072249",
        "http://www.ncbi.nlm.nih.gov/pubmed/12552001"
      ],
      "ideal_answer": [
        "Molluscum contagiosum virus (MCV) is a human poxvirus that causes tumor-like skin lesions."
      ],
      "exact_answer": [
        "human poxvirus"
      ],
      "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:8867",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008977",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008976"
      ],
      "type": "factoid",
      "id": "58bfd0db02b8c60953000017",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 161,
          "text": "Molluscum contagiosum virus (MCV), a poxvirus pathogenic for humans, replicates well in human skin in vivo, but not in vitro in standard monolayer cell cultures.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22688765",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 85,
          "text": "Molluscum contagiosum virus (MCV) is a poxvirus that causes tumor-like skin lesions. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21228810",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 112,
          "text": "Molluscum contagiosum poxvirus (MCV) type 1 and type 2 encode two chemokine-like proteins MC148R1 and MC148R2. I",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21802105",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 162,
          "text": "Molluscum contagiosum virus (MCV) is a common, human poxvirus that causes small papular skin lesions that persist for long periods without signs of inflammation. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10500212",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 311,
          "text": "All poxviruses studied encode a type 1B topoisomerase that introduces transient nicks into DNA and thereby relaxes DNA supercoils. Here we present a study of the protein domains of the topoisomerase of the poxvirus molluscum contagiosum (MCV), which allows us to specify DNA contacts made by different domains. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10502526",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 96,
          "text": "Molluscum contagiosum virus (MCV) causes molluscum contagiosum (MC) in both children and adults.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8850036",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 165,
          "offsetInEndSection": 357,
          "text": "MC54L, the IL-18 binding protein of the human poxvirus that causes molluscum contagiosum, is unique in having a C-terminal tail of nearly 100 amino acids that is dispensable for IL-18 binding.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12552001",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 113,
          "text": "Molluscum contagiosum is a common superficial skin infection caused by the poxvirus, Molluscum Contagiosum virus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24155912",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 145,
          "text": "Molluscum contagiosum is a common skin and mucosal disease of viral origin, caused by molluscum contagiosum virus (MCV) virus of poxvirus family.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23598933",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 74,
          "text": "Molluscum contagiosum is a benign contagious disease caused by a poxvirus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15284701",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 112,
          "text": "Molluscum contagiosum is a common superficial skin infection caused by the poxvirus, Molluscum Contagiosum virus",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24155912",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 144,
          "text": "Molluscum contagiosum is a common skin and mucosal disease of viral origin, caused by molluscum contagiosum virus (MCV) virus of poxvirus family",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23598933",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 140,
          "text": "Molluscum contagiosum is a viral infection of the skin and mucous membranes that is caused by infection with the molluscum contagiosum virus",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18950398",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 128,
          "text": "Molluscum contagiosum (MC) is a very common benign self-limiting cutaneous viral infection caused by molluscum contagiosum virus",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26672647",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 311,
          "text": "Molluscum contagiosum is caused by the molluscum contagiosum virus (MCV) and is a very common skin disorder mainly involving young children Cryotherapy, curettage or some topical therapies have been applied for MC, but all of these treatments need several sessions, can be somewhat ineffective, and very painful",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24155550",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 152,
          "text": "Molluscum contagiosum virus (MCV) causes an innocuous yet persistent skin infection in immunocompetent individuals and is spread by contact with lesions",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25072249",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 96,
          "text": "Molluscum contagiosum virus (MCV) is a poxvirus that causes localized papules in healthy persons",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22262788",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 101,
          "text": "Molluscum contagiosum is a virus that causes characteristic pearly lesions on the surface of the skin",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18616033",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "text": "Molluscum contagiosum virus (MCV) is a poxvirus that causes tumor-like skin lesions",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21228810",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 136,
          "text": "Molluscum contagiosum virus is a human and animal dermatotropic pathogen, which causes a severe disease in immunocompromised individuals",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24491904",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 984,
          "offsetInEndSection": 1313,
          "text": "Given that human diseases caused by poxviruses can be as lethal as smallpox or as benign as Molluscum contagiosum, and that vaccinia virus, the prototypic member of the pox family, persists as a mainstay of vaccine design and has potential as an oncolytic virus for tumor therapy, further research in this area remains important.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23372568",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 168,
          "offsetInEndSection": 358,
          "text": "These cases support earlier evidence that the molluscum contagiosum virus may act as cases support earlier evidence that the molluscum contagiosum virus may act as an opportunistic pathogen.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3814509",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 141,
          "text": "Molluscum contagiosum is a viral infection of the skin and mucous membranes that is caused by infection with the molluscum contagiosum virus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18950398",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Does Yersinia pestis causes a respiratory infection?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17041851",
        "http://www.ncbi.nlm.nih.gov/pubmed/19629028",
        "http://www.ncbi.nlm.nih.gov/pubmed/16239527",
        "http://www.ncbi.nlm.nih.gov/pubmed/21859946",
        "http://www.ncbi.nlm.nih.gov/pubmed/26123398",
        "http://www.ncbi.nlm.nih.gov/pubmed/25928467",
        "http://www.ncbi.nlm.nih.gov/pubmed/25974210",
        "http://www.ncbi.nlm.nih.gov/pubmed/16714568",
        "http://www.ncbi.nlm.nih.gov/pubmed/26463167",
        "http://www.ncbi.nlm.nih.gov/pubmed/12474416",
        "http://www.ncbi.nlm.nih.gov/pubmed/16964684",
        "http://www.ncbi.nlm.nih.gov/pubmed/24721571",
        "http://www.ncbi.nlm.nih.gov/pubmed/25691593"
      ],
      "ideal_answer": [
        "Inhalation of Yersinia pestis results in primary pneumonic plague."
      ],
      "exact_answer": "yes",
      "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015010",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015007",
        "http://www.disease-ontology.org/api/metadata/DOID:0050069",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D015009"
      ],
      "type": "yesno",
      "id": "58caf86f02b8c60953000030",
      "snippets": [
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 140,
          "text": "Inhalation of Yersinia pestis results in primary pneumonic plague, a highly lethal and rapidly progressing necrotizing pneumonia",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25691593",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 70,
          "text": "Yersinia pestis causes the fatal respiratory disease pneumonic plague.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26123398",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "Pulmonary infection by Yersinia pestis causes pneumonic plague, a rapidly progressing and often fatal disease.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16714568",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 147,
          "text": "Pulmonary infection with the bacterium Yersinia pestis causes pneumonic plague, an often-fatal disease for which no vaccine is presently available.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16239527",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 69,
          "text": "Yersinia pestis causes the fatal respiratory disease pneumonic plague",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26123398",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 74,
          "text": "Pneumonic plague is a deadly respiratory disease caused by Yersinia pestis",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24721571",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 236,
          "text": "On July 8, 2014, the Colorado Department of Public Health and Environment (CDPHE) laboratory identified Yersinia pestis, the bacterium that causes plague, in a blood specimen collected from a man (patient A) hospitalized with pneumonia.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25928467",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 69,
          "text": "Early emergence of Yersinia pestis as a severe respiratory pathogen.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26123398",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 102,
          "text": "The aerosol form of the bacterium Yersinia pestis causes the pneumonic plague, a rapidly fatal disease",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17041851",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 17,
          "offsetInEndSection": 331,
          "text": " plague bacterium, Yersinia pestis, has historically been regarded as one of the deadliest pathogens known to mankind, having caused three major pandemics. After being transmitted by the bite of an infected flea arthropod vector, Y. pestis can cause three forms of human plague: bubonic, septicemic, and pneumonic,",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21859946",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 561,
          "text": "Plague is an infectious disease caused by the Yersinia pestis microorganism, which is transmitted to the human host from a natural reservoir (different rodent species) by a flea bite. Plague is still encountered in humans in the areas of its enzootic prevalence in local rodent populations. Infection by flea bite results in a bubonic or septicemic plague, possibly complicated by secondary pneumonia. The person with pneumonic symptoms may be a source of a droplet-borne inhalatory infection for other people who consequently develop primary pneumonic plague. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12474416",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 13,
          "offsetInEndSection": 166,
          "text": "uring pneumonic plague, the bacterium Yersinia pestis elicits the development of inflammatory lung lesions that continue to expand throughout infection. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26463167",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 385,
          "offsetInEndSection": 582,
          "text": "In November 2006, the Uganda Ministry of Health received reports of an increase in bubonic plague cases and a possible outbreak of pneumonic plague among residents in the Arua and Nebbi districts. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19629028",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 124,
          "text": "Pneumonic plague is a fatal disease caused by Yersinia pestis that is associated with a delayed immune response in the lungs",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25974210",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is Cryptococcus neoformans a frequent cause of isolated skin infections in immunocompromised individuals",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26246081",
        "http://www.ncbi.nlm.nih.gov/pubmed/12602722",
        "http://www.ncbi.nlm.nih.gov/pubmed/27852678",
        "http://www.ncbi.nlm.nih.gov/pubmed/12219115"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0010414",
          "o": "http://linkedlifedata.com/resource/umls/label/A18683550"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A18683550",
          "o": "cryptococcus neoformans"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://linkedlifedata.com/resource/umls/id/C0010416",
          "o": "Cryptococcus neoformans"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0010416",
          "o": "http://linkedlifedata.com/resource/umls/label/A0043970"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0010414",
          "o": "http://linkedlifedata.com/resource/umls/label/A8355137"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A8355137",
          "o": "Infection by Cryptococcus neoformans"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#prefLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0010414",
          "o": "http://linkedlifedata.com/resource/umls/label/A0560486"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0560486",
          "o": "Infection by Cryptococcus neoformans"
        }
      ],
      "ideal_answer": [
        "Primary cutaneous cryptococcosis (PCC) without systemic infection is rare."
      ],
      "exact_answer": "no",
      "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003453",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012874",
        "http://www.disease-ontology.org/api/metadata/DOID:12053",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003455",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D003454"
      ],
      "type": "yesno",
      "id": "58e120036fddd3e83e00000d",
      "snippets": [
        {
          "offsetInBeginSection": 10,
          "offsetInEndSection": 284,
          "text": " Cryptococcus is an opportunistic yeast with a worldwide distribution that primarily causes significant infections in immunocompromised individuals, generally by affecting the respiratory tract. But primary cutaneous cryptococcosis (PCC) without systemic infection is rare. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26246081",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 130,
          "text": "Cryptococcus is a ubiquitous fungus and is known for causing meningitis and cutaneous infections in immunocompromised individuals.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27852678",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 215,
          "text": "Cryptococcus neoformans is an encapsulated yeast that can cause primary pulmonary infections or disseminate and cause infections of the central nervous system, meninges, skin, and bone in the immunocompromised host.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12602722",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 189,
          "text": "The authors report a male patient, a seller with no detected immunosuppression, with an extensive ulcerated skin lesion localized on the left forearm, caused by Cryptococcus neoformans var.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12219115",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "How are Arboviruses transmitted?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10488638",
        "http://www.ncbi.nlm.nih.gov/pubmed/21658241",
        "http://www.ncbi.nlm.nih.gov/pubmed/26363996",
        "http://www.ncbi.nlm.nih.gov/pubmed/26925368",
        "http://www.ncbi.nlm.nih.gov/pubmed/16893487",
        "http://www.ncbi.nlm.nih.gov/pubmed/25597441",
        "http://www.ncbi.nlm.nih.gov/pubmed/27220616",
        "http://www.ncbi.nlm.nih.gov/pubmed/1973949",
        "http://www.ncbi.nlm.nih.gov/pubmed/27869394",
        "http://www.ncbi.nlm.nih.gov/pubmed/26141429",
        "http://www.ncbi.nlm.nih.gov/pubmed/1297177",
        "http://www.ncbi.nlm.nih.gov/pubmed/24941331",
        "http://www.ncbi.nlm.nih.gov/pubmed/26283013",
        "http://www.ncbi.nlm.nih.gov/pubmed/8158611",
        "http://www.ncbi.nlm.nih.gov/pubmed/25053841"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://linkedlifedata.com/resource/umls/id/C0003725",
          "o": "Arboviruses"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0003725",
          "o": "http://linkedlifedata.com/resource/umls/label/A18608581"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A18608581",
          "o": "arboviruses"
        }
      ],
      "ideal_answer": [
        "Arboviruses are transmitted by arthropods."
      ],
      "exact_answer": [
        "By arthropods"
      ],
      "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D007303",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D018562",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001103",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001102"
      ],
      "type": "factoid",
      "id": "58f4b85f70f9fc6f0f000015",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 156,
          "text": "Epizootic congenital abnormalities, encephalomyelitis and febrile illnesses in cattle caused by arthropod-borne viruses (arboviruses) are prevalent in Japan",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25597441",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 11,
          "offsetInEndSection": 97,
          "text": " Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) transmitted by mosquitoes. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26283013",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 201,
          "text": "Nine different arboviruses are known to be transmitted by, or associated with, mosquitoes in Europe, and several (West Nile, Sindbis and Tahyna viruses) are reported to cause outbreaks of human disease",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16893487",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 124,
          "text": "Arthropod-borne viruses (arboviruses) are transmitted to humans primarily through the bites of infected mosquitoes and ticks",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24941331",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 114,
          "offsetInEndSection": 207,
          "text": "Arboviruses are transmitted among vertebrates by biting insects, chiefly mosquitoes and ticks",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21658241",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 129,
          "text": "Arboviruses are transmitted by distantly related arthropod vectors such as mosquitoes (class Insecta) and ticks (class Arachnida)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25053841",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 215,
          "text": "Mosquito-transmitted arthropod-borne viruses (arboviruses) such as dengue virus, chikungunya virus, and West Nile virus constitute a major public health burden and are increasing in severity and frequency worldwide.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26363996",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 263,
          "offsetInEndSection": 564,
          "text": "Malaria and Japanese encephalitis are the two most serious human diseases transmitted by riceland mosquitoes, but they have been incriminated as vectors of dozens of arboviruses and other parasites and pathogens including the causal agents of West Nile and Rift Valley Fevers and lymphatic filariasis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1973949",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 130,
          "text": "Arboviruses are transmitted by distantly related arthropod vectors such as mosquitoes (class Insecta) and ticks (class Arachnida).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25053841",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 594,
          "offsetInEndSection": 786,
          "text": "Many of them are transmitted by insects (arboviruses, e.g. yellow fever virus) or by rodents (e.g. Hanta viruses), others by contact with patients and nosocomial infections (e.g. Ebola virus).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10488638",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 166,
          "text": "Arboviruses - viruses transmitted by haematophagous arthropods - are responsible for febrile syndromes, which sometimes include haemorrhagic or neurological symptoms.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141429",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 168,
          "offsetInEndSection": 289,
          "text": "Arboviruses are transmitted to vertebral hosts during blood feedings by mosquitoes, ticks, biting flies, mites, and nits.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27220616",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "text": "Arboviruses transmitted by mosquitoes are a major cause of human disease worldwide.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26925368",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 161,
          "text": "Diseases caused by arboviruses transmitted by Aedes aegypti, such as dengue, chikungunya and Zika, continue to rise in annual incidence and geographic expansion.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869394",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 223,
          "offsetInEndSection": 414,
          "text": "Arboviruses transmitted by ticks must adapt to the peculiar physiological and behavioral characteristics of ticks, particularly with regard to blood feeding, bloodmeal digestion, and molting.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8158611",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 330,
          "offsetInEndSection": 532,
          "text": "The last decade has seen significant changes in the epidemiology of arboviruses transmitted by mosquitoes of the genus Aedes, particularly in relation to the intercontinental spread of Aedes albopictus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141429",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 381,
          "offsetInEndSection": 687,
          "text": "This technique enables the detection of 70 of the 80 arboviruses transmitted by mosquitoes in Africa and very easily detects arbovirus associations by using either monospecific or monoclonal immune ascitic fluids (dengue-1-2-3-4 and yellow fever viruses) used in the indirect immunofluorescence technique..",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1297177",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is autophagy the process where bacteria ingest viral particles?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24906121",
        "http://www.ncbi.nlm.nih.gov/pubmed/23121192",
        "http://www.ncbi.nlm.nih.gov/pubmed/27814601",
        "http://www.ncbi.nlm.nih.gov/pubmed/21946213",
        "http://www.ncbi.nlm.nih.gov/pubmed/23388380",
        "http://www.ncbi.nlm.nih.gov/pubmed/21175768",
        "http://www.ncbi.nlm.nih.gov/pubmed/27027951",
        "http://www.ncbi.nlm.nih.gov/pubmed/24198400",
        "http://www.ncbi.nlm.nih.gov/pubmed/24384599",
        "http://www.ncbi.nlm.nih.gov/pubmed/27812870"
      ],
      "ideal_answer": [
        "Autophagy, a cellular degradation process"
      ],
      "exact_answer": "yes",
      "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001343"
      ],
      "type": "yesno",
      "id": "58dd2cb08acda34529000029",
      "snippets": [
        {
          "offsetInBeginSection": 255,
          "offsetInEndSection": 296,
          "text": "Autophagy, a cellular degradation process",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27812870",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "Autophagy, a form of lysosomal degradation capable of eliminating dysfunctional proteins and organelles, is a cellular process associated with homeostasis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27814601",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 362,
          "text": "Autophagy, a programmed process in which cell contents are delivered to lysosomes for degradation, appears to have both tumor-suppressive and tumor-promoting functions; both stimulation and inhibition of autophagy have been reported to induce cancer cell death, and particular genes and proteins have been associated both positively and negatively with autophagy",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24906121",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 204,
          "text": "Autophagy is a lysosome-mediated catabolic process involving the degradation of intracellular contents (e.g., proteins and organelles) as well as invading microbes (e.g., parasites, bacteria and viruses).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23388380",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 187,
          "text": "Autophagy is a cellular process that targets proteins, lipids and organelles to lysosomes for degradation, but it has also been shown to combat infection with various pathogenic bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24384599",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 163,
          "text": "Autophagy, an intracellular degradation process highly conserved from yeast to humans, is viewed as an important defence mechanism to clear intracellular bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23121192",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 89,
          "offsetInEndSection": 274,
          "text": "Autophagy has intracellular anti-viral and anti-bacterial functions, and plays a role in the initiation of innate and adaptive immune system responses to viral and bacterial infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21175768",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1562,
          "offsetInEndSection": 1756,
          "text": "documented abundant autophagy within VZV-infected cells throughout the infectious cycle but also demonstrated that VZV-induced autophagy facilitated VZV glycoprotein biosynthesis and processing.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24198400",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 126,
          "text": "Autophagy is a highly conserved process by which cells can recycle organelles and proteins by degrading them in the lysosomes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027951",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is the link between TB (Turbeculosis) infection and TNFa inhibition?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19176545",
        "http://www.ncbi.nlm.nih.gov/pubmed/25095612",
        "http://www.ncbi.nlm.nih.gov/pubmed/24295645",
        "http://www.ncbi.nlm.nih.gov/pubmed/19075965",
        "http://www.ncbi.nlm.nih.gov/pubmed/19107015"
      ],
      "ideal_answer": [
        "The occurrence of tuberculosis (TB) in patients treated with immunosuppressive drugs (ISD) is an old problem that has been highlighted by cases occurring in patients using anti-TNFalpha drugs."
      ],
      "type": "summary",
      "id": "58ea521d3e8b6dc87c00000f",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 81,
          "text": "The use of TNFalpha blockers is associated with reactivation of tuberculosis (TB)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25095612",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 207,
          "text": "We present two patients with inflammatory bowel disease who, despite negative tuberculosis screening, developed a de novo tuberculosis infection after the start of anti tumor necrosis factor alpha treatment.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24295645",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 11,
          "offsetInEndSection": 302,
          "text": "To compare the performance of two interferon gamma release assays (IGRAs) and conventional screening tests in patients with inflammatory arthritis undergoing screening for latent tuberculosis infection (LTBI) before treatment with anti-tumour necrosis factor alpha (anti-TNFalpha) compounds.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19176545",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 192,
          "text": "The occurrence of tuberculosis (TB) in patients treated with immunosuppressive drugs (ISD) is an old problem that has been highlighted by cases occurring in patients using anti-TNFalpha drugs.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19107015",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 198,
          "text": "TNFalpha plays a pivotal role not only in the inflammatory process but also in the normal response against pathogens and therefore, interfering with this cytokine may increase the risk of infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19075965",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "The pathogen Fusarium graminearum affects what type of plant species?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/18179606",
        "http://www.ncbi.nlm.nih.gov/pubmed/26693688",
        "http://www.ncbi.nlm.nih.gov/pubmed/26585460",
        "http://www.ncbi.nlm.nih.gov/pubmed/22516221",
        "http://www.ncbi.nlm.nih.gov/pubmed/26607286",
        "http://www.ncbi.nlm.nih.gov/pubmed/26305050",
        "http://www.ncbi.nlm.nih.gov/pubmed/17031651",
        "http://www.ncbi.nlm.nih.gov/pubmed/22028654",
        "http://www.ncbi.nlm.nih.gov/pubmed/21639892",
        "http://www.ncbi.nlm.nih.gov/pubmed/24779355",
        "http://www.ncbi.nlm.nih.gov/pubmed/17555271",
        "http://www.ncbi.nlm.nih.gov/pubmed/17222149",
        "http://www.ncbi.nlm.nih.gov/pubmed/26198851",
        "http://www.ncbi.nlm.nih.gov/pubmed/26882849",
        "http://www.ncbi.nlm.nih.gov/pubmed/26679010",
        "http://www.ncbi.nlm.nih.gov/pubmed/12492838"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0032098",
          "o": "http://linkedlifedata.com/resource/umls/label/A18593376"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A18593376",
          "o": "plants"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://linkedlifedata.com/resource/umls/id/C0032098",
          "o": "plant"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0032098",
          "o": "http://linkedlifedata.com/resource/umls/label/A0486695"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0486695",
          "o": "plant"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://linkedlifedata.com/resource/umls/id/C0450254",
          "o": "Pathogenic organism"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0450254",
          "o": "http://linkedlifedata.com/resource/umls/label/A18639324"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A18639324",
          "o": "pathogenic organism"
        }
      ],
      "ideal_answer": [
        "Fusarium graminearum is a broad host pathogen threatening cereal crops in temperate regions around the world.",
        "Fusarium graminearum is a broad host pathogen threatening cereal crops in temperate regions around the world. "
      ],
      "exact_answer": [
        "cereal crops"
      ],
      "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D005670",
        "http://www.biosemantics.org/jochem#4053737",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D010945"
      ],
      "type": "factoid",
      "id": "58f3ca5c70f9fc6f0f00000d",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "Fusarium graminearum is a broad host pathogen threatening cereal crops in temperate regions around the world. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26693688",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 342,
          "text": "Fusarium head blight (FHB) of small cereals is a disease of global importance with regard to economic losses and mycotoxin contamination harmful to human and animal health. In Germany, FHB is predominantly associated with wheat and F. graminearum is recognised as the major causal agent of the disease, but little is known about FHB of barley",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26679010",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 92,
          "text": "Fusarium graminearum is a filamentous fungal pathogen that causes wheat Fusarium head blight",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26607286",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 121,
          "text": "Disruption of the GABA shunt affects mitochondrial respiration and virulence in the cereal pathogen Fusarium graminearum.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26305050",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 97,
          "text": "Fusarium graminearum is an important plant pathogen that causes head blight of major cereal crops",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22028654",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 97,
          "text": "Fusarium graminearum is a ubiquitous pathogen of cereal crops, including wheat, barley, and maize",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17555271",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 122,
          "text": "Disruption of the GABA shunt affects mitochondrial respiration and virulence in the cereal pathogen Fusarium graminearum.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26305050",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 117,
          "text": "The Ascomycete pathogen Fusarium graminearum can infect all cereal species and lower grain yield, quality and safety.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18179606",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 113,
          "text": "Arabidopsis is susceptible to the cereal ear blight fungal pathogens Fusarium graminearum and Fusarium culmorum.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12492838",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 159,
          "text": "Fusarium head blight (FHB) is a devastating disease of small grain cereal crops caused by the necrotrophic pathogen Fusarium graminearum and Fusarium culmorum.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17031651",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 86,
          "text": "The cereal pathogen Fusarium graminearum threatens food and feed production worldwide.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26305050",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 14,
          "offsetInEndSection": 165,
          "text": " necrotrophic fungal pathogen Fusarium that cause head blight and crown rot of cereals including wheat also infect a number of alternative host plants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17222149",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 101,
          "text": "Fusarium species cause Fusarium head blight (FHB) and other important diseases of cereals",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21639892",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 131,
          "text": "usarium graminearum is a toxigenic fungal pathogen that causes Fusarium head blight (FHB) and crown rot on cereal crops worldwide.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24779355",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 95,
          "text": "usarium graminearum is the fungal pathogen that causes globally important diseases of cereals ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26882849",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 223,
          "offsetInEndSection": 344,
          "text": "Fusarium graminearum, the causal agent of head scab disease of small grain cereals which threatens global food security. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26198851",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is hydroxyurea usually used to treated infectious disease?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21196716",
        "http://www.ncbi.nlm.nih.gov/pubmed/26275071",
        "http://www.ncbi.nlm.nih.gov/pubmed/27677923",
        "http://www.ncbi.nlm.nih.gov/pubmed/15307105",
        "http://www.ncbi.nlm.nih.gov/pubmed/20008183"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://linkedlifedata.com/resource/umls/id/C0020402",
          "o": "hydroxyurea"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0020402",
          "o": "http://linkedlifedata.com/resource/umls/label/A0481276"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0481276",
          "o": "hydroxyurea"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#prefLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0020402",
          "o": "http://linkedlifedata.com/resource/umls/label/A7996376"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A7996376",
          "o": "hydroxyurea"
        }
      ],
      "ideal_answer": [
        "Hydroxyurea represents the only available disease-modifying therapy for Sickle Cell Anemia (SCA)."
      ],
      "exact_answer": "no",
      "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:10923",
        "http://www.biosemantics.org/jochem#4275774",
        "http://www.biosemantics.org/jochem#http://www.biosemantics.org/jochem#:4275774",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D000755",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006450",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006918"
      ],
      "type": "yesno",
      "id": "58dbbdac8acda3452900001e",
      "snippets": [
        {
          "offsetInBeginSection": 156,
          "offsetInEndSection": 294,
          "text": "Hydroxyurea represents the only available disease-modifying therapy for SCA, and has proven safety and efficacy in high-resource countries",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26275071",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1579,
          "offsetInEndSection": 1777,
          "text": "In conclusion, the data here presented suggests that hydroxyurea may prevent priapism attacks in sickle cell disease, probably at higher doses than usually prescribed for painful crisis prevention..",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15307105",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 75,
          "text": "Clinical follow-up of hydroxyurea-treated adults with sickle cell disease.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21196716",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 405,
          "offsetInEndSection": 546,
          "text": "t may also attenuate optimal response to hydroxyurea therapy, the only effective and practical treatment option for SCD in sub-Saharan Africa",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27677923",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 82,
          "text": "Hydroxyurea is one of the most successfully used therapies for sickle cell disease",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15307105",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 252,
          "text": "Clinical experience with hydroxyurea for patients with sickle cell disease (SCD) has been accumulating for the past 25 years. The bulk of the current evidence suggests that hydroxyurea is well-tolerated, safe, and efficacious for most patients with SCD",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20008183",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What type of genome, (RNA or DNA, double stranded single stranded) is found in the the virus that causes blue tongue disease?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22549161"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0042776",
          "o": "http://linkedlifedata.com/resource/umls/label/A0491591"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A0491591",
          "o": "virus"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://linkedlifedata.com/resource/umls/id/C0319157",
          "o": "virus"
        },
        {
          "p": "http://www.w3.org/2000/01/rdf-schema#label",
          "s": "http://linkedlifedata.com/resource/umls/id/C0042776",
          "o": "Viruses"
        }
      ],
      "ideal_answer": [
        "The Bluetongue virus (BTV) genome contains ten double-stranded RNA segments.",
        "Bluetongue virus (BTV) genome contains ten double-stranded RNA segments. ",
        "Bluetongue virus (BTV) genome contains ten double-stranded RNA segments.",
        "Bluetongue virus (BTV) genome contains ten double-stranded RNA segments",
        "bluetongue virus (btv) genome contains ten double-stranded rna segments."
      ],
      "exact_answer": [
        "double stranded, segmented RNA"
      ],
      "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:1301",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012330",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D001820",
        "http://www.disease-ontology.org/api/metadata/DOID:0050498"
      ],
      "type": "factoid",
      "id": "58f3c4b970f9fc6f0f00000a",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 71,
          "text": "Bluetongue virus (BTV) genome contains ten double-stranded RNA segments",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22549161",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "The MMR vaccine protects against what 3 viruses?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/7686463",
        "http://www.ncbi.nlm.nih.gov/pubmed/26265115"
      ],
      "triples": [
        {
          "p": "http://www.w3.org/2008/05/skos-xl#altLabel",
          "s": "http://linkedlifedata.com/resource/umls/id/C0065828",
          "o": "http://linkedlifedata.com/resource/umls/label/A18558018"
        },
        {
          "p": "http://www.w3.org/2008/05/skos-xl#literalForm",
          "s": "http://linkedlifedata.com/resource/umls/label/A18558018",
          "o": "mmr vaccine"
        }
      ],
      "ideal_answer": [
        "The MMR vaccine provides immunity to measles, mumps and rubella.",
        " measles, mumps and rubella (mmr) vaccine ."
      ],
      "exact_answer": [
        [
          "Measles"
        ],
        [
          "Mumps"
        ],
        [
          "Rubella"
        ]
      ],
      "concepts": [
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012411",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D012412",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D008458",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D022542",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009109",
        "https://www.nlm.nih.gov/cgi/mesh/2017/MB_cgi?field=uid&exact=Find+Exact+Term&term=D009108",
        "http://www.disease-ontology.org/api/metadata/DOID:934"
      ],
      "type": "list",
      "id": "58f4b73b70f9fc6f0f000014",
      "snippets": [
        {
          "offsetInBeginSection": 29,
          "offsetInEndSection": 71,
          "text": " measles, mumps and rubella (MMR) vaccine ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26265115",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 115,
          "text": "Measles, mumps, rubella (MMR) vaccine is a live vaccine preparation containing attenuated strains of all 3 viruses.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7686463",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is the function of the dormancy survival regulator (DosR) in Mycobacterium tuberculosis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22833514",
        "http://www.ncbi.nlm.nih.gov/pubmed/23819907",
        "http://www.ncbi.nlm.nih.gov/pubmed/20023019",
        "http://www.ncbi.nlm.nih.gov/pubmed/15353557",
        "http://www.ncbi.nlm.nih.gov/pubmed/25659138",
        "http://www.ncbi.nlm.nih.gov/pubmed/23651670",
        "http://www.ncbi.nlm.nih.gov/pubmed/28255560",
        "http://www.ncbi.nlm.nih.gov/pubmed/25535276",
        "http://www.ncbi.nlm.nih.gov/pubmed/22544737",
        "http://www.ncbi.nlm.nih.gov/pubmed/24939385",
        "http://www.ncbi.nlm.nih.gov/pubmed/22439727",
        "http://www.ncbi.nlm.nih.gov/pubmed/22719925",
        "http://www.ncbi.nlm.nih.gov/pubmed/19487478",
        "http://www.ncbi.nlm.nih.gov/pubmed/22759512",
        "http://www.ncbi.nlm.nih.gov/pubmed/12446625",
        "http://www.ncbi.nlm.nih.gov/pubmed/19795912"
      ],
      "ideal_answer": [
        "During this phase, at least 48 genes, collectively named Dormancy survival regulator (DosR) regulon, are important for the long-term survival of bacilli under a non-respiring state.",
        "The dormancy survival regulator (DosR) regulon, composed of 48 co-regulated genes, is held as essential for Mtb persistence to anti-tuberculosis drugs. The DosR regulon enables the pathogen to persist during lengthy hypoxia. Upon oxygen shift-down, Mycobacterium tuberculosis complex bacteria can induce a genetic program characterized by halted duplication, which is called Non-replicating persistence (NRP). During this phase, at least 48 genes, collectively named Dormancy survival regulator (DosR) regulon, are important for the long-term survival of bacilli under a non-respiring state, a condition that bacilli encounter inside granulomatous lesions."
      ],
      "type": "summary",
      "id": "58edfaf4eda5a57672000012",
      "snippets": [
        {
          "offsetInBeginSection": 391,
          "offsetInEndSection": 841,
          "text": "The discovery that the tubercle bacillus can develop a drug-tolerant dormant form and the identification of the underlying genetic program 10 years ago paved the way for a deeper understanding of the life of the parasite inside human lesions and for new approaches to antimycobacterial drug discovery. Here, we summarize what we have learnt since the discovery of the master regulator of dormancy, DosR, and the key gaps in our knowledge that remain.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22439727",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 907,
          "offsetInEndSection": 1135,
          "text": "M. tb-expanded CD4+CD25+ (85% Foxp3(+)) cells and D4GDI induced intracellular M. tb to express the dormancy survival regulator DosR and DosR-dependent genes, suggesting that D4GDI induces a non-replicating state in the pathogen.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25659138",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 185,
          "offsetInEndSection": 431,
          "text": "During this phase, at least 48 genes, collectively named Dormancy survival regulator (DosR) regulon, are important for the long-term survival of bacilli under a non-respiring state, a condition that bacilli encounter inside granulomatous lesions.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23651670",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 152,
          "offsetInEndSection": 438,
          "text": "The non-replicating or dormancy like state of this pathogen which is impervious to anti-tuberculosis drugs is widely recognized as the culprit for this scenario. The dormancy survival regulator (DosR) regulon, composed of 48 co-regulated genes, is held as essential for Mtb persistence.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22833514",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 755,
          "offsetInEndSection": 827,
          "text": "The DosR regulon enables the pathogen to persist during lengthy hypoxia.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22833514",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 184,
          "text": "Upon oxygen shift-down, Mycobacterium tuberculosis complex bacteria can induce a genetic program characterized by halted duplication, which is called Non-replicating persistence (NRP).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23651670",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 139,
          "offsetInEndSection": 337,
          "text": "The dormancy survival (Dos) regulon, regulated by the response regulator DosR, appears to be essential for hypoxic survival in M. tuberculosis, but it is not known how the regulon promotes survival.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22544737",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 247,
          "offsetInEndSection": 374,
          "text": "The dormancy survival regulon (DosR regulon) is chiefly responsible for encoding dormancy related functions of M. tuberculosis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22719925",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 980,
          "offsetInEndSection": 1249,
          "text": "Our results demonstrate induction of dosR (Rv3133c) and 20 other members of the DosR regulon believed to mediate the transition into dormancy, and that rel(Mtb) is required for Mycobacterium tuberculosis survival during extracellular persistence within host granulomas.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15353557",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 96,
          "text": "Unique roles of DosT and DosS in DosR regulon induction and Mycobacterium tuberculosis dormancy.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19487478",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 228,
          "text": "In Mycobacterium tuberculosis, the sensor kinases DosT and DosS activate the transcriptional regulator DosR, resulting in the induction of the DosR regulon, which is important for anaerobic survival and perhaps latent infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19487478",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 131,
          "text": "The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20023019",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 159,
          "text": "The DosR dormancy regulator of Mycobacterium tuberculosis stimulates the Na(+)/K (+) and Ca (2+) ATPase activities in plasma membrane vesicles of mycobacteria.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24939385",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 100,
          "offsetInEndSection": 226,
          "text": "DosR/DevR of M. tuberculosis is a two component dormancy survival response regulator which induces the expression of 48 genes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22759512",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 314,
          "offsetInEndSection": 438,
          "text": "The dormancy survival regulator (DosR) regulon, composed of 48 co-regulated genes, is held as essential for Mtb persistence.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22833514",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 606,
          "offsetInEndSection": 719,
          "text": "DosR (Dormancy Survival Regulator, Rv3133c) regulon genes are expressed under the conditions of latency/dormancy.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19795912",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1335,
          "offsetInEndSection": 1462,
          "text": "Based on these two functions, dormancy survival and regulation, we named the Rv3133c gene dosR for dormancy survival regulator.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12446625",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 566,
          "offsetInEndSection": 738,
          "text": "A binding motif similar to the dormancy survival regulator (DosR) binding site of M. tuberculosis has been identified in the upstream sequences of most genes in these loci.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25535276",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1463,
          "offsetInEndSection": 1597,
          "text": "Our results provide conclusive evidence that DosR is a key regulator in the oxygen starvation-induced mycobacterial dormancy response.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12446625",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 911,
          "offsetInEndSection": 1139,
          "text": "M. tb-expanded CD4+CD25+ (85% Foxp3(+)) cells and D4GDI induced intracellular M. tb to express the dormancy survival regulator DosR and DosR-dependent genes, suggesting that D4GDI induces a non-replicating state in the pathogen.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25659138",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 91,
          "offsetInEndSection": 194,
          "text": "Dormancy survival regulator (DosR) regulon-encoded proteins may have a role in the maintenance of LTBI.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28255560",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 157,
          "offsetInEndSection": 294,
          "text": "The proteins encoded by the dormancy survival regulon (DosR regulon) are mainly responsible for survival of the bacilli in a latent form.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23819907",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 99,
          "text": "How Mycobacterium tuberculosis goes to sleep: the dormancy survival regulator DosR a decade later.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22439727",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 565,
          "offsetInEndSection": 649,
          "text": "A binding motif similar to the dormancy survival regulator (DosR) binding site of M.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25535276",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 139,
          "offsetInEndSection": 268,
          "text": "The dormancy survival (Dos) regulon, regulated by the response regulator DosR, appears to be essential for hypoxic survival in M.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22544737",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 160,
          "text": "The DosR dormancy regulator of Mycobacterium tuberculosis stimulates the Na(+)/K (+) and Ca (2+) ATPase activities in plasma membrane vesicles of mycobacteria.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24939385",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 97,
          "text": "Unique roles of DosT and DosS in DosR regulon induction and Mycobacterium tuberculosis dormancy.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19487478",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "What is the role of the positive effector of transcription (pet) in the hepatitis B virus?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/9311882",
        "http://www.ncbi.nlm.nih.gov/pubmed/8107218"
      ],
      "ideal_answer": [
        "This element, which we have named pet (positive effector of transcription), exerts its effect in cis in a position and orientation-dependent manner, suggesting that it may function as part of the nascent pregenome transcript.  In the presence of this region, deletion of pet activates transcription from downstream promoters, suggesting that pregenome transcription complexes fail to reach the downstream promoters. In vitro transcription experiments support the model that pet is required for transcription elongation on the DHBV template. We speculate that pet is required to suppress transcription termination during the first passage of pregenome transcription complexes through a viral termination region on the circular viral DNA.",
        "PET (positive effector of transcription), exerts its effect in cis in a position and orientation-dependent manner, suggesting that it may function as part of the nascent pregenome transcript. In the presence of this region, deletion of pet activates transcription from downstream promoters, suggesting that pregenome transcription complexes fail to reach the downstream promoters. In vitro transcription experiments support the model that pet is required for transcription elongation on the DHBV template. We speculate that pet is required to suppress transcription termination during the first passage of pregenome transcription complexes through a viral termination region on the circular viral DNA.",
        "In the presence of this region, deletion of pet activates transcription from downstream promoters, suggesting that pregenome transcription complexes fail to reach the downstream promoters. In vitro transcription from downstream promoters, suggesting that pregenome transcription complexes fail to reach the downstream promoters. We speculate that pet is required to suppress transcription termination during the first passage of pregenome transcription complexes through a viral termination region on the circular viral DNA. In vitro transcription experiments support the model that pet is required for transcription elongation on the DHBV template. This element, which we have named pet , exerts its effect in cis in a position and orientation-dependent manner, suggesting that pregenome transcription complexes fail to reach the downstream promoters. We speculate that pet , exerts its effect in cis in a position and orientation-dependent manner, suggesting that it may function as part of the nascent pregenome transcript. ",
        "This element, which we have named pet (positive effector of transcription), exerts its effect in cis in a position and orientation-dependent manner, suggesting that it may function as part of the nascent pregenome transcript.In the presence of this region, deletion of pet activates transcription from downstream promoters, suggesting that pregenome transcription complexes fail to reach the downstream promoters.In vitro transcription experiments support the model that pet is required for transcription elongation on the DHBV template.We speculate that pet is required to suppress transcription termination during the first passage of pregenome transcription complexes through a viral termination region on the circular viral DNA.",
        "This element, which we have named pet (positive effector of transcription), exerts its effect in cis in a position and orientation-dependent manner, suggesting that it may function as part of the nascent pregenome transcript.  In the presence of this region, deletion of pet activates transcription from downstream promoters, suggesting that pregenome transcription complexes fail to reach the downstream promoters. In vitro transcription experiments support the model that pet is required for transcription elongation on the DHBV template.",
        "This element, which we have named pet (positive effector of transcription), exerts its effect in cis in a position and orientation-dependent manner, suggesting that it may function as part of the nascent pregenome transcript.",
        "This element, which we have named pet (positive effector of transcription), exerts its effect in cis in a position and orientation-dependent manner, suggesting that it may function as part of the nascent pregenome transcript. ",
        "This element, which we have named pet , exerts its effect in cis in a position and orientation-dependent manner, suggesting that it may function as part of the nascent pregenome transcript. In vitro transcription experiments support the model that pet is required for transcription elongation on the DHBV template. We speculate that pet is required to suppress transcription termination during the first passage of pregenome transcription complexes through a viral termination region on the circular viral DNA. In the presence of this region, deletion of pet activates transcription from downstream promoters, suggesting that pregenome transcription complexes fail to reach the downstream promoters. "
      ],
      "type": "summary",
      "id": "5916f14070f9fc6f0f00001f",
      "snippets": [
        {
          "offsetInBeginSection": 220,
          "offsetInEndSection": 446,
          "text": "This element, which we have named pet (positive effector of transcription), exerts its effect in cis in a position and orientation-dependent manner, suggesting that it may function as part of the nascent pregenome transcript. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8107218",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 665,
          "offsetInEndSection": 1174,
          "text": "In the presence of this region, deletion of pet activates transcription from downstream promoters, suggesting that pregenome transcription complexes fail to reach the downstream promoters. In vitro transcription experiments support the model that pet is required for transcription elongation on the DHBV template. We speculate that pet is required to suppress transcription termination during the first passage of pregenome transcription complexes through a viral termination region on the circular viral DNA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8107218",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 133,
          "text": "We report the presence of two elements, pet and net, that are required for proper transcription of the duck hepatitis B virus (DHBV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9311882",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 220,
          "offsetInEndSection": 445,
          "text": "This element, which we have named pet (positive effector of transcription), exerts its effect in cis in a position and orientation-dependent manner, suggesting that it may function as part of the nascent pregenome transcript.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8107218",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 455,
          "offsetInEndSection": 651,
          "text": "We observed that pet was required for pregenome transcription from circular viral monomers, and in the absence of pet-dependent transcription, expression of the viral envelope genes was increased.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9311882",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 446,
          "offsetInEndSection": 664,
          "text": "The requirement for pet depends on the presence in the transcription unit of a region of the DHBV genome located upstream of the envelope promoters, which specifically suppresses transcription of templates lacking pet.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8107218",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 854,
          "offsetInEndSection": 978,
          "text": "In vitro transcription experiments support the model that pet is required for transcription elongation on the DHBV template.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8107218",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "How many genes constitute the DosR regulon, controlled by the dormancy survival regulator (DosR) in Mycobacterium tuberculosis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22833514",
        "http://www.ncbi.nlm.nih.gov/pubmed/17502400",
        "http://www.ncbi.nlm.nih.gov/pubmed/19553548",
        "http://www.ncbi.nlm.nih.gov/pubmed/23651670",
        "http://www.ncbi.nlm.nih.gov/pubmed/18294384",
        "http://www.ncbi.nlm.nih.gov/pubmed/21653552",
        "http://www.ncbi.nlm.nih.gov/pubmed/22759512"
      ],
      "ideal_answer": [
        "The Mycobacterium dormancy survival regulator (DosR) regulon is composed of 48 co-regulated genes.",
        "During this phase, at least 48 genes, collectively named Dormancy survival regulator (DosR) regulon, are important for the long-term survival of bacilli under a non-respiring state, a condition that bacilli encounter inside granulomatous lesions.  DosR/DevR of M. tuberculosis is a two component dormancy survival response regulator which induces the expression of 48 genes. ",
        "During this phase, at least 48 genes, collectively named Dormancy survival regulator (DosR) regulon, are important for the long-term survival of bacilli under a non-respiring state, a condition that bacilli encounter inside granulomatous lesions. The dormancy survival regulator (DosR) regulon, composed of 48 co-regulated genes, is held as essential for Mtb persistence.",
        "The dormancy survival regulator  regulon, composed of 48 co-regulated genes, is held as essential for Mtb persistence. The two component sensor/regulator dosRS is a major mediator in the transcriptional response of M. tuberculosis to hypoxia and controls a regulon of approximately 50 genes that are induced under this condition. ",
        "During this phase, at least 48 genes, collectively named Dormancy survival regulator (DosR) regulon, are important for the long-term survival of bacilli under a non-respiring state, a condition that bacilli encounter inside granulomatous lesions.",
        "The dormancy survival regulator (DosR) regulon, composed of 48 co-regulated genes, is held as essential for Mtb persistence. During this phase, at least 48 genes, collectively named Dormancy survival regulator (DosR) regulon, are important for the long-term survival of bacilli under a non-respiring state, a condition that bacilli encounter inside granulomatous lesions."
      ],
      "exact_answer": [
        "48 genes"
      ],
      "type": "factoid",
      "id": "58edf567eda5a57672000011",
      "snippets": [
        {
          "offsetInBeginSection": 185,
          "offsetInEndSection": 431,
          "text": "During this phase, at least 48 genes, collectively named Dormancy survival regulator (DosR) regulon, are important for the long-term survival of bacilli under a non-respiring state, a condition that bacilli encounter inside granulomatous lesions.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23651670",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 314,
          "offsetInEndSection": 438,
          "text": "The dormancy survival regulator (DosR) regulon, composed of 48 co-regulated genes, is held as essential for Mtb persistence.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22833514",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 99,
          "offsetInEndSection": 227,
          "text": " DosR/DevR of M. tuberculosis is a two component dormancy survival response regulator which induces the expression of 48 genes. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22759512",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 675,
          "offsetInEndSection": 923,
          "text": "The functional importance of tandem arrangement was established by analyzing promoter variants harboring Dev boxes with altered spacing. Conserved sequence logos were generated from 47 binding sequences which included 24 newly discovered Dev boxes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21653552",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 141,
          "offsetInEndSection": 352,
          "text": " The two component sensor/regulator dosRS is a major mediator in the transcriptional response of M. tuberculosis to hypoxia and controls a regulon of approximately 50 genes that are induced under this condition.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18294384",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 564,
          "offsetInEndSection": 720,
          "text": "In silico analysis of the DosR regulon in BCG and M. tuberculosis showed at least 97% amino acid sequence homology, with 41 out of 48 genes being identical.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17502400",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 100,
          "offsetInEndSection": 226,
          "text": "DosR/DevR of M. tuberculosis is a two component dormancy survival response regulator which induces the expression of 48 genes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22759512",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 116,
          "offsetInEndSection": 226,
          "text": "tuberculosis is a two component dormancy survival response regulator which induces the expression of 48 genes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22759512",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which individuals show preferential colonization of the Prevotellaceae bacteria in their guts?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26216344",
        "http://www.ncbi.nlm.nih.gov/pubmed/19567577",
        "http://www.ncbi.nlm.nih.gov/pubmed/19164560",
        "http://www.ncbi.nlm.nih.gov/pubmed/26207384",
        "http://www.ncbi.nlm.nih.gov/pubmed/21408168",
        "http://www.ncbi.nlm.nih.gov/pubmed/25864056",
        "http://www.ncbi.nlm.nih.gov/pubmed/23548695",
        "http://www.ncbi.nlm.nih.gov/pubmed/27570628"
      ],
      "ideal_answer": [
        "Although the distinction of enterotypes as either discrete clusters or a continuum will require additional investigation, numerous studies have demonstrated the co-exclusion of the closely related Prevotellaceae and Bacteroides genera in the gut microbiota of healthy human subjects where Prevotella appears to be a discriminatory taxon for residence in more agrarian societies."
      ],
      "exact_answer": [
        "members of agrarian societies"
      ],
      "type": "factoid",
      "id": "58ee2515eda5a57672000016",
      "snippets": [
        {
          "offsetInBeginSection": 138,
          "offsetInEndSection": 244,
          "text": "a new member of the Prevotellaceae family that was isolated from stool samples from a 45-year-old patient.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27570628",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1070,
          "offsetInEndSection": 1432,
          "text": "Using univariate non-parametric statistics, there were no differences regarding alpha or beta diversity between AH8.1 carriers (categories I and II) and non-carriers (categories III and IV), however four different taxa (Prevotellaceae, Clostridium XVIII, Coprococcus, Enterorhabdus) had nominally significant lower abundances in AH8.1 carriers than non-carriers.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26207384",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 761,
          "offsetInEndSection": 887,
          "text": "The increase in Bacteroidetes was found to be due to an increase in members of the families Bacteroidaceae or Prevotellaceae. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25864056",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 545,
          "offsetInEndSection": 675,
          "text": "Fecal communities clustered into previously described enterotypes distinguished primarily by levels of Bacteroides and Prevotella.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23548695",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 815,
          "offsetInEndSection": 1192,
          "text": "Although the distinction of enterotypes as either discrete clusters or a continuum will require additional investigation, numerous studies have demonstrated the co-exclusion of the closely related Prevotellaceae and Bacteroides genera in the gut microbiota of healthy human subjects where Prevotella appears to be a discriminatory taxon for residence in more agrarian societies",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23548695",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 713,
          "offsetInEndSection": 861,
          "text": "Lachnospiraceae, Ruminococcaceae, Bacteroidaceae, Prevotellaceae, and Rickenellaceae were the predominant families detected in the active microbiota",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21408168",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 629,
          "offsetInEndSection": 918,
          "text": "Specifically, Firmicutes were dominant in normal-weight and obese individuals but significantly decreased in post-gastric-bypass individuals, who had a proportional increase of Gammaproteobacteria. Numbers of the H(2)-producing Prevotellaceae were highly enriched in the obese individuals.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19164560",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 532,
          "offsetInEndSection": 794,
          "text": "A comparative sequence analysis revealed that these two species are members of the family 'Prevotellaceae' but are phylogenetically distant (<88% sequence similarity) from the known genera belonging to this family, including Prevotella, Hallela and Xylanibacter.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19567577",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Do bacteria from the genus Morexella cause respiratory infections?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/8007629",
        "http://www.ncbi.nlm.nih.gov/pubmed/24786571"
      ],
      "ideal_answer": [
        "Bacteria from the genus Morexella can cause respiratory infections"
      ],
      "exact_answer": "yes",
      "concepts": [
        "https://meshb.nlm.nih.gov/record/ui?ui=D001419",
        "https://meshb.nlm.nih.gov/record/ui?ui=D012141",
        "https://meshb.nlm.nih.gov/record/ui?ui=D012818"
      ],
      "type": "yesno",
      "id": "5a679875b750ff4455000004",
      "snippets": [
        {
          "offsetInBeginSection": 746,
          "offsetInEndSection": 918,
          "text": "gainst pathogens associated with respiratory tract ailments [Staphylococcus aureus (ATCC 25923), Klebsiella pneumoniae (ATCC 13883) and Morexella cattarhalis (ATCC 14468)] ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24786571",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 438,
          "text": "The efficacy and safety of oral ofloxacin, 400 mg once daily, for the treatment of patients with lower respiratory tract infections were studied. The most common species recovered from the sputum specimens of these patients were Haemophilus influenzae, followed by Streptococcus pneumoniae (S. pneumoniae), Staphylococcus aureus (S. aureus), Gram positive cocci unidentified, Pseudomonas aeruginosa (P. aeruginosa), Morexella catarrhalis,",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8007629",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 773,
          "text": "the efficacy and safety of oral ofloxacin 400 mg once daily for the treatment of patients with lower respiratory tract infections were studied the most common species recovered from the sputum specimens of these patients were haemophilus influenzae followed by streptococcus pneumoniae s pneumoniae staphylococcus aureus s aureus gram positive cocci unidentified pseudomonas aeruginosa p aeruginosa morexella catarrhalis streptococcus epidermidis and another haemophilus species in this order all these bacteria were susceptible to ofloxacin except for one strain of methicillin resistant s aureus a satisfactory clinical outcome was achieved in 34 of 40 patients 85 it is concluded that ofloxacin 400 mg once daily is useful for patients with respiratory tract infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8007629",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which virus can be diagnosed with the monospot test?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28130396",
        "http://www.ncbi.nlm.nih.gov/pubmed/11369969",
        "http://www.ncbi.nlm.nih.gov/pubmed/1295944",
        "http://www.ncbi.nlm.nih.gov/pubmed/22123662",
        "http://www.ncbi.nlm.nih.gov/pubmed/24650116",
        "http://www.ncbi.nlm.nih.gov/pubmed/21045362",
        "http://www.ncbi.nlm.nih.gov/pubmed/24686796",
        "http://www.ncbi.nlm.nih.gov/pubmed/6270614",
        "http://www.ncbi.nlm.nih.gov/pubmed/21886730",
        "http://www.ncbi.nlm.nih.gov/pubmed/26275628",
        "http://www.ncbi.nlm.nih.gov/pubmed/28761605"
      ],
      "ideal_answer": [
        "Epstein-Barr virus (EBV) can be detected with the monospot test. EBV is a highly prevalent virus, transmitted via saliva, which often causes asymptomatic infection in children but frequently results in infectious mononucleosis in adolescents."
      ],
      "exact_answer": [
        "Epstein-Barr virus"
      ],
      "concepts": [
        "http://amigo.geneontology.org/amigo/term/GO:0009597",
        "https://meshb.nlm.nih.gov/record/ui?ui=D003933",
        "https://meshb.nlm.nih.gov/record/ui?ui=D014780"
      ],
      "type": "factoid",
      "id": "5a690487b750ff445500001f",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 420,
          "text": "Epstein-Barr virus (EBV) is a highly prevalent virus, transmitted via saliva, which often causes asymptomatic infection in children but frequently results in infectious mononucleosis in adolescents. Heterophile antibody tests, including the Monospot test, are red cell or latex agglutination assays, which detect antired cell antibodies produced as part of a polyclonal antibody response occurring during EBV infection. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28130396",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 589,
          "offsetInEndSection": 828,
          "text": "Laboratory investigations revealed that monospot test was positive, EBV serology tests; Anti-EA-D Ig G: 3+, Anti-VCA gp125 Ig G: 3+, Anti-VCA p19 Ig M: 2+, Anti EBNA-1 Ig M: negative, Anti EBNA-1 Ig M: negative, Anti EBNA-1 Ig G: negative.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28761605",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 547,
          "text": "A 75-year-old woman presented with altered mental status, septic picture, and influenza-like symptoms. Initial investigations revealed atypical lymphocytosis, thrombocytopenia, elevated liver enzymes, and a positive monospot test result. Further investigation showed the Epstein-Barr virus viral capsid antibody IgM/IgG and Epstein-Barr virus DNA by polymerase chain reaction to be negative; however, interestingly her cytomegalovirus (CMV) IgM and IgG were positive, suggesting that her mononucleosis-like syndrome was due to acute CMV infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26275628",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 456,
          "offsetInEndSection": 974,
          "text": "Monospot test was positive. He subsequently had both a CT pulmonary angiogram and a CT angiogram of the aorta to exclude pulmonary embolism and aortic dissection. The CT revealed splenomegaly with a large subdiaphragmatic haematoma secondary to splenic rupture. This had likely caused referred pain through diaphragmatic irritation. He was taken to theatre for urgent splenectomy. The unifying diagnosis was infectious mononucleosis complicated by spontaneous splenic rupture secondary to Epstein-Barr virus infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24686796",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 623,
          "text": "BACKGROUND: Infection with Epstein-Barr virus (EBV) is almost ubiquitous in humans and generally occurs at two ages: infantile, which is usually asymptomatic and associated with poorer socioeconomic conditions, and adolescent, which causes infectious mononucleosis (IM) in ~25% cases. The determinants of whether the infection causes IM remain uncertain. We aimed to evaluate seasonality and temporal trends in IM.METHODS: Data from all Monospot tests, used as a marker for IM, were collected from the Grampian population over 16 years.RESULTS: Positive Monospot test results peaked at 17 years in females and 19 in males. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24650116",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 582,
          "offsetInEndSection": 856,
          "text": "The evaluated diagnostic methods were real-time PCR (RT-PCR), IgM/IgG antibodies measured with different assays [measurement of Epstein-Barr virus viral load (EBV-VL) in peripheral blood, neutrophil/lymphocyte/monocyte counts, C-reactive protein values, and monospot test]. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22123662",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 920,
          "offsetInEndSection": 1099,
          "text": "Serological tests for EBV infection were consistent with acute infection (EBV virus capsid antigen was reactive with IgM and IgG antibodies). The Monospot test was also positive. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21045362",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 505,
          "offsetInEndSection": 821,
          "text": "Investigations revealed lymphocytosis and activated atypical lymphocytes in the peripheral smear, and positive monospot test. The boy subsequently recovered in one week with total disappearance of his rash. Epstein-Barr virus-related infectious mononucleosis was considered the most likely diagnosis for our patient.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21886730",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 223,
          "offsetInEndSection": 576,
          "text": "Sera negative for the markers of both viruses: Hepatitis A (HAV) and Hepatitis B (HBV) were subsequently tested for IGM Heterophil antibodies against Epstein-Barr virus (EBV) by the Monospot slide test to diagnose acute infectious mononucleosis and tested for anti-CMV (IgM) by ELISA technique for the diagnosis of acute Cytomegalovirus (CMV) infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1295944",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 262,
          "offsetInEndSection": 391,
          "text": "A serologic test for early antigen (EA) is more specific for diagnosing active EBV disease than the monospot or heterophile test.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6270614",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 243,
          "offsetInEndSection": 355,
          "text": "His septic screen was negative, but he had a positive Monospot test and immunoglobulin G for Epstein-Barr virus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11369969",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 199,
          "offsetInEndSection": 419,
          "text": "Heterophile antibody tests, including the Monospot test, are red cell or latex agglutination assays, which detect antired cell antibodies produced as part of a polyclonal antibody response occurring during EBV infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28130396",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which bacteria causes erythrasma?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/8469500",
        "http://www.ncbi.nlm.nih.gov/pubmed/18558055",
        "http://www.ncbi.nlm.nih.gov/pubmed/16719870",
        "http://www.ncbi.nlm.nih.gov/pubmed/25477907",
        "http://www.ncbi.nlm.nih.gov/pubmed/18937649",
        "http://www.ncbi.nlm.nih.gov/pubmed/12010076",
        "http://www.ncbi.nlm.nih.gov/pubmed/21393451",
        "http://www.ncbi.nlm.nih.gov/pubmed/25815650",
        "http://www.ncbi.nlm.nih.gov/pubmed/9614412",
        "http://www.ncbi.nlm.nih.gov/pubmed/21977942",
        "http://www.ncbi.nlm.nih.gov/pubmed/3965026",
        "http://www.ncbi.nlm.nih.gov/pubmed/6859802"
      ],
      "ideal_answer": [
        "Corynebacterium minutissimum is the bacteria that leads to cutaneous eruptions of erythrasma and is the most common cause of interdigital foot infections."
      ],
      "exact_answer": [
        "Corynebacterium minutissimum"
      ],
      "concepts": [
        "https://meshb.nlm.nih.gov/record/ui?ui=D004894",
        "http://www.disease-ontology.org/api/metadata/DOID:4131",
        "https://meshb.nlm.nih.gov/record/ui?ui=D001419"
      ],
      "type": "factoid",
      "id": "5a68f448b750ff4455000018",
      "snippets": [
        {
          "offsetInBeginSection": 115,
          "offsetInEndSection": 206,
          "text": "Erythrasma caused by Corynebacterium minutissimum can be confused with superficial mycoses.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25477907",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 120,
          "text": "Exogenous coproporphyrin III production by Corynebacterium aurimucosum and Microbacterium oxydans in erythrasma lesions.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21393451",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 89,
          "text": "Erythrasma is a superficial skin disease caused by Gram-positive Corynebacterium species.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21393451",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 159,
          "offsetInEndSection": 387,
          "text": "AIM: To study a series of demographic features of patients suffering from pitted keratolysis, and to present a review of the Corynebacterium-associated infections, including pitted keratolysis, erythrasma, and trichobacteriosis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18937649",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "Corynebacterium minutissimum is the bacteria that leads to cutaneous eruptions of erythrasma and is the most common cause of interdigital foot infections. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12010076",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 215,
          "offsetInEndSection": 333,
          "text": "Bacterial skin infections caused by corynebacteria include erythrasma, trichomycosis axillaris and pitted keratolysis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9614412",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 154,
          "text": "Corynebacterium minutissimum is the bacteria that leads to cutaneous eruptions of erythrasma and is the most common cause of interdigital foot infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12010076",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 403,
          "offsetInEndSection": 473,
          "text": "Corynebacteria causes erythrasma, trichomycosis or pitted keratolysis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6859802",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 94,
          "text": "BACKGROUND Erythrasma is a superficial skin infection caused by Corynebacterium minutissimum .",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25815650",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 1105,
          "text": "skin infections are common and may be caused by bacteria fungi or viruses breaks in the skin integrity particularly those that inoculate pathogens into the dermis frequently cause or exacerbate skin infections bacterial skin infections caused by corynebacteria include erythrasma trichomycosis axillaris and pitted keratolysis staphylococci may cause impetigo ecthyma and folliculitis streptococcal skin infections include impetigo and erysipelas human papillomavirus skin infections present as several different types of warts depending on the surface infected and its relative moisture and the patterns of pressure the many dermatomycoses skin infections caused by fungi or yeasts include tinea capitis tinea barbae tinea cruris tinea manus tinea pedis and tinea unguium onychomycosis candidal infections occur in moist areas such as the vulva mouth penis skinfolds and diaper area wounds caused by wood splinters or thorns may result in sporotrichosis animal bites may result in complex serious infections requiring tetanus and possibly rabies prophylaxis in addition to appropriate antibiotic therapy.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9614412",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 1210,
          "text": "erythrasma is a superficial skin disease caused by gram positive corynebacterium species coral red fluorescence under wood s light strongly suggestive of erythrasma can be attributed to the presence of porphyrins fractionated porphyrin analysis in erythrasma lesions is yet to be reported we attempted to investigate erythrasma lesions by isolating the responsible bacteria and determining their exogenous porphyrin production by hplc analysis we observed a 78 year old woman with erythrasma who had a well demarcated slightly scaling patch on her left foot between the fourth and fifth toes two kinds of colonies on 5 sheep blood agar were obtained from this lesion analysis of the 16s rrna sequence revealed the colonies to be corynebacterium aurimucosum and microbacterium oxydans hplc analysis demonstrated that coproporphyrin iii copro iii levels were clearly elevated although the amounts of protoporphyrin were diminished these results indicate that the fluorescent substance was copro iii this study supports the view that excess copro iii synthesis by c aurimucosum and m oxydans leads to accumulation of porphyrin in cutaneous tissue which emits a coral red fluorescence when exposed to wood s light.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21393451",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 1297,
          "text": "interdigital foot infections are mostly caused initially by dermatophytes yeasts and less frequently by bacteria erythrasma caused by corynebacterium minutissimum can be confused with superficial mycoses the aim of the study was to determine the prevalence of the etiologic agents of superficial mycoses and the frequency of corynebacterium minutissimum in interdigital foot infections all the samples obtained from the 121 patients with interdigital foot infections were examined directly with the use of 20 potassium hydroxide mounts and gram stain under the microscope and cultured on sabouraud s dextrose agar plates in identification of superficial mycoses the rate was found to be 14 with the cultural method and 14 with direct microscopic examination using a combination of direct microscopic examination and culture a 33 8 ratio was achieved in the culture of these samples the most isolated factor was trichophyton rubrum 33 7 in 24 of the patients 19 8 corynebacterium minutissimum was detected by gram staining in 6 of these patients trichophyton rubrum was found trichophyton mentagrophytes was found in 2 and trichosporon spp was found in 1 the examination of interdigital foot lesions in the laboratory the coexistence of erythrasma with dermatophytes and yeast should be considered.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25477907",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 120,
          "text": "exogenous coproporphyrin iii production by corynebacterium aurimucosum and microbacterium oxydans in erythrasma lesions",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21393451",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 2119,
          "text": "corynebacterium minutissimum is the bacteria that leads to cutaneous eruptions of erythrasma and is the most common cause of interdigital foot infections it is found mostly in occluded intertriginous areas such as the axillae inframammary areas interspaces of the toes intergluteal and crural folds and is more common in individuals with diabetes mellitus than other clinical patients this organism can be isolated from a cutaneous site along with a concurrent dermatophyte or candida albicans infection the differential diagnosis of erythrasma includes psoriasis dermatophytosis candidiasis and intertrigo and methods for differentiating include wood s light examination and bacterial and mycological cultures erythromycin 250mg four times daily for 14 days is the treatment of choice and other antibacterials include tetracycline and chloramphenicol however the use of chloramphenicol is limited by bone marrow suppression potentially leading to neutropenia agranulocytosis and aplastic anaemia further studies are needed but clarithromycin may be an additional drug for use in the future where there is therapeutic failure or intertriginous involvement topical solutions such as clindamycin whitfield s ointment sodium fusidate ointment and antibacterial soaps may be required for both treatment and prophylaxis limited studies on the efficacy of these medications exist however systemic erythromycin demonstrates cure rates as high as 100 compared with tetracyclines systemic erythromycin has greater efficacy in patients with involvement of the axillae and groin and similar efficacy for interdigital infections whitfield s ointment has equal efficacy to systemic erythromycin in the axillae and groin but shows greater efficacy in the interdigital areas and is comparable with 2 sodium fusidate ointment for treatment of all areas adverse drug effects and potential drug interactions need to be considered no cost effectiveness data are available but there are limited data on cost related treatment issues a guideline is proposed for the detection evaluation treatment and prophylaxis of this cutaneous eruption.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12010076",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 1382,
          "text": "erythrasma is a superficial skin infection caused by corynebacterium minutissimum interdigital erythrasma is the most common form and is easily confused with tinea pedis the aim of this study was to determine the prevalence of interdigital erythrasma in patients with clinically suspected tinea pedis this study was performed between january 1 2011 and january 31 2012 it included 182 patients who presented with concerns about interdigital lesions all of the patients were examined with a wood s lamp and smears were stained with gram s method direct examination with 20 potassium hydroxide was performed of 182 patients with interdigital lesions 73 40 1 were diagnosed as having erythrasma the mean sd age of the patients with erythrasma was 45 52 10 83 years range 22 70 years most of the patients with erythrasma were women 56 2 the most often clinical finding was desquamation using only wood s lamp examination or gram s staining resulted in 31 42 5 or 14 19 2 positive patients respectively using wood s lamp examination and gram s staining concurrently resulted in 28 positive patients 38 4 interdigital erythrasma is a common condition and can be difficult to differentiate from tinea pedis simple and rapid diagnosis can be made with wood s lamp examination but gram s staining is also a useful method especially in patients with negative wood s lamp examination findings.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25815650",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 795,
          "text": "erythrasma is an uncommon vulvar infection best diagnosed by its fluorescence under the wood lamp this report shows that despite a negative wood lamp examination the diagnosis can be made histologically a 42 year old woman was referred to our clinic with a persistent candidal infection evaluation included a wood lamp examination wet mount and potassium hydroxide test of the affected skin all of which were negative a biopsy of the area demonstrated rods and filamentous organisms in the keratotic layer consistent with a corynebacterium minutissimum infection the patient was diagnosed as having erythrasma and she responded to oral erythromycin persistent vulvar diseases may be caused by erythrasma despite a negative wood lamp examination the diagnosis can be made by biopsy of the lesion.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8469500",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 1613,
          "text": "erythrasma is a skin infection which is caused by corynebacterium minutissimum interdigital erythrasma is the most common form the aim of this study was to detect the frequency and risk factors of interdigital erythrasma in patients with clinically suspected tinea pedis this study was conducted between june and december 2010 and included 122 patients who had interdigital foot lesions all patients were examined using a wood s lamp the smears were stained using gram s method direct examination was performed using 20 potassium hydroxide sabouraud dextrose agar and brain heart infusion agar were used for cultures moreover the demographical characteristics of patients concomitant diseases and clinical findings were also recorded cases that were found to be positive on wood s lamp examination and or gram staining culture were considered as erythrasma the rate of erythrasma was found to be 46 7 the mean age was 43 6 years and the disease was more prevalent in men the most common clinical finding was desquamation mycological examination was found as positive in 40 35 of the patients no growth was observed in bacteriological cultures it was found that using only wood s lamp examination or gram staining resulted in 11 9 and 19 positive patients 15 6 respectively whereas using both wood s lamp examination and gram staining concurrently resulted in 27 positive patients 22 1 interdigital erythrasma is a commonly seen condition and can clinically mimic tinea pedis a wood s lamp is a good diagnostic tool but gram staining particularly in those with a negative wood s lamp result may be a useful method.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21977942",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 1771,
          "text": "erythrasma is a superficial infection caused by corynebacterium minutissimum and affects the major skin folds and the interdigital regions of the feet it is characterized by erythematous brown scaly patches and maceration and exhibits coral red fluorescence under wood light the aim of this study was to determine the frequency of erythrasma in patients with interdigital lesions an open prospective longitudinal observational study was performed in a hospital in mexico city between march and december 2006 all patients with interdigital lesions were examined with a wood lamp and direct examination was performed with 20 potassium hydroxide cultures were done in sabouraud dextrose agar and brain heart infusion agar and smears were analyzed general characteristics and concomitant diseases were recorded we examined 73 patients of whom 24 32 8 were diagnosed with erythrasma based on coral red fluorescence under wood light and identification of corynebacteria by gram staining the disease was more common in women 83 33 and the mean age of the patients was 43 5 years the main clinical findings were scaling and maceration and the fourth interdigital web was the most commonly affected corynebacterium could not be isolated in any of the cases mycology was positive in 15 cases 62 5 and the following microorganisms were isolated candida 16 6 dermatophytes 12 5 and trichosporon 4 1 interdigital erythrasma is a common condition and can be easily confused with interdigital tinea it persists if not treated appropriately rapid diagnosis is easily obtained by examination with a wood lamp while culture is difficult and unnecessary for diagnosis the coexistence of erythrasma with dermatophytes and candida should be considered when the interdigital webs are affected.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18558055",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 1622,
          "text": "erythrasma is a superficial cutaneous infection caused by corynebacterium minutissimum and is characterized by fluorescence under wood s light uv because of the presence of porphyrins these molecules are photosensitizing and we propose to assess efficacy of red light that activates porphyrins photodynamic reaction in treatment of this pathology assessment of effects of photodynamic action of red light for treatment of erythrasma without exogenous photosensitizing molecules thirteen patients with erythrasma were treated by one illumination 80 j cm2 by red light broad band peak at 635 nm without exogenous photosensitizing molecules disappearance or reduction of extent of lesions were observed 2 weeks later if lesions were still present a second irradiation was conducted with the same method preliminary results are presented as a result of red light irradiation we noticed a complete recovery for three patients and in most other cases reduction of extent of lesions mean 29 after one session the treatment was well tolerated we report first cases of photodynamic treatment of erythrasma there are other reports of clinical applications of antimicrobial action of photodynamic therapy in dermatology acne vulgaris leishmaniasis warts etc but there are few applications without addition of exogenous photosensitizing agent the originality and interest of our study is to use spontaneous presence of porphyrins in the lesions this technique seems to be an interesting alternative inexpensive and easy for the treatment of this localized infection but an optimal method is still to be determined to improve efficacy.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16719870",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 700,
          "text": "bacterial skin infections are important to recognize because we have the means to eradicate almost all of them primary skin infections are mainly caused by staphylococci or streptococci staphylococci infections present as furuncles and carbuncles superficial folliculitis impetigo or rarely the scalded skin syndrome streptococcal infections present as impetigo ecthyma erysipelas or cellulitis corynebacteria causes erythrasma trichomycosis or pitted keratolysis gram negative primary skin infections although uncommon may occur bacterial cultures are generally necessary for diagnosis secondary bacterial infections of pre existing wounds burns dermatitic skin or retention cysts are common events.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6859802",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 773,
          "text": "infective embolic retinopathy as a sequela of bacterial endocarditis is described in a 31 year old woman with mitral valve prolapse the infective organism corynebacterium minutissimum has not been previously found to cause ocular or multisystem diseases it is a common mucocutaneous inhabitant which causes erythrasma in our case report both ocular involvement and septicaemia were present the infection was confirmed by positive serial blood cultures mitral valve prolapse was confirmed by echocardiography on clinical examination the retinopathy consisted of white intraretinal lesions which resolved with antibiotic therapy by fluorescein angiography focal areas of hypofluorescence corresponding to the white fundus lesions were present optic disc oedema was also seen.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3965026",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Are organisms in the genus Morexella associated with sepsis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24669633"
      ],
      "ideal_answer": [
        "Moraxella species may cause neonatal sepsis"
      ],
      "exact_answer": "yes",
      "concepts": [
        "https://meshb.nlm.nih.gov/record/ui?ui=D000071074",
        "https://meshb.nlm.nih.gov/record/ui?ui=D018805"
      ],
      "type": "yesno",
      "id": "5a679be1b750ff4455000005",
      "snippets": [
        {
          "offsetInBeginSection": 889,
          "offsetInEndSection": 1390,
          "text": "Out of 130 culture proven cases of neonatal sepsis, gram negative bacteria were found in 71 (54.6%) cases and gram positive bacteria in 59 (45.4%) cases. Staphylococcus aureus was the most common bacteria found in 35 (26.9%) cases followed by Escherichia coli in 30 (23.1%) cases. Acinetobacter species, Staphylococcus epidermidis, Klebseila, Streptococci, Enterobacter cloacae and Morexella species were found in 17 (13.1%), 17 (13.1%), 13 (10%), 7 (5.4%), 6 (4.6%), and 5 (3.8%) cases respectively. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24669633",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Fusarium oxysporum f. sp lycopersici. is a plant pathogen in plants producing what common food?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17022176",
        "http://www.ncbi.nlm.nih.gov/pubmed/26810104",
        "http://www.ncbi.nlm.nih.gov/pubmed/16042017",
        "http://www.ncbi.nlm.nih.gov/pubmed/9237400",
        "http://www.ncbi.nlm.nih.gov/pubmed/18624637",
        "http://www.ncbi.nlm.nih.gov/pubmed/23997634",
        "http://www.ncbi.nlm.nih.gov/pubmed/28549197",
        "http://www.ncbi.nlm.nih.gov/pubmed/24909710",
        "http://www.ncbi.nlm.nih.gov/pubmed/21942452",
        "http://www.ncbi.nlm.nih.gov/pubmed/24561899",
        "http://www.ncbi.nlm.nih.gov/pubmed/21053907",
        "http://www.ncbi.nlm.nih.gov/pubmed/28605157",
        "http://www.ncbi.nlm.nih.gov/pubmed/24313955",
        "http://www.ncbi.nlm.nih.gov/pubmed/18943372",
        "http://www.ncbi.nlm.nih.gov/pubmed/28683401",
        "http://www.ncbi.nlm.nih.gov/pubmed/28323535",
        "http://www.ncbi.nlm.nih.gov/pubmed/17408002"
      ],
      "ideal_answer": [
        "Fusarium oxysporum f. sp lycopersici.produces causes vascular wilt disease in tomatoes.",
        "Fusarium wilt caused by Fusarium oxysporum f. sp lycopersici (Fol) is one of the main diseases affecting tomatoes. "
      ],
      "exact_answer": [
        "Tomato"
      ],
      "type": "factoid",
      "id": "5a8b1264fcd1d6a10c00001d",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 120,
          "text": "The Fusarium wilt caused by Fusarium oxysporum strains is the most devastating disease of cucumber, banana, and tomato. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26810104",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 215,
          "text": "Seventy-four Fusarium oxysporum soil isolates were assayed for known effector genes present in an F. oxysporum f. sp. lycopersici race 3 tomato wilt strain (FOL MN-25) obtained from the same fields in Manatee County",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28323535",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 115,
          "text": "Fusarium wilt caused by Fusarium oxysporum f. sp lycopersici (Fol) is one of the main diseases affecting tomatoes. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28549197",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 192,
          "text": "Fusarium wilt is one of the most prevalent and damaging diseases of tomato. Among various toxins secreted by the Fusarium oxysporum f. sp. lycopersici (causal agent of Fusarium wilt of tomato)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28683401",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 140,
          "text": "In vitro antifugal activity of medicinal plant extract against Fusarium oxysporum f. sp. lycopersici race 3 the causal agent of tomato wilt.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24561899",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 122,
          "text": "Inhibitory Effect of Algal Extracts on Mycelial Growth of the Tomato-Wilt Pathogen, Fusarium oxysporum f. sp. lycopersici.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23997634",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 190,
          "text": "The present study was undertaken to explore the inhibitory effect of cyanobacterial extracts of Nostoc commune FA-103 against the tomato-wilt pathogen, Fusarium oxysporum f. sp. lycopersici.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23997634",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 299,
          "offsetInEndSection": 404,
          "text": " we focused on the tomato (Solanum lycopersicum) and its pathogenic F. oxysporum f. sp. lycopersici (FOL)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24909710",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 186,
          "offsetInEndSection": 253,
          "text": "Fusarium wilt of tomato caused by F. oxysporum f. sp. lycopersici. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17408002",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 88,
          "offsetInEndSection": 182,
          "text": "Fusarium oxysporum f. sp. lycopersici is the causal agent of Fusarium wilt disease in tomato. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24313955",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 15,
          "offsetInEndSection": 77,
          "text": "tomato pathogen Fusarium oxysporum f. sp. radicis-lycopersici ",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17022176",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 39,
          "offsetInEndSection": 100,
          "text": " vascular wilt pathogen Fusarium oxysporum f. sp. lycopersici",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21942452",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 9,
          "offsetInEndSection": 114,
          "text": "Fusarium oxysporum f. sp. radicis-lycopersici, the causal agent of Fusarium crown and root rot of tomato,",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18943372",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 204,
          "text": "The soilborne fungus Fusarium oxysporum f. sp. radicis-lycopersici causes tomato foot and root rot (TFRR), which can be controlled by the addition of the nonpathogenic fungus F. oxysporum Fo47 to the soil",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16042017",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 113,
          "offsetInEndSection": 169,
          "text": "Fusarium oxysporum f. sp lycopersici, a tomato pathogen,",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18624637",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 154,
          "offsetInEndSection": 224,
          "text": "Fusarium oxysporum f. sp. lycopersici, a vascular pathogen of tomato, ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9237400",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 244,
          "text": "The purpose of this work was to gain an insight on the potential role of the phytopathogenic fungus Fusarium oxysporum f. sp. lycopersici in the translocation of metals and metalloids from soil to plant roots in tomato (Lycopersicum esculentum)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21053907",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Can Logic Alignment Free (LAF) be used for bacterial genomes classification?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26664519"
      ],
      "ideal_answer": [
        "Yes. Logic Alignment Free (LAF), a method that combines alignment-free techniques and rule-based classification algorithms can be used in order to assign biological samples to their taxa."
      ],
      "exact_answer": "yes",
      "concepts": [
        "https://meshb.nlm.nih.gov/record/ui?ui=D008128",
        "https://meshb.nlm.nih.gov/record/ui?ui=D016680",
        "https://meshb.nlm.nih.gov/record/ui?ui=D002965"
      ],
      "type": "yesno",
      "id": "5a75f1f383b0d9ea66000006",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 82,
          "text": "LAF: Logic Alignment Free and its application to bacterial genomes classification.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26664519",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 315,
          "offsetInEndSection": 1235,
          "text": "In this paper, we present Logic Alignment Free (LAF), a method that combines alignment-free techniques and rule-based classification algorithms in order to assign biological samples to their taxa. This method searches for a minimal subset of k-mers whose relative frequencies are used to build classification models as disjunctive-normal-form logic formulas (if-then rules). We apply LAF successfully to the classification of bacterial genomes to their corresponding taxonomy. In particular, we succeed in obtaining reliable classification at different taxonomic levels by extracting a handful of rules, each one based on the frequency of just few k-mers. State of the art methods to adjust the frequency of k-mers to the character distribution of the underlying genomes have negligible impact on classification performance, suggesting that the signal of each class is strong and that LAF is effective in identifying it.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26664519",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 315,
          "offsetInEndSection": 511,
          "text": "In this paper, we present Logic Alignment Free (LAF), a method that combines alignment-free techniques and rule-based classification algorithms in order to assign biological samples to their taxa.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26664519",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 83,
          "text": "LAF: Logic Alignment Free and its application to bacterial genomes classification.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26664519",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "Clue cells are characteristics to which causative bacteria of vaginitis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/11025268",
        "http://www.ncbi.nlm.nih.gov/pubmed/18459549",
        "http://www.ncbi.nlm.nih.gov/pubmed/10948822",
        "http://www.ncbi.nlm.nih.gov/pubmed/20006195",
        "http://www.ncbi.nlm.nih.gov/pubmed/11845812",
        "http://www.ncbi.nlm.nih.gov/pubmed/22555524",
        "http://www.ncbi.nlm.nih.gov/pubmed/20949462"
      ],
      "ideal_answer": [
        "Clue cells are characteristic to Gardnerella vaginalis vaginitis (bacterial vaginosis). Depopulation of lactobacilli from the normal vaginal flora and overgrowth of Gardnerella vaginalis and other anaerobic species are the presumed etiology. The diagnosis is confirmed when at least three of the following four findings are present (Amsel's criteria): 1) thin, homogenous discharge, 2) pH greater than 4.5, 3) positive amine test, and 4) presence of clue cell."
      ],
      "exact_answer": [
        "Gardnerella vaginalis"
      ],
      "concepts": [
        "https://meshb.nlm.nih.gov/record/ui?ui=D014627",
        "http://www.disease-ontology.org/api/metadata/DOID:2170"
      ],
      "type": "factoid",
      "id": "5a68f965b750ff445500001a",
      "snippets": [
        {
          "offsetInBeginSection": 921,
          "offsetInEndSection": 1030,
          "text": "Most of these 290 smears contained clue cells (indicating Gardnerella infection) and a lack of lactobacilli. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20949462",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 292,
          "offsetInEndSection": 487,
          "text": "As part of the routine screening process, all smears were screened for the overgrowth of Gardnerella (i.e. smears with an abundance of clue cells) and for the presence of Trichomonas and Candida.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22555524",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 454,
          "offsetInEndSection": 722,
          "text": "Positive criteria for a Gram stain included greater than 10 white blood cells per high-power field, gram-negative intracellular/extracellular diplococci (suggesting N gonorrhoeae), clue cells (suggesting T vaginalis), or direct visualization of T vaginalis organisms. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20006195",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 249,
          "offsetInEndSection": 373,
          "text": "he appraised infectious agents were Coccobacilli, Candida sp, Trichomonas vaginalis, and clue cells (Gardnerella vaginalis).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18459549",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 417,
          "offsetInEndSection": 540,
          "text": "Smears deficient in lactobacilli and positive for clue cells were considered to indicate a diagnosis of bacterial vaginosis",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11845812",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 746,
          "text": "Bacterial vaginosis is the most common cause of vaginitis, affecting over 3 million women in the United States annually. Depopulation of lactobacilli from the normal vaginal flora and overgrowth of Gardnerella vaginalis and other anaerobic species are the presumed etiology. To date, no scientific evidence shows that bacterial vaginosis is a sexually transmitted disease. Malodorous vaginal discharge is the most common symptom. Differential diagnoses include trichomoniasis, moniliasis, and allergic or chemical dermatitis. The diagnosis is confirmed when at least three of the following four findings are present (Amsel's criteria): 1) thin, homogenous discharge, 2) pH greater than 4.5, 3) positive amine test, and 4) presence of clue cells. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11025268",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1010,
          "offsetInEndSection": 1189,
          "text": "Although the presence of clue cells and amine-like odor in KOH test have relationship with Gardnerella vaginalis, these tests could also suggest the presence of these mycoplasmas.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10948822",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is subacute sclerosing panencephalitis caused by the Measles vaccine?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28750182",
        "http://www.ncbi.nlm.nih.gov/pubmed/26765654",
        "http://www.ncbi.nlm.nih.gov/pubmed/28116334",
        "http://www.ncbi.nlm.nih.gov/pubmed/21311432",
        "http://www.ncbi.nlm.nih.gov/pubmed/15464644",
        "http://www.ncbi.nlm.nih.gov/pubmed/26587021",
        "http://www.ncbi.nlm.nih.gov/pubmed/15384893",
        "http://www.ncbi.nlm.nih.gov/pubmed/29062617",
        "http://www.ncbi.nlm.nih.gov/pubmed/23188587",
        "http://www.ncbi.nlm.nih.gov/pubmed/2019970",
        "http://www.ncbi.nlm.nih.gov/pubmed/27777245",
        "http://www.ncbi.nlm.nih.gov/pubmed/25761293",
        "http://www.ncbi.nlm.nih.gov/pubmed/29112137",
        "http://www.ncbi.nlm.nih.gov/pubmed/1468866",
        "http://www.ncbi.nlm.nih.gov/pubmed/6685828",
        "http://www.ncbi.nlm.nih.gov/pubmed/15566859",
        "http://www.ncbi.nlm.nih.gov/pubmed/2807674",
        "http://www.ncbi.nlm.nih.gov/pubmed/15246492",
        "http://www.ncbi.nlm.nih.gov/pubmed/21245918",
        "http://www.ncbi.nlm.nih.gov/pubmed/2774513",
        "http://www.ncbi.nlm.nih.gov/pubmed/6879001",
        "http://www.ncbi.nlm.nih.gov/pubmed/18037676",
        "http://www.ncbi.nlm.nih.gov/pubmed/22408143",
        "http://www.ncbi.nlm.nih.gov/pubmed/15557053",
        "http://www.ncbi.nlm.nih.gov/pubmed/25802788",
        "http://www.ncbi.nlm.nih.gov/pubmed/11545478",
        "http://www.ncbi.nlm.nih.gov/pubmed/28387784",
        "http://www.ncbi.nlm.nih.gov/pubmed/27634625"
      ],
      "ideal_answer": [
        "Subacute sclerosing panencephalitis is caused by the Measles and can be prevented by the measles vaccine.",
        "Subacute sclerosing panencephalitis (SSPE) is a potentially fatal complication of measles. "
      ],
      "exact_answer": "no",
      "concepts": [
        "https://meshb.nlm.nih.gov/record/ui?ui=D008458",
        "http://www.disease-ontology.org/api/metadata/DOID:8970",
        "https://meshb.nlm.nih.gov/record/ui?ui=D013344",
        "https://meshb.nlm.nih.gov/record/ui?ui=D022542",
        "https://meshb.nlm.nih.gov/record/ui?ui=D008457"
      ],
      "type": "yesno",
      "id": "5aa3fa73d6d6b54f79000008",
      "snippets": [
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 103,
          "text": "Subacute sclerosing panencephalitis (SSPE) is a potentially fatal complication of measles. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28116334",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 155,
          "text": "Subacute sclerosing panencephalitis (SSPE) is a fatal complication of measles. We reviewed California cases from 1998-2015 to understand risk f",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28387784",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 79,
          "text": "Subacute sclerosing panencephalitis should be eliminated by measles vaccination",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28750182",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 974,
          "offsetInEndSection": 1102,
          "text": "The mean interval between measles infection and onset of subacute sclerosing panencephalitis was 6.5 years (range = 3-11 years).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15246492",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1231,
          "offsetInEndSection": 1429,
          "text": "Active surveillance of subacute sclerosing panencephalitis for those with measles infection during the 1988 outbreak is necessary to conduct multicenter drug trials for this devastating disease.<br>",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15246492",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1103,
          "offsetInEndSection": 1230,
          "text": "There has been an increasing trend of subacute sclerosing panencephalitis in southern China after the measles outbreak in 1988.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15246492",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 379,
          "offsetInEndSection": 532,
          "text": "The prevalence rate of subacute sclerosing panencephalitis in Hong Kong and Macau in 2002 was 1 per million total population or 5.5 per million children.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15246492",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 580,
          "offsetInEndSection": 825,
          "text": "Because a positive correlation was found between the prevalence of measles and the onset of subacute sclerosing panencephalitis, particularly among children infected at an early age, it is vital to eradicate measles infection by vaccination.<br>",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22408143",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 100,
          "text": "Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2807674",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 179,
          "text": "UNLABELLED Subacute sclerosing panencephalitis (SSPE), in the majority of cases, is caused by the wild measles virus, although there are some reports relating SSPE to vaccination.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15384893",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 159,
          "text": "Subacute sclerosing panencephalitis (SSPE) is a progressive neurodegenerative disease caused by the measles (rubeola) virus and is most often seen in children.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2019970",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 827,
          "offsetInEndSection": 888,
          "text": "There was no indication that measles vaccine can induce SSPE.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6685828",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 183,
          "text": "Subacute Sclerosing Panencephalitis (SSPE), a rare lethal disease of children and young adults due to persistence of measles virus (MeV) in the brain, is caused by wild type (wt) MeV.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26587021",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 162,
          "text": "Subacute sclerosing panencephalitis (SSPE) is a progressive neurological disorder of childhood and early adolescence caused by persistent defective measles virus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21311432",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 156,
          "text": "Subacute sclerosing panencephalitis (SSPE) is a devastating disease of the central nervous system (CNS) caused by persistent mutant measles virus infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25802788",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 164,
          "text": "Subacute sclerosing panencephalitis (SSPE) caused by persistent defective measles virus strains, is a progressive neurological disorder of children and adolescents.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23188587",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 168,
          "text": "Subacute sclerosing panencephalitis (SSPE), in the majority of cases, is caused by the wild measles virus, although there are some reports relating SSPE to vaccination.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15384893",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 154,
          "text": "Measles can persist in the central nervous system and cause subacute sclerosing panencephalitis (SSPE), a progressive disease that is almost always fatal.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6879001",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1117,
          "offsetInEndSection": 1198,
          "text": "However, because of the median 8-year interval between measles and onset of SSPE,",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1468866",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1023,
          "offsetInEndSection": 1261,
          "text": "The prevention of endemic circulation of measles virus in England and Wales through the high coverage achieved with MMR vaccine, together with the measles/rubella vaccination campaign of 1994, has resulted in the near elimination of SSPE.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15557053",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 511,
          "offsetInEndSection": 1276,
          "text": "We applied the polymerase chain reaction (PCR) to detect the measles virus genome in specimens from a 12-year-old boy with SSPE who had received measles vaccine 10 years before and had no history of apparent natural measles. The oligonucleotide primers for PCR were prepared based on the nucleotide sequence of the F and NP genes of the measles virus Edmonston strain.RESULTS: F and NP genes were detected in both the cerebrospinal fluid and peripheral blood lymphocytes. Nucleotide and deduced amino acid sequence analysis of the F gene showed that the patient's virus was different from that of the vaccine strain. Judging from these results, it was likely that the SSPE-associated strain in this case was derived from the wild-type rather than the vaccine strain",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15566859",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 14,
          "offsetInEndSection": 125,
          "text": "subacute sclerosing panencephalitis (SSPE) is a late, rare and usually fatal complication of measles infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21245918",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 130,
          "text": "Subacute sclerosing panencephalitis (SSPE) is a chronic central nervous (CNS) system infection caused by measles virus",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11545478",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1745,
          "offsetInEndSection": 1832,
          "text": " Epidemiological and virological data suggest that measles vaccine does not cause SSPE.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18037676",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 135,
          "text": "Subacute sclerosing panencephalitis, a rare, progressive, fatal central nervous system disease of children, is caused by measles virus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2774513",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 152,
          "text": "Subacute sclerosing panencephalitis is a form of chronic persistent measles encephalitis in childhood which rarely manifests after wild virus infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15464644",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 136,
          "text": "Subacute sclerosing panencephalitis is a fatal infectious disease of childhood caused by persistence of the measles virus in the brain. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27777245",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 144,
          "text": "Subacute sclerosing panencephalitis (SSPE) is a fatal encephalitis manifesting a number of years after a primary measles infection. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25761293",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 88,
          "text": "Subacute sclerosing panencephalitis (SSPE) is a fatal complication of measles infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27634625",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 162,
          "text": "In 2015, the Oregon Health Authority was notified of the death of a boy with subacute sclerosing panencephalitis (SSPE), a rare and fatal complication of measles.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26765654",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 225,
          "text": "Subacute sclerosing panencephalitis (SSPE) is a rare progressive neurological disorder of early adolescence caused by persistent infection of the measles virus, which remains prevalent worldwide despite an effective vaccine. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29112137",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 121,
          "text": "Subacute Sclerosing Panencephalitis (SSPE) is a debilitating disorder associated with the measles infection in childhood.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29062617",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which method is available for whole genome identification of pathogenic regulatory variants in mendelian disease?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27569544"
      ],
      "ideal_answer": [
        "Genomiser"
      ],
      "exact_answer": [
        "Genomiser"
      ],
      "type": "factoid",
      "id": "5a67c497b750ff4455000012",
      "snippets": [
        {
          "offsetInBeginSection": 216,
          "offsetInEndSection": 717,
          "text": "Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases. Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to\u00a0discover variants associated to specific Mendelian disorders.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 718,
          "offsetInEndSection": 927,
          "text": "Overall, Genomiser is able to identify causal regulatory variants as the\u00a0top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 216,
          "offsetInEndSection": 422,
          "text": "Here we present Genomiser, an analysis framework that is able not only to score the relevance of variation in the non-coding genome, but also to associate regulatory variants to specific Mendelian diseases.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 719,
          "offsetInEndSection": 929,
          "text": "Overall, Genomiser is able to identify causal regulatory variants as the\u00a0top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 423,
          "offsetInEndSection": 718,
          "text": "Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to\u00a0discover variants associated to specific Mendelian disorders.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 423,
          "offsetInEndSection": 717,
          "text": "Genomiser scores variants through either existing methods such as CADD or a bespoke machine learning method and combines these with allele frequency, regulatory sequences, chromosomal topological domains, and phenotypic relevance to\u00a0discover variants associated to specific Mendelian disorders.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 718,
          "offsetInEndSection": 928,
          "text": "Overall, Genomiser is able to identify causal regulatory variants as the\u00a0top candidate in 77% of simulated whole genomes, allowing effective detection and discovery of regulatory variants in Mendelian disease.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27569544",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is Citrobacter rodentium pathogenic?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27633986",
        "http://www.ncbi.nlm.nih.gov/pubmed/27624779",
        "http://www.ncbi.nlm.nih.gov/pubmed/27821583",
        "http://www.ncbi.nlm.nih.gov/pubmed/28085133"
      ],
      "ideal_answer": [
        "Yes, the mouse pathogen Citrobacter rodentium, colonize the gut mucosa via attaching and effacing lesion formation and cause diarrheal diseases."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5aa4faaed6d6b54f7900000b",
      "snippets": [
        {
          "offsetInBeginSection": 759,
          "offsetInEndSection": 855,
          "text": "One day after colonization, mice were infected with the colonic pathogen, Citrobacter rodentium.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27633986",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 211,
          "text": "The human pathogen enteropathogenic Escherichia coli (EPEC), as well as the mouse pathogen Citrobacter rodentium, colonize the gut mucosa via attaching and effacing lesion formation and cause diarrheal diseases.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27624779",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1578,
          "offsetInEndSection": 1624,
          "text": "EPEC-like mouse pathogen Citrobacter rodentium",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28085133",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 414,
          "offsetInEndSection": 581,
          "text": "Here, we develop a model that provides that link for the investigation of Citrobacter rodentium infection, a mouse model for enteropathogenic Escherichia coli (EPEC). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27821583",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Gallbladder carriage is a well recognised means of spread of which bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25253258",
        "http://www.ncbi.nlm.nih.gov/pubmed/23732169",
        "http://www.ncbi.nlm.nih.gov/pubmed/24349565",
        "http://www.ncbi.nlm.nih.gov/pubmed/27600501",
        "http://www.ncbi.nlm.nih.gov/pubmed/25065707",
        "http://www.ncbi.nlm.nih.gov/pubmed/27131005"
      ],
      "ideal_answer": [
        "Gallbladder carriage is associated with spread of Salmonella Typhi."
      ],
      "exact_answer": [
        "Salmonella Typhi"
      ],
      "concepts": [
        "https://meshb.nlm.nih.gov/record/ui?ui=D001419",
        "https://meshb.nlm.nih.gov/record/ui?ui=D005704"
      ],
      "type": "factoid",
      "id": "5a7347a02dc08e987e00001b",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 113,
          "text": "Carriage prevalence of Salmonella enterica serotype Typhi in gallbladders of adult autopsy cases from Mozambique.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27131005",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 897,
          "offsetInEndSection": 1008,
          "text": "CONCLUSIONS: We report a high prevalence of S. Typhi in gallbladders among adult autopsy cases from Mozambique.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27131005",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 100,
          "text": "Salmonella Extracellular Matrix Components Influence Biofilm Formation and Gallbladder Colonization.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27600501",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 266,
          "text": "Salmonella enterica serovar Typhi, the causative agent of typhoid fever in humans, forms biofilms encapsulated by an extracellular matrix (ECM). Biofilms facilitate colonization and persistent infection in gallbladders of humans and mouse models of chronic carriage.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27600501",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 73,
          "text": "In vitro modeling of gallbladder-associated Salmonella spp. colonization.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25253258",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 259,
          "text": "The host-pathogen interactions occurring in the gallbladder during Salmonella Typhi colonization contribute to typhoid fever pathogenesis during the acute and chronic stages of disease. The gallbladder is the primary reservoir during chronic typhoid carriage.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25253258",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 82,
          "text": "Salmonella chronic carriage: epidemiology, diagnosis, and gallbladder persistence.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25065707",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 216,
          "offsetInEndSection": 381,
          "text": "Gallbladder carriage has been demonstrated to be mediated by biofilm formation on gallstones and by intracellular persistence in the gallbladder epithelium of mice. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24349565",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 66,
          "text": "Gallbladder epithelium as a niche for chronic Salmonella carriage.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23732169",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 181,
          "offsetInEndSection": 483,
          "text": "This chronic state is highly associated with the presence of gallstones in the gallbladder of infected carriers upon which Salmonella can form robust biofilms. However, we hypothesize that in addition to gallstones, the gallbladder epithelium aids in the establishment/maintenance of chronic carriage. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23732169",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 114,
          "text": "Carriage prevalence of Salmonella enterica serotype Typhi in gallbladders of adult autopsy cases from Mozambique.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27131005",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "What drug cures hepatitis C?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26085900",
        "http://www.ncbi.nlm.nih.gov/pubmed/26209383"
      ],
      "ideal_answer": [
        "Sofosbuvir-based therapy cures hepatitis C virus infection"
      ],
      "exact_answer": [
        "Sofosbuvir based therapy"
      ],
      "concepts": [
        "http://www.disease-ontology.org/api/metadata/DOID:1883",
        "https://meshb.nlm.nih.gov/record/ui?ui=D006526"
      ],
      "type": "factoid",
      "id": "5aa3fb7ad6d6b54f79000009",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 58,
          "text": "Sofosbuvir-based therapy cures hepatitis C virus infection",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26209383",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 128,
          "text": "Sofosbuvir-based therapy cures hepatitis c virus infection after prior treatment failures in a patient with concurrent lymphoma.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26209383",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 430,
          "offsetInEndSection": 548,
          "text": "The emerging archetypal example is the outcry over the cost of sofosbuvir, a drug proved to cure hepatitis C infection",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26085900",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "The Mantoux test detects what latent infection/disease?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28337457",
        "http://www.ncbi.nlm.nih.gov/pubmed/12238571",
        "http://www.ncbi.nlm.nih.gov/pubmed/27187878",
        "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
        "http://www.ncbi.nlm.nih.gov/pubmed/28276801",
        "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
        "http://www.ncbi.nlm.nih.gov/pubmed/11089393",
        "http://www.ncbi.nlm.nih.gov/pubmed/27529924",
        "http://www.ncbi.nlm.nih.gov/pubmed/25401733",
        "http://www.ncbi.nlm.nih.gov/pubmed/21822042"
      ],
      "ideal_answer": [
        "screened for TB infection with a Mantoux tuberculin skin testtuberculin skin test (TST) performed according to the Mantoux method.",
        "screened for TB infection with a Mantoux tuberculin skin test ",
        "The Mantoux tuberculin skin test tests for latent tuberculosis",
        "screened for TB infection with a Mantoux tuberculin skin test. "
      ],
      "exact_answer": [
        "tuberculosis"
      ],
      "concepts": [
        "https://meshb.nlm.nih.gov/record/ui?ui=D055985",
        "https://meshb.nlm.nih.gov/record/ui?ui=D012882",
        "https://meshb.nlm.nih.gov/record/ui?ui=D014374"
      ],
      "type": "factoid",
      "id": "5ab147edfcf4565872000013",
      "snippets": [
        {
          "offsetInBeginSection": 659,
          "offsetInEndSection": 721,
          "text": "screened for TB infection with a Mantoux tuberculin skin test ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28276801",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 447,
          "offsetInEndSection": 606,
          "text": "The present study reports the results of a three-year TB surveillance among HCW in a large teaching hospital in Rome, using TST (by standard Mantoux technique)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28337457",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1447,
          "offsetInEndSection": 1594,
          "text": "Laboratory diagnostic testing of cellular immunity against pathogenic mycobacteria employs the tuberculin skin test (TST, Mantoux tuberculin test) ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27187878",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 421,
          "offsetInEndSection": 491,
          "text": "tuberculin skin test (TST) performed according to the Mantoux method. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25401733",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 273,
          "text": "Diaskintest\u00ae test and Mantoux test with 2TE PPD-L were concurrently carried out in 300 children and adolescents with tuberculosis and followed up in risk groups at a tuberculosis dispensary to determine the sensitivity of the new skin test in active tuberculosis infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27529924",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1545,
          "offsetInEndSection": 1624,
          "text": "Latent tuberculosis treatment was recommended in all Mantoux-positive contacts.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17663901",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 236,
          "offsetInEndSection": 440,
          "text": "The prevalence of tuberculosis infection among hospitalized patients in a pneumological department of an inner-city hospital was evaluated, using the intradermal tuberculin skin test (Mantoux technique). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11089393",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 491,
          "offsetInEndSection": 657,
          "text": "he 100-year-old tuberculin skin test (Mantoux) has been the only available diagnostic test for latent tuberculosis infection, despite its many well-known limitations.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 288,
          "text": "In order to determine the prevalence of latent infection due to Mycobacterium tuberculosis in drug users and to provide centres for drug users with a practical tool for tuberculosis screening, 237 drug users were subjected to the Monotest and, for reference purposes, to the Mantoux test.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12238571",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which bacteria was EcoRI, restriction endonuclease isolated from?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/2996987",
        "http://www.ncbi.nlm.nih.gov/pubmed/6099579",
        "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
        "http://www.ncbi.nlm.nih.gov/pubmed/349563"
      ],
      "ideal_answer": [
        "Among hundreds of restriction endonucleases, the Eco R1 enzyme is the most useful and widely investigated enzyme and was isolated from E. coli RY 13"
      ],
      "exact_answer": [
        "E coli"
      ],
      "concepts": [
        "https://meshb.nlm.nih.gov/record/ui?ui=D015246",
        "http://www.uniprot.org/uniprot/T2E1_ECOLX",
        "https://meshb.nlm.nih.gov/record/ui?ui=D015280",
        "https://meshb.nlm.nih.gov/record/ui?ui=D004262",
        "http://www.uniprot.org/uniprot/MTE1_ECOLX"
      ],
      "type": "factoid",
      "id": "5abd5a62fcf4565872000031",
      "snippets": [
        {
          "offsetInBeginSection": 91,
          "offsetInEndSection": 281,
          "text": ". Among hundreds of restriction endonucleases, the Eco R1 enzyme is the most useful and widely investigated enzyme. After sonication and ultracentrifugation, crude extracts of E. coli RY 13 ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6099579",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 94,
          "text": "An endonuclease having EcoRI specificity is produced by bacteria containing the ColE1 plasmid.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 95,
          "offsetInEndSection": 379,
          "text": "Such bacterial cells fail to express restriction or modification functions in vivo, and phage or plasmid DNA obtained from ColE1-containing cells has unmodified EcoRI sites that are cleaved in vitro by purified EcoRI endonuclease or by enzyme extracted from bacteria that carry ColE1.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 122,
          "text": "[Characteristics of RecA-independent recombination of plasmids in E. coli cells producing restriction endonuclease EcoRI].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 386,
          "offsetInEndSection": 641,
          "text": " The purification of the EcoRI restriction enzyme from a strain of Escherichia coli that over-produces this enzyme was hampered by the insolubility of the protein, and hence the purification procedure was modified to optimize the recovery of active enzyme",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2996987",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which are the two main bacterial phyla in human gut?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28293225",
        "http://www.ncbi.nlm.nih.gov/pubmed/27900395"
      ],
      "ideal_answer": [
        "Out of thousands of bacterial species-level phylotypes inhabiting the human gut, the majority belong to two dominant phyla, the Bacteroidetes and Firmicutes"
      ],
      "exact_answer": [
        "Bacteroidetes and Firmicutes"
      ],
      "type": "factoid",
      "id": "5abd2ce0fcf456587200002a",
      "snippets": [
        {
          "offsetInBeginSection": 147,
          "offsetInEndSection": 303,
          "text": "Out of thousands of bacterial species-level phylotypes inhabiting the human gut, the majority belong to two dominant phyla, the Bacteroidetes and Firmicutes",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27900395",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 223,
          "offsetInEndSection": 366,
          "text": "the prevalence of some representative viable bacteria from the four dominant phyla (Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria) ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28293225",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/16432264",
        "http://www.ncbi.nlm.nih.gov/pubmed/20834094"
      ],
      "ideal_answer": [
        "Etravirine is an effective and well-tolerated recently approved non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV type-1-infected patients with previous antiretroviral treatment experience.  Etravirine is a weak inducer of cytochrome P450 (CYP)3A",
        "Four CYP3A inducers were used: rifampicin, rifabutin, carbamazepine, and efavirenz Etravirine is an effective and well-tolerated recently approved non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV type-1-infected patients with previous antiretroviral treatment experience."
      ],
      "exact_answer": [
        "HIV"
      ],
      "concepts": [
        "https://meshb.nlm.nih.gov/record/ui?ui=D014780"
      ],
      "type": "factoid",
      "id": "5ab2cc66fcf4565872000015",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 451,
          "text": "Etravirine is an effective and well-tolerated recently approved non-nucleoside reverse transcriptase inhibitor (NNRTI) for HIV type-1-infected patients with previous antiretroviral treatment experience. Considering the importance of combining antiretrovirals for their optimal use in treating HIV, a number of drug-drug interactions with etravirine and other antiretrovirals have been evaluated. Etravirine is a weak inducer of cytochrome P450 (CYP)3A",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20834094",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 445,
          "offsetInEndSection": 643,
          "text": "oreover, medications prescribed to HIV-positive patients may also be CYP3A inhibitors and inducers: Tipranavir, in the absence of ritonavir, is a CYP3A inducer, and ritonavir is a CYP3A inhibitor. F",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16432264",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is the origin of human breast milk bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25398740"
      ],
      "ideal_answer": [
        "It is believed that certain bacteria from the maternal gastrointestinal tract could translocate through a mechanism involving mononuclear immune cells, migrate to the mammary glands via an endogenous cellular route (the bacterial entero-mammary pathway), and subsequently colonize the gastrointestinal tract of the breast-fed neonate"
      ],
      "exact_answer": [
        "Bacterial endero-mammary pathway"
      ],
      "type": "factoid",
      "id": "5be44ed3133db5eb78000016",
      "snippets": [
        {
          "offsetInBeginSection": 183,
          "offsetInEndSection": 575,
          "text": "In the past years, results provided by different research groups suggest that certain bacteria from the maternal gastrointestinal tract could translocate through a mechanism involving mononuclear immune cells, migrate to the mammary glands via an endogenous cellular route (the bacterial entero-mammary pathway), and subsequently colonize the gastrointestinal tract of the breast-fed neonate.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25398740",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which species is the carrier of the SFTS ( severe fever with thrombocytopenia syndrome) virus?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26957392",
        "http://www.ncbi.nlm.nih.gov/pubmed/24793967",
        "http://www.ncbi.nlm.nih.gov/pubmed/29665796",
        "http://www.ncbi.nlm.nih.gov/pubmed/25711611",
        "http://www.ncbi.nlm.nih.gov/pubmed/27495089"
      ],
      "ideal_answer": [
        "The possibility that SFTSV transmission may occur by both the transstadial and transovarial routes was suggested by the fact that viral RNA was detected in Haemaphysalis longicornis at all developmental stages. Tick-derived sequences shared over 95.6% identity with human- and animal-derived isolates. This study provides evidence that implicates ticks as not only vectors but also, reservoirs of SFTSV.",
        "Seroprevalence in animal species were: goats (66.8%), cattle (28.2%), dogs (7.4%), pigs (4.7%), chickens (1.2%), geese (1.7%), rodents (4.4%) and hedgehogs (2.7%). The possibility that SFTSV transmission may occur by both the transstadial and transovarial routes was suggested by the fact that viral RNA was detected in H. longicornis at all developmental stages. Tick-derived sequences shared over 95.6% identity with human- and animal-derived isolates.",
        "The possibility that SFTSV transmission may occur by both the transstadial and transovarial routes was suggested by the fact that viral RNA was detected in H. longicornis at all developmental stages. Severe fever with thrombocytopenia syndrome (SFTS) is a new emerging zoonosis."
      ],
      "exact_answer": [
        "Haemaphysalis longicornis"
      ],
      "type": "factoid",
      "id": "5ad83cd6133db5eb78000010",
      "snippets": [
        {
          "offsetInBeginSection": 1161,
          "offsetInEndSection": 1324,
          "text": "Seroprevalence in animal species were: goats (66.8%), cattle (28.2%), dogs (7.4%), pigs (4.7%), chickens (1.2%), geese (1.7%), rodents (4.4%) and hedgehogs (2.7%).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24793967",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 764,
          "offsetInEndSection": 1156,
          "text": "The possibility that SFTSV transmission may occur by both the transstadial and transovarial routes was suggested by the fact that viral RNA was detected in H. longicornis at all developmental stages. Tick-derived sequences shared over 95.6% identity with human- and animal-derived isolates. This study provides evidence that implicates ticks as not only vectors but also, reservoirs of SFTSV.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25711611",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 90,
          "text": "Severe fever with thrombocytopenia syndrome (SFTS) is a new emerging zoonosis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27495089",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 258,
          "text": "A survey of reptile-associated ticks and their infection status with severe fever with thrombocytopenia syndrome (SFTS) virus was conducted to determine the relative abundance and distribution among lizards, skinks, and snakes in the Republic of Korea (ROK).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26957392",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 390,
          "offsetInEndSection": 526,
          "text": "In total, 84 ixodid ticks belonging to two genera (Ixodes and Amblyomma) were collected from 28/132 (21.2%) lizards, skinks, and snakes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26957392",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1696,
          "offsetInEndSection": 1772,
          "text": "These results implicate lizards and snakes as potential hosts of SFTS virus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26957392",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 105,
          "offsetInEndSection": 230,
          "text": "Haemophysalis longicornis ticks have been considered the vector of severe fever with thrombocytopenia syndrome virus (SFTSV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29665796",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 718,
          "offsetInEndSection": 927,
          "text": "The patient gradually recovered with treatments of corticosteroids and immunoglobulin.<br><b>CONCLUSION</b>: These findings provide further evidence of SFTS viral transmission from H. longicornis to human.<br>",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29665796",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which bacteria are enriched in the gut microbiome of infants following exposure to fury pets?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28381231"
      ],
      "ideal_answer": [
        "Pre- and postnatal pet exposure enriched the abundance of Oscillospira and/or Ruminococcus in infants."
      ],
      "exact_answer": [
        [
          "Oscillospira"
        ],
        [
          "Ruminococcus"
        ]
      ],
      "type": "list",
      "id": "5be47df8133db5eb78000019",
      "snippets": [
        {
          "offsetInBeginSection": 1315,
          "offsetInEndSection": 1522,
          "text": "As a common effect in all birth scenarios, pre- and postnatal pet exposure enriched the abundance of Oscillospira and/or Ruminococcus (P\u2009<\u20090.05) with more than a twofold greater likelihood of high abundance.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28381231",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2111,
          "offsetInEndSection": 2359,
          "text": "The impact of pet ownership varies under different birth scenarios; however, in common, exposure to pets increased the abundance of two bacteria, Ruminococcus and Oscillospira, which have been negatively associated with childhood atopy and obesity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28381231",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is Baloxavir effective for influenza?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30395523",
        "http://www.ncbi.nlm.nih.gov/pubmed/30316915",
        "http://www.ncbi.nlm.nih.gov/pubmed/29623652",
        "http://www.ncbi.nlm.nih.gov/pubmed/30184455",
        "http://www.ncbi.nlm.nih.gov/pubmed/30476172",
        "http://www.ncbi.nlm.nih.gov/pubmed/30396860",
        "http://www.ncbi.nlm.nih.gov/pubmed/30203386",
        "http://www.ncbi.nlm.nih.gov/pubmed/29941893"
      ],
      "ideal_answer": [
        "Yes. Baloxavir is approved for influenza A or B virus infections."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5c58a74e86df2b917400000d",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 358,
          "text": "Baloxavir marboxil (Xofluza\u2122; baloxavir) is an oral cap-dependent endonuclease inhibitor that has been developed by Roche and Shionogi. The drug blocks influenza virus proliferation by inhibiting the initiation of mRNA synthesis. In February 2018, baloxavir received its first global approval in Japan for the treatment of influenza A or B virus infections. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29623652",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 448,
          "offsetInEndSection": 595,
          "text": "This article summarized the milestones in the development of baloxavir leading to this first global approval for influenza A or B virus infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29623652",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 200,
          "text": "Baloxavir acid (BXA), derived from the prodrug baloxavir marboxil (BXM), potently and selectively inhibits the cap-dependent endonuclease within the polymerase PA subunit of influenza A and B viruses.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29941893",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 117,
          "text": "Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29941893",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 73,
          "text": "Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30184455",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 248,
          "text": "BACKGROUND: Baloxavir marboxil is a selective inhibitor of influenza cap-dependent endonuclease. It has shown therapeutic activity in preclinical models of influenza A and B virus infections, including strains resistant to current antiviral agents.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30184455",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1917,
          "offsetInEndSection": 2209,
          "text": "CONCLUSIONS: Single-dose baloxavir was without evident safety concerns, was superior to placebo in alleviating influenza symptoms, and was superior to both oseltamivir and placebo in reducing the viral load 1 day after initiation of the trial regimen in patients with uncomplicated influenza.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30184455",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 321,
          "offsetInEndSection": 469,
          "text": "A single oral dose of baloxavir is usually well tolerated; it hastens alleviation of influenza symptoms and shortens the duration of viral shedding.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30396860",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 69,
          "offsetInEndSection": 156,
          "text": "Japan was the first country to approve baloxavir marboxil as a treatment for influenza.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30396860",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 448,
          "offsetInEndSection": 599,
          "text": "This article summarized the milestones in the development of baloxavir leading to this first global approval for influenza A or B virus infections.<br>",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29623652",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 230,
          "offsetInEndSection": 357,
          "text": "In February 2018, baloxavir received its first global approval in Japan for the treatment of influenza A or B virus infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29623652",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What does gepotidacin do to bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28483959"
      ],
      "ideal_answer": [
        "Gepotidacin inhibits bacterial DNA replication."
      ],
      "exact_answer": [
        "Inhibits bacterial DNA replication"
      ],
      "type": "factoid",
      "id": "5c011448133db5eb78000027",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 185,
          "text": "Gepotidacin is a first-in-class, novel triazaacenaphthylene antibiotic that inhibits bacterial DNA replication and hasin vitroactivity against susceptible and drug-resistant pathogens. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28483959",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is Tecovirimat effective for smallpox?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20393639",
        "http://www.ncbi.nlm.nih.gov/pubmed/25480757",
        "http://www.ncbi.nlm.nih.gov/pubmed/23530860",
        "http://www.ncbi.nlm.nih.gov/pubmed/30120738",
        "http://www.ncbi.nlm.nih.gov/pubmed/24100494",
        "http://www.ncbi.nlm.nih.gov/pubmed/29773767",
        "http://www.ncbi.nlm.nih.gov/pubmed/25896687",
        "http://www.ncbi.nlm.nih.gov/pubmed/29982575",
        "http://www.ncbi.nlm.nih.gov/pubmed/29972742"
      ],
      "ideal_answer": [
        "Yes, tecovirimat FDA approved for treatment of smallpox."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5c58923c86df2b9174000005",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 47,
          "text": "Oral Tecovirimat for the Treatment of Smallpox.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29972742",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 2001,
          "offsetInEndSection": 2206,
          "text": "CONCLUSIONS: On the basis of its efficacy in two animal models and pharmacokinetic and safety data in humans, tecovirimat is being advanced as a therapy for smallpox in accordance with the FDA Animal Rule.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29972742",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "Background: Tecovirimat (ST-246) is being developed as an antiviral therapeutic for smallpox for use in the event of an accidental or intentional release. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29982575",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1065,
          "offsetInEndSection": 1384,
          "text": "Conclusions: Tecovirimat treatment initiated up to 8 days following a lethal aerosol MPXV challenge improves survival and, when initiated earlier than 5 days after challenge, provides protection from clinical effects of disease, supporting the conclusion that it is a promising smallpox antiviral therapeutic candidate.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29982575",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 35,
          "text": "Tecovirimat: First Global Approval.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30120738",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 444,
          "offsetInEndSection": 618,
          "text": "In July 2018, oral tecovirimat was approved in the USA for the treatment of human smallpox disease caused by variola virus in adults and paediatric patients weighing \u2265\u00a013\u00a0kg.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30120738",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 756,
          "offsetInEndSection": 873,
          "text": "An intravenous formulation of tecovirimat is undergoing phase I development for the treatment of smallpox infection. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30120738",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 692,
          "offsetInEndSection": 1084,
          "text": "Brincidofovir, an oral antiviral in late stage development, has proven effective against orthopoxviruses in vitro and in vivo, has a different mechanism of action from tecovirimat (the only oral smallpox antiviral currently in the US Strategic National Stockpile), and has a resistance profile that reduces concerns in the scenario of a bioterror attack using genetically engineered smallpox.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29773767",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 181,
          "text": "Treatment with the smallpox antiviral tecovirimat (ST-246) alone or in combination with ACAM2000 vaccination is effective as a postsymptomatic therapy for monkeypox virus infection.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25896687",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 2035,
          "offsetInEndSection": 2216,
          "text": "Tecovirimat appears to be an effective smallpox therapeutic in nonhuman primates, suggesting that it is reasonably likely to provide therapeutic benefit in smallpox-infected humans.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24100494",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is P. gingivalis bacteria found in brain?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28800332",
        "http://www.ncbi.nlm.nih.gov/pubmed/30281647"
      ],
      "ideal_answer": [
        "Yes"
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5c5f2b771a4c55d80b000020",
      "snippets": [
        {
          "offsetInBeginSection": 185,
          "offsetInEndSection": 439,
          "text": "studies using animal model of periodontitis and human post-mortem brain tissues from subjects with AD strongly suggest that a gram-negative periodontal pathogen, Porphyromonas gingivalis (Pg) and/or its product gingipain is/are translocated to the brain.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30281647",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 182,
          "text": "The polymicrobial dysbiotic subgingival biofilm microbes associated with periodontal disease appear to contribute to developing pathologies in distal body sites, including the brain.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28800332",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Does gepotidacin activate bacterial topoisomerase?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26586303"
      ],
      "ideal_answer": [
        "No, gepotidacin is a bacterial topoisomerase inhibitor."
      ],
      "exact_answer": "no",
      "type": "yesno",
      "id": "5c0114ec133db5eb78000028",
      "snippets": [
        {
          "offsetInBeginSection": 3,
          "offsetInEndSection": 116,
          "text": "GSK2140944 is a novel bacterial topoisomerase inhibitor in development for the treatment of bacterial infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26586303",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Are gut proteobacteria associated with inflammatory disease?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26764594",
        "http://www.ncbi.nlm.nih.gov/pubmed/26749064",
        "http://www.ncbi.nlm.nih.gov/pubmed/26574491",
        "http://www.ncbi.nlm.nih.gov/pubmed/24668769",
        "http://www.ncbi.nlm.nih.gov/pubmed/25018784",
        "http://www.ncbi.nlm.nih.gov/pubmed/28842640"
      ],
      "ideal_answer": [
        "The onset of inflammatory bowel disease is associated with enteric proteobacterial infection, yet the mechanistic basis for this association is unclear."
      ],
      "type": "summary",
      "id": "5ad3130c0340b9f05800001d",
      "snippets": [
        {
          "offsetInBeginSection": 642,
          "offsetInEndSection": 751,
          "text": "In the IBD group, Firmicutes, Proteobacteria, Verrucomicrobia, and Fusobacteria were significantly increased,",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28842640",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 940,
          "offsetInEndSection": 1094,
          "text": "Bacterial microbiota in Crohn's disease patients was characterised by a restriction in biodiversity. with an increase of Proteobacteria and Fusobacteria. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26574491",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 147,
          "offsetInEndSection": 299,
          "text": "the onset of inflammatory bowel disease is associated with enteric proteobacterial infection, yet the mechanistic basis for this association is unclear.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26764594",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1109,
          "offsetInEndSection": 1384,
          "text": "Similar to the findings in inflammatory disease states, SSc patients had decreased levels of commensal bacteria, such as Faecalibacterium and Clostridium, and increased levels of pathobiont bacteria, such as Fusobacterium and \u03b3-Proteobacteria, compared with healthy controls.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26749064",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 852,
          "offsetInEndSection": 1074,
          "text": " The colonic and cecal microbiota of healthy mice fed \u03b1-MG but no DSS shifted to an increased abundance of Proteobacteria and decreased abundance of Firmicutes and Bacteroidetes, a profile similar to that found in human UC",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24668769",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 980,
          "offsetInEndSection": 1140,
          "text": "Significant increase in abundance of unusual aerobes and facultative anaerobes, including members from the phylum Proteobacteria (p-\u2009=\u20090.031) was also observed.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25018784",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What are the 3 main bacteria found in human milk?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27940404"
      ],
      "ideal_answer": [
        "Human milk is rich in diverse bacteria, particularly Staphylococcus, Streptococcus and Pseudomonas genera."
      ],
      "exact_answer": [
        [
          "Staphylococcus"
        ],
        [
          "Streptococcus"
        ],
        [
          "Pseudomonas"
        ]
      ],
      "type": "list",
      "id": "5be44d8b133db5eb78000015",
      "snippets": [
        {
          "offsetInBeginSection": 56,
          "offsetInEndSection": 213,
          "text": "Instead, it provides infants a rich source of diverse bacteria, particularly microbes belonging to the Staphylococcus, Streptococcus, and Pseudomonas genera.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940404",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Has Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) been reported to be a plasminogen receptor in pathogenic bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28011643",
        "http://www.ncbi.nlm.nih.gov/pubmed/15039372",
        "http://www.ncbi.nlm.nih.gov/pubmed/17449317",
        "http://www.ncbi.nlm.nih.gov/pubmed/25666684"
      ],
      "ideal_answer": [
        "Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) has been reported to be a plasminogen receptor in many pathogenic bacteria."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5c57031107647bbc4b000014",
      "snippets": [
        {
          "offsetInBeginSection": 177,
          "offsetInEndSection": 508,
          "text": " binding of plasminogen (Plg) to bacterial surfaces, as it has been shown that this interaction contributes to bacterial adhesion to host cells, invasion of host tissues, and evasion of the immune system. Several bacterial proteins are known to serve as receptors for Plg including glyceraldehyde-3-phosphate dehydrogenase (GAPDH),",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28011643",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 379,
          "offsetInEndSection": 556,
          "text": "Moreover, several isoforms of the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and galectin (GAL) were identified in both antigenic extracts as plasminogen-binding proteins.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25666684",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1230,
          "offsetInEndSection": 1339,
          "text": "Purified GAPDH was found to bind human plasminogen and fibrinogen in Far-Western blot and ELISA-based assays.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17449317",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 352,
          "offsetInEndSection": 446,
          "text": "GAPDH exhibits a high affinity for plasmin and a significantly lower affinity for plasminogen.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15039372",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 538,
          "offsetInEndSection": 715,
          "text": "Moreover, several isoforms of the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and galectin (GAL) were identified in both antigenic extracts as plasminogen-binding proteins. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25666684",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Can CPX-351 be used for the treatment of tuberculosis?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29167924"
      ],
      "ideal_answer": [
        "No, CPX-351 is a novel liposomal formulation of cytarabine and daunorubicin which has recently been FDA approved for treatment of acute myeloid leukemia (AML)."
      ],
      "exact_answer": "no",
      "type": "yesno",
      "id": "5c6549e1e842deac67000022",
      "snippets": [
        {
          "offsetInBeginSection": 9,
          "offsetInEndSection": 164,
          "text": "CPX-351 is a novel liposomal formulation of cytarabine and daunorubicin which has recently been FDA approved for treatment of acute myeloid leukemia (AML).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29167924",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Please list symptoms of measles.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26613224",
        "http://www.ncbi.nlm.nih.gov/pubmed/27168928",
        "http://www.ncbi.nlm.nih.gov/pubmed/29310585",
        "http://www.ncbi.nlm.nih.gov/pubmed/15230469"
      ],
      "ideal_answer": [
        "The leading symptoms of the disease are high fever that presents after an incubation period of 9-10 days and the red rash that begins several days after the fever starts. Beyond specific generalized symptoms, measles may have ocular symptoms. The most commonly occuring satellite symptoms are conjunctivitis, coryza and cough."
      ],
      "exact_answer": [
        [
          "red rash on skin"
        ],
        [
          "high fever"
        ],
        [
          "conjunctivitis"
        ],
        [
          "coryza"
        ],
        [
          "cough"
        ]
      ],
      "type": "list",
      "id": "5c53131e7e3cb0e231000012",
      "snippets": [
        {
          "offsetInBeginSection": 375,
          "offsetInEndSection": 484,
          "text": "ever and generalized maculopapular rash, plus \u22651 of the following symptoms: Coryza, conjunctivitis, or cough.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29310585",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 190,
          "text": "Measles is a highly contagious viral infection associated with clinical symptoms such as fever, cough, conjunctivitis, coryza, eruption and increased serum immunoglobulin M (IgM) antibodies.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26613224",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 160,
          "offsetInEndSection": 252,
          "text": "This patient had typical clinical measles infection symptoms: fever, rash, cough and coryza.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15230469",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Where, in what US state, was there a measles outbreak in an Amish community",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28302434",
        "http://www.ncbi.nlm.nih.gov/pubmed/27705270",
        "http://www.ncbi.nlm.nih.gov/pubmed/26103154"
      ],
      "ideal_answer": [
        "The measles outbreak started an Amish community in Ohio"
      ],
      "exact_answer": [
        "Ohio"
      ],
      "type": "factoid",
      "id": "5c5312097e3cb0e231000011",
      "snippets": [
        {
          "offsetInBeginSection": 395,
          "offsetInEndSection": 474,
          "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio, ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28302434",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 180,
          "text": "Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26103154",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1607,
          "offsetInEndSection": 1874,
          "text": "CONCLUSIONS\nThe key epidemiologic features of a measles outbreak in the Amish community in Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community who sought vaccination.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27705270",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 267,
          "text": "Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio pushing the annual cases to the highest national number reported in the last 20 years.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26103154",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 394,
          "offsetInEndSection": 505,
          "text": "Recent outbreaks in Amish communities include a 2014 measles outbreak in Ohio, resulting in 368 cases reported.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28302434",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1607,
          "offsetInEndSection": 1874,
          "text": "CONCLUSIONS The key epidemiologic features of a measles outbreak in the Amish community in Ohio were transmission primarily within households, the small proportion of Amish people affected, and the large number of people in the Amish community who sought vaccination.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27705270",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 359,
          "text": "Modeling Measles Transmission in the North American Amish and Options for Outbreak Response.Measles outbreaks in the United States continue to occur in subpopulations with sufficient numbers of undervaccinated individuals, with a 2014 outbreak in Amish communities in Ohio pushing the annual cases to the highest national number reported in the last 20 years. ",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26103154",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "What is known about the gut bacteria and depression.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28215162",
        "http://www.ncbi.nlm.nih.gov/pubmed/29432299",
        "http://www.ncbi.nlm.nih.gov/pubmed/28455694",
        "http://www.ncbi.nlm.nih.gov/pubmed/29134359"
      ],
      "ideal_answer": [
        "Evidence indicates that major depression is accompanied by increased translocation of gut commensal Gram-negative bacteria (leaky gut) and consequent activation of oxidative and nitrosative (O&NS) pathways.\n\nMajor depressive disorder (MDD) is a highly prevalent and debilitating mental illness, which is associated with disorder of gut microbiota."
      ],
      "type": "summary",
      "id": "5c5f2d5a1a4c55d80b000023",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 207,
          "text": "Evidence indicates that major depression is accompanied by increased translocation of gut commensal Gram-negative bacteria (leaky gut) and consequent activation of oxidative and nitrosative (O&NS)\u00a0pathways. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28455694",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 121,
          "text": "Comparative metaproteomics analysis shows altered fecal microbiota signatures in patients with major depressive disorder.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29432299",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 140,
          "text": "Major depressive disorder (MDD) is a highly prevalent and debilitating mental illness, which is associated with disorder of gut microbiota. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29432299",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "List bacterial families for which delafloxacin has been shown to be effective.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27216072",
        "http://www.ncbi.nlm.nih.gov/pubmed/27458220"
      ],
      "ideal_answer": [
        "Delafloxacin has been shown to be effective against multiple gram-positive and gram-negative bacteria, including Strepotococcus pneumoniae, Haemophilus influenzae, Moraxella atarrhalis, Staphylococcus aureus, Klebsiella pneumoniae and more."
      ],
      "exact_answer": [
        [
          "Streptococcus pneumoniae"
        ],
        [
          "Haemophilus influenzae"
        ],
        [
          "Moraxella catarrhalis"
        ],
        [
          "Staphylococcus aureus"
        ],
        [
          "Klebsiella pneumoniae"
        ]
      ],
      "type": "list",
      "id": "5c0119f3133db5eb7800002b",
      "snippets": [
        {
          "offsetInBeginSection": 135,
          "offsetInEndSection": 440,
          "text": "In this study, 200 Streptococcus pneumoniae (plus 30 levofloxacin-resistant isolates), 200 Haemophilus influenzae, and 100 Moraxella catarrhalis isolates selected primarily from the United States (2014) were tested against delafloxacin and comparator agents. Delafloxacin was the most potent agent tested.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27458220",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2358,
          "offsetInEndSection": 2516,
          "text": "Delafloxacin demonstrated in vitro and in vivo potency against a diverse group of pathogens, including those with phenotypic drug resistance to other classes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27216072",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 117,
          "offsetInEndSection": 322,
          "text": "The goal of the study was to determine the pharmacokinetic/pharmacodynamic (PK/PD) targets in the murine lung infection model for Staphylococcus aureus, Streptococcus pneumoniae, and Klebsiella pneumoniae ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27216072",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "There is no drug available to prevent HIV infection, Pre-exposure prophylaxis (PrEP), yes or no?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26746652",
        "http://www.ncbi.nlm.nih.gov/pubmed/27900502",
        "http://www.ncbi.nlm.nih.gov/pubmed/28370177",
        "http://www.ncbi.nlm.nih.gov/pubmed/21799568",
        "http://www.ncbi.nlm.nih.gov/pubmed/29278542",
        "http://www.ncbi.nlm.nih.gov/pubmed/27177804",
        "http://www.ncbi.nlm.nih.gov/pubmed/28657199",
        "http://www.ncbi.nlm.nih.gov/pubmed/23570850",
        "http://www.ncbi.nlm.nih.gov/pubmed/23972284",
        "http://www.ncbi.nlm.nih.gov/pubmed/25987851"
      ],
      "ideal_answer": [
        "Pre-exposure prophylaxis (PrEP) with the drug combination Truvada can substantially decrease HIV transmission in individuals at risk.",
        "The antiviral agent tenofovir is highly effective for the treatment of HIV and hepatitis B virus infections, and the older prodrug tenofovir disoproxil fumarate (TDF) is also a component of daily preexposure prophylaxis (PrEP) to reduce the risk of HIV infection in high-risk populations."
      ],
      "exact_answer": "no",
      "type": "yesno",
      "id": "5c5f2cef1a4c55d80b000022",
      "snippets": [
        {
          "offsetInBeginSection": 26,
          "offsetInEndSection": 169,
          "text": "pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28657199",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 19,
          "offsetInEndSection": 308,
          "text": "The antiviral agent tenofovir is highly effective for the treatment of HIV and hepatitis B virus infections, and the older prodrug tenofovir disoproxil fumarate (TDF) is also a component of daily preexposure prophylaxis (PrEP) to reduce the risk of HIV infection in high-risk populations. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29278542",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 352,
          "text": "Following US Food and Drugs Administration approval in July 2012 of daily oral tenofovir and emtricitabine for pre-exposure prophylaxis (PrEP) to prevent HIV infection in high-risk individuals in the USA, there has been much controversy about the implementation of this PrEP regimen in other countries throughout the world, and in Europe in particular.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23972284",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 126,
          "text": "Daily oral pre-exposure prophylaxis (PrEP) is the use of antiretroviral drugs by HIV-negative people to prevent HIV infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27900502",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 154,
          "offsetInEndSection": 332,
          "text": "HIV pre-exposure prophylaxis (PrEP) is a new approach that involves the ongoing use of antiretroviral medications by HIV-negative individuals to reduce the risk of HIV infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987851",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1107,
          "offsetInEndSection": 1254,
          "text": "CONCLUSIONS Combined ART + PrEP is likely to prevent more HIV infections than either strategy alone, but with higher prevalence of drug resistance.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23570850",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 151,
          "text": "INTRODUCTION Use of pre-exposure prophylaxis (PrEP) among people who inject drugs (PWID) has been shown to be effective in preventing HIV transmission.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27177804",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 239,
          "text": "Pre-exposure prophylaxis (PrEP) is an experimental approach to HIV prevention and consists of antiretroviral drugs to be taken before potential HIV exposure in order to reduce the risk of HIV infection and continued during periods of risk.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799568",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 131,
          "text": "HIV pre-exposure prophylaxis (PrEP) is the use of one or more antiretroviral medications (in combination) to prevent HIV infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28370177",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 132,
          "offsetInEndSection": 183,
          "text": "The most commonly used PrEP medication (Truvada<br>",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28370177",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 102,
          "text": "The use of antiretrovirals as pre-exposure prophylaxis (PrEP) is highly efficacious in HIV prevention.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26746652",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "RV3-BB vaccine is used for prevention of which viral infection?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26318715",
        "http://www.ncbi.nlm.nih.gov/pubmed/29688121",
        "http://www.ncbi.nlm.nih.gov/pubmed/28059609",
        "http://www.ncbi.nlm.nih.gov/pubmed/30145099",
        "http://www.ncbi.nlm.nih.gov/pubmed/23597719",
        "http://www.ncbi.nlm.nih.gov/pubmed/28481726"
      ],
      "ideal_answer": [
        "The RV3-BB human neonatal rotavirus vaccine aims to provide protection from severe rotavirus disease from birth."
      ],
      "exact_answer": [
        "rotavirus disease"
      ],
      "type": "factoid",
      "id": "5c6e05f37c78d69471000049",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 108,
          "text": "Serological responses to rotavirus NSP2 following administration of RV3-BB human neonatal rotavirus vaccine.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29688121",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 196,
          "offsetInEndSection": 523,
          "text": "Serological responses to rotavirus NSP2 occur following wild-type infection; however, it is unknown if serological responses to NSP2 occur following administration of rotavirus vaccines. The phase IIa immunogenicity trial of RV3-BB provided an opportunity to investigate the serological responses to NSP2 following vaccination.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29688121",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 143,
          "text": "Molecular characterisation of rotavirus strains detected during a clinical trial of the human neonatal rotavirus vaccine (RV3-BB) in Indonesia.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30145099",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 124,
          "text": "BACKGROUND: The RV3-BB human neonatal rotavirus vaccine aims to provide protection from severe rotavirus disease from birth.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30145099",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 111,
          "text": "Rotavirus specific maternal antibodies and immune response to RV3-BB neonatal rotavirus vaccine in New Zealand.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28059609",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 197,
          "offsetInEndSection": 482,
          "text": "This study aimed to investigate the effect of rotavirus specific maternal antibodies on the serum IgA response or stool excretion of vaccine virus after any dose of an oral rotavirus vaccine, RV3-BB, in parallel to a Phase IIa clinical trial conducted at Dunedin Hospital, New Zealand.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28059609",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1319,
          "offsetInEndSection": 1455,
          "text": "RESULTS: Forty infants received 3 doses of RV3-BB rotavirus vaccine and were included in the analysis of the neonatal and infant groups.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28059609",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1886,
          "offsetInEndSection": 2164,
          "text": "CONCLUSIONS: The level of IgA in colostrum or breast milk and level of placental IgG and SNA did not impact on the serum IgA response or stool excretion following 3 doses of RV3-BB Rotavirus Vaccine administered using either a neonatal or infant schedule in New Zealand infants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28059609",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 87,
          "text": "Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28481726",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 113,
          "text": "The RV3-BB human neonatal rotavirus vaccine aims to provide protection from severe rotavirus disease from birth. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28481726",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 164,
          "offsetInEndSection": 269,
          "text": "RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23597719",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 112,
          "text": "The RV3-BB human neonatal rotavirus vaccine aims to provide protection from severe rotavirus disease from birth.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28481726",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 123,
          "text": "BACKGROUND The RV3-BB human neonatal rotavirus vaccine aims to provide protection from severe rotavirus disease from birth.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30145099",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1665,
          "offsetInEndSection": 1769,
          "text": "CONCLUSION A single dose of RV3-BB rotavirus vaccine was well tolerated in adults, children and infants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23597719",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 172,
          "offsetInEndSection": 584,
          "text": "RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.<br><b>METHODS</b>: A single-centre, double-blind, randomised placebo-controlled Phase I study evaluated the safety and tolerability of a single oral dose of the second generation RV3-BB rotavirus vaccine (8.3\u00d710(6)FFU/mL) in 20 adults, 20 children and 20 infants (10 vaccine and 10 placebo per age cohort).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23597719",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1458,
          "offsetInEndSection": 1804,
          "text": "Two infants in the placebo group had serological evidence of a rotavirus infection within the 28-day study period: one demonstrated an IgA and the other an SNA response, with wild-type virus replication detected in another infant.<br><b>CONCLUSION</b>: A single dose of RV3-BB rotavirus vaccine was well tolerated in adults, children and infants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23597719",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2545,
          "offsetInEndSection": 2673,
          "text": "A birth dose strategy of RV3-BB vaccine has the potential to improve the effectiveness and implementation of rotavirus vaccines.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26318715",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 149,
          "offsetInEndSection": 254,
          "text": "RV3-BB rotavirus vaccine has been developed as a rotavirus vaccine candidate for administration at birth.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23597719",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1628,
          "offsetInEndSection": 1721,
          "text": "A single dose of RV3-BB rotavirus vaccine was well tolerated in adults, children and infants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23597719",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Fecal transplantation is used to treat infection with what bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28178876",
        "http://www.ncbi.nlm.nih.gov/pubmed/27999162",
        "http://www.ncbi.nlm.nih.gov/pubmed/27194400",
        "http://www.ncbi.nlm.nih.gov/pubmed/25548572",
        "http://www.ncbi.nlm.nih.gov/pubmed/28125667",
        "http://www.ncbi.nlm.nih.gov/pubmed/29450831",
        "http://www.ncbi.nlm.nih.gov/pubmed/29020255",
        "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
        "http://www.ncbi.nlm.nih.gov/pubmed/29104169",
        "http://www.ncbi.nlm.nih.gov/pubmed/26204547",
        "http://www.ncbi.nlm.nih.gov/pubmed/28195180",
        "http://www.ncbi.nlm.nih.gov/pubmed/29076071",
        "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
        "http://www.ncbi.nlm.nih.gov/pubmed/24939885",
        "http://www.ncbi.nlm.nih.gov/pubmed/26616138",
        "http://www.ncbi.nlm.nih.gov/pubmed/23844515",
        "http://www.ncbi.nlm.nih.gov/pubmed/26901316",
        "http://www.ncbi.nlm.nih.gov/pubmed/24440934",
        "http://www.ncbi.nlm.nih.gov/pubmed/27648772"
      ],
      "ideal_answer": [
        "Fecal microbiota transplantation is used to treat Clostridium difficile infection"
      ],
      "exact_answer": [
        "Clostridium difficile"
      ],
      "type": "factoid",
      "id": "5c71d6d27c78d6947100006a",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 165,
          "text": "Fecal microbiota transplantation is a highly effective intervention for patients suffering from recurrent Clostridium difficile, a common hospital-acquired infection",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28178876",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 113,
          "text": "Mini-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis Following Total Colectomy.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29020255",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 127,
          "text": "We aimed to assess the asymptomatic Clostridium difficile carriage rates following fecal microbiota transplantation",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29104169",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 290,
          "text": "High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria.Fecal microbiota transplantation (FMT) is becoming a more widely used technology for treatment of recurrent Clostridum difficile infection (CDI). ",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 605,
          "offsetInEndSection": 879,
          "text": "Fecal transplantation, the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26616138",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 351,
          "text": "Comparison of Different Strategies for Providing Fecal Microbiota Transplantation to Treat Patients with Recurrent Clostridium difficile Infection in Two English Hospitals: A Review.Fecal microbiota transplant (FMT) has emerged as a highly efficacious treatment for difficult cases of refractory and/or recurrent Clostridium difficile infection (CDI). ",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29450831",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 288,
          "offsetInEndSection": 367,
          "text": "Recently, fecal microbiota transplantation (FMT) has been applied to treat CDI. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29076071",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 291,
          "offsetInEndSection": 495,
          "text": "While previous treatments used fresh fecal slurries as a source of microbiota for FMT, we recently reported the successful use of standardized, partially purified and frozen fecal microbiota to treat CDI. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 152,
          "text": "Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27999162",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1756,
          "offsetInEndSection": 1974,
          "text": "Our results demonstrate that frozen fecal microbiota from a healthy donor can be used to effectively treat recurrent CDI resulting in restoration of the structure of gut microbiota and clearing of Clostridum difficile.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 145,
          "text": "Fecal microbiota transplantation (FMT) is becoming a more widely used technology for treatment of recurrent Clostridum difficile infection (CDI).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1604,
          "offsetInEndSection": 1822,
          "text": "Our results demonstrate that frozen fecal microbiota from a healthy donor can be used to effectively treat recurrent CDI resulting in restoration of the structure of gut microbiota and clearing of Clostridum difficile.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 146,
          "offsetInEndSection": 350,
          "text": "While previous treatments used fresh fecal slurries as a source of microbiota for FMT, we recently reported the successful use of standardized, partially purified and frozen fecal microbiota to treat CDI.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 498,
          "offsetInEndSection": 772,
          "text": "Fecal transplantation, the infusion of donor feces into a recipient's intestinal tract, has been used for decades to treat recurrent Clostridium difficile infection, and case reports document its use in the successful treatment of constipation, diarrhea, and abdominal pain.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26616138",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 971,
          "offsetInEndSection": 1121,
          "text": "Here we present the case of a child with SBS and recurrent, debilitating D-lactic acidosis, which was successfully treated with fecal transplantation.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26616138",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 203,
          "offsetInEndSection": 321,
          "text": "Recently, fecal microbiota transplantation (FMT) has been successfully used to treat recurrent C. difficile infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24939885",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 145,
          "text": "Fecal microbiota transplantation (FMT) has an incomparable efficacy to treat recurrent Clostridium difficile infection, with near 90% of success.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26204547",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1937,
          "offsetInEndSection": 2131,
          "text": "Fecal microbiota transplantation (FMT) has provided a successful treatment method for some patients with recurrent C. difficile infection, but its mechanism and long-term effects remain unknown.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24939885",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 273,
          "offsetInEndSection": 468,
          "text": "Fecal microbiota transplantation (FMT), a highly effective treatment for recurrent Clostridium difficile infection, has emerged as a promising therapy for intestinal MDR bacterial decolonization.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27194400",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 188,
          "text": "OBJECTIVES\nFecal microbiota transplantation (FMT) is increasingly being used for treatment of recurrent Clostridium difficile infection (R-CDI) that cannot be cured with antibiotics alone.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28195180",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 195,
          "text": "BACKGROUND\nFecal microbiota transplantation (FMT) restores a diverse bacterial profile to the gastrointestinal tract and may effectively treat patients with Clostridium difficile infection (CDI).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27648772",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 273,
          "text": "Bacterial communities from subjects treated for recurrent Clostridium difficile infection (rCDI) by fecal microbiota transplantation (FMT), using either heterologous donor stool samples or autologous stool samples, were characterized by Illumina next-generation sequencing.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27999162",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 200,
          "text": "Fecal microbiota transplantation is a compelling treatment for recurrent Clostridium difficile infections, with potential applications against other diseases associated with changes in gut microbiota.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28125667",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 611,
          "offsetInEndSection": 839,
          "text": "Fecal microbiota transplantation (FMT) holds considerable promise as a therapy for recurrent Clostridium difficile infection, but well-designed, randomized-controlled trials and Long-term follow-up registries are stilt required.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23844515",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 191,
          "text": "Fecal microbiota transplantation (FMT) is an effective treatment for recurrent Clostridium difficile infection (CDI) and is considered as a treatment for other gastrointestinal (GI) diseases.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25548572",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 163,
          "offsetInEndSection": 303,
          "text": "BACKGROUND Fecal microbiota microbiota transplantation from a healthy donor into an individual with CD infection (CDI) can resolve symptoms.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24440934",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 586,
          "offsetInEndSection": 816,
          "text": "Fecal microbiota transplantation is relatively simple to perform, well-tolerated, safe and effective in recurrent Clostridium difficile infection with ulcerative pancolitis, as an alternative in case of antibiotic therapy failure.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 147,
          "text": "The use of fecal microbiota transplantation in recurrent Clostridium difficile infection and coexistent inflammatory bowel disease remains unclear.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28506071",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 211,
          "offsetInEndSection": 329,
          "text": "Recently, fecal microbiota transplantation (FMT) has been successfully used to treat recurrent C. difficile infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24939885",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 192,
          "offsetInEndSection": 310,
          "text": "Recently, fecal microbiota transplantation (FMT) has been successfully used to treat recurrent C. difficile infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24939885",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1607,
          "offsetInEndSection": 1825,
          "text": "Our results demonstrate that frozen fecal microbiota from a healthy donor can be used to effectively treat recurrent CDI resulting in restoration of the structure of gut microbiota and clearing of Clostridum difficile.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23333862",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1544,
          "offsetInEndSection": 1678,
          "text": "Fecal transplantation by colonoscopy (or enema, if colonoscopy is unavailable) is cost-effective for treating recurrent CDI in Canada.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26901316",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "When did delafloxacin receive its first approval in the USA for acute bacterial skin and skin structure infections?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28748399"
      ],
      "ideal_answer": [
        "Delafoxacin received approval in the USA for the treatment of acute bacterial skin and skin structure infections in 2017."
      ],
      "exact_answer": [
        "2017"
      ],
      "type": "factoid",
      "id": "5c0117fd133db5eb7800002a",
      "snippets": [
        {
          "offsetInBeginSection": 169,
          "offsetInEndSection": 381,
          "text": "The drug is being investigated or considered as a treatment for various bacterial infections and in June 2017 received approval in the USA for the treatment of acute bacterial skin and skin structure infections. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28748399",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What periodontal disease associated bacteria is also associated with Alzheimer's disease?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22546352",
        "http://www.ncbi.nlm.nih.gov/pubmed/29249963",
        "http://www.ncbi.nlm.nih.gov/pubmed/28294067",
        "http://www.ncbi.nlm.nih.gov/pubmed/29046054"
      ],
      "ideal_answer": [
        "Porphyromonas gingivalis, a keystone pathogen in chronic periodontitis, has been found to associate with remote body organ inflammatory pathologies, including atherosclerosis and Alzheimer's disease (AD).",
        "Among bacteria special attention is focused on spirochetes family and on periodontal pathogens such as Porphyromonas gingivalis or Treponema denticola that could cause chronic periodontitis and possibly contribute to the clinical onset of AD."
      ],
      "exact_answer": [
        "Porphyromonas gingivalis"
      ],
      "type": "factoid",
      "id": "5c53191a7e3cb0e231000016",
      "snippets": [
        {
          "offsetInBeginSection": 1229,
          "offsetInEndSection": 1471,
          "text": "Among bacteria special attention is focused on spirochetes family and on periodontal pathogens such as Porphyromonas gingivalis or Treponema denticola that could cause chronic periodontitis and possibly contribute to the clinical onset of AD.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28294067",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 223,
          "offsetInEndSection": 527,
          "text": " working hypothesis links extrinsic inflammation as a secondary cause of AD. This hypothesis suggests a compromised oral hygiene leads to a dysbiotic oral microbiome whereby Porphyromonas gingivalis, a keystone periodontal pathogen, with its companion species, orchestrates immune subversion in the host.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29249963",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "How does the Cholera toxin enter a cell?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26405107",
        "http://www.ncbi.nlm.nih.gov/pubmed/27914621",
        "http://www.ncbi.nlm.nih.gov/pubmed/26478842"
      ],
      "ideal_answer": [
        "Cholera toxin (CT), which is secreted by V. cholerae, can enter host cells by binding to GM1, a monosialoganglioside widely distributed on the plasma membrane surface of various animal epithelial cells."
      ],
      "exact_answer": [
        "Cholera toxin (CT) can enter host cells by binding to GM1, a monosialoganglioside widely distributed on the plasma membrane surface of various animal epithelial cells."
      ],
      "type": "factoid",
      "id": "5c7813f57c78d694710000b0",
      "snippets": [
        {
          "offsetInBeginSection": 258,
          "offsetInEndSection": 461,
          "text": "Cholera toxin (CT), which is secreted by V. cholerae, can enter host cells by binding to GM1, a monosialoganglioside widely distributed on the plasma membrane surface of various animal epithelial cells. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26405107",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 279,
          "text": "The five B-subunits (CTB5) of the Vibrio cholerae (cholera) toxin can bind to the intestinal cell surface so the entire AB5 toxin can enter the cell. Simultaneous binding can occur on more than one of the monosialotetrahexosylganglioside (GM1) units present on the cell surface. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26478842",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 330,
          "offsetInEndSection": 549,
          "text": "we test the role of glycolipid crosslinking as a raft targeting and ordering mechanism using the well-studied raft marker cholera toxin B pentamer (CTxB) that binds up to five GM1 glycosphingolipids to enter host cells.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27914621",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is the role of CD28 with respect to bacterial superantigen toxins?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24022021",
        "http://www.ncbi.nlm.nih.gov/pubmed/21931534",
        "http://www.ncbi.nlm.nih.gov/pubmed/30404186"
      ],
      "ideal_answer": [
        "CD28 is a direct receptor of bacterial superantigen toxins.",
        "cd28 is a homodimer expressed on t cells that functions as the principal costimulatory ligand in the immune response"
      ],
      "type": "summary",
      "id": "5c72bd967c78d69471000078",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 238,
          "text": "Bacterial superantigens, a diverse family of toxins, induce an inflammatory cytokine storm that can lead to lethal shock. CD28 is a homodimer expressed on T cells that functions as the principal costimulatory ligand in the immune response",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21931534",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1383,
          "offsetInEndSection": 1533,
          "text": "The novel role of CD28 as receptor for a class of microbial pathogens, the superantigen toxins, broadens the scope of pathogen recognition mechanisms.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21931534",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 604,
          "offsetInEndSection": 734,
          "text": "Our finding that CD28 is a direct receptor of superantigen toxins broadens the scope of microbial pathogen recognition mechanisms.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24022021",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 59,
          "text": "CD28: direct and critical receptor for superantigen toxins.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24022021",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 409,
          "offsetInEndSection": 746,
          "text": "The need to protect from superantigen toxins led to our discovery that in addition to the well-known MHC class II and T cell receptors, the principal costimulatory receptor, CD28, and its constitutively expressed coligand, B7-2 (CD86), previously thought to have only costimulatory function, are actually critical superantigen receptors. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30404186",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1052,
          "offsetInEndSection": 1418,
          "text": "Structural analysis showed that when a superantigen binds to the T cell receptor on the T cell and major histocompatibility class II molecule on the antigen-presenting cell, CD28 can be accommodated readily as third superantigen receptor in the quaternary complex, with the CD28 dimer interface oriented towards the \u03b2-strand/hinge/\u03b1-helix domain in the superantigen. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21931534",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 663,
          "offsetInEndSection": 793,
          "text": "Our finding that CD28 is a direct receptor of superantigen toxins broadens the scope of microbial pathogen recognition mechanisms. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24022021",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1519,
          "offsetInEndSection": 1669,
          "text": "The novel role of CD28 as receptor for a class of microbial pathogens, the superantigen toxins, broadens the scope of pathogen recognition mechanisms.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21931534",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 257,
          "text": "Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock.Bacterial superantigens, a diverse family of toxins, induce an inflammatory cytokine storm that can lead to lethal shock. ",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21931534",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 122,
          "offsetInEndSection": 435,
          "text": "CD28 is a homodimer expressed on T cells that functions as the principal costimulatory ligand in the immune response through an interaction with its B7 coligands, yet we show here that to elicit inflammatory cytokine gene expression and toxicity, superantigens must bind directly into the dimer interface of CD28.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21931534",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1283,
          "offsetInEndSection": 1382,
          "text": "Our findings identify the CD28 homodimer interface as a critical receptor target for superantigens.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21931534",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1383,
          "offsetInEndSection": 1537,
          "text": "The novel role of CD28 as receptor for a class of microbial pathogens, the superantigen toxins, broadens the scope of pathogen recognition mechanisms.<br>",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21931534",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What antibiotic is currently used as the standard of care for Clostridium Difficile infection as of 2018",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27601193",
        "http://www.ncbi.nlm.nih.gov/pubmed/28009682"
      ],
      "ideal_answer": [
        "Fidaxomicin has recently been introduced as a new antibiotic that has been shown to significantly reduce the recurrence of this infection. Fidaxomicin is a new antibiotic used to treat Clostridium difficile infection (CDI).",
        "Fidaxomicin has recently been introduced as a new antibiotic that has been shown to significantly reduce the recurrence of this infection.Fidaxomicin is a new antibiotic used to treat Clostridium difficile infection (CDI)",
        "fidaxomicin has recently been introduced as a new antibiotic that has been shown to significantly reduce the recurrence of this infection. fidaxomicin is a new antibiotic used to treat clostridium difficile infection (cdi).",
        "Clostridium difficile continues to be one of the most prevalent hospital-acquired bacterial infections in the developed world, despite the recent introduction of a novel and effective antibiotic agent  fidaxomicin"
      ],
      "exact_answer": [
        "Fidaxomicin"
      ],
      "type": "factoid",
      "id": "5c85234775a4a5d219000007",
      "snippets": [
        {
          "offsetInBeginSection": 156,
          "offsetInEndSection": 295,
          "text": " Fidaxomicin has recently been introduced as a new antibiotic that has been shown to significantly reduce the recurrence of this infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27601193",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 22,
          "offsetInEndSection": 107,
          "text": "Fidaxomicin is a new antibiotic used to treat Clostridium difficile infection (CDI). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28009682",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 69,
          "text": "Outcomes With Fidaxomicin Therapy in Clostridium difficile Infection.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28009682",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "What is the name of the Cas13 based diagnostic test for the Zika and dengue viruses?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29700266"
      ],
      "ideal_answer": [
        "The Cas13-based platform that can detect Zika and dengue viruses is called SHERLOCK (specific high-sensitivity enzymatic reporter unlocking)."
      ],
      "exact_answer": [
        "SHERLOCK (specific high-sensitivity enzymatic reporter unlocking)"
      ],
      "type": "factoid",
      "id": "5c92871decadf2e73f000016",
      "snippets": [
        {
          "offsetInBeginSection": 123,
          "offsetInEndSection": 371,
          "text": "In this study, we demonstrate that the Cas13-based SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) platform can detect Zika virus (ZIKV) and dengue virus (DENV) in patient samples at concentrations as low as 1 copy per microliter.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29700266",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Please list 2 antitoxin antibodies approved by the FDA for reducing the recurrence of Clostridium difficile infection",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28232034",
        "http://www.ncbi.nlm.nih.gov/pubmed/27905086",
        "http://www.ncbi.nlm.nih.gov/pubmed/29760164",
        "http://www.ncbi.nlm.nih.gov/pubmed/28636484",
        "http://www.ncbi.nlm.nih.gov/pubmed/28480750",
        "http://www.ncbi.nlm.nih.gov/pubmed/28865041",
        "http://www.ncbi.nlm.nih.gov/pubmed/29234211",
        "http://www.ncbi.nlm.nih.gov/pubmed/25486992",
        "http://www.ncbi.nlm.nih.gov/pubmed/28730660",
        "http://www.ncbi.nlm.nih.gov/pubmed/27757389"
      ],
      "ideal_answer": [
        "The antitoxin antibodies actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. Bezlotoxumab was recently approved by the FDA for reducing the recurrence of CDI."
      ],
      "exact_answer": [
        [
          "bezlotoxumab"
        ],
        [
          "actoxumab"
        ]
      ],
      "type": "list",
      "id": "5c851c2675a4a5d219000006",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 297,
          "text": "The exotoxins toxin A (TcdA) and toxin B (TcdB) are produced by the bacterial pathogen Clostridium difficile and are responsible for the pathology associated with C. difficile infection (CDI). The antitoxin antibodies actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB, respectively. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28232034",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 297,
          "offsetInEndSection": 378,
          "text": "Bezlotoxumab was recently approved by the FDA for reducing the recurrence of CDI.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28232034",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 164,
          "text": "The Monoclonal Antitoxin Antibodies (Actoxumab-Bezlotoxumab) Treatment Facilitates Normalization of the Gut Microbiota of Mice with Clostridium difficile Infection.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27757389",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 193,
          "offsetInEndSection": 296,
          "text": "The antitoxin antibodies actoxumab and bezlotoxumab bind to and neutralize TcdA and TcdB, respectively.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28232034",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 131,
          "text": "Mechanisms of protection against Clostridium difficile infection by the monoclonal antitoxin antibodies actoxumab and bezlotoxumab.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25486992",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 104,
          "text": "Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28636484",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 118,
          "text": "Bezlotoxumab (Zinplava\u2122) is a human monoclonal antibody against Clostridium difficile toxin B developed by Merck & Co.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27905086",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 212,
          "text": "Bezlotoxumab (Zinplava\u2122) is a fully human monoclonal antibody against Clostridium difficile toxin B indicated for the prevention of C. difficile infection (CDI) recurrence in patients with a high recurrence risk.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28865041",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 122,
          "text": "Bezlotoxumab (Zinplava\u2122) is a human monoclonal antibody against Clostridium difficile toxin B developed by Merck &amp; Co.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27905086",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is Quorum Sensing in bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22825856",
        "http://www.ncbi.nlm.nih.gov/pubmed/29130162",
        "http://www.ncbi.nlm.nih.gov/pubmed/29130160",
        "http://www.ncbi.nlm.nih.gov/pubmed/22269240",
        "http://www.ncbi.nlm.nih.gov/pubmed/15151251",
        "http://www.ncbi.nlm.nih.gov/pubmed/29095463",
        "http://www.ncbi.nlm.nih.gov/pubmed/27634359",
        "http://www.ncbi.nlm.nih.gov/pubmed/23125205",
        "http://www.ncbi.nlm.nih.gov/pubmed/27688408",
        "http://www.ncbi.nlm.nih.gov/pubmed/20819164"
      ],
      "ideal_answer": [
        "In many pathogenic microorganisms, communication systems, collectively termed quorum sensing (QS),",
        "In many pathogenic microorganisms, communication systems, collectively termed quorum sensing (QS), have been observed",
        "In most bacteria, a global level of regulation, termed quorum sensing (QS), exists involving intercellular communication via the production and response to cell density-dependent signal molecules."
      ],
      "type": "summary",
      "id": "5c978924ecadf2e73f000023",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 174,
          "text": "Many Proteobacteria synthesize acyl-homoserine lactone (AHL) molecules for use as signals in cell density-dependent gene regulation known as quorum sensing (QS) and response.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29130162",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 197,
          "text": "In most bacteria, a global level of regulation, termed quorum sensing (QS), exists involving intercellular communication via the production and response to cell density-dependent signal molecules. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29130160",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 358,
          "offsetInEndSection": 596,
          "text": " In many pathogenic microorganisms, communication systems, collectively termed quorum sensing (QS), have been observed to control a number of bacterial behaviours including expression of virulence factors and the development of biofilms. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29095463",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 825,
          "offsetInEndSection": 1049,
          "text": "Bacteria can communicate within their own species (intra-species) but also between species (inter-species), for which they employ an autoinducer-2 quorum sensing system which is called the universal language of the bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27688408",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 217,
          "text": "Quorum sensing is a signaling mechanism through which bacteria modulate a number of cellular functions (genes), including sporulation, biofilm formation, bacteriocin production, virulence responses, as well as others.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15151251",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 218,
          "offsetInEndSection": 395,
          "text": "Quorum sensing is a mechanism of cell-to-cell communication and is mediated by extracellular chemical signals generated by the bacteria when specific cell densities are reached.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15151251",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 117,
          "text": "Quorum sensing is used by a large variety of bacteria to regulate gene expression in a cell-density-dependent manner.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22825856",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 138,
          "text": "BACKGROUND\nQuorum sensing or the bacterial information flow in an orchestrated manner is an essential feature of many pathogenic bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27634359",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 931,
          "offsetInEndSection": 1056,
          "text": "Quorum sensing is the means of communication between these bacteria to regulate a wide range of behavior patterns among them.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22269240",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "Quorum sensing is a process of cell-cell communication that allows bacteria to share information about cell density and adjust gene expression accordingly.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23125205",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 103,
          "text": "Quorum sensing is the phenomenon, whereby bacteria use signal molecules to communicate with each other.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20819164",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 153,
          "text": "The term 'quorum sensing' describes intercellular bacterial communication which regulates bacterial gene expression according to population cell density.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27688408",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Rickettsia felis was described as a human pathogen almost two decades ago, what is it's main arthropod vector?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/19645274",
        "http://www.ncbi.nlm.nih.gov/pubmed/26824189",
        "http://www.ncbi.nlm.nih.gov/pubmed/21722253",
        "http://www.ncbi.nlm.nih.gov/pubmed/24149035",
        "http://www.ncbi.nlm.nih.gov/pubmed/29217417",
        "http://www.ncbi.nlm.nih.gov/pubmed/29079185"
      ],
      "ideal_answer": [
        "Cat fleas (Ctenocephalides felis) carry Rickettsia felis",
        "Cat fleas (Ctenocephalides felis) carrying Rickettsia felis and Bartonella species in Hong Kong.",
        "Cat fleas (Ctenocephalides felis) carrying Rickettsia felis and Bartonella species in Hong Kong"
      ],
      "exact_answer": [
        "Cat fleas (Ctenocephalides felis)"
      ],
      "type": "factoid",
      "id": "5c9791d2ecadf2e73f000026",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 96,
          "text": "Cat fleas (Ctenocephalides felis) carrying Rickettsia felis and Bartonella species in Hong Kong.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29217417",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 231,
          "offsetInEndSection": 358,
          "text": " Morphological examination of 174 fleas from dogs and cats living in Hong Kong revealed only cat fleas (Ctenocephalides felis).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29217417",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 375,
          "offsetInEndSection": 560,
          "text": "The main arthropod reservoir and vector is the cat flea, Ctenocephalides felis, yet more than 20 other species of fleas, ticks, and mites species have been reported to harbour R. felis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24149035",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 207,
          "offsetInEndSection": 437,
          "text": "The cat flea, Ctenocephalides felis, is currently the only known biological vector of R. felis; however, molecular evidence of R. felis in other species of fleas as well as in ticks and mites suggests a variety of arthropod hosts.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19645274",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 451,
          "text": "Rickettsia felis: from a rare disease in the USA to a common cause of fever in sub-Saharan Africa.Rickettsia felis is a spotted fever group rickettsia that has been definitely described in 2002. Within the last 20 years, there have been a growing number of reports implicating R. felis as a human pathogen, parallel to the fast-growing reports of the worldwide detection of R. felis in arthropod hosts, mainly the cat flea Ctenocephalides felis felis. ",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21722253",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 437,
          "offsetInEndSection": 622,
          "text": "The main arthropod reservoir and vector is the cat flea, Ctenocephalides felis, yet more than 20 other species of fleas, ticks, and mites species have been reported to harbour R. felis. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24149035",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 98,
          "offsetInEndSection": 234,
          "text": "Another rickettsia, Rickettsia felis, found in cat fleas, Ctenocephalides felis, has also been implicated as a potential human pathogen.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26824189",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which was the first adeno-associated virus vector gene therapy product approved in the United States?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30089698"
      ],
      "ideal_answer": [
        "The first adeno-associated virus vector gene therapy product in the United States was Luxturna."
      ],
      "exact_answer": [
        "Luxturna"
      ],
      "type": "factoid",
      "id": "5c897555d558e5f232000009",
      "snippets": [
        {
          "offsetInBeginSection": 1755,
          "offsetInEndSection": 2009,
          "text": "Gene therapy utilizing viral vectors has experienced recent success, culminating in U.S. Food and Drug Administration approval of the first adeno-associated virus vector gene therapy product in the United States: Luxturna for inherited retinal dystrophy.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30089698",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is the role of Acyl-Homoserine Lactone  in bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28887424",
        "http://www.ncbi.nlm.nih.gov/pubmed/30352386",
        "http://www.ncbi.nlm.nih.gov/pubmed/27896412",
        "http://www.ncbi.nlm.nih.gov/pubmed/12426339",
        "http://www.ncbi.nlm.nih.gov/pubmed/26989738",
        "http://www.ncbi.nlm.nih.gov/pubmed/29130184",
        "http://www.ncbi.nlm.nih.gov/pubmed/19464950"
      ],
      "ideal_answer": [
        "A number of bacteria use a class of chemical compounds called acyl-homoserine lactones (AHLs) as quorum sensing (QS) signals to coordinate their behavior at the population level, including pathogens like Pseudomonas aeruginosa.",
        "Some bacteria use a class of chemical compounds called acyl-homoserine lactones (AHLs) as quorum sensing (QS) signals to coordinate their behavior at the population level.",
        "tructural analogues of acyl homoserine lactones with Quorum Sensing antagonist activity."
      ],
      "type": "summary",
      "id": "5c979383ecadf2e73f000027",
      "snippets": [
        {
          "offsetInBeginSection": 173,
          "offsetInEndSection": 261,
          "text": "tructural analogues of acyl homoserine lactones with Quorum Sensing antagonist activity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30352386",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 177,
          "text": "A number of bacteria use a class of chemical compounds called acyl-homoserine lactones (AHLs) as quorum sensing (QS) signals to coordinate their behavior at the population level",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29130184",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 164,
          "text": "OBJECTIVE\nBacterial colonization relies on communication between bacteria via so-called \"quorum-sensing molecules\", which include the acyl-homoserine lactone group.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27896412",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 175,
          "text": "BACKGROUND\nN-Acyl homoserine lactone (AHL) is found to be the main component of quorum sensing (QS) in Gram-negative bacteria and plays an important role in biofilm formation.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26989738",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 190,
          "text": "Diverse Gram-negative bacteria communicate with each other by using diffusible N-acyl-homoserine lactone (AHL) signaling molecules to coordinate gene expression with cell population density.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19464950",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 192,
          "text": "The genomes of many bacteria that participate in nitrogen cycling through the process of nitrification contain putative genes associated with acyl-homoserine lactone (AHL) quorum sensing (QS).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28887424",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 75,
          "text": "Many proteobacteria use acyl-homoserine lactones as quorum-sensing signals.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12426339",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 152,
          "text": "Bacterial colonization relies on communication between bacteria via so-called quorum-sensing molecules, which include the acyl-homoserine lactone group.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27896412",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27457797"
      ],
      "ideal_answer": [
        "The Fluzone Intradermal Quadrivalent vaccine contains 9 ug hemagglutinin per strain of the two A-strain viruses and both B-strain lineage viruses (Victoria and Yamagata)."
      ],
      "exact_answer": [
        [
          "strain of A/H1N1"
        ],
        [
          "strain of A/H3N2"
        ],
        [
          "B Victoria lineage"
        ],
        [
          "B Yamagata lineage"
        ]
      ],
      "type": "list",
      "id": "5e7f5b43835f4e4777000014",
      "snippets": [
        {
          "offsetInBeginSection": 322,
          "offsetInEndSection": 569,
          "text": "In advance of the 2015-2016 season, Fluzone Intradermal was replaced with Fluzone Intradermal Quadrivalent vaccine, which contains 9\u00a0\u00b5g hemagglutinin per strain of the two A-strain viruses and both B-strain lineage viruses (Victoria and Yamagata).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27457797",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which bacteria causes rat bite fever?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/9486709",
        "http://www.ncbi.nlm.nih.gov/pubmed/29912693",
        "http://www.ncbi.nlm.nih.gov/pubmed/29644421",
        "http://www.ncbi.nlm.nih.gov/pubmed/18061376",
        "http://www.ncbi.nlm.nih.gov/pubmed/17223620",
        "http://www.ncbi.nlm.nih.gov/pubmed/28322713",
        "http://www.ncbi.nlm.nih.gov/pubmed/20619014",
        "http://www.ncbi.nlm.nih.gov/pubmed/7360458",
        "http://www.ncbi.nlm.nih.gov/pubmed/11064988",
        "http://www.ncbi.nlm.nih.gov/pubmed/21292904",
        "http://www.ncbi.nlm.nih.gov/pubmed/11943086",
        "http://www.ncbi.nlm.nih.gov/pubmed/27809782",
        "http://www.ncbi.nlm.nih.gov/pubmed/7707673"
      ],
      "ideal_answer": [
        "Rat bite fever is caused by Streptobacillus moniliformis. Infection induces typical but not pathognomonic clinical signs, such as local purulent wound infection followed by maculopapular exanthema, myalgia as well as purulent joint infections."
      ],
      "exact_answer": [
        "Streptobacillus moniliformis"
      ],
      "type": "factoid",
      "id": "5e30fa32fbd6abf43b000048",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 226,
          "text": "Rat bite fever due to Streptobacillus moniliformis induces typical but not pathognomonic clinical signs, such as local purulent wound infection followed by maculopapular exanthema, myalgia as well as purulent joint infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29644421",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 96,
          "text": "[Infections after bite wounds : For example rat bite fever due to Streptobacillus moniliformis].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29644421",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 72,
          "text": "Rat-Bite Fever in Human with Streptobacillus notomytis Infection, Japan.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29912693",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 318,
          "text": "We report a case of rat-bite fever in a 94-year-old woman with Streptobacillus notomytis infection. We established an epidemiologic link between exposure to rats and human infection by performing nested PCRs that detected S. notomytis in the intraoral swab specimens obtained from rats captured in the patient's house.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29912693",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 108,
          "text": "Acute Tetraplegia Caused by Rat Bite Fever in Snake Keeper and Transmission of Streptobacillus moniliformis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28322713",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 139,
          "text": "We report acute tetraplegia caused by rat bite fever in a 59-year old man (snake keeper) and transmission of Streptobacillus moniliformis. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28322713",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 252,
          "text": "BACKGROUND: The Leptotrichiaceae are a family of fairly unnoticed bacteria containing both microbiota on mucous membranes as well as significant pathogens such as Streptobacillus moniliformis, the causative organism of streptobacillary rat bite fever. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27809782",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 251,
          "text": "BACKGROUND\n\nThe Leptotrichiaceae are a family of fairly unnoticed bacteria containing both microbiota on mucous membranes as well as significant pathogens such as Streptobacillus moniliformis, the causative organism of streptobacillary rat bite fever.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27809782",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 77,
          "offsetInEndSection": 169,
          "text": "One of the two etiological agents that cause rat bite fever is Streptobacillus moniliformis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18061376",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 84,
          "text": "Rat bite fever is a rare infection typically caused by Streptobacillus moniliformis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11064988",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 48,
          "text": "Rat bite fever and Streptobacillus moniliformis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17223620",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 142,
          "text": "Rat bite fever, caused by Streptobacillus moniliformis, is a systemic illness classically characterized by fever, rigors, and polyarthralgias.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17223620",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 162,
          "text": "Streptobacillus moniliformis is a Gram-negative bacterium found in various laboratory animal species and is the cause of rat bite fever and Haverhill fever in man",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11943086",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 307,
          "offsetInEndSection": 397,
          "text": "The bacterium was identified as Streptobacillus moniliformis , the agent of rat-bite fever",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7360458",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 165,
          "text": "Streptobacillus moniliformis ( Sm) , the causative agent of rat-bite fever and Haverhill fever in man , is also a pathogen in certain laboratory and domestic animals",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7707673",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 239,
          "text": "The Leptotrichiaceae are a family of fairly unnoticed bacteria containing both microbiota on mucous membranes as well as significant pathogens such as Streptobacillus moniliformis , the causative organism of streptobacillary rat bite fever",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27809782",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 227,
          "text": "Rat bite fever due to Streptobacillus moniliformis induces typical but not pathognomonic clinical signs , such as local purulent wound infection followed by maculopapular exanthema , myalgia as well as purulent joint infections",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29644421",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 105,
          "text": "Streptobacillus moniliformis is a fastidious growing Gram-negative bacillus responsible of rat-bite fever",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21292904",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2,
          "offsetInEndSection": 95,
          "text": "Infections after bite wounds : For example rat bite fever due to Streptobacillus moniliformis",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29644421",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 77,
          "offsetInEndSection": 170,
          "text": "One of the two etiological agents that cause rat bite fever is Streptobacillus moniliformis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18061376",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 227,
          "text": "Rat bite fever due to Streptobacillus moniliformis induces typical but not pathognomonic clinical signs, such as local purulent wound infection followed by maculopapular exanthema, myalgia as well as purulent joint infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29644421",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 154,
          "text": "Rat-bite fever is an uncommon bacterial illness resulting from infection with Streptobacillus moniliformis that is often transmitted by the bite of a rat.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9486709",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 193,
          "offsetInEndSection": 348,
          "text": "We determined that he had bacteraemia caused by a Streptobacillus moniliformis infection, which led to the development of an illness called rat bite fever.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20619014",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is there a vaccine for rotavirus?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/9015114",
        "http://www.ncbi.nlm.nih.gov/pubmed/2851185",
        "http://www.ncbi.nlm.nih.gov/pubmed/7707626",
        "http://www.ncbi.nlm.nih.gov/pubmed/22796685",
        "http://www.ncbi.nlm.nih.gov/pubmed/16397431",
        "http://www.ncbi.nlm.nih.gov/pubmed/8920706",
        "http://www.ncbi.nlm.nih.gov/pubmed/24422678",
        "http://www.ncbi.nlm.nih.gov/pubmed/28442435",
        "http://www.ncbi.nlm.nih.gov/pubmed/27443593",
        "http://www.ncbi.nlm.nih.gov/pubmed/19995190",
        "http://www.ncbi.nlm.nih.gov/pubmed/9949951",
        "http://www.ncbi.nlm.nih.gov/pubmed/22702319",
        "http://www.ncbi.nlm.nih.gov/pubmed/22431803",
        "http://www.ncbi.nlm.nih.gov/pubmed/22119590",
        "http://www.ncbi.nlm.nih.gov/pubmed/22423021",
        "http://www.ncbi.nlm.nih.gov/pubmed/26263200",
        "http://www.ncbi.nlm.nih.gov/pubmed/19931717",
        "http://www.ncbi.nlm.nih.gov/pubmed/21504245",
        "http://www.ncbi.nlm.nih.gov/pubmed/8752295",
        "http://www.ncbi.nlm.nih.gov/pubmed/11389295",
        "http://www.ncbi.nlm.nih.gov/pubmed/27522178",
        "http://www.ncbi.nlm.nih.gov/pubmed/25680314",
        "http://www.ncbi.nlm.nih.gov/pubmed/20661105",
        "http://www.ncbi.nlm.nih.gov/pubmed/30046133",
        "http://www.ncbi.nlm.nih.gov/pubmed/28340179",
        "http://www.ncbi.nlm.nih.gov/pubmed/29102168",
        "http://www.ncbi.nlm.nih.gov/pubmed/15502699",
        "http://www.ncbi.nlm.nih.gov/pubmed/31023829",
        "http://www.ncbi.nlm.nih.gov/pubmed/28369477"
      ],
      "ideal_answer": [
        "Effectiveness of rotavirus pentavalent vaccine  rotavirus pentavalent vaccine (RotaTeq(r)) as a sole vaccine",
        "safety and immunogenicity of pentavalent rotavirus vaccine (rv5 )",
        "Yes, there is a vaccine against rotavirus infection that is approved for Europe, Canada and Australia.",
        "Yes, there is a human neonatal rotavirus vaccine against serogroup B Rotavirus.",
        "Yes, there is a 4-component vaccine against capsular rotavirus vaccine.",
        "Effectiveness of rotavirus pentavalent vaccine",
        "Yes, there is a human neonatal rotavirus vaccine.",
        "Yes, there is a pentavalent vaccine for Rotavirus",
        "yes,  rotavirus pentavalent vaccine (RotaTeq(r)) as a sole vaccine",
        "High effectiveness of RotaTeq as the sole rotavirus vaccine in a universal immunization programme was demonstrated in a high-income country.",
        " rotavirus pentavalent vaccine (RotaTeq(r)) as a sole vaccine"
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5e64f1921af46fc130000018",
      "snippets": [
        {
          "offsetInBeginSection": 38,
          "offsetInEndSection": 102,
          "text": "Safety and Immunogenicity of Pentavalent Rotavirus Vaccine (RV5)",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28340179",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 88,
          "text": "This study compares the safety and immunogenicity of pentavalent rotavirus vaccine (RV5)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28340179",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 46,
          "text": "Effectiveness of rotavirus pentavalent vaccine",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28442435",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 22,
          "offsetInEndSection": 81,
          "text": " rotavirus pentavalent vaccine (RotaTeq\u00ae) as a sole vaccine",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28442435",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 285,
          "offsetInEndSection": 375,
          "text": "We describe rotavirus vaccine coverage and missed opportunities for rotavirus vaccination.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31023829",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1877,
          "offsetInEndSection": 2048,
          "text": "CONCLUSIONS\n\nAddressing missed opportunities for rotavirus vaccination is essential to achieving the 80% rotavirus vaccine coverage target outlined by Healthy People 2020.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31023829",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1734,
          "offsetInEndSection": 1875,
          "text": "Complete rotavirus vaccine coverage could be improved to 81% if all missed opportunities within the ACIP-recommended schedule were addressed.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31023829",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1045,
          "offsetInEndSection": 1194,
          "text": "RESULTS\n\nThe national coverage for rotavirus vaccine achieved a year after the introduction was 89% for one dose and 82% for two doses, respectively.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27522178",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1747,
          "offsetInEndSection": 1989,
          "text": "CONCLUSIONS\n\nNorway achieved a high national coverage and excellent adherence with the strict age limits for rotavirus vaccine administration during the first year of introduction, indicating robustness of the national immunisation programme.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27522178",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1563,
          "offsetInEndSection": 1679,
          "text": "Upper age limit recommendations for rotavirus vaccine administration contributed to suboptimal vaccination coverage.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26263200",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 111,
          "text": "Catching-up with pentavalent vaccine: Exploring reasons behind lower rotavirus vaccine coverage in El Salvador.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26263200",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 95,
          "offsetInEndSection": 131,
          "text": "US Rotavirus Vaccine Efficacy Group.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7707626",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 284,
          "offsetInEndSection": 374,
          "text": "We describe rotavirus vaccine coverage and missed opportunities for rotavirus vaccination.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31023829",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 39,
          "text": "Rotavirus vaccines: a story of success.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25680314",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 57,
          "text": "Clinical and immunological studies of rotavirus vaccines.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2851185",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 92,
          "text": "Impact of rotavirus vaccine on rotavirus diarrhoea in countries of East and Southern Africa.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29102168",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1079,
          "offsetInEndSection": 1133,
          "text": "Rotavirus diarrheal episodes were identified by ELISA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8920706",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2032,
          "offsetInEndSection": 2170,
          "text": "The decrease in rotavirus positivity was inversely related to increase in rotavirus vaccine coverage showing impact of rotavirus vaccines.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29102168",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1050,
          "offsetInEndSection": 1169,
          "text": "We described trends in rotavirus positivity among tested stool samples before and after rotavirus vaccine introduction.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29102168",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 150,
          "text": "The RIT 4237 bovine rotavirus vaccine has served as a useful model for rotavirus vaccination, but the vaccine will not be further developed or tested.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2851185",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2156,
          "offsetInEndSection": 2272,
          "text": "Only the RRV vaccine induced a low level of protection against rotavirus diarrhea mainly of serotype G1 specificity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8920706",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2543,
          "offsetInEndSection": 2719,
          "text": "It is recommended that new rotavirus vaccine candidates be developed at cheaper price to speed up the introduction of rotavirus immunization in the developing world in general.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22119590",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 46,
          "text": "Review of rotavirus vaccine trials in Finland.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8752295",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 63,
          "text": "Risk of intussusception after monovalent rotavirus vaccination.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24422678",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 213,
          "offsetInEndSection": 283,
          "text": "Rotavirus vaccines are underused compared with other routine vaccines.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31023829",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 261,
          "text": "With rotavirus vaccines now available globally , it will be useful to assemble the available evidence on the epidemiology and burden of rotavirus gastroenteritis in India , in order to weigh the urgency of introducing a vaccine to help control rotavirus disease",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22796685",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 183,
          "offsetInEndSection": 328,
          "text": "Is there evidence that rotavirus vaccines are effective in preventing acute gastroenteritis complications such as dehydration and hospitalization",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22423021",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1325,
          "offsetInEndSection": 1506,
          "text": "With the introduction of new rotavirus vaccines in sight , rotavirus gastroenteritis may be regarded as the single most frequent vaccine-preventable disease among children in the EU",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16397431",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 374,
          "offsetInEndSection": 658,
          "text": "With the recent introduction of the two rotavirus vaccines , RotaTeq and Rotarix , in many countries , it appears that the total number of hospitalizations due to rotavirus infections is being reduced , at least in developed countries that implemented a universal immunization program",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19995190",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 97,
          "text": "Change in rotavirus epidemiology in northeast Florida after the introduction of rotavirus vaccine",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20661105",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 265,
          "text": "With the recent postlicensure identification of an increased risk of intussusception with rotavirus vaccine , the 14 Latin American countries currently using rotavirus vaccine must now weigh the health benefits versus risks to assess whether to continue vaccination",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22431803",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 49,
          "text": "Impact of rotavirus vaccines on rotavirus disease",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22702319",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 457,
          "offsetInEndSection": 630,
          "text": "With safe and efficacious rotavirus vaccines now on the verge of widespread adoption , researchers can be vital advocates for their uptake into routine immunization programs",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19931717",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 145,
          "text": "Rotavirus vaccine RIX4414 (Rotarix\u2122): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developed countries.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21504245",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 450,
          "offsetInEndSection": 633,
          "text": "In addition, various naturalistic studies have demonstrated 'real-world' effectiveness after the introduction of widespread rotavirus vaccination programmes in the community setting.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21504245",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 238,
          "offsetInEndSection": 450,
          "text": "The monovalent rotavirus vaccine RIX4414 (Rotarix\u2122) is administered as a two-dose oral series in infants and has demonstrated protective efficacy against RVGE in clinical trials conducted in developed countries.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21504245",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 633,
          "offsetInEndSection": 844,
          "text": "Numerous cost-effectiveness analyses have been conducted in developed countries in which a universal rotavirus vaccination programme using RIX4414 was compared with no universal rotavirus vaccination programme.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21504245",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1507,
          "offsetInEndSection": 1716,
          "text": "It is also difficult to draw conclusions regarding the cost effectiveness of rotavirus vaccine RIX4414 relative to that of the pentavalent rotavirus vaccine, which is administered as a three-dose oral series.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21504245",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1716,
          "offsetInEndSection": 1995,
          "text": "Although indirect comparisons in cost-effectiveness analyses indicate that RIX4414 provided more favourable incremental cost-effectiveness ratios when each vaccine was compared with no universal rotavirus vaccination programme, results were generally sensitive to vaccine costs.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21504245",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 81,
          "text": "A rotavirus vaccine for prophylaxis of infants against rotavirus gastroenteritis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15502699",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 138,
          "offsetInEndSection": 307,
          "text": "A live attenuated monovalent rotavirus vaccine (Rotarix) containing human rotavirus strain RIX4414 of G1P1A P[8] specificity is being developed to meet the global need.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15502699",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 814,
          "offsetInEndSection": 985,
          "text": "Rotarix significantly reduced rotavirus gastroenteritis episodes and rotavirus-related hospitalizations in vaccinated infants compared with placebo recipients (P < 0.05).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15502699",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 99,
          "offsetInEndSection": 364,
          "text": "We describe the intussusception epidemiology prior to rotavirus vaccine, temporal association of intussusception cases to administration of rotavirus vaccine, and estimate the additional number of intussusception cases that may be associated with rotavirus vaccine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30046133",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 88,
          "text": "Epidemiology of intussusception before and after rotavirus vaccine introduction in Fiji.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30046133",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 98,
          "text": "In 2012, Fiji introduced rotavirus vaccine (Rotarix, GSK) into the national immunisation schedule.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30046133",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 414,
          "offsetInEndSection": 635,
          "text": "Four trials of RIT 4237 bovine rotavirus vaccine, one trial of group A RRV-1 rhesus rotavirus vaccine, and one trial of rhesus-human reassortant rotavirus vaccines D x RRV and DS1 x RRV were carried out between 1983-1989.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9015114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1009,
          "offsetInEndSection": 1248,
          "text": "Problems associated with the use of any oral rotavirus vaccine include acid lability of the vaccine virus, which requires buffering, and a slight but significant interference of oral poliovirus vaccine with the uptake of rotavirus vaccine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9015114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1249,
          "offsetInEndSection": 1374,
          "text": "In the near future, oral heterologous rotavirus vaccines may be available for prevention of severe rotavirus gastroenteritis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9015114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 856,
          "offsetInEndSection": 1008,
          "text": "There was no apparent difference between bovine and rhesus-based rotavirus vaccines in the protective efficacy against severe rotavirus gastroenteritis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9015114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 148,
          "offsetInEndSection": 413,
          "text": "Efficacy studies of this vaccine in 6-12 month-old children gave results characteristic of the performance of oral rotavirus vaccines in general: 58% protective efficacy against any rotavirus gastroenteritis and 82% against \"clinically significant\" gastroenteritis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9015114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 147,
          "text": "Live oral rotavirus vaccine strain RIT 4237, derived from group A bovine rotavirus NCDV, was given to human volunteers in Tampere, Finland in 1982.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9015114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 683,
          "offsetInEndSection": 881,
          "text": "Targeted efforts to evaluate indirect effects of rotavirus vaccine in low income countries are required to understand the total impact of rotavirus vaccine on the global burden of rotavirus disease.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27443593",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 127,
          "text": "Widespread introduction of rotavirus vaccines has led to major reductions in the burden of rotavirus gastroenteritis worldwide.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27443593",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 451,
          "offsetInEndSection": 682,
          "text": "While rotavirus vaccine indirect effects have been demonstrated in high and middle income countries, there are very little data from low income countries where force of infection, population structures and vaccine schedules differ.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27443593",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 72,
          "text": "Measuring indirect effects of rotavirus vaccine in low income countries.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27443593",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 109,
          "text": "Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11389295",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "Rotavirus vaccine was licensed on August 31, 1998, and subsequently recommended for routine use among infants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11389295",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 184,
          "offsetInEndSection": 355,
          "text": "To describe the cases of intussusception among rotavirus vaccine recipients reported to the Vaccine Adverse Event Reporting System from October 1998 through December 1999.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11389295",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 356,
          "offsetInEndSection": 419,
          "text": "Infants vaccinated with rotavirus vaccine in the United States.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11389295",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 569,
          "offsetInEndSection": 785,
          "text": "There were 98 confirmed cases of intussusception after vaccination with rotavirus vaccine reported to the Vaccine Adverse Event Reporting System; 60 of these developed intussusception within 1 week after vaccination.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11389295",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1011,
          "offsetInEndSection": 1222,
          "text": "Using a passive surveillance system for vaccine adverse events, we observed at least a fourfold increase over the expected number of intussusception cases occurring within 1 week of receipt of rotavirus vaccine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11389295",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1223,
          "offsetInEndSection": 1333,
          "text": "Other studies were initiated to further define the relationship between rotavirus vaccine and intussusception.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11389295",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1334,
          "offsetInEndSection": 1548,
          "text": "In light of these and other data, the rotavirus vaccine manufacturer voluntarily removed its product from the market, and the recommendation for routine use of rotavirus vaccine among US infants has been withdrawn.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11389295",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 86,
          "offsetInEndSection": 255,
          "text": "To review the biology, immunology, and virology of rotavirus infections and describe the efforts towards the construction of vaccines using human and animal rotaviruses.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9949951",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 396,
          "offsetInEndSection": 511,
          "text": "In August 1998 the Food and Drug Administration in the United States approved the licensure of a rotavirus vaccine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9949951",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Can MVA85A confer immunity against smallpox?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25726088"
      ],
      "ideal_answer": [
        "No MVA85A is a candidate tuberculosis vaccine."
      ],
      "exact_answer": "no",
      "type": "yesno",
      "id": "5e776541835f4e4777000009",
      "snippets": [
        {
          "offsetInBeginSection": 142,
          "offsetInEndSection": 326,
          "text": "We assessed the safety, immunogenicity, and efficacy of a candidate tuberculosis vaccine, modified vaccinia virus Ankara expressing antigen 85A (MVA85A), in adults infected with HIV-1.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25726088",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 169,
          "text": "Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25726088",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "The virus that causes FIP, Feline Infectious Peritonitis belongs to what family?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22546085",
        "http://www.ncbi.nlm.nih.gov/pubmed/27712624",
        "http://www.ncbi.nlm.nih.gov/pubmed/31375588",
        "http://www.ncbi.nlm.nih.gov/pubmed/29329682",
        "http://www.ncbi.nlm.nih.gov/pubmed/30065095",
        "http://www.ncbi.nlm.nih.gov/pubmed/23865689",
        "http://www.ncbi.nlm.nih.gov/pubmed/29478397",
        "http://www.ncbi.nlm.nih.gov/pubmed/29778200",
        "http://www.ncbi.nlm.nih.gov/pubmed/25701212",
        "http://www.ncbi.nlm.nih.gov/pubmed/23763835",
        "http://www.ncbi.nlm.nih.gov/pubmed/26656689"
      ],
      "ideal_answer": [
        "The virus that causes FIP, Feline Infectious Peritonitis belongs to the family coronavirus.",
        "Feline coronavirus (fcov) is an etiological agent that causes a benign enteric illness and the fatal systemic disease feline infectious peritonitis (fip).",
        "Feline coronavirus (FCoV) is an etiological agent that causes a benign enteric illness and the fatal systemic disease feline infectious peritonitis (FIP)",
        "Feline Infectious Peritonitis (FIP) belongs to the family of coronavirus.",
        "Feline infectious peritonitis (FIP) is a common and highly lethal coronavirus disease of domestic cats.",
        "Feline infectious peritonitis (FIP) is a common and highly lethal coronavirus disease of domestic cats",
        "Feline Infectious Peritonitis virus (FIP) belongs to the coronavirus family of the genus Flavivirus which cause central nervous system disease.",
        "Feline infectious peritonitis (FIP) is a cat virus caused by a member of the coronavirus family coronaviruses."
      ],
      "exact_answer": [
        "Coronavirus"
      ],
      "type": "factoid",
      "id": "5e3eba5548dab47f26000009",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 102,
          "text": "Feline infectious peritonitis (FIP) is a common and highly lethal coronavirus disease of domestic cats",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29778200",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "Feline coronavirus (FCoV) is an etiological agent that causes a benign enteric illness and the fatal systemic disease feline infectious peritonitis (FIP). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29329682",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 21,
          "offsetInEndSection": 247,
          "text": "Feline coronavirus (FCoV) infection is very common in cats, usually causing only mild intestinal signs such as diarrhoea. Up to 10% of FCoV infections, however, result in the fatal disease feline infectious peritonitis (FIP). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29478397",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 92,
          "offsetInEndSection": 350,
          "text": "Feline infectious peritonitis virus (FIPV) belongs to the genus Alphacoronavirus, resulting in a lethal systemic granulomatous disease called feline infectious peritonitis (FIP), which is one of the most important fatal infectious diseases of cats worldwide.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26656689",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 278,
          "offsetInEndSection": 412,
          "text": "The causative agent of this deadly disease, feline infectious peritonitis virus (FIPV), arises from feline enteric coronavirus (FECV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27712624",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 101,
          "text": "Feline infectious peritonitis (FIP) is a fatal disease caused by feline coronavirus (FCoV) infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23865689",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 172,
          "text": "Feline infectious peritonitis virus (FIP virus: FIPV), a feline coronavirus of the family Coronaviridae, causes a fatal disease called FIP in wild and domestic cat species.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25701212",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 136,
          "text": "Feline infectious peritonitis (FIP) is one of the most important infectious diseases in cats and is caused by feline coronavirus (FCoV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31375588",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1642,
          "offsetInEndSection": 1824,
          "text": "IMPORTANCE  Feline coronavirus (FCoV) is one of the most significant coronaviruses, because this virus induces feline infectious peritonitis (FIP), which is a lethal disease in cats.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31375588",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 206,
          "text": "Feline infectious peritonitis (FIP), one of the most important lethal infections of cats, is caused by feline infectious peritonitis virus (FIPV), the high-virulence biotype of feline coronaviruses (FCoVs).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30065095",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 148,
          "text": "The feline infectious peritonitis virus ( FIPV ) is a member of the feline coronavirus family that causes FIP , which is incurable and fatal in cats",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22546085",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 174,
          "text": "Feline infectious peritonitis virus ( FIP virus: FIPV) , a feline coronavirus of the family Coronaviridae , causes a fatal disease called FIP in wild and domestic cat species",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25701212",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 91,
          "offsetInEndSection": 350,
          "text": "Feline infectious peritonitis virus (FIPV) belongs to the genus Alphacoronavirus, resulting in a lethal systemic granulomatous disease called feline infectious peritonitis (FIP), which is one of the most important fatal infectious diseases of cats worldwide.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26656689",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 278,
          "offsetInEndSection": 413,
          "text": "The causative agent of this deadly disease, feline infectious peritonitis virus (FIPV), arises from feline enteric coronavirus (FECV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27712624",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 130,
          "text": "Feline coronaviruses (FCoV) exist as 2 biotypes: feline enteric coronavirus (FECV) and feline infectious peritonitis virus (FIPV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23763835",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is SARS virus interacting with ACE2 encoded protein?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26487711",
        "http://www.ncbi.nlm.nih.gov/pubmed/27082314",
        "http://www.ncbi.nlm.nih.gov/pubmed/29190287",
        "http://www.ncbi.nlm.nih.gov/pubmed/30356097",
        "http://www.ncbi.nlm.nih.gov/pubmed/30102747"
      ],
      "ideal_answer": [
        "Yes,\nThe infection of target cells by the SARS CoV is mediated through the interaction of the viral Spike (S) protein (1255 amino acids) and its cellular receptor, angiotensin-converting enzyme 2 (ACE2)."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5e80675d835f4e4777000026",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 286,
          "text": "The trimeric SARS coronavirus (SARS-CoV) surface spike (S) glycoprotein consisting of three S1-S2 heterodimers binds the cellular receptor angiotensin-converting enzyme 2 (ACE2) and mediates fusion of the viral and cellular membranes through a pre- to postfusion conformation transition",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30102747",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 133,
          "offsetInEndSection": 369,
          "text": "The viral spike glycoprotein (S) utilizes angiotensin-converting enzyme 2 (ACE2) as a host protein receptor and mediates fusion of the viral and host membranes, making S essential to viral entry into host cells and host species tropism.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30356097",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1538,
          "offsetInEndSection": 1690,
          "text": "Cell entry studies demonstrated that three newly identified SARSr-CoVs with different S protein sequences are all able to use human ACE2 as the receptor",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29190287",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 837,
          "offsetInEndSection": 1145,
          "text": "Angiotensin-converting enzyme 2 (ACE2), a relatively new member of the RAS, has drawn extensive attention since 2003, because of the findings that ACE2 is the receptor for SARS Corona virus and that maintenance of normal ACE2 levels in the lung is beneficial for the host to combat inflammatory lung disease.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27082314",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 147,
          "offsetInEndSection": 345,
          "text": "The infection of target cells by the SARS CoV is mediated through the interaction of the viral Spike (S) protein (1255 amino acids) and its cellular receptor, angiotensin-converting enzyme 2 (ACE2).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26487711",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is the FIP virus thought to be a mutated strain for the Feline enteric Coronavirus?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22280883",
        "http://www.ncbi.nlm.nih.gov/pubmed/24209771",
        "http://www.ncbi.nlm.nih.gov/pubmed/24707494",
        "http://www.ncbi.nlm.nih.gov/pubmed/26822958",
        "http://www.ncbi.nlm.nih.gov/pubmed/27027316",
        "http://www.ncbi.nlm.nih.gov/pubmed/23964891",
        "http://www.ncbi.nlm.nih.gov/pubmed/19889934",
        "http://www.ncbi.nlm.nih.gov/pubmed/30691609"
      ],
      "ideal_answer": [
        "yes, Feline infectious peritonitis (FIP) results from mutations in the viral genome during a common feline enteric coronavirus (FECV) infection.",
        "Yes. The FIP virus is a mutated strain of the Feline enteric Coronavirus (FECV) causing infectious peritonitis and neoplasia",
        " Feline infectious peritonitis (FIP) results from mutations in the viral genome during a common feline enteric coronavirus (FECV) infection.",
        "  Feline infectious peritonitis (FIP) results from mutations in the viral genome during a common feline enteric coronavirus (FECV) infection.",
        "Feline infectious peritonitis (FIP) results from mutations in the viral genome during a common feline enteric coronavirus (FECV) infection.",
        "Yes. The FIP virus is a mutated strain of the Feline enteric coronavirus (FECV) infects cats, and is thought to be a newly identified strain with heterozygous mutations that create a K27M amino acid substitution."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5e3ebaa348dab47f2600000a",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 139,
          "text": "Feline infectious peritonitis (FIP) results from mutations in the viral genome during a common feline enteric coronavirus (FECV) infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26822958",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 98,
          "offsetInEndSection": 194,
          "text": "It is caused by FIP virus (FIPV), a virulent mutant strain of Feline Enteric Coronavirus (FECV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24707494",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 166,
          "text": "Feline infectious peritonitis virus (FIPV) was presumed to arise from mutations in the 3c of a ubiquitous and largely nonpathogenic feline enteric coronavirus (FECV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22280883",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 391,
          "offsetInEndSection": 597,
          "text": "Feline enteric coronavirus (FECV) causes inapparent or mild enteritis in cats, but a highly fatal disease, called feline infectious peritonitis (FIP), can arise through mutation of FECV to FIP virus (FIPV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027316",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 160,
          "text": "Feline infectious peritonitis (FIP) is a lethal systemic disease caused by FIP virus (FIPV), a virulent mutant of apathogenic feline enteric coronavirus (FECV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19889934",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 200,
          "text": "Feline infectious peritonitis (FIP) is an almost invariably fatal feline coronavirus (FCoV)-induced disease thought to arise from a combination of viral mutations and an overexuberant immune response.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30691609",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 165,
          "text": "BACKGROUND\n\nFeline Infectious Peritonitis (FIP) is a lethal systemic disease, caused by the FIP Virus (FIPV); a virulent mutant of Feline Enteric Coronavirus (FECV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24209771",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 164,
          "text": "BACKGROUND Feline Infectious Peritonitis (FIP) is a lethal systemic disease, caused by the FIP Virus (FIPV); a virulent mutant of Feline Enteric Coronavirus (FECV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24209771",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 145,
          "offsetInEndSection": 245,
          "text": "This coronavirus is a virulent mutant of the harmless, ubiquitous feline enteric coronavirus (FECV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23964891",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 167,
          "text": "Feline infectious peritonitis virus (FIPV) was presumed to arise from mutations in the 3c of a ubiquitous and largely nonpathogenic feline enteric coronavirus (FECV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22280883",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 404,
          "offsetInEndSection": 569,
          "text": "Whilst intact in all FECVs, the 3c gene was mutated in the majority (71.4 %) of FIPVs, but not in all, implying that mutation in 3c is not the (single) cause of FIP.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19889934",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Autophagy is the process where a virus obtains nutrients from it's host, yes or no?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29022289",
        "http://www.ncbi.nlm.nih.gov/pubmed/22475795",
        "http://www.ncbi.nlm.nih.gov/pubmed/24779013",
        "http://www.ncbi.nlm.nih.gov/pubmed/30544615",
        "http://www.ncbi.nlm.nih.gov/pubmed/28884441",
        "http://www.ncbi.nlm.nih.gov/pubmed/28889353",
        "http://www.ncbi.nlm.nih.gov/pubmed/24914338",
        "http://www.ncbi.nlm.nih.gov/pubmed/31803515"
      ],
      "ideal_answer": [
        "No, autophagy is important in cellular homeostasis for the cell survival mechanism and is involved apoptosis.",
        "Autophagy is a cellular survival pathway that is necessary for the degradation of cellular constituents such as long-lived proteins and damaged organelles.",
        "Autophagy is important in cellular homeostasis for the cell survival mechanism."
      ],
      "exact_answer": "no",
      "type": "yesno",
      "id": "5e3d8edf48dab47f26000003",
      "snippets": [
        {
          "offsetInBeginSection": 392,
          "offsetInEndSection": 537,
          "text": "In this study, we demonstrate that autophagy is a critical mediator of the viral degradation pathway and that this pathway is not HIV-1 specific.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28884441",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 79,
          "text": "Autophagy is important in cellular homeostasis for the cell survival mechanism.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28889353",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "Autophagy is a cellular survival pathway that is necessary for the degradation of cellular constituents such as long-lived proteins and damaged organelles.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29022289",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 302,
          "offsetInEndSection": 457,
          "text": "Autophagy-related genes (ATGs) regulate the autophagy and also control the crosstalk with autophagy-associated cell death and apoptosis in some condition. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28889353",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 204,
          "text": "Autophagy is an evolutionarily conserved cellular process in which intracellular components are eliminated via lysosomal degradation to supply nutrients for organelle biogenesis and metabolic homeostasis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30544615",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 161,
          "text": "Autophagy is a lysosome-associated, degradative process that catabolizes cytosolic components to recycle nutrients for further use and maintain cell homeostasis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24914338",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 165,
          "text": "Autophagy is a self-eating process, in which the damaged or excessed cell organelles and misfolded protein aggregates are removed from the cellular microenvironment.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31803515",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 162,
          "text": "Autophagy is a lysosome-associated, degradative process that catabolizes cytosolic components to recycle nutrients for further use and maintain cell homeostasis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24914338",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 205,
          "text": "Autophagy is an evolutionarily conserved cellular process in which intracellular components are eliminated via lysosomal degradation to supply nutrients for organelle biogenesis and metabolic homeostasis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30544615",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 184,
          "text": "Autophagy is a homeostatic process involved in the turnover or elimination of cytoplasmic components, damaged organelles, and protein aggregates via a lysosomal degradation mechanism.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22475795",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 268,
          "offsetInEndSection": 363,
          "text": "Autophagy is known as a catabolic process for the recycling of the cytoplasmic macromolecules.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24779013",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Name two rotavirus vaccines.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29436336"
      ],
      "ideal_answer": [
        "Two rotavirus vaccines licensed for global use are RotaTeq and Rotarix."
      ],
      "exact_answer": [
        [
          "Rotateq"
        ],
        [
          "Rotarix"
        ]
      ],
      "type": "list",
      "id": "5e7659db835f4e4777000001",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 180,
          "text": "Two rotavirus vaccines, RotaTeq and Rotarix, are licensed for global use; however, the protection they confer to unvaccinated individuals through indirect effects remains unknown. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29436336",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Please list 2 human diseases caused by a coronavirus.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29896174",
        "http://www.ncbi.nlm.nih.gov/pubmed/24769571",
        "http://www.ncbi.nlm.nih.gov/pubmed/26290414",
        "http://www.ncbi.nlm.nih.gov/pubmed/27840203",
        "http://www.ncbi.nlm.nih.gov/pubmed/28616501",
        "http://www.ncbi.nlm.nih.gov/pubmed/28466096",
        "http://www.ncbi.nlm.nih.gov/pubmed/28220326",
        "http://www.ncbi.nlm.nih.gov/pubmed/28643204",
        "http://www.ncbi.nlm.nih.gov/pubmed/31226023"
      ],
      "ideal_answer": [
        "Middle East respiratory syndrome (MERS) and SARS are diseases caused by a coronavirus.",
        "MERS and SARS are 2 human diseases caused by coronaviruses"
      ],
      "exact_answer": [
        [
          "MERS"
        ],
        [
          "SARS"
        ]
      ],
      "type": "list",
      "id": "5e2f43bafbd6abf43b000029",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 200,
          "text": "Since severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses (CoVs) share similar characteristics with respect to clinical signs, etiology, and transmission",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28220326",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 410,
          "text": "Human coronaviruses (hCoVs) can be divided into low pathogenic and highly pathogenic coronaviruses. The low pathogenic CoVs infect the upper respiratory tract and cause mild, cold-like respiratory illness. In contrast, highly pathogenic hCoVs such as severe acute respiratory syndrome CoV (SARS-CoV) and Middle East respiratory syndrome CoV (MERS-CoV) predominantly infect lower airways and cause fatal pneumon",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28466096",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 93,
          "offsetInEndSection": 306,
          "text": "In the last 15 years, we have witnessed the emergence of two zoonotic, highly pathogenic HCoVs: severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31226023",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 265,
          "text": "First identified in 2012 , Middle East respiratory syndrome ( MERS ) is caused by an emerging human coronavirus , which is distinct from the severe acute respiratory syndrome coronavirus ( SARS-CoV) , and represents a novel member of the lineage C betacoronoviruses",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290414",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 136,
          "offsetInEndSection": 365,
          "text": "The virus was termed Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and is taken notice of important coronavirus caused severe diseases to human after the outbreak of severe acute respiratory syndrome (SARS) coronavirus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24769571",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 78,
          "offsetInEndSection": 321,
          "text": "They mostly cause enteric or respiratory disease, which can be severe and life threatening, e.g., in the case of the zoonotic coronaviruses causing severe acute respiratory syndrome (SARS) and Middle East Respiratory Syndrome (MERS) in humans.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28643204",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is modified vaccinia Ankara effective for smallpox?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/17977963",
        "http://www.ncbi.nlm.nih.gov/pubmed/26143613",
        "http://www.ncbi.nlm.nih.gov/pubmed/26380340",
        "http://www.ncbi.nlm.nih.gov/pubmed/15227622",
        "http://www.ncbi.nlm.nih.gov/pubmed/16840346",
        "http://www.ncbi.nlm.nih.gov/pubmed/28374245",
        "http://www.ncbi.nlm.nih.gov/pubmed/18683106",
        "http://www.ncbi.nlm.nih.gov/pubmed/25879867",
        "http://www.ncbi.nlm.nih.gov/pubmed/27146001",
        "http://www.ncbi.nlm.nih.gov/pubmed/17604541",
        "http://www.ncbi.nlm.nih.gov/pubmed/28256358",
        "http://www.ncbi.nlm.nih.gov/pubmed/27327616",
        "http://www.ncbi.nlm.nih.gov/pubmed/19093767",
        "http://www.ncbi.nlm.nih.gov/pubmed/23523410",
        "http://www.ncbi.nlm.nih.gov/pubmed/29652929",
        "http://www.ncbi.nlm.nih.gov/pubmed/26949713",
        "http://www.ncbi.nlm.nih.gov/pubmed/23523407"
      ],
      "ideal_answer": [
        "Yes, modified vaccinia Ankara is effective for smallpox."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5e30f23cfbd6abf43b000042",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 134,
          "text": "BACKGROUND: Modified Vaccinia Ankara (MVA) is a live, viral vaccine under advanced development as a non-replicating smallpox vaccine. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29652929",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1394,
          "offsetInEndSection": 1549,
          "text": "The three MVA lots induced equivalent antibody titers two weeks after the second vaccination, with seroconversion rates of 99\u00b78% (PRNT) and 99\u00b77% (ELISA). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29652929",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 324,
          "text": "INTRODUCTION: To guide the use of modified vaccinia Ankara (MVA) vaccine in response to a release of smallpox virus, the immunogenicity and safety of shorter vaccination intervals, and administration by jet injector (JI), were compared to the standard schedule of administration on Days 1 and 29 by syringe and needle (S&N).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28256358",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 231,
          "text": "Erratum: Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26949713",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 70,
          "text": "Modified vaccinia Ankara virus (MVA) is a smallpox vaccine candidate. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27146001",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 188,
          "text": "A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN\u00ae) in 56-80-Year-Old Subjects.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27327616",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "BACKGROUND: Modified Vaccinia Ankara MVA-BN\u00ae is a live, highly attenuated, viral vaccine under advanced development as a non-replicating smallpox vaccine. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27327616",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2243,
          "offsetInEndSection": 2360,
          "text": "CONCLUSIONS: One or two doses of MVA were safe and immunogenic in a 56-80 years old vaccinia-experienced population. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27327616",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2592,
          "offsetInEndSection": 2825,
          "text": "The results suggest that a single dose of MVA in a 56-80 years old population was well tolerated and sufficient to rapidly boost the long-term B cell memory response induced by a prior vaccination with a traditional smallpox vaccine.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27327616",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 285,
          "offsetInEndSection": 407,
          "text": "Modified Vaccinia Ankara (MVA) poxvirus has been assessed for cardiac safety in a large placebo-controlled clinical trial.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25879867",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 266,
          "text": "BACKGROUND: Modified vaccinia Ankara (MVA) is being developed as a safer smallpox vaccine and is being placed in the US Strategic National Stockpile (SNS) as a liquid formulation for subcutaneous (SC) administration at a dose of 1\u00d710(8) TCID50 in a volume of 0.5mL. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26143613",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 86,
          "text": "IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18683106",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 307,
          "text": "Bavarian Nordic is developing IMVAMUNE, which is based on a live attenuated modified vaccinia Ankara virus, for the potential prevention of smallpox infection, particularly in those patients contraindicated to traditional smallpox vaccines, such as the immunocompromised and those with eczema or dermatitis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18683106",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 76,
          "text": "IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19093767",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 71,
          "text": "Modified vaccinia Ankara: potential as an alternative smallpox vaccine.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15227622",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 152,
          "text": "Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17604541",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 70,
          "text": "Modified vaccinia Ankara: potential as an alternative smallpox vaccine",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15227622",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 261,
          "text": "Modified vaccinia Ankara ( MVA ) is being developed as a safer smallpox vaccine and is being placed in the US Strategic National Stockpile ( SNS ) as a liquid formulation for subcutaneous ( SC ) administration at a dose of 1\u00d710 ( 8 ) TCID50 in a volume of 0.5mL",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26143613",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1429,
          "offsetInEndSection": 1603,
          "text": "Modified vaccinia Ankara was safe and immunogenic in subjects infected with HIV and represents a promising smallpox vaccine candidate for use in immunocompromised populations",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26380340",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 310,
          "text": "Bavarian Nordic is developing IMVAMUNE , which is based on a live attenuated modified vaccinia Ankara virus , for the potential prevention of smallpox infection , particularly in those patients contraindicated to traditional smallpox vaccines , such as the immunocompromised and those with eczema or dermatitis",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18683106",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 359,
          "offsetInEndSection": 558,
          "text": "One of the most advanced and most promising vectors is the attenuated , non-replicating poxvirus MVA ( modified vaccinia virus Ankara) , a safer derivative of the uniquely successful smallpox vaccine",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23523407",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 166,
          "text": "Modified vaccinia virus Ankara ( MVA ) is a highly attenuated vaccinia virus that is under consideration as an alternative to the conventional smallpox vaccine Dryvax",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17977963",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 235,
          "offsetInEndSection": 463,
          "text": "Modified Vaccinia virus Ankara ( MVA ) is an attenuated derivative , also used in the smallpox eradication campaign and now being developed as a recombinant viral vector to produce vaccines against infectious diseases and cancer",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28374245",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 271,
          "text": "While modified vaccinia virus Ankara ( MVA ) is currently in clinical development as a safe vaccine against smallpox and heterologous infectious diseases , its immunogenicity is likely limited due to the inability of the virus to replicate productively in mammalian hosts",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16840346",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1408,
          "offsetInEndSection": 1584,
          "text": "Modified vaccinia Ankara was safe and immunogenic in subjects infected with HIV and represents a promising smallpox vaccine candidate for use in immunocompromised populations.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26380340",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 214,
          "offsetInEndSection": 465,
          "text": "Modified Vaccinia virus Ankara (MVA) is a replication-deficient and attenuated derivative, also used in the smallpox eradication campaign and now being developed as a recombinant viral vector to produce vaccines against infectious diseases and cancer.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23523410",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1407,
          "offsetInEndSection": 1583,
          "text": "\u2003Modified vaccinia Ankara was safe and immunogenic in subjects infected with HIV and represents a promising smallpox vaccine candidate for use in immunocompromised populations.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26380340",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which diagnostic test is approved for coronavirus infection screening?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/14707219",
        "http://www.ncbi.nlm.nih.gov/pubmed/28191331",
        "http://www.ncbi.nlm.nih.gov/pubmed/24153118",
        "http://www.ncbi.nlm.nih.gov/pubmed/14522060"
      ],
      "ideal_answer": [
        "Real-time reverse transcription-PCR (rRT-PCR) is mostly used as the lab test for screening coronaviral infection."
      ],
      "exact_answer": [
        "real-time reverse transcription-PCR"
      ],
      "type": "factoid",
      "id": "5e5b8170b761aafe09000010",
      "snippets": [
        {
          "offsetInBeginSection": 447,
          "offsetInEndSection": 845,
          "text": ": In this study, we present two real-time reverse-transcription polymerase chain reaction (rRT-PCR) assays for in-house rapid and sensitive diagnostic testing of MERS-CoV, detecting the regions upstream of the envelope gene (upE) and open reading frame (ORF) 1b, respectively, for initial screening and final confirmation of MERS-CoV infection, as recommended by the world health organization (WHO)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28191331",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 148,
          "offsetInEndSection": 473,
          "text": " In response, we developed two real-time reverse transcription-PCR (rRT-PCR) assays targeting the MERS-CoV nucleocapsid (N) gene and evaluated these assays as a panel with a previously published assay targeting the region upstream of the MERS-CoV envelope gene (upE) for the detection and confirmation of MERS-CoV infection. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24153118",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 953,
          "offsetInEndSection": 1100,
          "text": "SARS-CoV was detected by means of reverse-transcriptase polymerase chain reaction (RT-PCR) in at least one specimen in 59 (54.1%) of 109 patients. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14707219",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 66,
          "text": "Early diagnosis of SARS coronavirus infection by real time RT-PCR.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/14522060",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "What bacteria is associated with Gastric cancer and peptic ulcers?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/7886456",
        "http://www.ncbi.nlm.nih.gov/pubmed/29432909",
        "http://www.ncbi.nlm.nih.gov/pubmed/29764950",
        "http://www.ncbi.nlm.nih.gov/pubmed/15610081",
        "http://www.ncbi.nlm.nih.gov/pubmed/25539656",
        "http://www.ncbi.nlm.nih.gov/pubmed/16583309",
        "http://www.ncbi.nlm.nih.gov/pubmed/29446491",
        "http://www.ncbi.nlm.nih.gov/pubmed/8341988"
      ],
      "ideal_answer": [
        "Helicobacter pylori (H. pylori), a gram-negative microaerophilic bacterial pathogen that colonizes the stomachs of more than half of all humans, is linked to chronic gastritis, peptic ulcers and gastric cancer.",
        "Peptic ulcer and gastric cancer are caused by the same bacteria, Helicobacter pylori."
      ],
      "exact_answer": [
        "helicobacter pylori"
      ],
      "type": "factoid",
      "id": "5e3c6c9eb5b409ea53000022",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 229,
          "text": "Helicobacter Pylori (H. pylori) is a gram-negative bacteria infecting numerous people all over the world. It has been established that H. pylori play an important role in pathogenesis of gastritis, peptic ulcer and gastric cancer",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29432909",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 210,
          "text": "Helicobacter pylori (H. pylori), a gram-negative microaerophilic bacterial pathogen that colonizes the stomachs of more than half of all humans, is linked to chronic gastritis, peptic ulcers and gastric cancer.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29446491",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 65,
          "text": "Strains of Helicobacter pylori that cause ulcer or gastric cancer",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29764950",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 120,
          "text": "BACKGROUND Helicobacter pylori chronic infection is associated with chronic gastritis, peptic ulcer, and gastric cancer.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25539656",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 135,
          "text": "Helicobacter pylori has been linked to chronic gastritis, peptic ulcers, gastric cancer and mucosa-associated lymphoid tissue lymphoma.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15610081",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "The human pathogen Helicobacter pylori is associated with gastritis, peptic ulcer disease, and gastric cancer.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7886456",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 415,
          "offsetInEndSection": 572,
          "text": "The pathogenesis of peptic ulcer and gastric cancer is closely associated with H. pylori gastritis and its subsequent atrophic sequelae (atrophic gastritis).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8341988",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is Impetigo a viral infection that affects the skin?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28178083",
        "http://www.ncbi.nlm.nih.gov/pubmed/15482208",
        "http://www.ncbi.nlm.nih.gov/pubmed/29745242",
        "http://www.ncbi.nlm.nih.gov/pubmed/26280141",
        "http://www.ncbi.nlm.nih.gov/pubmed/29898217",
        "http://www.ncbi.nlm.nih.gov/pubmed/26336623",
        "http://www.ncbi.nlm.nih.gov/pubmed/25250996",
        "http://www.ncbi.nlm.nih.gov/pubmed/16218885",
        "http://www.ncbi.nlm.nih.gov/pubmed/7899177",
        "http://www.ncbi.nlm.nih.gov/pubmed/28196318",
        "http://www.ncbi.nlm.nih.gov/pubmed/29063621",
        "http://www.ncbi.nlm.nih.gov/pubmed/17367045",
        "http://www.ncbi.nlm.nih.gov/pubmed/29416987"
      ],
      "ideal_answer": [
        "No, impetigo is a highly contagious bacterial skin infection"
      ],
      "exact_answer": "no",
      "type": "yesno",
      "id": "5e4fd4d56d0a277941000034",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 251,
          "text": "Importance: Ozenoxacin, a novel topical antibacterial agent with potent bactericidal activity against gram-positive bacteria, has been developed as a cream with 1% active drug for the treatment of impetigo, a highly contagious bacterial skin infection",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29898217",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 3,
          "offsetInEndSection": 185,
          "text": ": To compare the in vitro activity of the anti-impetigo agent, ozenoxacin, and other antimicrobial agents against Gram-positive clinical isolates from skin and soft tissue infections",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29745242",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 159,
          "text": "Streptococcus pyogenes is responsible for a wide variety of cutaneous infections ranging from superficial impetigo to fulminant invasive necrotizing fasciitis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29416987",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 29,
          "offsetInEndSection": 143,
          "text": "Impetigo is a highly contagious bacterial skin infection and is one of the most common skin infections in children",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29063621",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 910,
          "offsetInEndSection": 1020,
          "text": "Impetigo is a superficial bacterial infection that most commonly affects the face and extremities of children.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26280141",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 114,
          "offsetInEndSection": 179,
          "text": "Impetigo is the most common bacterial skin infection of children.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7899177",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 90,
          "text": "Impetigo is the most common bacterial skin infection in children two to five years of age.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25250996",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 70,
          "text": "BACKGROUND Impetigo can result from Staphylococcus aureus (S. aureus).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26336623",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 509,
          "offsetInEndSection": 720,
          "text": "Impetigo , cellulitis , and abscess comprise the majority of childhood bacterial skin infections and are treated with topical or systemic antibiotics that cover group A Streptococcus and Staphylococcus aureus . ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28196318",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 71,
          "text": "BACKGROUND\nImpetigo can result from Staphylococcus aureus (S. aureus).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26336623",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 910,
          "offsetInEndSection": 1021,
          "text": "Impetigo is a superficial bacterial infection that most commonly affects the face and extremities of children.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26280141",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 141,
          "text": "Impetigo is a superficial, but contagious, bacterial infection of the skin that predominantly affects children and is common in primary care.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17367045",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 119,
          "text": "Impetigo is a common, superficial, bacterial infection of the skin characterized by an inflamed and infected epidermis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15482208",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 202,
          "text": "Impetigo, a bacterial skin infection that involves the superficial layers of the skin, is one of the most common skin infections in children ages 2 to 5 but can occur in individuals across the lifespan.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28178083",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 194,
          "text": "Impetigo contagiosa is a common, superficial, bacterial infection of the skin characterised by an inflamed and infected epidermis caused by Staphylococcus aureus, Streptococcus pyogenes or both.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16218885",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Has the Spanich flu virus been reconstructed?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30142572",
        "http://www.ncbi.nlm.nih.gov/pubmed/22967978",
        "http://www.ncbi.nlm.nih.gov/pubmed/19385726"
      ],
      "ideal_answer": [
        "Tes,\nReconstruction of the 1918 influenza virus has facilitated considerable advancements in our understanding of this extraordinary pandemic virus."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5e5d27531af46fc130000007",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 143,
          "text": "Reconstruction of the 1918 influenza virus has facilitated considerable advancements in our understanding of this extraordinary pandemic virus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30142572",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 414,
          "offsetInEndSection": 723,
          "text": "These viral RNA sequences eventually permitted reconstruction of the complete 1918 virus, which has yielded, almost a century after the deaths of its victims, novel insights into influenza virus biology and pathogenesis and has provided important information about how to prevent and control future pandemics.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22967978",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 249,
          "offsetInEndSection": 441,
          "text": "Reconstruction of the 1918 virus and studies elucidating the exceptional virulence and transmissibility of the virus are providing exciting new insights into this devastating pandemic strain. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19385726",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is a zoonotic virus?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29351657",
        "http://www.ncbi.nlm.nih.gov/pubmed/29655214",
        "http://www.ncbi.nlm.nih.gov/pubmed/29563201",
        "http://www.ncbi.nlm.nih.gov/pubmed/28202592",
        "http://www.ncbi.nlm.nih.gov/pubmed/28192435",
        "http://www.ncbi.nlm.nih.gov/pubmed/29495551"
      ],
      "ideal_answer": [
        "A zoonotic disease is a disease that can be passed from animals to humans. Zoonotic viruses may adapt to a human host eventually becoming endemic in humans, but before doing so punctuated outbreaks of the zoonotic virus may be observed."
      ],
      "type": "summary",
      "id": "5e5d2b4c1af46fc130000008",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 143,
          "text": "Rift Valley fever virus (RVFV) is a mosquito-borne, zoonotic virus that infects ruminants, including cattle, sheep, goats, camels, and buffalo.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29563201",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 111,
          "text": "Hepatitis E virus (HEV) is a zoonotic virus which circulates in pigs and wild boars as main reservoir species. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29655214",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 128,
          "text": "Rodents and bats are now widely recognised as important sources of zoonotic virus infections in other mammals, including humans.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29495551",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 70,
          "text": "Nipah virus is a zoonotic virus harbored by bats and lethal to humans.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29351657",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 237,
          "text": "A zoonotic disease is a disease that can be passed from animals to humans. Zoonotic viruses may adapt to a human host eventually becoming endemic in humans, but before doing so punctuated outbreaks of the zoonotic virus may be observed. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28202592",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 106,
          "text": "Monkeypox virus (MPXV), a close relative of Variola virus, is a zoonotic virus with an unknown reservoir. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28192435",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/27425792"
      ],
      "ideal_answer": [
        "The protective efficacy of vaxchora  against moderate to severe cholera is 80-100%."
      ],
      "exact_answer": [
        "80-100%"
      ],
      "type": "factoid",
      "id": "5e76452fc6a8763d23000015",
      "snippets": [
        {
          "offsetInBeginSection": 255,
          "offsetInEndSection": 614,
          "text": "The oral live cholera vaccine CVD 103-HgR (Orochol, Mutachol), the first genetically modified organism (GMO) used as vaccine, was in its time (launched 1993, Switzerland) the ideal cholera vaccine: single-dose, protective efficacy of 80-100% against moderate to severe cholera, acting within 8 days and exhibiting excellent safety, indiscernible from placebo.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27425792",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which was the first cholera vaccine approved in the US?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29018300"
      ],
      "ideal_answer": [
        "Vaxchora is the first vaccine approved by the Food and Drug Administration for the prophylaxis of cholera infection."
      ],
      "exact_answer": [
        "Vaxchora"
      ],
      "type": "factoid",
      "id": "5e7641a0c6a8763d23000011",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 74,
          "text": "Vaxchora: The First FDA-Approved Cholera Vaccination in the United States.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29018300",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 117,
          "text": "Vaxchora is the first vaccine approved by the Food and Drug Administration for the prophylaxis of cholera infection. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29018300",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What virus is the  Gardisil vaccine used for?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22777095"
      ],
      "ideal_answer": [
        "Gardisil is a quadrivalent HPV vaccine would have been useful in the prevention of infections with human papillomavirus.",
        "Gardisil is a 4-component vaccine against capsular HPV 16 (4C HPV16), which has recently been licensed in Europe, Canada and Australia.",
        "Gordisil is a 4-component vaccine against capsular Meningococcus serogroup B (4CMenB), which has recently been licensed in Europe, Canada and Australia.",
        "Gardisil, the quadrivalent HPV vaccine would have been useful in the prevention of 28% (13/46) of these infections ",
        "Gardisil is a 16-component vaccine against human papillomavirus (HPV), which has recently been licensed in Europe, Canada and Australia.",
        "Gardisil, the quadrivalent HPV vaccine would have been useful in the prevention of 28% (13/46) of these infections"
      ],
      "type": "summary",
      "id": "5e3df59348dab47f26000006",
      "snippets": [
        {
          "offsetInBeginSection": 1177,
          "offsetInEndSection": 1291,
          "text": "Gardisil, the quadrivalent HPV vaccine would have been useful in the prevention of 28% (13/46) of these infections",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22777095",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1181,
          "offsetInEndSection": 1296,
          "text": "Gardisil, the quadrivalent HPV vaccine would have been useful in the prevention of 28% (13/46) of these infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22777095",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1177,
          "offsetInEndSection": 1292,
          "text": "Gardisil, the quadrivalent HPV vaccine would have been useful in the prevention of 28% (13/46) of these infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22777095",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What animal is thought to be the host for the Coronavirus causing MERS?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29239118",
        "http://www.ncbi.nlm.nih.gov/pubmed/30146782",
        "http://www.ncbi.nlm.nih.gov/pubmed/25791336",
        "http://www.ncbi.nlm.nih.gov/pubmed/29336306"
      ],
      "ideal_answer": [
        "The animal thought to be the host for the Coronavirus causing MERS is camels.",
        "The Virus causing MERS is though to have originated in dromedary camels"
      ],
      "exact_answer": [
        "camel"
      ],
      "type": "factoid",
      "id": "5e2f4a8bfbd6abf43b00002a",
      "snippets": [
        {
          "offsetInBeginSection": 1260,
          "offsetInEndSection": 1437,
          "text": "hese data demonstrate a genetic link for each of these clusters to a camel and support the hypothesis that human MERS-CoV diversity results from multiple zoonotic introductions.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29239118",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 563,
          "offsetInEndSection": 821,
          "text": "The exact origin of MERS-CoV remains unknown, but the transmission pattern and evidence from virological studies suggest that dromedary camels are the major reservoir host, from which human infections may sporadically occur through the zoonotic transmission.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30146782",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 166,
          "text": "Middle East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic virus from camels causing significant mortality and morbidity in humans in the Arabian Peninsula",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29336306",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 401,
          "offsetInEndSection": 528,
          "text": " Here, we use existing MERS-CoV sequence data to explore its phylodynamics in two of its known major hosts, humans and camels. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29336306",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 581,
          "offsetInEndSection": 704,
          "text": "ong-term MERS-CoV evolution occurs exclusively in camels, whereas humans act as a transient, and ultimately terminal host. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29336306",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 811,
          "offsetInEndSection": 926,
          "text": " human outbreaks in the Arabian peninsula are driven by seasonally varying zoonotic transfer of viruses from camels",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29336306",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 72,
          "offsetInEndSection": 291,
          "text": "While bats may be the primary reservoir for both viruses, SARS coronavirus (SARS-CoV) likely crossed into humans from civets in China, and MERS coronavirus (MERS-CoV) has been transmitted from camels in the Middle East.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25791336",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 576,
          "offsetInEndSection": 835,
          "text": "The exact origin of MERS-CoV remains unknown , but the transmission pattern and evidence from virological studies suggest that dromedary camels are the major reservoir host , from which human infections may sporadically occur through the zoonotic transmission",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30146782",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 72,
          "offsetInEndSection": 292,
          "text": "While bats may be the primary reservoir for both viruses, SARS coronavirus (SARS-CoV) likely crossed into humans from civets in China, and MERS coronavirus (MERS-CoV) has been transmitted from camels in the Middle East.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25791336",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "List 3 human diseases caused by  viruses in the family Paramyxoviridae.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29110978",
        "http://www.ncbi.nlm.nih.gov/pubmed/10717292",
        "http://www.ncbi.nlm.nih.gov/pubmed/22065774",
        "http://www.ncbi.nlm.nih.gov/pubmed/27110811",
        "http://www.ncbi.nlm.nih.gov/pubmed/17230540",
        "http://www.ncbi.nlm.nih.gov/pubmed/15318694",
        "http://www.ncbi.nlm.nih.gov/pubmed/18453612",
        "http://www.ncbi.nlm.nih.gov/pubmed/22531181",
        "http://www.ncbi.nlm.nih.gov/pubmed/25965801",
        "http://www.ncbi.nlm.nih.gov/pubmed/19445268",
        "http://www.ncbi.nlm.nih.gov/pubmed/17410634",
        "http://www.ncbi.nlm.nih.gov/pubmed/3496981",
        "http://www.ncbi.nlm.nih.gov/pubmed/15699418",
        "http://www.ncbi.nlm.nih.gov/pubmed/28361207",
        "http://www.ncbi.nlm.nih.gov/pubmed/30866768",
        "http://www.ncbi.nlm.nih.gov/pubmed/20552729",
        "http://www.ncbi.nlm.nih.gov/pubmed/21915289",
        "http://www.ncbi.nlm.nih.gov/pubmed/25595799",
        "http://www.ncbi.nlm.nih.gov/pubmed/24488776",
        "http://www.ncbi.nlm.nih.gov/pubmed/15330446"
      ],
      "ideal_answer": [
        "Measles, mumps and encephalitis are diseases caused by viruses in the family Paramyxoviridae.",
        "Viruses in the family Paramyxoviridae can cuase , measles, mumps and encephalitis as well as respiratory illness in humans."
      ],
      "exact_answer": [
        [
          "measles"
        ],
        [
          "mumps"
        ],
        [
          "encephalitis"
        ],
        [
          "respiratory disease"
        ],
        [
          "newcastle disease"
        ]
      ],
      "type": "list",
      "id": "5e4163b848dab47f2600000f",
      "snippets": [
        {
          "offsetInBeginSection": 10,
          "offsetInEndSection": 103,
          "text": ": Previous controversy was generated over the hypothesis that a paramyxovirus such as measles",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17230540",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 139,
          "text": "Measles are a systemic infectious disease caused by a single stranded ribonucleic acid virus (measles virus) from the paramyxovirus family.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19445268",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 46,
          "text": "Mumps is a Paramyxoviridae virus. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29110978",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 420,
          "offsetInEndSection": 545,
          "text": "Since chronic paramyxovirus infection with measles is known to be accompanied by increased production of antiviral antibodies",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28361207",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 120,
          "text": "Nipah virus (NiV) is a highly pathogenic paramyxovirus which causes fatal encephalitis in up to 75% of infected humans. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20552729",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 78,
          "text": "Measles is caused by the paramyxovirus which spreads through airborne droplets",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15318694",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 121,
          "text": "Newcastle disease virus (NDV) is classified as a member of the superfamily Mononegavirales in the family Paramyxoviridae.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10717292",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 412,
          "offsetInEndSection": 638,
          "text": "Many of these identified genes were also required for infection by two other NS RNA viruses, the lymphocytic choriomeningitis virus of the Arenaviridae family and human parainfluenza virus type 3 of the Paramyxoviridae family.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22065774",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 109,
          "text": "Measles virus ( MeV) , a highly contagious member of the Paramyxoviridae family , causes measles in humans . ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27110811",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 191,
          "text": "The human metapneumovirus ( hMPV ) is a newly reported respiratory virus belonging to the Paramyxoviridae family that has been associated with bronchiolitis and pneumonia in young children . ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15699418",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 271,
          "text": "Two members of the morbillivirus genus of the family Paramyxoviridae , canine distemper virus ( CDV ) and measles virus ( MV) , are well-known for their ability to cause a chronic demyelinating disease of the CNS in their natural hosts , dogs and humans , respectively . ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17410634",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 238,
          "text": "Respiratory syncytial virus ( RSV ) belongs to the family Paramyxoviridae and is the single most important cause of serious lower respiratory tract infections in young children , yet no highly effective treatment or vaccine is available. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25965801",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 168,
          "text": "Human respiratory syncytial virus ( RSV) , a member of the Paramyxoviridae family , is the most important viral agent of pediatric respiratory tract disease worldwide. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18453612",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 121,
          "text": "Respiratory syncytial virus ( RSV) , an RNA virus in the family Paramyxoviridae , causes respiratory disease in humans . ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15330446",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 199,
          "text": "Measles virus ( MV ) is a member of the Paramyxoviridae family and an important human pathogen causing strong immunosuppression in affected individuals and a considerable number of deaths worldwide. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21915289",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 200,
          "text": "Hendra ( HeV ) and Nipah ( NiV ) viruses ( genus Henipavirus ( HNV; family Paramyxoviridae ) are emerging zoonotic agents that can cause severe respiratory distress and acute encephalitis in humans . ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24488776",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 218,
          "text": "Many of the common respiratory illnesses of infancy and childhood are caused by viruses of the Paramyxoviridae family, in particular measles virus, respiratory syncytial (RS) virus and parainfluenzavirus type 3 (PI3).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/3496981",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 88,
          "offsetInEndSection": 460,
          "text": "Here we report simultaneous outbreaks of two distinct human respiratory viruses, human metapneumovirus (MPV; Pneumoviridae: Metapneumovirus) and human respirovirus 3 (HRV3; Paramyxoviridae; Respirovirus, formerly known as parainfluenza virus 3), in two chimpanzee (Pan troglodytes schweinfurthii) communities in the same forest in Uganda in December 2016 and January 2017.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30866768",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 230,
          "text": "The large virus family Paramyxoviridae includes some of the most significant human and livestock viruses, such as measles-, distemper-, mumps-, parainfluenza-, Newcastle disease-, respiratory syncytial virus and metapneumoviruses.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22531181",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What do HA and NA stand for with respect to the flue virus, e.g. H1N1?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/24027333",
        "http://www.ncbi.nlm.nih.gov/pubmed/30967460",
        "http://www.ncbi.nlm.nih.gov/pubmed/33065852",
        "http://www.ncbi.nlm.nih.gov/pubmed/23349854",
        "http://www.ncbi.nlm.nih.gov/pubmed/29699789",
        "http://www.ncbi.nlm.nih.gov/pubmed/25609803",
        "http://www.ncbi.nlm.nih.gov/pubmed/10067670",
        "http://www.ncbi.nlm.nih.gov/pubmed/2300562",
        "http://www.ncbi.nlm.nih.gov/pubmed/23125526",
        "http://www.ncbi.nlm.nih.gov/pubmed/29625056",
        "http://www.ncbi.nlm.nih.gov/pubmed/25751873",
        "http://www.ncbi.nlm.nih.gov/pubmed/29167344",
        "http://www.ncbi.nlm.nih.gov/pubmed/29113775",
        "http://www.ncbi.nlm.nih.gov/pubmed/15925433",
        "http://www.ncbi.nlm.nih.gov/pubmed/32362450",
        "http://www.ncbi.nlm.nih.gov/pubmed/28141594",
        "http://www.ncbi.nlm.nih.gov/pubmed/12443663",
        "http://www.ncbi.nlm.nih.gov/pubmed/32825107"
      ],
      "ideal_answer": [
        "VaxArray assays for influenza hemagglutinin (HA) and neuraminidase (NA) have been developed to address this need.",
        "HA and NA stand for  hemagglutinin (HA) and neuraminidase (NA), two components of the flue virus genome.",
        "HA and NA, (sometimes H or N) refer to influenza surface proteins neuraminidase (NA) and hemagglutinin (HA)."
      ],
      "type": "summary",
      "id": "5e722812c6a8763d2300000a",
      "snippets": [
        {
          "offsetInBeginSection": 247,
          "offsetInEndSection": 266,
          "text": "neuraminidase (NA) ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29167344",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 116,
          "text": "Genetic variation of influenza neuraminidase (NA), unlike for hemagglutinin (HA), has not been fully characterized. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29113775",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 151,
          "offsetInEndSection": 265,
          "text": "VaxArray assays for influenza hemagglutinin (HA) and neuraminidase (NA) have been developed to address this need. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29699789",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 257,
          "text": "Antibody (Ab) responses and protection against influenza virus infection in mice immunized intranasally with hemagglutinin (HA) or neuraminidase (NA) purified from the A/Beijing/262/95 (A/Beijing) (H1N1) virus were compared among B10 congenic mouse strains.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12443663",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 205,
          "offsetInEndSection": 407,
          "text": "Since antibodies against HA and neuraminidase (NA) contribute independently to protection against disease, antigenic changes in NA may allow A(H1N1)pdm09 viruses to escape from vaccine-induced immunity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30967460",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 295,
          "text": "The ability of plasmid DNA encoding hemagglutinin (HA), neuraminidase (NA) or matrix protein (M1) from influenza virus A/PR/8/34 (PR8) (H1N1), and mixtures of these plasmid DNAs (HA + NA and HA + NA + M1) to protect against homologous or heterologous virus infection was examined in BALB/c mice.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10067670",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 369,
          "offsetInEndSection": 537,
          "text": "ODS: Alignments were made with H1N1 hemagglutinin and neuraminidase (HA and NA, respectively) sequences; only conserved sites were used for antigenicity prediction. Two",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32362450",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 353,
          "offsetInEndSection": 522,
          "text": "LTS: In this report, 72 hemagglutinin (HA) and 45 neuraminidase (NA) H1N1 virus gene sequences, isolated in 2009 from various regions of Saudi Arabia, were analyzed. Gen",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28141594",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 172,
          "text": "Two surface glycoproteins of influenza virus, haemagglutinin (HA) and neuraminidase (NA), play opposite roles in terms of their interaction with host sialic acid receptors.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23349854",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "Hemagglutinin (HA) and neuraminidase (NA) are major glycoproteins expressed on the surface of influenza virus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33065852",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 181,
          "text": "UNLABELLED: In nearly all characterized influenza viruses, hemagglutinin (HA) is the receptor-binding protein while neuraminidase (NA) is a receptor-cleaving protein that aids in vi",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25609803",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 259,
          "text": "The hemagglutinin (HA) and neuraminidase (NA) external glycoprotein antigens of H1N1 and H3N2 subtypes of epidemiologically important influenza A viruses prevalent during recent decades were subjected to intensive antigenic analysis by four different methods.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2300562",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 247,
          "text": "In the vast majority of influenza A viruses characterized to date, hemagglutinin (HA) is the receptor-binding and fusion protein, whereas neuraminidase (NA) is a receptor-cleaving protein that facilitates viral release but is expendable for entry.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24027333",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 212,
          "text": "The ability of a single dose of plasmid DNA encoding neuraminidase (NA) or hemagglutinin (HA) from influenza virus A/PR/8/34 (PR8) (H1N1) to protect against homologous virus infection was examined in BALB/c mice.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15925433",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 146,
          "text": "Antibodies to the hemagglutinin (HA) and neuraminidase (NA) glycoproteins are the major mediators of\u00a0protection against influenza virus infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29625056",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 217,
          "offsetInEndSection": 338,
          "text": "Previous studies have suggested that Cal-derived chimeric hemagglutinin (HA) and neuraminidase (NA) improve virus yields.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32825107",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 133,
          "text": "Influenza type A viruses are classified into subtypes based on their two surface proteins, hemagglutinin (HA) and neuraminidase (NA).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25751873",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 291,
          "offsetInEndSection": 518,
          "text": "There are two glycoproteins in this lipid membrane; namely, hemagglutinin (HA) which helps in attachment of the viral strain on the host cell surface and neuraminidase (NA) that is responsible for initiation of viral infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23125526",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which are the predominant rotavirus genotypes around the world?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/25224179",
        "http://www.ncbi.nlm.nih.gov/pubmed/30156344"
      ],
      "ideal_answer": [
        "The predominant RV genotypes circulating all over the world are G1P[8], G2P[4], G3P[8], G4P[8], and G9P[8], while G12[P6] and G12[P8] are emerging genotypes."
      ],
      "exact_answer": [
        [
          "G1P[8]"
        ],
        [
          "G2P[4]"
        ],
        [
          "G3P[8]"
        ],
        [
          "G4P[8]"
        ],
        [
          "G9P[8]"
        ]
      ],
      "type": "list",
      "id": "5e76611b835f4e4777000002",
      "snippets": [
        {
          "offsetInBeginSection": 928,
          "offsetInEndSection": 1086,
          "text": "The predominant RV genotypes circulating all over the world are G1P[8], G2P[4], G3P[8], G4P[8], and G9P[8], while G12[P6] and G12[P8] are emerging genotypes. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30156344",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 928,
          "offsetInEndSection": 1085,
          "text": "The predominant RV genotypes circulating all over the world are G1P[8], G2P[4], G3P[8], G4P[8], and G9P[8], while G12[P6] and G12[P8] are emerging genotypes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30156344",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 183,
          "text": "Comprehensive reviews of pre licensure rotavirus strain prevalence data indicated the global importance of six rotavirus genotypes, G1P[8], G2P[4], G3P[8], G4P[8], G9P[8] and G12P[8].",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25224179",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Are bacteria in the genus Clostridium facultative anaerobes?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
        "http://www.ncbi.nlm.nih.gov/pubmed/25700419",
        "http://www.ncbi.nlm.nih.gov/pubmed/31076745",
        "http://www.ncbi.nlm.nih.gov/pubmed/20526574",
        "http://www.ncbi.nlm.nih.gov/pubmed/21067677",
        "http://www.ncbi.nlm.nih.gov/pubmed/18430081",
        "http://www.ncbi.nlm.nih.gov/pubmed/31991218"
      ],
      "ideal_answer": [
        "Clostridia belong to those bacteria which are considered as obligate anaerobe, e.g. oxygen is harmful or lethal to these bacteria.",
        "No, bacteria in the genus Clostridium are obligate anaerobes"
      ],
      "exact_answer": "no",
      "type": "yesno",
      "id": "5e6f774ec6a8763d23000009",
      "snippets": [
        {
          "offsetInBeginSection": 50,
          "offsetInEndSection": 92,
          "text": "strict anaerobe Clostridium acetobutylicum",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18430081",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 130,
          "text": "Clostridia belong to those bacteria which are considered as obligate anaerobe, e.g. oxygen is harmful or lethal to these bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18430081",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "We report here the closed genome of Clostridium pasteurianum ATCC 6013, a saccharolytic, nitrogen-fixing, and spore-forming Gram-positive obligate anaerobe",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25700419",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 80,
          "text": "Clostridium pasteurianum BB, a saccharolytic and spore-forming obligate anaerobe",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21067677",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 118,
          "text": "Clostridium difficile is a spore-forming obligate anaerobe that is a leading cause of healthcare-associated infections",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26231446",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 537,
          "offsetInEndSection": 682,
          "text": "However, the discovery of antimicrobials has been biased towards aerobes and facultative anaerobes, and strict anaerobes such as Clostridium spp.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31991218",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 154,
          "text": "Clostridium is a large genus of obligate anaerobes belonging to the Firmicutes phylum of bacteria, most of which have a Gram-positive cell wall structure.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31076745",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 515,
          "offsetInEndSection": 665,
          "text": "Such bacteria are either obligate anaerobic bacteria like Clostridium or Bifidobacterium or facultative anaerobic like Escherichia coli or Salmonella.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20526574",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 63,
          "text": "Antimicrobial production by strictly anaerobic Clostridium spp.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31991218",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "List the deadliest viruses in the world.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20049699",
        "http://www.ncbi.nlm.nih.gov/pubmed/30252528",
        "http://www.ncbi.nlm.nih.gov/pubmed/27622648",
        "http://www.ncbi.nlm.nih.gov/pubmed/29425816",
        "http://www.ncbi.nlm.nih.gov/pubmed/27979676"
      ],
      "ideal_answer": [
        "The filoviruses, Ebola virus (EBOV) and Marburg virus (MARV), are among the deadliest viruses that cause disease in humans, with reported case fatality rates of up to 90% in some outbreaks.\r\nWHO ranks HIV as one of the deadliest diseases.\r\nInfluenza virus"
      ],
      "exact_answer": [
        [
          "Ebola virus"
        ],
        [
          "Marburg virus"
        ],
        [
          "Influenza virus"
        ],
        [
          "HIV"
        ]
      ],
      "type": "list",
      "id": "5e92005c2d3121100d000003",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 78,
          "text": "The Ebola and Marburg viruses are some of the deadliest viruses in the world. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27979676",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 190,
          "text": "The filoviruses, Ebola virus (EBOV) and Marburg virus (MARV), are among the deadliest viruses that cause disease in humans, with reported case fatality rates of up to 90% in some outbreaks. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27622648",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 128,
          "text": "Filoviruses are zoonotic and among the deadliest viruses known to mankind, with mortality rates in outbreaks reaching up to 90%.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20049699",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 357,
          "offsetInEndSection": 374,
          "text": "influenza viruses",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30252528",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 276,
          "offsetInEndSection": 322,
          "text": "WHO ranks HIV as one of the deadliest diseases",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29425816",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What was the predominant rotavirus genotype in the pre-vaccine era, in Australia?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29790933",
        "http://www.ncbi.nlm.nih.gov/pubmed/30755297",
        "http://www.ncbi.nlm.nih.gov/pubmed/32060546"
      ],
      "ideal_answer": [
        "G1P[8] was the dominant genotype in Australia in the prevaccine era (1995-2006)."
      ],
      "exact_answer": [
        "G1P[8]"
      ],
      "type": "factoid",
      "id": "5e7667b1835f4e4777000004",
      "snippets": [
        {
          "offsetInBeginSection": 789,
          "offsetInEndSection": 867,
          "text": "G1P[8] was the dominant genotype nationally in the prevaccine era (1995-2006).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29790933",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 436,
          "offsetInEndSection": 638,
          "text": "From 1995 to 2015, the Australian Rotavirus Surveillance Program conducted genotypic analysis on 13051 rotavirus-positive samples from children <5 years of age, hospitalized with acute gastroenteritis. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29790933",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 873,
          "offsetInEndSection": 979,
          "text": "In the pre-vaccine era, G1P[8] was most prevalent, ranging from 39% (411/1,057) to 74% (527/709) per year.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30755297",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Have the rotavirus vaccines changed the predominant rotavirus genotypes?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/29790933"
      ],
      "ideal_answer": [
        "The increased diversity and differences in genotype dominance observed in states using RotaTeq (G12P[8]), and in states and territories using Rotarix (equine-like G3P[8] and G2P[4]), suggest that these vaccines exert different immunological pressures that influence the diversity of rotavirus strains."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "5e766256835f4e4777000003",
      "snippets": [
        {
          "offsetInBeginSection": 166,
          "offsetInEndSection": 313,
          "text": "This study describes the distribution and diversity of rotavirus genotypes before and after rotavirus vaccine introduction into the Australian NIP.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29790933",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 789,
          "offsetInEndSection": 1182,
          "text": "G1P[8] was the dominant genotype nationally in the prevaccine era (1995-2006). Following vaccine introduction (2007-2015), greater genotype diversity was observed with fluctuating genotype dominance. Genotype distribution varied based on the vaccine implemented, with G12P[8] dominant in states using RotaTeq, and equine-like G3P[8] and G2P[4] dominant in states and territories using Rotarix.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29790933",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1195,
          "offsetInEndSection": 1521,
          "text": "The increased diversity and differences in genotype dominance observed in states using RotaTeq (G12P[8]), and in states and territories using Rotarix (equine-like G3P[8] and G2P[4]), suggest that these vaccines exert different immunological pressures that influence the diversity of rotavirus strains circulating in Australia.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29790933",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "List as many European influenza vaccines as possible.",
      "_type": "yesno",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/8801083"
      ],
      "_body": "\"DPM1001\"",
      "ideal_answer": [
        "Three split-virion vaccines (Vaxigrip, Begrivac, and Influsplit/Fluarix) and three subunit vaccines containing only viral surface glycoproteins (Influvac, Agrippal, and Fluvirin)."
      ],
      "exact_answer": [
        [
          "Vaxigrip"
        ],
        [
          "Begrivac"
        ],
        [
          "Influsplit",
          "Fluarix"
        ],
        [
          "Influvac"
        ],
        [
          "Agrippal"
        ],
        [
          "Fluvirin"
        ]
      ],
      "type": "list",
      "id": "5e29f732aa19d74431000003",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 276,
          "text": "Three split-virion vaccines (Vaxigrip, Begrivac, and Influsplit/Fluarix) and three subunit vaccines containing only viral surface glycoproteins (Influvac, Agrippal, and Fluvirin) available for the 1994-95 season were analysed by biological, molecular, and biochemical methods.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/8801083",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/10400712",
        "http://www.ncbi.nlm.nih.gov/pubmed/19493999",
        "http://www.ncbi.nlm.nih.gov/pubmed/28508218",
        "http://www.ncbi.nlm.nih.gov/pubmed/9525637",
        "http://www.ncbi.nlm.nih.gov/pubmed/25683441",
        "http://www.ncbi.nlm.nih.gov/pubmed/24501400",
        "http://www.ncbi.nlm.nih.gov/pubmed/10482624",
        "http://www.ncbi.nlm.nih.gov/pubmed/16325221",
        "http://www.ncbi.nlm.nih.gov/pubmed/9568033",
        "http://www.ncbi.nlm.nih.gov/pubmed/25948749",
        "http://www.ncbi.nlm.nih.gov/pubmed/22892200",
        "http://www.ncbi.nlm.nih.gov/pubmed/29992955",
        "http://www.ncbi.nlm.nih.gov/pubmed/23707921",
        "http://www.ncbi.nlm.nih.gov/pubmed/25831513",
        "http://www.ncbi.nlm.nih.gov/pubmed/28601688"
      ],
      "ideal_answer": [
        "The paramyxovirus family has a genome consisting of a SINGLE STRAND of negative sense RNA",
        "The paramyxovirus family has a genome consisting of a single strand of negative sense RNA.",
        "The paramyxovirus family has a genome consisting of a single strand of negative sense RNA"
      ],
      "exact_answer": "no",
      "type": "yesno",
      "id": "5e64f11a1af46fc130000017",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 89,
          "text": "The paramyxovirus family has a genome consisting of a single strand of negative sense RNA",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25683441",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 161,
          "text": "The avian paramyxovirus type 1 (APMV-1), or Newcastle disease virus (NDV), comprise a diverse group of viruses with a single-stranded, negative-sense RNA genome.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22892200",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 169,
          "text": "Members of the Paramyxoviridae such as measles, mumps, and parainfluenza viruses have pleomorphic, enveloped virions that contain negative-sense unsegmented RNA genomes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19493999",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 231,
          "text": "UNLABELLED: Mumps virus (MuV), a paramyxovirus containing a negative-sense nonsegmented RNA genome, is a human pathogen that causes an acute infection with symptoms ranging from parotitis to mild meningitis and severe encephalitis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24501400",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 95,
          "text": "UNLABELLED: Mumps virus (MuV) is a paramyxovirus with a negative-sense nonsegmented RNA genome.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25948749",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 294,
          "text": "Paramyxoviridae, a large family of enveloped viruses harboring a nonsegmented negative-sense RNA\u00a0genome, include important human pathogens as measles, mumps, respiratory syncytial virus (RSV), parainfluenza\u00a0viruses, and henipaviruses, which cause some of the deadliest emerging zoonoses. There ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29992955",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 223,
          "text": "Parainfluenza virus 5 (PIV5) is a member of the Paramyxoviridae family of membrane-enveloped viruses with a negative-sense RNA genome that is packaged and protected by long filamentous nucleocapsid-helix structures (RNPs). ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25831513",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 295,
          "text": "The paramyxovirus genome, a nonsegmented, negative-polarity, single-stranded RNA of approximately 15 kb, contains six transcription units flanked at the 3' and 5' ends by a short (approximately 50- to 60-nucleotide) extracistronic sequence, dubbed the positive and negative leader regions. These",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9525637",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 260,
          "text": "The replication of nonsegmented minus-strand RNA genomes, like that of Sendai paramyxovirus (SeV), are controlled by the short leader regions present at each end of the linear genomes and antigenomes; the left and right promoters (PL and PR), respectively. Wil",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9568033",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 221,
          "text": "UNLABELLED: Mumps virus (MuV), a paramyxovirus containing a negative-sense nonsegmented RNA genome, is a human pathogen that causes an acute infection with symptoms ranging from parotitis to mild meningitis and severe enc",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24501400",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 189,
          "offsetInEndSection": 465,
          "text": "s viral glycoprotein cytoplasmic domains may play a role in this coordination, we have investigated the importance of the hemagglutinin-neuraminidase (HN) protein cytoplasmic domain in the assembly of the nonsegmented negative-strand RNA paramyxovirus simian virus 5 (SV5). By",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10482624",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 108,
          "text": "Beilong virus, a novel paramyxovirus with the largest genome of non-segmented negative-stranded RNA viruses.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16325221",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 289,
          "text": "The paramyxovirus genome, a nonsegmented, negative-polarity, single-stranded RNA of approximately 15 kb, contains six transcription units flanked at the 3' and 5' ends by a short (approximately 50- to 60-nucleotide) extracistronic sequence, dubbed the positive and negative leader regions.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9525637",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 246,
          "offsetInEndSection": 412,
          "text": "Paramyxovirus particles are pleomorphic, with a lipid envelope, nonsegmented RNA genomes of negative polarity, and densely packed glycoproteins on the virion surface.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28601688",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 214,
          "text": "An alternative method to determine the 5' extremities of non-segmented, negative sense RNA viral genomes using positive replication intermediate 3' tailing: application to two members of the Paramyxoviridae family.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23707921",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 123,
          "text": "Simian parainfluenza virus 5 (SV5) is a prototype of the Paramyxoviridae family of nonsegmented negative-sense RNA viruses.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10400712",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 224,
          "text": "Human metapneumovirus (HMPV), a single-stranded negative-sense RNA virus belonging to the family Paramyxoviridae, is associated with respiratory tract illness, primarily in young children and persons with underlying disease.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28508218",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Herpes viruses have what type of genome?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/22020814",
        "http://www.ncbi.nlm.nih.gov/pubmed/26121674",
        "http://www.ncbi.nlm.nih.gov/pubmed/16160176",
        "http://www.ncbi.nlm.nih.gov/pubmed/12716057",
        "http://www.ncbi.nlm.nih.gov/pubmed/21390711",
        "http://www.ncbi.nlm.nih.gov/pubmed/17296606",
        "http://www.ncbi.nlm.nih.gov/pubmed/1652278",
        "http://www.ncbi.nlm.nih.gov/pubmed/10774200",
        "http://www.ncbi.nlm.nih.gov/pubmed/21491367",
        "http://www.ncbi.nlm.nih.gov/pubmed/10627574",
        "http://www.ncbi.nlm.nih.gov/pubmed/9514102",
        "http://www.ncbi.nlm.nih.gov/pubmed/18687114"
      ],
      "ideal_answer": [
        "The Herpesviridae are a family of viruses which have a large genome of linear, double-stranded DNA (> 120 kb)",
        "The genome of Herpes viruses is composed of linear, double-stranded DNA.",
        "Herpes simplex virus 1 (HSV-1) and HSV-2 are nuclear-replicating viruses composed of a double-stranded DNA genome",
        "Herpes simplex virus 1 (HSV-1) has a double-stranded linear DNA genome that is approximately 152 kbp in length.",
        "Herpesviridae are a family of viruses which have a large genome of linear, double-stranded DNA.",
        "Herpes viruses have a linear, double-stranded DNA genome."
      ],
      "exact_answer": [
        "double stranded DNA"
      ],
      "type": "factoid",
      "id": "601f105e1cb411341a000071",
      "snippets": [
        {
          "offsetInBeginSection": 149,
          "offsetInEndSection": 263,
          "text": "Herpes simplex virus 1 (HSV-1) and HSV-2 are nuclear-replicating viruses composed of a double-stranded DNA genome ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22020814",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 670,
          "text": "Vectors derived from herpes simplex virus provide a means of gene delivery to postmitotic neurons. The virus is readily taken up at nerve terminals, passes by rapid retrograde and anterograde transport within neurons, and is selectively transferred across synapses, thus allowing it entry from the periphery into the brain. This virus can enter a state of latency in some neurons, where it exists as an episomal element in the nucleus and is transcriptionally active to a reduced extent. In this state, the virus is apparently benign and can effect stable expression of foreign genes. The large (150 kb) genome of this double-stranded virus has been completely sequenced",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1652278",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 109,
          "text": "The Herpesviridae are a family of viruses which have a large genome of linear, double-stranded DNA (> 120 kb)",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10774200",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 143,
          "text": "Herpesviruses have large double-stranded linear DNA genomes that are formed by site-specific cleavage from complex concatemeric intermediates. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10627574",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 111,
          "text": "BACKGROUND: Herpes Simplex virus types 1 and 2 are enveloped viruses with a linear dsDNA genome of approximatel",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18687114",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 131,
          "text": "Human cytomegalovirus (HCMV) is a double-stranded DNA virus with the largest genome (~235 kb) of the known human herpes viruses. Th",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21491367",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 441,
          "offsetInEndSection": 746,
          "text": "quence-independent nuclear innate sensor ALR, recognizes episomal dsDNA genomes of herpes viruses such as KSHV, EBV, and HSV-1 in the infected cell nuclei, forms an inflammasome complex with ASC and procaspase1, and relocates into the cytoplasm leading into Caspase-1 and IL-1\u03b2 generation. IFI16 also indu",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26121674",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 215,
          "text": "For many years, the generally accepted model for the replication of the double-stranded DNA genome of herpes simplex virus type 1 (HSV-1) incorporated initial circularization of linear molecules in the cell nucleus.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16160176",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 116,
          "text": "Herpes simplex viruses types 1 and 2 (HSV-1 and HSV-2) are doublestranded DNA viruses with a genome size of 152 kbp.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21390711",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 155,
          "text": "Herpes simplex virus has a linear double-stranded DNA genome with directly repeated terminal sequences needed for cleavage and packaging of replicated DNA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17296606",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 354,
          "offsetInEndSection": 463,
          "text": "Like all herpes viruses, the virus has a large double-stranded DNA genome within an icosahedral nucleocapsid.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/9514102",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 133,
          "text": "Herpesviruses are large double stranded DNA animal viruses with the distinguishing ability to establish latent, life-long infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12716057",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/32573705"
      ],
      "ideal_answer": [
        "The Regutools R package to facilitates programmatic access to RegulonDB data in computational biology. regutools gives researchers the possibility of writing reproducible workflows with automated queries to RegulonDB. The regutools package serves as a bridge between RegulonDB data and the Bioconductor ecosystem by reusing the data structures and statistical methods powered by other Bioconductor packages.",
        "RegulonDB has collected, harmonized and centralized data from hundreds of experiments for nearly two decades and is considered a point of reference for transcriptional regulation in Escherichia coli K12. The regutools package serves as a bridge between RegulonDB data and the Bioconductor ecosystem by reusing the data structures and statistical methods powered by other Bioconductor packages."
      ],
      "exact_answer": [
        "regutools"
      ],
      "type": "factoid",
      "id": "606081e594d57fd879000041",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 68,
          "text": "Programmatic access to bacterial regulatory networks with regutools.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32573705",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 9,
          "offsetInEndSection": 1076,
          "text": "RegulonDB has collected, harmonized and centralized data from hundreds of experiments for nearly two decades and is considered a point of reference for transcriptional regulation in Escherichia coli K12. Here, we present the regutools R package to facilitate programmatic access to RegulonDB data in computational biology. regutools gives researchers the possibility of writing reproducible workflows with automated queries to RegulonDB. The regutools package serves as a bridge between RegulonDB data and the Bioconductor ecosystem by reusing the data structures and statistical methods powered by other Bioconductor packages. We demonstrate the integration of regutools with Bioconductor by analyzing transcription factor DNA binding sites and transcriptional regulatory networks from RegulonDB. We anticipate that regutools will serve as a useful building block in our progress to further our understanding of gene regulatory networks.AVAILABILITY AND IMPLEMENTATION: regutools is an R package available through Bioconductor at bioconductor.org/packages/regutools.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32573705",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "How many groups of viruses exist  in the Baltimore Classification?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/28588308",
        "http://www.ncbi.nlm.nih.gov/pubmed/32132243"
      ],
      "ideal_answer": [
        "There are seven \"Baltimore classes\" (BCs) that define the major features of virus reproduction.",
        "seven \"Baltimore classes\" (BCs) that define the major features of virus reproduction",
        "The Baltimore Classification system consists of seven classes (A, B, C, D, E, F, G, C and D) that are classified into seven different regions based on sequence similarity."
      ],
      "exact_answer": [
        "7",
        "seven"
      ],
      "type": "factoid",
      "id": "601f10b71cb411341a000072",
      "snippets": [
        {
          "offsetInBeginSection": 289,
          "offsetInEndSection": 374,
          "text": " seven \"Baltimore classes\" (BCs) that define the major features of virus reproduction",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32132243",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 684,
          "offsetInEndSection": 1002,
          "text": "Phylogenetic analyses of virus hallmark genes combined with analyses of gene-sharing networks show that replication modules of five BCs (three classes of RNA viruses and two classes of reverse-transcribing viruses) evolved from a common ancestor that encoded an RNA-directed RNA polymerase or a reverse transcriptase. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32132243",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 221,
          "offsetInEndSection": 375,
          "text": "Comparison of these routes led to the classification of viruses into seven \"Baltimore classes\" (BCs) that define the major features of virus reproduction.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32132243",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 221,
          "offsetInEndSection": 378,
          "text": "Comparison of these routes led to the classification of viruses into seven \"Baltimore classes\" (BCs) that define the major features of virus reproduction. Ho",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32132243",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1007,
          "offsetInEndSection": 1202,
          "text": "In each of 13 validation datasets encompassing human, macaque, chimpanzee, pig, mouse, rat and all seven Baltimore virus classification groups, the signature provides statistically significant (p",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28588308",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 684,
          "offsetInEndSection": 1001,
          "text": "Phylogenetic analyses of virus hallmark genes combined with analyses of gene-sharing networks show that replication modules of five BCs (three classes of RNA viruses and two classes of reverse-transcribing viruses) evolved from a common ancestor that encoded an RNA-directed RNA polymerase or a reverse transcriptase.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32132243",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What are commensal bacteria?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/30672882",
        "http://www.ncbi.nlm.nih.gov/pubmed/31049923",
        "http://www.ncbi.nlm.nih.gov/pubmed/32758517",
        "http://www.ncbi.nlm.nih.gov/pubmed/33186243"
      ],
      "ideal_answer": [
        "The gut microbiota is composed of a large number of microbes, usually regarded as commensal bacteria. Maintenance of the commensal bacteria that comprise the gut microbiome is essential to both gut and systemic health."
      ],
      "type": "summary",
      "id": "6032866a1cb411341a000142",
      "snippets": [
        {
          "offsetInBeginSection": 652,
          "offsetInEndSection": 791,
          "text": "Predominant bacteria vary, but overall, patients with vasculitis tend to have more pathogenic and less commensal bacteria in active disease",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33186243",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 101,
          "text": "The gut microbiota is composed of a large number of microbes, usually regarded as commensal bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32758517",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 116,
          "text": "Maintenance of the commensal bacteria that comprise the gut microbiome is essential to both gut and systemic health.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30672882",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 91,
          "text": "Commensal bacteria are a major factor in human health and disease pathogenesis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31049923",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is colistin an antibiotic?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/33057672",
        "http://www.ncbi.nlm.nih.gov/pubmed/30892111",
        "http://www.ncbi.nlm.nih.gov/pubmed/30088449"
      ],
      "ideal_answer": [
        "Yes,\ncolistin is an antibiotic."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "6081af3c4e6a4cf630000008",
      "snippets": [
        {
          "offsetInBeginSection": 493,
          "offsetInEndSection": 538,
          "text": "all antibiotics tested, apart from colistin, ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33057672",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 668,
          "offsetInEndSection": 1273,
          "text": "Among the selected antibiotics, there were 12 fluoroquinolone antibiotics (tosufloxacin, levofloxacin, sparfloxacin, clinafloxacin, pazufloxacin, gatifloxacin, enrofloxacin, lomefloxacin, norfloxacin, fleroxacin, flumequine, ciprofloxacin), 15 beta-lactam or cephalosporin antibiotics (cefmenoxime, cefotaxime, ceftizoxime, cefotiam, cefdinir, cefoperazone, cefpiramide, cefamandole, cefixime, ceftibuten, cefmetazole, cephalosporin C, aztreonam, piperacillintazobactam, mezlocillin), 3 tetracycline antibiotics (meclocycline, doxycycline, tetracycline), 2 membrane-acting agents (colistin and clofoctol),",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30088449",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 291,
          "offsetInEndSection": 403,
          "text": " Mice received an antibiotic cocktail (kanamycin, gentamicin, colistin, metronidazole, and vancomycin) for 96\u2009h.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30892111",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which animal bite can cause Capnocytophaga canimorsus infection?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/20407357",
        "http://www.ncbi.nlm.nih.gov/pubmed/25828064",
        "http://www.ncbi.nlm.nih.gov/pubmed/30706413",
        "http://www.ncbi.nlm.nih.gov/pubmed/16904274",
        "http://www.ncbi.nlm.nih.gov/pubmed/31857872",
        "http://www.ncbi.nlm.nih.gov/pubmed/29593919",
        "http://www.ncbi.nlm.nih.gov/pubmed/26947740",
        "http://www.ncbi.nlm.nih.gov/pubmed/15201655",
        "http://www.ncbi.nlm.nih.gov/pubmed/30776586",
        "http://www.ncbi.nlm.nih.gov/pubmed/10352221",
        "http://www.ncbi.nlm.nih.gov/pubmed/12613462",
        "http://www.ncbi.nlm.nih.gov/pubmed/27837588",
        "http://www.ncbi.nlm.nih.gov/pubmed/25024773",
        "http://www.ncbi.nlm.nih.gov/pubmed/26608488",
        "http://www.ncbi.nlm.nih.gov/pubmed/32197716",
        "http://www.ncbi.nlm.nih.gov/pubmed/11269682",
        "http://www.ncbi.nlm.nih.gov/pubmed/23267527",
        "http://www.ncbi.nlm.nih.gov/pubmed/19201139",
        "http://www.ncbi.nlm.nih.gov/pubmed/2915017",
        "http://www.ncbi.nlm.nih.gov/pubmed/25445385",
        "http://www.ncbi.nlm.nih.gov/pubmed/24997586",
        "http://www.ncbi.nlm.nih.gov/pubmed/18926295",
        "http://www.ncbi.nlm.nih.gov/pubmed/28831382",
        "http://www.ncbi.nlm.nih.gov/pubmed/18366884",
        "http://www.ncbi.nlm.nih.gov/pubmed/22293076",
        "http://www.ncbi.nlm.nih.gov/pubmed/29523423",
        "http://www.ncbi.nlm.nih.gov/pubmed/27364692",
        "http://www.ncbi.nlm.nih.gov/pubmed/7588825",
        "http://www.ncbi.nlm.nih.gov/pubmed/21242095",
        "http://www.ncbi.nlm.nih.gov/pubmed/26608484",
        "http://www.ncbi.nlm.nih.gov/pubmed/17205476",
        "http://www.ncbi.nlm.nih.gov/pubmed/31742204"
      ],
      "ideal_answer": [
        "Capnocytophaga canimorsus infection is typically associated with dog bites, especially in asplenic or immunocompromised patients, and typically manifest as sepsis and/or bacteremia."
      ],
      "exact_answer": [
        "Dog"
      ],
      "type": "factoid",
      "id": "6020a9f11cb411341a000080",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 188,
          "text": "INTRODUCTION: Capnocytophaga canimorsus infections are associated with dog bites, especially in asplenic or immunocompromised patients, and typically manifest as sepsis and/or bacteremia. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30706413",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2065,
          "offsetInEndSection": 2219,
          "text": "CONCLUSION: C. canimorsus meningitis is a rare but increasingly important clinical entity occurring in patients of all ages, typically after dog exposure.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30706413",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 192,
          "text": "INTRODUCTION: The gram-negative bacteria known as Capnocytophaga canimorsus (C. canimorsus) is found in dog saliva and rarely can cause severe infection in humans following a bite or scratch. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30776586",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 332,
          "offsetInEndSection": 557,
          "text": "PRESENTATION OF CASE: Here we describe the second ever published case of C. canimorsus bacteremia presenting with acute cholecystitis. The patient presented with epigastric pain and sepsis three weeks post domestic dog bite. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30776586",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1153,
          "offsetInEndSection": 1491,
          "text": "CONCLUSION: We strongly advocate blood cultures in patients who present with abdominal pain and sepsis, particularly when they have a recent history of animal bite. In cases of cholecystitis secondary to C. canimorsus it may be necessary to monitor the patient's progress more closely and treat with prolonged targeted antibiotic therapy.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30776586",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 61,
          "text": "Being Licked by a Dog Can Be Fatal: Capnocytophaga canimorsus",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31742204",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 576,
          "offsetInEndSection": 920,
          "text": "LEARNING POINTS: Pet owners with banal, for instance flu-like, symptoms should urgently seek medical advice when symptoms are unusual.Capnocytophaga canimorsus infection should be considered and empirical antibiotic therapy immediately started or adjusted in the presence of purpura fulminans in the absence of animal bites or immunodeficiency.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31742204",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 199,
          "text": "BACKGROUND: Capnocytophaga canimorsus is a bacterium of the normal oral flora of dogs and cats. Human infection is caused by animal bite but is rarely observed, mainly in immunocompromised patients. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29523423",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 365,
          "offsetInEndSection": 525,
          "text": "CASE REPORT: In the first case, we present a 69-year-old immunocompetent woman with septic shock derived from skin and soft tissue infection after a dog's bite.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29523423",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 754,
          "offsetInEndSection": 855,
          "text": "In the second case, we present a 65-year-old immunocompetent man with meningitis after a dog's bite. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29523423",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 174,
          "text": "A 70-year-old Caucasian woman was treated for Capnocytophaga canimorsus septicaemia. The source of bacteraemia was very likely to be her household pet, an Italian greyhound. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27364692",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 191,
          "text": "INTRODUCTION: The gram-negative bacteria known as Capnocytophaga canimorsus (C. canimorsus) is found in dog saliva and rarely can cause severe infection in humans following a bite or scratch.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30776586",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 90,
          "text": "Capnocytophaga canimorsus bacteremia presenting with acute cholecystitis after a dog bite.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25445385",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 190,
          "offsetInEndSection": 350,
          "text": "Capnocytophaga canimorsus (C. canimorsus) is a Gram-negative rod strongly associated with dog bites, and is known to cause life-threatening infection in humans.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19201139",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 117,
          "offsetInEndSection": 268,
          "text": "Capnocytophaga canimorsus, found in the normal oral flora of dogs, has the potential to cause conditions ranging from minor cellulitis to fatal sepsis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/23267527",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 558,
          "offsetInEndSection": 760,
          "text": "Dog bite injuries can be also associated with Capnocytophaga canimorsus, an aggressive organism which can cause disseminated infections (sepsis) and death, particularly in immunocompromised individuals.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26608484",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 123,
          "text": "Capnocytophaga canimorsus sepsis with purpura fulminans and symmetrical gangrene following a dog bite in a shelter employee",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15201655",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 89,
          "text": "Capnocytophaga canimorsus bacteremia presenting with acute cholecystitis after a dog bite",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25445385",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 109,
          "text": "Fatal dog bite in the absence of significant trauma: Capnocytophaga canimorsus infection and unexpected death",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/20407357",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 172,
          "text": "Newly named in 1989, Capnocytophaga canimorsus is a bacterial pathogen found in the saliva of healthy dogs and cats, and is transmitted to humans principally by dog bites. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25828064",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 158,
          "offsetInEndSection": 323,
          "text": "The species Capnocytophaga canimorsus is particularly associated with dog bites and is known to cause endocarditis, meningitis, and sepsis in the general population.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31857872",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 115,
          "text": "Capnocytophaga canimorsus: an emerging cause of sepsis, meningitis, and post-splenectomy infection after dog bites.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25828064",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 96,
          "text": "Capnocytophaga canimorsus is a gram-negative rod that can be transmitted primarily by dog bites.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28831382",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 171,
          "text": "Newly named in 1989, Capnocytophaga canimorsus is a bacterial pathogen found in the saliva of healthy dogs and cats, and is transmitted to humans principally by dog bites.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25828064",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 67,
          "text": "[Severe sepsis after dog bite caused by Capnocytophaga canimorsus].",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26608488",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 205,
          "text": "Described in this study is the case of a 53-year-old woman who developed a life-threatening infection caused by the bacterium Capnocytophaga canimorsus (C. canimorsus), subsequent to being bitten by a dog.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21242095",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 85,
          "text": "Capnocytophaga canimorsis a cause of septicaemia following a dog bite: a case review.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21242095",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 97,
          "text": "Capnocytophaga canimorsus \u2013 an underestimated danger after dog or cat bite \u2013 review of literature",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27837588",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 124,
          "text": "Capnocytophaga canimorsus, commonly transmitted by dog bites, can cause severe sepsis, and the mortality rate is very high. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32197716",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 141,
          "text": "Capnocytophaga canimorsus, a commensal bacterium from dogs' mouths, can cause septicemia or meningitis in humans through bites or scratches. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17205476",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 217,
          "text": "BACKGROUND: Capnocytophaga canimorsus is a commensal bacterium found in the saliva of dogs and cats. Clinically significant infections in humans after a bite are often associated with the presence of immune deficiency",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/24997586",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 194,
          "text": "C. canimorsus and C. cynodegmi are dog and cat commensals which can be transmitted to humans via bites or scratches and can cause sepsis, meningitis, endocarditis, and eye- or wound infections. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26947740",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 157,
          "text": "Capnocytophaga canimorsus is a commensal bacterium from the canine oral flora, which can cause septicemia or meningitis in humans upon bite wound infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18926295",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 241,
          "text": "A 66-year-old man developed a hemolytic uremic syndrome (HUS) with acute renal failure, thrombocytopenia, fragmented red cells in the blood film and elevated serum LDH following a capnocytophaga canimorsus (DF-2) infection after a dog bite. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/11269682",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 290,
          "text": "Capnocytophaga canimorsus is a fastidious, slow-growing, gram-negative, rod-shaped bacterium that belongs to the normal oral flora of dogs and cats. Human septicemic infections are associated with a high mortality; most cases occur in immunocompromised patients with a history of dog bite. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/7588825",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 274,
          "text": "Capnocytophaga canimorsus has been recognized as an opportunistic pathogen causing systemic infections in immunocompromised individuals. It is part of the normal oral flora of the dog, and can be responsible for localized wound infections in humans in consequence of bites. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18366884",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 124,
          "text": "Capnocytophaga canimorsus causes dog-bite wound induced sepsis in adults, but infection may follow mucous membrane exposure.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/12613462",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 87,
          "text": "Hemolytic uremic syndrome due to Capnocytophaga canimorsus bacteremia after a dog bite.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/10352221",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 99,
          "text": "Capnocytophaga canimorsus was cultured from an infected, dog-inflicted bite wound in a pet rabbit. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/16904274",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 247,
          "offsetInEndSection": 452,
          "text": "We describe an interesting case presenting with hypertensive emergency and type 2 myocardial infarction resulting from Pheochromocytoma associated with Capnocytophaga canimorsus infection from a dog bite. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25024773",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 186,
          "text": "Capnocytophaga canimorsus is a Gram-negative bacilli that is part of the normal oral flora of dogs and some cats; it is well known to cause septicemia and endocarditis after their bite. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29593919",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 158,
          "text": "Capnocytophaga canimorsus is a gram-negative bacterial species hosted in the oral cavity of dogs. C. canimorsus can cause sepsis, meningitis and endocarditis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22293076",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 186,
          "text": "Capnocytophaga canimorsus sp. nov. (formerly CDC group DF-2), a cause of septicemia following dog bite, and C. cynodegmi sp. nov., a cause of localized wound infection following dog bite",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/2915017",
          "endSection": "title"
        }
      ]
    },
    {
      "body": "Are Gram positive bacteria able to release extracellular vesicles?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/31988111",
        "http://www.ncbi.nlm.nih.gov/pubmed/31675472",
        "http://www.ncbi.nlm.nih.gov/pubmed/31776460"
      ],
      "ideal_answer": [
        "Yes, Gram-negative and Gram-positive bacteria release a variety of membrane vesicles through different formation routes."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "6032187e1cb411341a000132",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 116,
          "text": "Gram-negative and Gram-positive bacteria release a variety of membrane vesicles through different formation routes. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31776460",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 231,
          "text": "Release of extracellular vesicles (EVs) is a common feature among eukaryotes, archaea, and bacteria. However, the biogenesis and downstream biological effects of EVs released from gram-positive bacteria remain poorly characterized.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31988111",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1485,
          "offsetInEndSection": 1597,
          "text": " Our findings provide new insight into the role of EVs from gram-positive oral bacteria in periodontal diseases.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31675472",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Do bacteria release extracellular vesicles?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/33264437",
        "http://www.ncbi.nlm.nih.gov/pubmed/31776460",
        "http://www.ncbi.nlm.nih.gov/pubmed/31633842"
      ],
      "ideal_answer": [
        "Yes, Bacterial extracellular vesicles (EVs) are bilayered lipid membrane structures, bearing integral proteins and able to carry diverse cargo outside the cell to distant sites."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "603213ea1cb411341a000131",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 172,
          "text": "Bacterial extracellular vesicles (EVs) are bilayered lipid membrane structures, bearing integral proteins and able to carry diverse cargo outside the cell to distant sites.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31633842",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 116,
          "offsetInEndSection": 287,
          "text": "Knowledge of the structure, molecular cargo and function of bacterial extracellular vesicles (BEVs) is primarily obtained from bacteria cultured in laboratory conditions. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31776460",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 367,
          "offsetInEndSection": 406,
          "text": "bacteria derived-extracellular vesicles",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33264437",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which component of the Influenza A Virus affects mRNA transcription termination?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21118126",
        "http://www.ncbi.nlm.nih.gov/pubmed/6328745",
        "http://www.ncbi.nlm.nih.gov/pubmed/29768209",
        "http://www.ncbi.nlm.nih.gov/pubmed/30177761",
        "http://www.ncbi.nlm.nih.gov/pubmed/18631147",
        "http://www.ncbi.nlm.nih.gov/pubmed/21207185",
        "http://www.ncbi.nlm.nih.gov/pubmed/1371285"
      ],
      "ideal_answer": [
        "Defective Pol II termination occurs independently of the ability of the viral NS1 protein to interfere with host mRNA processing. Instead, this termination defect is a common effect of diverse cellular stresses and underlies the production of previously reported downstream-of-gene transcripts (DoGs).",
        "Influenza A virus (IAV) infection induces global transcriptional defects at the 3' ends of active host genes and RNA polymerase II (RNAPII) run-through into extragenic regions. This phenomenon occurs with multiple strains of IAV, is dependent on influenza NS1 protein, and can be modulated by SUMOylation of an intrinsically disordered region (IDR) of NS1 expressed by the 1918 pandemic IAV strain"
      ],
      "exact_answer": [
        "NS1",
        "The IAV NS1 protein"
      ],
      "type": "factoid",
      "id": "5e4e3cee6d0a277941000030",
      "snippets": [
        {
          "offsetInBeginSection": 2059,
          "offsetInEndSection": 2232,
          "text": "Optimized conditions are presented for the T7 and SP6 phage polymerase systems to minimize these early termination events during in vitro transcription of H5 influenza vRNA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21207185",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 217,
          "text": "Viruses have evolved a number of translational control mechanisms to regulate the levels of expression of viral proteins on polycistronic mRNAs, including programmed ribosomal frameshifting and stop codon readthrough.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18631147",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 218,
          "offsetInEndSection": 350,
          "text": "More recently, another unusual mechanism has been described, that of termination-dependent re-initiation (also known as stop-start).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18631147",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1122,
          "offsetInEndSection": 1464,
          "text": "We conclude that (-)-carbovir 5'-triphosphate is a potent inhibitor of the HIV-1 reverse transcriptase enzyme and that (-)-carbovir most likely inhibits HIV by activity at the triphosphate level by a combination of direct competition for binding of the natural deoxynucleoside triphosphates to the reverse transcriptase and chain termination.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/1371285",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 145,
          "offsetInEndSection": 291,
          "text": " One such mechanism, that of termination-dependent reinitiation, has been described in a number of both negative- and positive-strand RNA viruses.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21118126",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 459,
          "offsetInEndSection": 708,
          "text": " For example, the segment 7 RNA of influenza B is dicistronic, and the stop codon of the M1 ORF and the start codon of the BM2 ORF overlap in the pentanucleotide UAAUG (the stop codon of M1 is shown in bold and the start codon of BM2 is underlined).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21118126",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1008,
          "offsetInEndSection": 1220,
          "text": "The present review summarizes how such interactions regulate reinitiation in an array of RNA viruses, and discusses what is known about reinitiation in viruses that do not rely on apparent mRNA-rRNA interactions.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/21118126",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 150,
          "offsetInEndSection": 396,
          "text": "Using cell biological, biochemical, and genetic tools, we reveal that influenza A virus (IAV) infection induces global transcriptional defects at the 3' ends of active host genes and RNA polymerase II (RNAPII) run-through into extragenic regions.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30177761",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 637,
          "offsetInEndSection": 857,
          "text": "This phenomenon occurs with multiple strains of IAV, is dependent on influenza NS1 protein, and can be modulated by SUMOylation of an intrinsically disordered region (IDR) of NS1 expressed by the 1918 pandemic IAV strain",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30177761",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 914,
          "offsetInEndSection": 1111,
          "text": "These studies establish that during influenza virus infections processing of the NS1 mRNA transcript undergoes a mechanism of splicing similar to that occurring with DNA-directed RNA transcription.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6328745",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 150,
          "text": "Influenza virus gene 8 codes for two nonstructural proteins (NS1 and NS2) which are translated, respectively, from a colinear and an interrupted mRNA.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/6328745",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 585,
          "offsetInEndSection": 714,
          "text": "Defective Pol II termination occurs independently of the ability of the viral NS1 protein to interfere with host mRNA processing.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29768209",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which processes are affected by pathogenic SPTBN1 variants?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34211179"
      ],
      "ideal_answer": [
        "SPTBN1 variants lead to effects that affect \u03b2II-spectrin stability, disrupt binding to key molecular partners, and disturb cytoskeleton organization and dynamics."
      ],
      "exact_answer": [
        [
          "\u03b2II-spectrin stability"
        ],
        [
          "Disrupt binding to key molecular partners"
        ],
        [
          "Disturb cytoskeleton organization and dynamics"
        ]
      ],
      "type": "list",
      "id": "61f7fca6882a024a10000039",
      "snippets": [
        {
          "offsetInBeginSection": 484,
          "offsetInEndSection": 1161,
          "text": "Here we identify heterozygous SPTBN1 variants in 29 individuals with developmental, language and motor delays; mild to severe intellectual disability; autistic features; seizures; behavioral and movement abnormalities; hypotonia; and variable dysmorphic facial features. We show that these SPTBN1 variants lead to effects that affect \u03b2II-spectrin stability, disrupt binding to key molecular partners, and disturb cytoskeleton organization and dynamics. Our studies define SPTBN1 variants as the genetic basis of a neurodevelopmental syndrome, expand the set of spectrinopathies affecting the brain and underscore the critical role of \u03b2II-spectrin in the central nervous system.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34211179",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is Mycobacterium abscessus a human pathogen?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/32662049",
        "http://www.ncbi.nlm.nih.gov/pubmed/34460298",
        "http://www.ncbi.nlm.nih.gov/pubmed/34526902",
        "http://www.ncbi.nlm.nih.gov/pubmed/34516254"
      ],
      "ideal_answer": [
        "Yes,\nMycobacterium abscessus is unique in terms of its high morbidity and treatment failure rates."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "6217db763a8413c653000028",
      "snippets": [
        {
          "offsetInBeginSection": 210,
          "offsetInEndSection": 302,
          "text": "Mycobacterium abscessus is unique in terms of its high morbidity and treatment failure rates",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32662049",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 101,
          "text": "Mycobacterium abscessus has emerged as a successful pathogen owing to its intrinsic drug resistance. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34460298",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 138,
          "text": "Mycobacterium abscessus lung disease is difficult to treat due to intrinsic drug resistance and the persistence of drug-tolerant bacteria.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34516254",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 213,
          "text": "Mycobacterium abscessus has been recognised as a dreadful respiratory pathogen among the non-tuberculous mycobacteria (NTM) because of misdiagnosis, prolonged therapy with poor treatment outcomes and a high cost. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34526902",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which syndrome is caused by pathogenic COL4A3-COL4A5 variants?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34245817",
        "http://www.ncbi.nlm.nih.gov/pubmed/34400539"
      ],
      "ideal_answer": [
        "Massively parallel sequencing identifies pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) in as many as 30% of individuals with focal and segmental glomerulosclerosis (FSGS), 10% of those with kidney failure of unknown cause, and 20% with familial immunoglobulin A (IgA) glomerulonephritis. The population frequencies for Alport syndrome are suggested by the frequencies of predicted pathogenic COL4A3-COL4A5 variants, but must be adjusted for the disease penetrance of individual variants and for the likelihood of already diagnosed disease and non-Gly substitutions.",
        "Pathogenic variants in the genes in Alport Syndrome (COL4A3-C4A5) are found in as many as 30% of individuals with focal and segmental glomerulosclerosis (FSGS), and 20% with familial immunoglobulin A (IGA) Glomerulonephritis. The population frequencies for Alport syndrome are suggested to be higher than the frequencies of predicted pathogenic variants, but must be adjusted for the disease penetrance individual variants and for the likelihood of already diagnosed disease and non-Gly substitutions.",
        "Massively parallel sequencing identifies pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) in as many as 30% of individuals with focal and segmental glomerulosclerosis (FSGS), 10% of those with kidney failure of unknown cause, and 20% with familial immunoglobulin A (IgA) glomerulonephritis."
      ],
      "exact_answer": [
        "Alport syndrome"
      ],
      "type": "factoid",
      "id": "61f56284882a024a10000005",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 137,
          "text": "Pathogenic Variants in the Genes Affected in Alport Syndrome (COL4A3-COL4A5) and Their Association With Other Kidney Conditions: A Review",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34245817",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 318,
          "text": "Massively parallel sequencing identifies pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) in as many as 30% of individuals with focal and segmental glomerulosclerosis (FSGS), 10% of those with kidney failure of unknown cause, and 20% with familial immunoglobulin A (IgA) glomerulonephritis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34245817",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1494,
          "offsetInEndSection": 1845,
          "text": "The population frequencies for Alport syndrome are suggested by the frequencies of predicted pathogenic COL4A3-COL4A5 variants, but must be adjusted for the disease penetrance of individual variants and for the likelihood of already diagnosed disease and non-Gly substitutions. Disease penetrance may depend on other genetic and environmental factors.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34400539",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 327,
          "text": "Massively parallel sequencing identifies pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) in as many as 30% of individuals with focal and segmental glomerulosclerosis (FSGS), 10% of those with kidney failure of unknown cause, and 20% with familial immunoglobulin A (IgA) glomerulonephritis. FSGS ass",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34245817",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Which disease do pathogenic NR2F1 variants cause?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/26986877"
      ],
      "ideal_answer": [
        "Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) is an autosomal-dominant disorder characterized by optic atrophy and intellectual disability caused by loss-of-function mutations in NR2F1.",
        "Bosch-Boonstra-Schaaf optic atrophy syndrome",
        "Bosch-Boonstra-Schaaf Optic Atrophy Syndrome"
      ],
      "exact_answer": [
        "Bosch-Boonstra-Schaaf optic atrophy syndrome",
        "BBSOAS"
      ],
      "type": "factoid",
      "id": "61f52f22882a024a10000002",
      "snippets": [
        {
          "offsetInBeginSection": 9,
          "offsetInEndSection": 202,
          "text": "Bosch-Boonstra-Schaaf optic atrophy syndrome (BBSOAS) is an autosomal-dominant disorder characterized by optic atrophy and intellectual disability caused by loss-of-function mutations in NR2F1.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26986877",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "List biomarkers for sepsis.",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/34517744",
        "http://www.ncbi.nlm.nih.gov/pubmed/34551574",
        "http://www.ncbi.nlm.nih.gov/pubmed/33274532",
        "http://www.ncbi.nlm.nih.gov/pubmed/34634653",
        "http://www.ncbi.nlm.nih.gov/pubmed/33140076",
        "http://www.ncbi.nlm.nih.gov/pubmed/31537145",
        "http://www.ncbi.nlm.nih.gov/pubmed/34524647",
        "http://www.ncbi.nlm.nih.gov/pubmed/32705879"
      ],
      "ideal_answer": [
        "HCK, PRKCD, SIRPA, DOK3, ITGAM, LTB4R, MAPK14, MALT1, NLRC3, LCK\nC-Reactive Protein (CRP), Procalcitonin (PCT) and Interleukin 6 (IL-6)\nsTM"
      ],
      "exact_answer": [
        [
          "CRP"
        ],
        [
          "PCT"
        ],
        [
          "IL-6"
        ],
        [
          "HCK"
        ],
        [
          "PRKCD"
        ],
        [
          "SIRPA"
        ],
        [
          "DOK3"
        ],
        [
          "ITGAM"
        ],
        [
          "LTB4R"
        ],
        [
          "MAPK14"
        ],
        [
          "MALT1"
        ],
        [
          "NLRC3"
        ],
        [
          "LCK"
        ],
        [
          "sTM"
        ]
      ],
      "type": "list",
      "id": "625ba1fae764a5320400002d",
      "snippets": [
        {
          "offsetInBeginSection": 1378,
          "offsetInEndSection": 1569,
          "text": "NLRP3 is useful for the early identification of high-risk septic patients, particularly septic shock patients. Moreover, elevated NRLP3 levels could result in poor septic prediction outcomes.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34634653",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 865,
          "offsetInEndSection": 980,
          "text": "the expression of CD45RO on T lymphocytes is the only useful biomarker for diagnosis of neonatal late-onset sepsis.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31537145",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1675,
          "offsetInEndSection": 1743,
          "text": "These results suggest that sepsis severity leads to CoQ10 depletion.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32705879",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 142,
          "text": "Procalcitonin (PCT) is useful for differentiating between viral and bacterial infections and for reducing the unnecessary use of antibiotics. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34517744",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1429,
          "offsetInEndSection": 1653,
          "text": "These data provide new evidence on the usefulness of plasma procalcitonin as a reliable diagnostic biomarker in the diagnostic algorithm of peripheral blood culture contamination among patients hospitalized in tertiary care.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34524647",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 113,
          "offsetInEndSection": 347,
          "text": "Soluble thrombomodulin (sTM), tissue plasminogen activator-inhibitor complex (t-PAIC), thrombin-antithrombin complex (TAT) and \u03b12-plasmin inhibitor-plasmin complex (PIC) are biomarkers of endothelium injury and coagulation dysfunction",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34551574",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1506,
          "offsetInEndSection": 1613,
          "text": "sTM was considered as a sensitive biomarker for the early prediction of septic shock and sepsis-induced DIC",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34551574",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1149,
          "offsetInEndSection": 1418,
          "text": "The selected hub gene of pediatric sepsis was combined with the markers of cell surface and found 10 core genes (HCK, PRKCD, SIRPA, DOK3, ITGAM, LTB4R, MAPK14, MALT1, NLRC3, LCK). ROC showed that AUC of the 10 core genes for diagnosis of pediatric sepsis was above 0.9.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33274532",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1250,
          "offsetInEndSection": 1439,
          "text": "The CEA POC reader was demonstrated for immunoassay of C-Reactive Protein (CRP), Procalcitonin (PCT) and Interleukin 6 (IL-6), towards a three biomarker panel to aid the diagnosis of sepsis",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33140076",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is there a way to distinguish COVID-19 clinically from other respiratory illnesses, particularly influenza?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/33135801",
        "http://www.ncbi.nlm.nih.gov/pubmed/32542934",
        "http://www.ncbi.nlm.nih.gov/pubmed/32881022",
        "http://www.ncbi.nlm.nih.gov/pubmed/32856744",
        "http://www.ncbi.nlm.nih.gov/pubmed/33537361",
        "http://www.ncbi.nlm.nih.gov/pubmed/33742041",
        "http://www.ncbi.nlm.nih.gov/pubmed/34016193",
        "http://www.ncbi.nlm.nih.gov/pubmed/32903584",
        "http://www.ncbi.nlm.nih.gov/pubmed/32445165"
      ],
      "ideal_answer": [
        "No, the clinical features of COVID-19 overlap substantially with influenza and other respiratory viral illnesses. There is no way to distinguish among them without testing.",
        "Findings indicate that clinical symptoms alone would be insufficient to distinguish between coronavirus disease 2019 and other respiratory infections (eg, influenza) and/or to evaluate the effects of preventive interventions (eg, vaccinations)",
        "Findings indicate that clinical symptoms alone would be insufficient to distinguish between coronavirus disease 2019 and other respiratory infections (eg, influenza) and/or to evaluate the effects of preventive interventions (eg, vaccinations). At present, clinical workup of COVID-19 remains a hard task to accomplish."
      ],
      "exact_answer": "no",
      "type": "yesno",
      "id": "627926bc56bf9aee6f00001a",
      "snippets": [
        {
          "offsetInBeginSection": 166,
          "offsetInEndSection": 410,
          "text": "Findings indicate that clinical symptoms alone would be insufficient to distinguish between coronavirus disease 2019 and other respiratory infections (eg, influenza) and/or to evaluate the effects of preventive interventions (eg, vaccinations).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33537361",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 778,
          "offsetInEndSection": 967,
          "text": "Our reasoning highlights how challenging a balanced approach to a patient with fever and flu-like symptoms can be. At present, clinical workup of COVID-19 remains a hard task to accomplish.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32445165",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 579,
          "offsetInEndSection": 1017,
          "text": "In our retrospective cohort study comparing the clinical presentation of COVID-19 and other respiratory viral infections, we found that anosmia and dysgeusia were symptoms independently associated with COVID-19 and can be important differentiating symptoms in patients presenting with acute respiratory illness. On the other hand, laboratory abnormalities and radiological findings were not statistically different between the two groups.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32881022",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 135,
          "offsetInEndSection": 249,
          "text": "COVID-19 has a similar pattern of infection, clinical symptoms, and chest imaging findings to influenza pneumonia.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33742041",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 354,
          "offsetInEndSection": 573,
          "text": "Here, we hypothesize the order of symptom occurrence could help patients and medical professionals more quickly distinguish COVID-19 from other respiratory diseases, yet such essential information is largely unavailable",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32903584",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 177,
          "text": "It is difficult to distinguish coronavirus disease-2019 (COVID-19) from other viral respiratory tract infections owing to the similarities in clinical and radiological findings.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33135801",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Can parasite infections by Schistosoma japonicum prevent or improve asthma?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/31496071",
        "http://www.ncbi.nlm.nih.gov/pubmed/34703270",
        "http://www.ncbi.nlm.nih.gov/pubmed/34358648",
        "http://www.ncbi.nlm.nih.gov/pubmed/26840774",
        "http://www.ncbi.nlm.nih.gov/pubmed/28614408",
        "http://www.ncbi.nlm.nih.gov/pubmed/17042799",
        "http://www.ncbi.nlm.nih.gov/pubmed/18654798",
        "http://www.ncbi.nlm.nih.gov/pubmed/18824533",
        "http://www.ncbi.nlm.nih.gov/pubmed/34169075"
      ],
      "ideal_answer": [
        "A peptide named as SJMHE1 from Schistosoma japonicum can suppress asthma in mice."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "622f6ad13a8413c6530000aa",
      "snippets": [
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 146,
          "text": "Helminths and their products can shape immune responses by modulating immune cells, which are dysfunctional in inflammatory diseases such as asthm",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31496071",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 95,
          "text": "Schistosoma japonicum peptide SJMHE1 suppresses airway inflammation of allergic asthma in mice.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31496071",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 107,
          "text": "Schistosoma japonicum infection downregulates house dust mite-induced allergic airway inflammation in mice.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28614408",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1091,
          "offsetInEndSection": 1294,
          "text": "To our knowledge, it is the first study to reveal the impact of S. japonicum infection on house dust mite induced severe asthma. More in depth investigation is need to elucidate the underlying mechanisms",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28614408",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 116,
          "text": "Novel T-cell epitopes on Schistosoma japonicum SjP40 protein and their preventive effect on allergic asthma in mice.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26840774",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 845,
          "offsetInEndSection": 1022,
          "text": "hese results reveal a novel form of immune protective mechanism, which may play an important role in the modulating effect of helminth infection on allergic asthmatic reactions.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26840774",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 597,
          "offsetInEndSection": 843,
          "text": "Using a panel of overlapping peptides, we identified T-cell epitopes on SjP40 protein of Schistosoma japonicum, which can induce Th1 cytokine and inhibit the production of Th2 cytokines and airway inflammation in a mouse model of allergic asthma.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26840774",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 9,
          "offsetInEndSection": 148,
          "text": "Helminths and their products can regulate immune response and offer new strategies to control and alleviate inflammation, including asthma.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34703270",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 115,
          "text": "SJMHE1 Peptide from Schistosoma japonicum Inhibits Asthma in Mice by Regulating Th17/Treg Cell Balance via miR-155.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34703270",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 149,
          "offsetInEndSection": 254,
          "text": "We previously found that a peptide named as SJMHE1 from Schistosoma japonicum can suppress asthma in mice",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34703270",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 608,
          "offsetInEndSection": 855,
          "text": "el of overlapping peptides, we identified T-cell epitopes on SjP40 protein of Schistosoma japonicum, which can induce Th1 cytokine and inhibit the production of Th2 cytokines and airway inflammation in a mouse model of allergic asthma. These resul",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26840774",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 150,
          "offsetInEndSection": 268,
          "text": "has been shown that helminth infections including Schistosoma mansoni may modulate atopic diseases including asthma. I",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18654798",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 106,
          "text": "Schistosoma japonicum infection downregulates house dust mite-induced allergic airway inflammation in mice",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28614408",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1109,
          "offsetInEndSection": 1237,
          "text": "it is the first study to reveal the impact of S. japonicum infection on house dust mite induced severe asthma. More in depth inv",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28614408",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 402,
          "offsetInEndSection": 675,
          "text": "s study, we investigated the impact of Schistosoma japonicum infection on the allergic airway inflammation induced by repeated intracheal inoculations of house dust mites (HDM), which is a Th17 and neutrophils dominant murine asthma model, mimicking severe asthma. We found",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28614408",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 101,
          "text": "Schistosoma japonicum infection showed protective effects against allergic airway inflammation (AAI).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34169075",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 152,
          "offsetInEndSection": 384,
          "text": "Therefore, we hypothesize that Schistosoma japonicum egg antigens, a type of native antigen, can induce production of CD4(+) CD25(+) T cells with regulatory activity, modulating airway inflammation and inhibiting asthma development.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17042799",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 106,
          "text": "Schistosoma japonicum infection modulates the development of allergen-induced airway inflammation in mice.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18654798",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 147,
          "offsetInEndSection": 266,
          "text": "It has been shown that helminth infections including Schistosoma mansoni may modulate atopic diseases including asthma.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18654798",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 123,
          "text": "Schistosoma japonicum egg antigens stimulate CD4 CD25 T cells and modulate airway inflammation in a murine model of asthma.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17042799",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 229,
          "offsetInEndSection": 511,
          "text": "Most previous studies focused on understanding the preventive effect of S. japonicum infection on asthma (infection before allergen sensitization), whereas the protective effects of S. japonicum infection (allergen sensitization before infection) on asthma were rarely investigated.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34169075",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1619,
          "offsetInEndSection": 1739,
          "text": "In conclusion, our data showed that lung-stage S. japonicum infection could relieve OVA-induced asthma in a mouse model.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34169075",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 512,
          "offsetInEndSection": 641,
          "text": "In this study, we investigated the protective effects of S. japonicum infection on AAI using a mouse model of OVA-induced asthma.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34169075",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 972,
          "offsetInEndSection": 1122,
          "text": " prior to OVA immunization. These results suggest that both bisexual and male S. japonicum infections may modulate the development of allergic asthma.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18654798",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 699,
          "offsetInEndSection": 849,
          "text": "aponicum, which can induce Th1 cytokine and inhibit the production of Th2 cytokines and airway inflammation in a mouse model of allergic asthma. These",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26840774",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 455,
          "offsetInEndSection": 605,
          "text": "ve found that Schistosoma infection or Schistosoma related products can improve or prevent some immune and inflammatory diseases, such as severe asthm",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34358648",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 904,
          "offsetInEndSection": 1090,
          "text": "Our findings indicated that S. japonicum infection was able to effectively inhibit host's allergic airway inflammation, which may be related to the upregulated Treg cells upon infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28614408",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1000,
          "offsetInEndSection": 1122,
          "text": "These results suggest that both bisexual and male S. japonicum infections may modulate the development of allergic asthma.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18654798",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 936,
          "offsetInEndSection": 1069,
          "text": "We found that lung-stage S. japonicum infection significantly ameliorated OVA-induced AAI, whereas post-lung-stage infection did not.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34169075",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1201,
          "offsetInEndSection": 1378,
          "text": "In a murine model of asthma, S. japonicum egg antigens decreased the expression of Th2 cytokines, relieved antigen-induced airway inflammation, and inhibited asthma development.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/17042799",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 667,
          "offsetInEndSection": 745,
          "text": "We found that S. japonicum infection downregulated airway hyperresponsiveness.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/28614408",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 419,
          "offsetInEndSection": 655,
          "text": "However, in recent years, studies have found that Schistosoma infection or Schistosoma related products can improve or prevent some immune and inflammatory diseases, such as severe asthma, inflammatory bowel disease, diabetes and so on.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34358648",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 159,
          "text": "In areas where schistosomiasis is endemic, a negative correlation is observed between atopy and helminth infection, associated with a low prevalence of asthma.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18824533",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Can reinfection occur after SARS-CoV-2 infection?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/33853339",
        "http://www.ncbi.nlm.nih.gov/pubmed/35899182",
        "http://www.ncbi.nlm.nih.gov/pubmed/35935779",
        "http://www.ncbi.nlm.nih.gov/pubmed/33257644",
        "http://www.ncbi.nlm.nih.gov/pubmed/34961403",
        "http://www.ncbi.nlm.nih.gov/pubmed/35263638",
        "http://www.ncbi.nlm.nih.gov/pubmed/35593164",
        "http://www.ncbi.nlm.nih.gov/pubmed/34447364",
        "http://www.ncbi.nlm.nih.gov/pubmed/34873592",
        "http://www.ncbi.nlm.nih.gov/pubmed/34367645",
        "http://www.ncbi.nlm.nih.gov/pubmed/35233580",
        "http://www.ncbi.nlm.nih.gov/pubmed/33849385",
        "http://www.ncbi.nlm.nih.gov/pubmed/36275814",
        "http://www.ncbi.nlm.nih.gov/pubmed/35931371",
        "http://www.ncbi.nlm.nih.gov/pubmed/36413551",
        "http://www.ncbi.nlm.nih.gov/pubmed/34755830",
        "http://www.ncbi.nlm.nih.gov/pubmed/34043841",
        "http://www.ncbi.nlm.nih.gov/pubmed/35488305",
        "http://www.ncbi.nlm.nih.gov/pubmed/36301607",
        "http://www.ncbi.nlm.nih.gov/pubmed/34632431",
        "http://www.ncbi.nlm.nih.gov/pubmed/33791729",
        "http://www.ncbi.nlm.nih.gov/pubmed/34120579",
        "http://www.ncbi.nlm.nih.gov/pubmed/33338197",
        "http://www.ncbi.nlm.nih.gov/pubmed/36176508",
        "http://www.ncbi.nlm.nih.gov/pubmed/35743421",
        "http://www.ncbi.nlm.nih.gov/pubmed/35904405",
        "http://www.ncbi.nlm.nih.gov/pubmed/33219681",
        "http://www.ncbi.nlm.nih.gov/pubmed/33630817",
        "http://www.ncbi.nlm.nih.gov/pubmed/34459525",
        "http://www.ncbi.nlm.nih.gov/pubmed/34908003",
        "http://www.ncbi.nlm.nih.gov/pubmed/35264078",
        "http://www.ncbi.nlm.nih.gov/pubmed/33315049",
        "http://www.ncbi.nlm.nih.gov/pubmed/33315061",
        "http://www.ncbi.nlm.nih.gov/pubmed/36298593",
        "http://www.ncbi.nlm.nih.gov/pubmed/33361342",
        "http://www.ncbi.nlm.nih.gov/pubmed/35262003",
        "http://www.ncbi.nlm.nih.gov/pubmed/36164552",
        "http://www.ncbi.nlm.nih.gov/pubmed/33930542",
        "http://www.ncbi.nlm.nih.gov/pubmed/34521025",
        "http://www.ncbi.nlm.nih.gov/pubmed/34468184",
        "http://www.ncbi.nlm.nih.gov/pubmed/34492110"
      ],
      "ideal_answer": [
        "Protective and detectable immune responses are induced after SARS-CoV-2 infection but it is not yet established to what degree and for how long protection against reinfection lasts. Evidence suggests that some of these responses can be detected for at least a year following infection.\n\nThe short-term risk of reinfection (e.g., within the first several months after initial infection) is low. Several studies estimated the risk of reinfection to be less than 1 percent in the subsequent 5-8 months following initial infection. The risk of reinfection may be greater with the Omicron variant."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "643c446357b1c7a31500002f",
      "snippets": [
        {
          "offsetInBeginSection": 14,
          "offsetInEndSection": 322,
          "text": "A precise estimate of the frequency and severity of SARS-CoV-2 reinfections would be critical to optimize restriction and vaccination policies for the hundreds of millions previously infected subjects. We performed a meta-analysis to evaluate the risk of reinfection and COVID-19 following primary infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35904405",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 921,
          "offsetInEndSection": 1185,
          "text": "Reinfection rates were still 0.66% after \u226512\u2009months from first infection, and the risk was substantially lower among vaccinated subjects (0.32% vs. 0.74% for unvaccinated individuals). During the first 3\u00a0months of Omicron wave, the reinfection rates reached 3.31%.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35904405",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1357,
          "offsetInEndSection": 1683,
          "text": "A strong natural immunity follows the primary infection and may last for more than one year, suggesting that the risk and health care needs of recovered subjects might be limited. Although the reinfection rates considerably increased during the Omicron wave, the risk of a secondary severe or lethal disease remained very low.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35904405",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 302,
          "text": "Despite over 140\u00a0million SARS-CoV-2 infections worldwide since the beginning of the pandemic, relatively few confirmed cases of SARS-CoV-2 reinfection have been reported. While immunity from SARS-CoV-2 infection is probable, at least in the short term, few studies have quantified the reinfection risk.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34043841",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1006,
          "offsetInEndSection": 1627,
          "text": "Reinfection was an uncommon event (absolute rate 0%-1.1%), with no study reporting an increase in the risk of reinfection over time. Only one study estimated the population-level risk of reinfection based on whole genome sequencing in a subset of patients; the estimated risk was low (0.1% [95% CI: 0.08-0.11%]) with no evidence of waning immunity for up to 7\u00a0months following primary infection. These data suggest that naturally acquired SARS-CoV-2 immunity does not wane for at least 10\u00a0months post-infection. However, the applicability of these studies to new variants or to vaccine-induced immunity remains uncertain.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34043841",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 227,
          "offsetInEndSection": 339,
          "text": "The risk of reinfection increased almost 18-fold following emergence of the Omicron variant compared with Delta.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35593164",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 120,
          "text": "Better understanding of the protective duration of prior SARS-CoV-2 infection against reinfection is needed.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35233580",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2153,
          "offsetInEndSection": 2375,
          "text": "This large US population-based study demonstrates that SARS-CoV-2 reinfection is uncommon among individuals with laboratory evidence of a previous infection. Protection from SARS-CoV-2 reinfection is stable up to one year.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35233580",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1807,
          "offsetInEndSection": 1926,
          "text": "The duration of protection against reinfection was stable over the median 5 months and up to 1-year follow-up interval.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35233580",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2800,
          "offsetInEndSection": 3066,
          "text": "Among >22 million individuals tested February 2020 through April 2021, the relative risk of reinfection among those with prior infection was 87% lower than the risk of infection among individuals without prior infection. This protection was durable for up to a year.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35233580",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 275,
          "offsetInEndSection": 695,
          "text": "The aim of this study was a comparison of antibody level after infection caused by Delta and Omicron variants. The study included 203 persons who underwent mild COVID-19 despite two doses of vaccine. The obtained results indicate that a significantly lower titer was observed in patients with the Omicron variant infection. Therefore, these patients may be at risk of reinfection with new strains of the Omicron variant.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36298593",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 199,
          "text": "SARS-CoV-2 infection does not confer long immunity. However, studies suggest that prior infection is associated with lower risk of reinfection and milder outcomes of recurrent infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36275814",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2115,
          "offsetInEndSection": 2343,
          "text": "Reinfection with the SARS-CoV-2 Delta variant resulted in fewer hospitalizations compared to the primary Delta infection, suggesting that primary infection may, to some extent, produce at least short lasting protective immunity.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36275814",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1386,
          "offsetInEndSection": 1705,
          "text": "The vast majority of anti-spike IgG positive individuals remain anti-spike IgG positive for at least 8 months regardless of initial COVID-19 disease severity. The presence of anti-spike IgG antibodies is associated with a substantially reduced risk of reinfection up to 9 months following asymptomatic to mild COVID-19.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34459525",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 266,
          "text": "Emerging data support detectable immune responses for months after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and vaccination, but it is not yet established to what degree and for how long protection against reinfection lasts.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34459525",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 107,
          "text": "Comparative genomic analysis demonstrates that true reinfection following SARS-CoV-2 infection is possible.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35262003",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 758,
          "offsetInEndSection": 974,
          "text": "Our findings indicate that reinfection results in restricted SARS-CoV-2 replication despite substantial levels of humoral immunity, denoting the potential for transmission through reinfected asymptomatic individuals.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35263638",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 188,
          "text": "Prior to the emergence of antigenically distinct SARS-CoV-2 variants, reinfections were reported infrequently - presumably due to the generation of durable and protective immune responses.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33791729",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 90,
          "offsetInEndSection": 212,
          "text": " It is currently unclear whether the previous infection with SARS-CoV-2 provides protection against reinfection with VOCs.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34120579",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1257,
          "offsetInEndSection": 1402,
          "text": "Our case supports the hypothesis that SARS-CoV-2 reinfection may occur once antibody titers decrease or following the emergence of a new variant.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35935779",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 213,
          "text": "Reinfection with SARS-CoV-2 has been well documented, yet little is known about the degree of protection a previous infection provides against reinfection, especially against Variants of Concern (VOC).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35935779",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1286,
          "offsetInEndSection": 1506,
          "text": "Reinfection with SARS-CoV-2 is a strong possibility. This case raises concerns that asymptomatic infections may not provide long-term protective immunity to all patients, which could make them susceptible to reinfection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33257644",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1149,
          "offsetInEndSection": 1319,
          "text": "The rate of reinfection with SARS-CoV-2 is relatively low. The protection against SARS-CoV-2 after natural infection is comparable to that estimated for vaccine efficacy.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34908003",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1497,
          "offsetInEndSection": 1669,
          "text": "SARS-CoV-2 reinfection can occur but is a rare phenomenon suggestive of protective immunity against reinfection that lasts for at least a few months post primary infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33315061",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1593,
          "offsetInEndSection": 1751,
          "text": "Reinfection by SARS-CoV-2 under endemic conditions would likely occur between 3 months and 5\u00b71 years after peak antibody response, with a median of 16 months.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34632431",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 318,
          "text": "It is currently unclear whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection will remain a rare event, only occurring in individuals who fail to mount an effective immune response, or whether it will occur more frequently when humoral immunity wanes following primary infection.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33315049",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is COVID-19 caused by the Omicron variant less severe than infection caused by other variants?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/35408618",
        "http://www.ncbi.nlm.nih.gov/pubmed/36419108",
        "http://www.ncbi.nlm.nih.gov/pubmed/35415869",
        "http://www.ncbi.nlm.nih.gov/pubmed/35043116",
        "http://www.ncbi.nlm.nih.gov/pubmed/35225672",
        "http://www.ncbi.nlm.nih.gov/pubmed/35468332",
        "http://www.ncbi.nlm.nih.gov/pubmed/36224216",
        "http://www.ncbi.nlm.nih.gov/pubmed/35313451",
        "http://www.ncbi.nlm.nih.gov/pubmed/35583528",
        "http://www.ncbi.nlm.nih.gov/pubmed/35788085",
        "http://www.ncbi.nlm.nih.gov/pubmed/35018384",
        "http://www.ncbi.nlm.nih.gov/pubmed/36417338",
        "http://www.ncbi.nlm.nih.gov/pubmed/35811082",
        "http://www.ncbi.nlm.nih.gov/pubmed/36285226",
        "http://www.ncbi.nlm.nih.gov/pubmed/35751531",
        "http://www.ncbi.nlm.nih.gov/pubmed/35404391",
        "http://www.ncbi.nlm.nih.gov/pubmed/36056686",
        "http://www.ncbi.nlm.nih.gov/pubmed/35961786",
        "http://www.ncbi.nlm.nih.gov/pubmed/35071500",
        "http://www.ncbi.nlm.nih.gov/pubmed/35594069",
        "http://www.ncbi.nlm.nih.gov/pubmed/35869843",
        "http://www.ncbi.nlm.nih.gov/pubmed/35746768",
        "http://www.ncbi.nlm.nih.gov/pubmed/35305296"
      ],
      "ideal_answer": [
        "Multiple contexts indicate that infection caused by the Omicron variant of COVID-19 is less severe than infection caused by other variants. Studies have shown that Omicron is associated with milder symptoms and a lower risk of hospitalization compared to previous variants such as Delta. However, it is important to note that not all infected individuals experience a mild Omicron infection, and the severity of the illness can still vary depending on factors such as age and comorbidities.",
        "Early data suggest that COVID-19 caused by the Omicron variant is less severe than infection caused by prior variants. Some studies have shown a reduced risk of hospitalization, intensive care unit admission, and in-hospital mortality. The relative mildness of disease reported in these studies may reflect the younger age of individuals impacted at this stage of the surge or a higher proportion of reinfections.",
        "COVID-19 caused by the Omicron variant appears to be less severe than infections caused by previous variants. Studies have reported milder symptoms and reduced hospitalization rates associated with Omicron infections. For instance, one study found a two-thirds reduction in the risk of COVID-19 hospitalization compared to the Delta variant. Another study comparing first-time SARS-CoV-2 infections during the emergence of Omicron and Delta variants found significantly less severe outcomes for Omicron cases. After adjusting for various factors, the 3-day risks of emergency department visits, hospitalizations, ICU admissions, and mechanical ventilation were consistently lower in the Omicron cohort compared to the Delta cohort. Furthermore, a large national cohort study assessing relative risks of hospital attendance, admission, or death showed that the risk of severe outcomes following SARS-CoV-2 infection is substantially lower for Omicron than for Delta. However, it is important to note that not all individuals infected with Omicron experience mild illness."
      ],
      "exact_answer": "yes",
      "type": "yesno",
      "id": "64299b6a57b1c7a315000001",
      "snippets": [
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 110,
          "text": "Omicron appears to lead to a milder illness for patients compared with previous COVID-19 variants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35811082",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1395,
          "offsetInEndSection": 1606,
          "text": "Most of those infected with Omicron experience symptoms, and the Omicron variant appears to lead to less severe disease. However, this does not mean that all the infected experience an Omicron infection as mild.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35811082",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1199,
          "offsetInEndSection": 1302,
          "text": "In this study, symptoms of COVID-19 tended to be milder than described for previous SARS-CoV2 variants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35751531",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1803,
          "offsetInEndSection": 1952,
          "text": "These early national data suggest that omicron is associated with a two-thirds reduction in the risk of COVID-19 hospitalisation compared with delta.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35468332",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 171,
          "text": "Globally, SARS CoV-2 omicron variant has led to a notable increase of COVID-19 diagnoses, although with less severe clinical manifestations and decreased hospitalizations.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36417338",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 305,
          "offsetInEndSection": 512,
          "text": "One of the newest variants is Omicron, which shows an increase in its transmissibility, but also reportedly reduces hospitalization rates and shows milder symptoms, such as in those who have been vaccinated.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35408618",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 261,
          "offsetInEndSection": 586,
          "text": "Here we compared 3-day risks of emergency department (ED) visit, hospitalization, intensive care unit (ICU) admission, and mechanical ventilation in patients who were first infected during a time period when the Omicron variant was emerging to those in patients who were first infected when the Delta variant was predominant.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35018384",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2651,
          "offsetInEndSection": 2870,
          "text": "First time SARS-CoV-2 infections occurring at a time when the Omicron variant was rapidly spreading were associated with significantly less severe outcomes than first-time infections when the Delta variant predominated.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35018384",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1670,
          "offsetInEndSection": 2194,
          "text": "After propensity-score matching for demographics, socio-economic determinants of health, comorbidities, medications and vaccination status, the 3-day risks in the Emergent Omicron cohort outcomes were consistently less than half those in the Delta cohort: ED visit: 4.55% vs. 15.22% (risk ratio or RR: 0.30, 95% CI: 0.28-0.33); hospitalization: 1.75% vs. 3.95% (RR: 0.44, 95% CI: 0.38-0.52]); ICU admission: 0.26% vs. 0.78% (RR: 0.33, 95% CI:0.23-0.48); mechanical ventilation: 0.07% vs. 0.43% (RR: 0.16, 95% CI: 0.08-0.32).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35018384",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 389,
          "offsetInEndSection": 534,
          "text": "The Omicron is highly transmissible and is spreading faster than any previous variant, but may cause less severe symptoms than previous variants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35071500",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 405,
          "text": "The omicron variant (B.1.1.529) of SARS-CoV-2 has demonstrated partial vaccine escape and high transmissibility, with early studies indicating lower severity of infection than that of the delta variant (B.1.617.2). We aimed to better characterise omicron severity relative to delta by assessing the relative risk of hospital attendance, hospital admission, or death in a large national cohort.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35305296",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1294,
          "offsetInEndSection": 1555,
          "text": "The adjusted hazard ratio (HR) of hospital attendance (not necessarily resulting in admission) with omicron compared with delta was 0\u00b756 (95% CI 0\u00b754-0\u00b758); for hospital admission and death, HR estimates were 0\u00b741 (0\u00b739-0\u00b743) and 0\u00b731 (0\u00b726-0\u00b737), respectively.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35305296",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 2756,
          "offsetInEndSection": 2951,
          "text": " The risk of severe outcomes following SARS-CoV-2 infection is substantially lower for omicron than for delta, with higher reductions for more severe endpoints and significant variation with age.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35305296",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 222,
          "text": "The Omicron variant (B.1.1.529) is estimated to be more transmissible than previous strains of SARS-CoV-2 especially among children, potentially resulting in croup which is a characteristic disease in children.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36419108",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1252,
          "offsetInEndSection": 1802,
          "text": "A significant difference between the age-specific susceptibility to the Omicron and that to the pre-Omicron variants was found in the younger age group. The rise in susceptibility to the Omicron/pre-Delta variant was highest in the 10-15 years age group (5.28 times [95% CI, 4.94-5.60]), and the rise in susceptibility to the Omicron/Delta variant was highest in the 15-19 years age group (3.21 times [95% CI, 3.12-3.31]), whereas in those aged 50 years or more, the susceptibility to the Omicron/pre-Omicron remained stable at approximately twofold.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36419108",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1815,
          "offsetInEndSection": 2023,
          "text": "Even after adjusting for contact pattern, vaccination status, and waning of vaccine effectiveness, the Omicron variant of SARS-CoV-2 tends to propagate more easily among children than the pre-Omicron strains.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36419108",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 174,
          "text": "Infection with SARS-CoV-2 variant Omicron is considered to be less severe than infection with variant Delta, with rarer occurrence of severe disease requiring intensive care.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36224216",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 447,
          "offsetInEndSection": 691,
          "text": "We found that infections caused by the Omicron variant caused significantly less morbidity, including admission to the hospital and requirement for oxygen supplementation, and significantly less mortality than those caused by the Delta variant.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35415869",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 76,
          "offsetInEndSection": 201,
          "text": " Early work suggests that infections caused by the Omicron variant may be less severe than those caused by the Delta variant.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35415869",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 388,
          "offsetInEndSection": 534,
          "text": " The Omicron is highly transmissible and is spreading faster than any previous variant, but may cause less severe symptoms than previous variants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35071500",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 372,
          "offsetInEndSection": 591,
          "text": " Early reports of Omicron variant confirmed patients indicated less severe disease course compared with the disease caused by previously encountered variants with absence of data regarding cardiac involvement by Omicron",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36285226",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 782,
          "offsetInEndSection": 913,
          "text": "However, we found that infections by Omicron were significantly less severe than those caused by Delta and other previous variants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35583528",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 15,
          "offsetInEndSection": 175,
          "text": "Severe acute respiratory syndrome coronavirus 2 infection from the Omicron variant in children/adolescents is less severe than infection from the Delta variant.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35404391",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1512,
          "offsetInEndSection": 1629,
          "text": "Omicron variant infection is associated with significantly lower severity of disease compared with the Delta variant.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35788085",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 146,
          "text": "In the general population, illness after infection with the SARS-CoV-2 Omicron variant is less severe compared with previous variants.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35869843",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "What drugs are used to treat FIP, Feline Infectious Peritonitis in cats?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/32441826",
        "http://www.ncbi.nlm.nih.gov/pubmed/30755068",
        "http://www.ncbi.nlm.nih.gov/pubmed/35934910",
        "http://www.ncbi.nlm.nih.gov/pubmed/15123155",
        "http://www.ncbi.nlm.nih.gov/pubmed/32220667",
        "http://www.ncbi.nlm.nih.gov/pubmed/32456286",
        "http://www.ncbi.nlm.nih.gov/pubmed/18196725",
        "http://www.ncbi.nlm.nih.gov/pubmed/27027316",
        "http://www.ncbi.nlm.nih.gov/pubmed/36297266",
        "http://www.ncbi.nlm.nih.gov/pubmed/34835034",
        "http://www.ncbi.nlm.nih.gov/pubmed/31585653",
        "http://www.ncbi.nlm.nih.gov/pubmed/29778200",
        "http://www.ncbi.nlm.nih.gov/pubmed/32848107",
        "http://www.ncbi.nlm.nih.gov/pubmed/22092616",
        "http://www.ncbi.nlm.nih.gov/pubmed/19482534",
        "http://www.ncbi.nlm.nih.gov/pubmed/25596968",
        "http://www.ncbi.nlm.nih.gov/pubmed/26850532",
        "http://www.ncbi.nlm.nih.gov/pubmed/32521771",
        "http://www.ncbi.nlm.nih.gov/pubmed/35078478",
        "http://www.ncbi.nlm.nih.gov/pubmed/18395801",
        "http://www.ncbi.nlm.nih.gov/pubmed/36387398",
        "http://www.ncbi.nlm.nih.gov/pubmed/25701212",
        "http://www.ncbi.nlm.nih.gov/pubmed/33799985"
      ],
      "ideal_answer": [
        "Drugs used to treat Feline Infectious Peritonitis (FIP) in cats include immune suppressive drugs such as prednisone or cyclophosphamide, recombinant feline interferon, glucocorticoids, antibiotics, passive immunization with Feliserin, Propentofylline (PPF), Polyprenyl Immunostimulant, antiviral RNAi, viroporin inhibitors, a broad-spectrum coronavirus protease inhibitor GC376, anti-feline TNF-alpha monoclonal antibody, the adenosine nucleoside analogue GS-441524, mefloquine, itraconazole, and remdesivir.",
        "Adalimumab (an anti-human-TNF-alpha monoclonal antibody) and itraconazole (ICZ) are used to treat FIP, Feline Infectious Peritonitis in cats.",
        "The most commonly used drugs to treat FIP in cats are Glucocorticoids, Interferon Omega, and Polyprenyl Immunostimulant (PI).",
        "While there are a few drugs like Propentofylline, Feline interferon-omega that have been shown to be ineffective for treatment of FIP Feline Infectious Peritonitis, therapies with GC 376, GS-441524, Mutian\u00ae Xraphconn (Mutian X), Mefloquine, Anti TNF alpha Antibody, remdesivir, and siRNA show promising results while the efficacy of treatment with viroporin inhibitors, itraconazole, prednisolone, and Polyprenyl Immunostimulant is inconclusive",
        "Prednisone and Cyclophosphamide are immune suppressive drugs used to treat Feline Infectious Peritonitis (FIP) in cats.",
        "Adalimumab (an anti-human-TNF-alpha monoclonal antibody) and itraconazole are used to treat FIP, Feline Infectious Peritonitis in cats.",
        "Feline infectious peritonitis (FIP) is considered a fatal disease, but treatment options are available to help control the immune response triggered by the infection with the feline coronavirus (FCoV). Immune suppressive drugs such as prednisone or cyclophosphamide may slow disease progression, while a combination of recombinant feline interferon and glucocorticoid, Feliserin, Polyprenyl Immunostimulant, protease inhibitors, antiviral RNAi, viroporin inhibitors, anti-fTNF-alpha antibody, GS-441524, Mutian\u00ae Xraphconn (Mutian X), mefloquine, and remdesivir have all been used to treat FIP in cats with varying degrees of success. Itraconazole in combination with prednisolone has also been used to treat effusive FIP.",
        "The drugs used to treat Feline Infectious Peritonitis (FIP) in cats include antiviral drugs such as interferon omega, lopinavir/ritonavir, and GS-441524, as well as immunomodulatory drugs such as glucocorticoids and cyclosporine.",
        "Glucocorticoids, immune modulators, and immune suppressive drugs such as prednisone or cyclophosphamide are used to treat FIP in cats."
      ],
      "exact_answer": [
        [
          "Prednisolone",
          "immune suppressive drugs",
          "glucocorticoid"
        ],
        [
          "Cyclophosphamide"
        ],
        [
          "Feline interferon-omega",
          "FeIFN-omega"
        ],
        [
          "Propentofylline",
          "PPF"
        ],
        [
          "Polyprenyl Immunostimulant"
        ],
        [
          "GC376",
          "3C-like protease (3CLpro) inhibitors"
        ],
        [
          "siRNA"
        ],
        [
          "viroporin inhibitor",
          "HMA",
          "DIDS"
        ],
        [
          "anti-feline TNF-alpha monoclonal antibody"
        ],
        [
          "GS-441524"
        ],
        [
          "Mutian\u00ae",
          "Xraphconn",
          "(Mutian X)"
        ],
        [
          "Mefloquine"
        ],
        [
          "itraconazole"
        ],
        [
          "remdesivir"
        ]
      ],
      "type": "list",
      "id": "64240f33690f196b51000049",
      "snippets": [
        {
          "offsetInBeginSection": 126,
          "offsetInEndSection": 407,
          "text": "s FIP is an immune-mediated disease, treatment is mainly aimed at controlling the immune response triggered by the infection with the feline coronavirus (FCoV). Immune suppressive drugs such as prednisone or cyclophosphamide may slow disease progression but do not produce a cure. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18395801",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 178,
          "text": "A total of 12 clinically ill cats previously diagnosed as feline infectious peritonitis (FIP) were treated with a combination of recombinant feline interferon and glucocorticoid.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15123155",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 109,
          "offsetInEndSection": 236,
          "text": "YPOTHESIS: Feline interferon-omega (FeIFN-omega) prolongs survival time and increases quality of life in cats with FIP.ANIMALS:",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18196725",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 615,
          "offsetInEndSection": 730,
          "text": "All cats received adjunctive treatment with glucocorticoids and antibiotics and passive immunization with Feliserin",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/18196725",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 125,
          "offsetInEndSection": 261,
          "text": "Propentofylline (PPF) can decrease vasculitis, and therefore prolong survival time in cats with FIP, and increase their quality of life.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22092616",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1423,
          "offsetInEndSection": 1535,
          "text": "Therefore, PPF does not appear to be an effective treatment option in cats with a late stage of the disease FIP.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22092616",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 393,
          "text": "Feline infectious peritonitis (FIP) is considered a fatal disease. Three cats with dry form FIP were treated with Polyprenyl Immunostimulant. Two of the three cats are still on treatment and are alive and well 2 years after diagnosis. The third cat survived 14 months but was treated for only 4.5 months. Further studies are necessary to assess the potential of the Polyprenyl Immunostimulant.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19482534",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 122,
          "text": "Effect of Polyprenyl Immunostimulant on the survival times of three cats with the dry form of feline infectious peritoniti",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19482534",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 310,
          "text": "Feline infectious peritonitis (FIP) is a highly fatal disease caused by a virulent feline coronavirus in domestic and wild cats. We have previously reported the synthesis of potent coronavirus 3C-like protease (3CLpro) inhibitors and the efficacy of a protease inhibitor, GC376, in client-owned cats with FIP. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/31585653",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 110,
          "text": "Combination siRNA therapy against feline coronavirus can delay the emergence of antiviral resistance in vitro.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25596968",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1780,
          "offsetInEndSection": 1867,
          "text": "these data inform the potential therapeutic application of antiviral RNAi against FIPV.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25596968",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 291,
          "offsetInEndSection": 474,
          "text": "We previously reported the successful in vitro inhibition of FIPV replication by synthetic siRNA mediated RNA interference (RNAi) in an immortalised cell line (McDonagh et al., 2011).",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25596968",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 108,
          "text": "Differential effects of viroporin inhibitors against feline infectious peritonitis virus serotypes I and II.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25701212",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 546,
          "offsetInEndSection": 643,
          "text": " However, it is not clear whether HMA and other viroporin inhibitors affect replication of FIPV. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25701212",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 644,
          "offsetInEndSection": 1010,
          "text": "e examined the effect of HMA and other viroporin inhibitors (DIDS [4,4'-disothiocyano-2,2'-stilbenedisulphonic acid] and amantadine) on infection by FIPV serotypes I and II. HMA treatment drastically decreased the titers of FIPV serotype I strains Black and KU-2 in a dose-dependent manner, but it only slightly decreased the titer of FIPV serotype II strain 79-1146",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25701212",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1012,
          "offsetInEndSection": 1206,
          "text": "In contrast, DIDS treatment decreased the titer of FIPV serotype II strain 79-1146 in dose-dependent manner, but it only slightly decreased the titers of FIPV serotype I strains Black and KU-2. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/25701212",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 118,
          "text": "Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027316",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1121,
          "offsetInEndSection": 1468,
          "text": "Here, we evaluated the therapeutic efficacy of our 3CLpro inhibitor in laboratory cats with FIP. Experimental FIP is 100% fatal once certain clinical and laboratory signs become apparent. We found that antiviral treatment led to full recovery of cats when treatment was started at a stage of disease that would be otherwise fatal if left untreated",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/27027316",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 98,
          "text": "Therapeutic effect of anti-feline TNF-alpha monoclonal antibody for feline infectious peritonitis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26850532",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 912,
          "offsetInEndSection": 1017,
          "text": "These results strongly suggested that the anti-fTNF-alpha antibody is effective for the treatment of FIP.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/26850532",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 147,
          "text": "Antiviral treatment using the adenosine nucleoside analogue GS-441524 in cats with clinically diagnosed neurological feline infectious peritonitis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32441826",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 1515,
          "offsetInEndSection": 1636,
          "text": "Treatment with GS-441524 shows clinical efficacy and may result in clearance and long-term resolution of neurological FIP",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32441826",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 213,
          "offsetInEndSection": 399,
          "text": "Mutian\u00ae Xraphconn (Mutian X) is a product marketed to treat cats with FIP but is also being used to stop virus shedding, although no clear guidelines exist for its use for this purpose. ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32220667",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 84,
          "text": "Oral Mutian\u00aeX stopped faecal feline coronavirus shedding by naturally infected cats.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32220667",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 181,
          "text": "Pharmacokinetic Profile of Oral Administration of Mefloquine to Clinically Normal Cats: A Preliminary In-Vivo Study of a Potential Treatment for Feline Infectious Peritonitis (FIP).",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32521771",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 218,
          "text": "The pharmacokinetic profile of mefloquine was investigated as a preliminary study towards a potential treatment for feline coronavirus infections (such as feline infectious peritonitis) or feline calicivirus infections",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32521771",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 918,
          "offsetInEndSection": 1033,
          "text": "Mefloquine may provide a safe effective treatment for feline coronavirus and feline calicivirus infections in cats.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32521771",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 638,
          "offsetInEndSection": 816,
          "text": "In conclusion, itraconazole partly exerted a beneficial effect in a cat with FIP. However, further investigation of a possible role of itraconazole in FIP treatment is warranted.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32848107",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 126,
          "text": "Clinical efficacy of combination therapy of itraconazole and prednisolone for treating effusive feline infectious peritonitis.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32848107",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 131,
          "text": "Efficacy and safety of the nucleoside analog GS-441524 for treatment of cats with naturally occurring feline infectious peritonitis",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30755068",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 199,
          "text": "The aim of this study was to determine the safety and efficacy of the nucleoside analog GS-441524 for cats suffering from various forms of naturally acquired feline infectious peritonitis",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30755068",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1800,
          "offsetInEndSection": 1940,
          "text": "S-441524 was shown to be a safe and effective treatment for FIP. The optimum dosage was found to be 4.0 mg/kg SC q24h for at least 12 weeks.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30755068",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 280,
          "offsetInEndSection": 485,
          "text": "This paper reports on the successful resolution of immunohistochemistry-confirmed effusive FIP in an adolescent cat in South Africa following monotherapy with remdesivir at 4.9-5.6 mg/kg daily for 80 days.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35934910",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1,
          "offsetInEndSection": 104,
          "text": "uccessful treatment of a South African cat with effusive feline infectious peritonitis with remdesivir.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35934910",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 318,
          "text": "BACKGROUND: Currently there is no drug proven to effectively treat cats with feline infectious peritonitis (FIP).HYPOTHESIS: Propentofylline (PPF) can decrease vasculitis, and therefore prolong survival time in cats with FIP, and increase their quality of life.ANIMALS: Twenty-three privately owned cats with FIP.METHO",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/22092616",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 181,
          "offsetInEndSection": 474,
          "text": "The aim of this study was to evaluate efficacy and toxicity of the multi-component drug Xraphconn\u00ae in vitro and as oral treatment in cats with spontaneous FIP by examining survival rate, development of clinical and laboratory parameters, viral loads, anti-FCoV antibodies, and adverse effects.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34835034",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 149,
          "text": "The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29778200",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 52,
          "offsetInEndSection": 202,
          "text": "fatal disease. Three cats with dry form FIP were treated with Polyprenyl Immunostimulant. Two of the three cats are still on treatment and are alive a",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/19482534",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 191,
          "offsetInEndSection": 341,
          "text": "ed, and most of the affected cats die or are euthanized. Anecdotally, doxycycline has been used to treat FIP-affected cats, but there are currently no",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33799985",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1427,
          "offsetInEndSection": 1577,
          "text": " and no relapse was observed.Conclusions and relevance: GS-441524 combined with GC376 can be safely and effectively used to treat FIP and reduces the ",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36387398",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 78,
          "offsetInEndSection": 228,
          "text": "ritonitis (FIP) were treated with a combination of recombinant feline interferon and glucocorticoid. A complete remission (over 2 years) and a partial",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/15123155",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1089,
          "offsetInEndSection": 1292,
          "text": "This study provides a proof of principle for the use of molnupiravir in cats and supports the need for future studies to further evaluate molnupiravir as a potentially safe and effective therapy for FIP.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36297266",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 337,
          "text": "Objectives: The main objectives of this study were to investigate the efficacy of the nucleotide analog GS-441524 in combination with the 3C-like protease inhibitor GC376 for the treatment of naturally aquired feline infectious peritonitis (FIP) and to test whether their combination shortens the dosing period and improves the cure rate",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36387398",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 882,
          "offsetInEndSection": 959,
          "text": "Our study suggested that HCQ and rfIFN-\u03c9 are applicable for treatment of FIP.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32456286",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 336,
          "text": "OBJECTIVES: The aim of this study was to determine the safety and efficacy of the nucleoside analog GS-441524 for cats suffering from various forms of naturally acquired feline infectious peritonitis (FIP).METHODS: Cats ranged from 3.4-73 months of age (mean 13.6 months); 26 had effusive or dry-to-effusive FIP and five had non-effusiv",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/30755068",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 102,
          "text": "Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524.",
          "beginSection": "title",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34835034",
          "endSection": "title"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 582,
          "text": "Feline infectious peritonitis (FIP) caused by feline coronavirus (FCoV) is a common dis-ease in cats, fatal if untreated, and no effective treatment is currently legally available. The aim of this study was to evaluate efficacy and toxicity of the multi-component drug Xraphconn\u00ae in vitro and as oral treatment in cats with spontaneous FIP by examining survival rate, development of clinical and laboratory parameters, viral loads, anti-FCoV antibodies, and adverse effects. Mass spectrometry and nuclear magnetic resonance identified GS-441524 as an active component of Xraphconn\u00ae.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34835034",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 394,
          "text": "Feline infectious peritonitis (FIP) is a common and highly lethal coronavirus disease of domestic cats. Recent studies of diseases caused by several RNA viruses in people and other species indicate that antiviral therapy may be effective against FIP in cats. The small molecule nucleoside analog GS-441524 is a molecular precursor to a pharmacologically active nucleoside triphosphate molecule.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/29778200",
          "endSection": "abstract"
        }
      ]
    },
    {
      "body": "Is there a way to distinguish COVID-19 clinically from other respiratory illnesses, such as influenza?",
      "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/32127123",
        "http://www.ncbi.nlm.nih.gov/pubmed/33135801",
        "http://www.ncbi.nlm.nih.gov/pubmed/36119462",
        "http://www.ncbi.nlm.nih.gov/pubmed/32881022",
        "http://www.ncbi.nlm.nih.gov/pubmed/34484383",
        "http://www.ncbi.nlm.nih.gov/pubmed/34226206",
        "http://www.ncbi.nlm.nih.gov/pubmed/33995342",
        "http://www.ncbi.nlm.nih.gov/pubmed/33615750",
        "http://www.ncbi.nlm.nih.gov/pubmed/32903584",
        "http://www.ncbi.nlm.nih.gov/pubmed/35412847"
      ],
      "ideal_answer": [
        "No, the clinical features of COVID-19 overlap substantially with influenza and other respiratory viral illnesses. There is no way to distinguish among them without testing.",
        "No, there isn't a definitive way to distinguish COVID-19 clinically from other respiratory illnesses, such as influenza, as they share many similar symptoms. Proper testing, such as PCR or antibody tests, is required for accurate diagnosis."
      ],
      "exact_answer": "no",
      "type": "yesno",
      "id": "6428da98690f196b51000053",
      "snippets": [
        {
          "offsetInBeginSection": 271,
          "offsetInEndSection": 574,
          "text": " Unfortunately, COVID-19 patients have symptoms similar to other common illnesses. Here, we hypothesize the order of symptom occurrence could help patients and medical professionals more quickly distinguish COVID-19 from other respiratory diseases, yet such essential information is largely unavailable.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32903584",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1275,
          "offsetInEndSection": 1382,
          "text": "No symptoms are characteristic of a single infectious agent, with flu-like disorders being the most common.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/36119462",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1227,
          "offsetInEndSection": 1563,
          "text": "We show that although COVID-19 and influenza are different in many ways, there are numerous similarities; thus, in addition to using nucleic acid-based polymerase chain reaction (PCR) and antibody-based approaches, clinicians and epidemiologists should distinguish between the two using their respective characteristics in early stages.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33615750",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 12,
          "offsetInEndSection": 210,
          "text": "An understanding of differences in clinical phenotypes and outcomes COVID-19 compared with other respiratory viral infections is important to optimise the management of patients and plan healthcare.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34226206",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1600,
          "offsetInEndSection": 1859,
          "text": "SARS-CoV-2 is associated with more severe outcomes compared with other respiratory viruses, and although associated with specific patient and clinical characteristics at admission, a substantial overlap precludes discrimination based on these characteristics.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34226206",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 272,
          "offsetInEndSection": 353,
          "text": "Unfortunately, COVID-19 patients have symptoms similar to other common illnesses.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32903584",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 168,
          "offsetInEndSection": 284,
          "text": "Clinical presentation of COVID-19, however, can be difficult to distinguish from other respiratory viral infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32881022",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 0,
          "offsetInEndSection": 177,
          "text": "It is difficult to distinguish coronavirus disease-2019 (COVID-19) from other viral respiratory tract infections owing to the similarities in clinical and radiological findings.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33135801",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 224,
          "offsetInEndSection": 370,
          "text": "Although COVID-19 has been extensively characterized clinically, the factors distinguishing SARS-CoV-2 from other respiratory viruses are unknown.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/33995342",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 297,
          "offsetInEndSection": 546,
          "text": " Since the symptoms are similar to other respiratory infections, differential diagnosis in travellers arriving from countries with wide-spread COVID-19 must include other more common infections such as influenza and other respiratory tract diseases.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32127123",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 167,
          "offsetInEndSection": 284,
          "text": " Clinical presentation of COVID-19, however, can be difficult to distinguish from other respiratory viral infections.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/32881022",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 1491,
          "offsetInEndSection": 1576,
          "text": "COVID-19 and flu are two respiratory illnesses which share similar clinical symptoms.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/35412847",
          "endSection": "abstract"
        },
        {
          "offsetInBeginSection": 700,
          "offsetInEndSection": 881,
          "text": "During influenza season, differentiating other causes of respiratory illness from COVID-19 is difficult, because common clinical manifestations of COVID-19 mimic those of influenza.",
          "beginSection": "abstract",
          "document": "http://www.ncbi.nlm.nih.gov/pubmed/34484383",
          "endSection": "abstract"
        }
      ]
    }
  ]
}